id,generic_name,company_name,contact_info,presentation,update_type,update_date,availability,related_info,resolved_note,reason_for_shortage,therapeutic_category,status,change_date,date_discontinued
2233,Abacavir Sulfate and Lamivudine Tablets,Teva Pharmaceuticals,800-545-8800,600 mg and 300 mg  (NDC 0093-5382-56),New,10/2/20,,,,,Antiviral,To be Discontinued,10/2/20,10/2/20
2234,Abciximab (ReoPro) Injection,"Janssen Biotech, Inc.",800-586-7736,2mg/mL (NDC 57894-200-01),Revised,8/15/19,,Janssen has made a business decision to discontinue manufacture of the drug product.,,,Cardiovascular,To be Discontinued,8/15/19,8/15/19
2235,Abiraterone Acetate Tablets,"Janssen Research and Development, LLC",800-526-7736,250 mg tablets (NDC 57894-155-12),New,6/5/20,,,,,Oncology,To be Discontinued,6/5/20,6/5/20
2236,Acarbose (Precose) Tablets,Bayer,888-842-2937,Bottles of 100 Tablets 25 mg (NDC 50419-863-51),New,2/1/19,,Business decision to discontinue marketing in the US.,,,Endocrinology/Metabolism,To be Discontinued,2/1/19,2/1/19
2237,Acarbose (Precose) Tablets,Bayer,888-842-2937,Bottles of 100 Tablets 50 mg (NDC 50419-861-51),New,2/1/19,,Business decision to discontinue marketing in the US.,,,Endocrinology/Metabolism,To be Discontinued,2/1/19,2/1/19
2238,Acarbose (Precose) Tablets,Bayer,888-842-2937,Bottles of 100 Tablets 100 mg (NDC 50419-862-51),New,2/1/19,,Business decision to discontinue marketing in the US.,,,Endocrinology/Metabolism,To be Discontinued,2/1/19,2/1/19
2239,Acarbose (Precose) Tablets,Bayer,888-842-2937,Unit Dose 50 mg (NDC 50419-861-48),New,2/1/19,,Business decision to discontinue marketing in the US.,,,Endocrinology/Metabolism,To be Discontinued,2/1/19,2/1/19
2240,Acetaminophen/Tramadol Hydrochloride (Ultracet) Tablets,Janssen Pharmaceuticals,800-526-7736,325 mg/1 unit || 37.5 mg/1 unit (NDC 50458-650-60),New,4/1/20,,"The Company has made a business decision to permanently discontinue Ultracet. Product should be maintained on the formularies until the last batch produced expires (31 Oct 2022), in order to maintain continuity of the reimbursement process.",,,Analgesia/Addiction,To be Discontinued,4/1/20,4/1/20
2241,Acrivastine and Pseudoephedrine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.",800-462-3636,"Semprex-D Capsules, 8 mg/ 60mg , 100 capsules, (NDC 52244-404-10)",New,6/2/20,,Endo has made a business decision to permanently discontinue the drug product.,,,Pulmonary/Allergy,To be Discontinued,6/2/20,6/2/20
2242,"Acyclovir Capsules, USP",Teva Pharmaceuticals,800-545-8800,"200 mg, 100 count (NDC 0093-8940-01)",New,3/21/19,,Teva made a business decision to discontinue product.,,,Antiviral,To be Discontinued,3/21/19,3/21/19
2243,"Acyclovir Capsules, USP",Teva Pharmaceuticals,800-545-8800,"200 mg, 500 count (NDC 0093-8940-05)",New,3/21/19,,Teva made a business decision to discontinue product.,,,Antiviral,To be Discontinued,3/21/19,3/21/19
2244,"Acyclovir Tablets, USP",Teva Pharmaceuticals,800-545-8800,"400 mg, 100 count (NDC 0093-8943-01)",New,3/21/19,,Teva made a business decision to discontinue product.,,,Antiviral,To be Discontinued,3/21/19,3/21/19
2245,"Acyclovir Tablets, USP",Teva Pharmaceuticals,800-545-8800,"400 mg, 500 count (NDC 0093-8943-05)",New,3/21/19,,Teva made a business decision to discontinue product.,,,Antiviral,To be Discontinued,3/21/19,3/21/19
2246,"Acyclovir Tablets, USP",Teva Pharmaceuticals,800-545-8800,"800 mg, 100 count (NDC 0093-8947-01)",New,3/21/19,,Teva made a business decision to discontinue product.,,,Antiviral,To be Discontinued,3/21/19,3/21/19
2247,"Acyclovir Tablets, USP",Teva Pharmaceuticals,800-545-8800,"800 mg, 500 count, (NDC 0093-8947-05)",New,3/21/19,,Teva made a business decision to discontinue product.,,,Antiviral,To be Discontinued,3/21/19,3/21/19
2248,Adalimumab (Humira) Pre-filled Syringe,Abbvie,800-255-5162,10 mg/0.2 mL pre-filled syringe (NDC 0074-6347-02),New,7/27/20,,The company has discontinued manufacture of these products based on a market assessment and product demand.,,,Dermatology;Gastroenterology;Ophthalmology;Rheumatology,To be Discontinued,7/27/20,7/27/20
2249,Adalimumab (Humira) Pre-filled Syringe,Abbvie,800-255-5162,20 mg/0.4 mL pre-filled syringe (NDC 0074-9374-02),New,7/27/20,,The company has discontinued manufacture of these products based on a market assessment and product demand.,,,Dermatology;Gastroenterology;Ophthalmology;Rheumatology,To be Discontinued,7/27/20,7/27/20
2250,Albuterol Sulfate and Ipratropium Bromide Inhalation Solution,Teva Pharmaceuticals,800-545-8800,0.3 mg mg/3 mL and 0.5 mg/3 mL (NDC 0591-3817-39),New,7/3/19,,This product discontinuation is a business related decision.,,,Pulmonary/Allergy,To be Discontinued,7/3/19,7/3/19
2251,Alfentanil Injection,"Hospira, Inc.",844-646-4398,1 mg/2 mL (500 mcg/mL) Glass Ampul (NDC 00409-2266-02),New,3/25/20,,Discontinuation of the manufacture of the drug. Current supply exhausted.,,,Analgesia/Addiction;Anesthesia,To be Discontinued,3/25/20,3/25/20
2252,Alfentanil Injection,"Hospira, Inc.",844-646-4398,2.5 mg/5 mL (500 mcg/mL) Glass Ampul (NDC 00409-2266-05),New,3/25/20,,Discontinuation of the manufacture of the drug. Current supply expected to deplete by May/June 2020 timeframe.,,,Analgesia/Addiction;Anesthesia,To be Discontinued,3/25/20,3/25/20
2253,Alogliptin Tablets,Perrigo Company PLC,269-673-8451,"12.5mg, 30 Tablets (NDC 45802-0103-65)",Revised,10/5/20,,,,,Endocrinology/Metabolism,Resolved,10/5/20,
2254,Alogliptin Tablets,Perrigo Company PLC,269-673-8451,"25mg, 30 Tablets (NDC 45802-0150-65)",Revised,10/5/20,,,,,Endocrinology/Metabolism,Resolved,10/5/20,
2255,Alogliptin Tablets,Perrigo Company PLC,269-673-8451,"6.25mg, 30 Tablets (NDC 45802-0087-65)",Revised,10/5/20,,,,,Endocrinology/Metabolism,Resolved,10/5/20,
2256,Alogliptin Tablets,Takeda Pharmaceuticals USA Inc.,877-825-3327,"6.25 mg, 30 Tablets (NDC 64764-625-30)",Revised,10/5/20,,,,,Endocrinology/Metabolism,Resolved,10/5/20,
2257,Alogliptin Tablets,Takeda Pharmaceuticals USA Inc.,877-825-3327,"12.5 mg, 30 Tablets (NDC 64764-125-30)",Revised,10/5/20,,,,,Endocrinology/Metabolism,Resolved,10/5/20,
2258,Alogliptin Tablets,Takeda Pharmaceuticals USA Inc.,877-825-3327,"25 mg, 30 Tablets (NDC 64764-250-30)",Revised,10/5/20,,,,,Endocrinology/Metabolism,Resolved,10/5/20,
2259,Amantadine Hydrochloride Capsules,Sandoz,800-525-8747,100 mg capsules  (NDCs 0781-2320-01 and 0781-2320-05),New,7/16/20,,,,,Antiviral;Neurology,To be Discontinued,7/16/20,7/16/20
2260,Amifostine Injection,"Clinigen, Inc.",877-776-5385,ETHYOL® (amifostine) for injection: 3 x 500 mg vials (NDC 76310-017-50),New,5/21/20,Shortage anticipated from June 2020; Estimated shortage duration:  Unknown,,,Other,Oncology;Other,Current,,
2261,Amino Acids,B. Braun Medical Inc.,800-227-2862,"15% Amino Acid (Plenamine) Pharmacy Bulk Package in 1,000 mL plastic container, catalog S4500, (NDC 0264-4500-00)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2262,Amino Acids,B. Braun Medical Inc.,800-227-2862,"15% Amino Acid (Plenamine) in 1,000mL glass container, catalog S3200-SS, (NDC 0264-3200-55)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,9/24/19
2263,Amino Acids,B. Braun Medical Inc.,800-227-2862,"10% FreAmine III (Amino Acid Injection) in 1,000mL glass container, catalog S9010-SS, (NDC 0264-9010-55)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2264,Amino Acids,B. Braun Medical Inc.,800-227-2862,"TrophAmine (10% Amino Acid Injection) in 500mL glass container, catalog S9341-SS, (NDC 0264-9341-55)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2265,Amino Acids,B. Braun Medical Inc.,800-227-2862,"TrophAmine (6% Amino Acid Injection) in 500mL glass container, catalog S9361-SS, (NDC 0264-9361-55)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2266,Amino Acids,"ICU Medical, Inc.",877-946-7747,"AMINOSYN™-PF 7%, Sulfite-Free, 500 mL (NDC 0409-4178-03)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2267,Amino Acids,"ICU Medical, Inc.",877-946-7747,"AMINOSYN II 10%, Sulfite-Free, (Pediatric Formula) 1000 mL (NDC 0409-4179-05)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2268,Amino Acids,"ICU Medical, Inc.",877-946-7747,Aminosyn II 10% Sulfite-Free BLK PK 2000 mL (NDC 0409-7172-17),Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2269,Amino Acids,"ICU Medical, Inc.",877-946-7747,Aminosyn II 15% Sulfite-Free BLK PK 2000 mL (NDC 0409-7171-17),Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2270,Amino Acids,Baxter Healthcare,888-229-0001,"PREMASOL - sulfite-free (Amino Acid) Injection in VIAFLEX Plastic Container. Pharmacy Bulk Package. Not for Direct Infusion.  Product Codes: 2B0009 10% 1000 mL (NDC 0338-1130-04), 2B0010 10% 2000 mL (NDC 0338-1130-06),
2B0012 10% 500 mL (NDC 0338-1130-03)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2271,Amino Acids,Baxter Healthcare,888-229-0001,"10% TRAVASOL (Amino Acid) Injection in VIAFLEX Plastic Container. Pharmacy Bulk Package. Not for Direct Infusion.  Product Codes: 1B6624 10% 1000 mL (NDC 0338-0644-04),
1B6623 10% 500 mL (NDC 0338-0644-03),
1B6626P 10% 2000 mL (NDC 0338-0644-06)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2272,Amino Acids,Baxter Healthcare,888-229-0001,"15% CLINISOL - sulfite-free (Amino Acid) Injection in VIAFLEX Plastic Container. Pharmacy Bulk Package. Not for Direct Infusion.  Product Codes: 2B6189 15% 2000 mL (NDC 0338-0502-06), 2B6187 15% 500 mL (NDC 0338-0502-03)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2273,Amino Acids,Baxter Healthcare,888-229-0001,"20% PROSOL - sulfite-free (Amino Acid) Injection, 2000 mL VIAFLEX Plastic Container. Pharmacy Bulk Package. Not for Direct Infusion.  Product Code 2B6186 (NDC 0338-0499-06)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2274,Amino Acids,Baxter Healthcare,888-229-0001,CLINIMIX E sulfite-free (Amino Acid with Electrolytes in Dextrose with Calcium) Injection in CLARITY Dual Chamber Container,Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2275,Amino Acids,Baxter Healthcare,888-229-0001,CLINIMIX sulfite-free (Amino Acid in Dextrose) Injection in CLARITY Dual Chamber Container,Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2276,Amino Acids,Baxter Healthcare,888-229-0001,SYNTHAMIN 17 without Electrolytes - 10% Amino Acids Intravenous Infusion 3000 mL. Product code FKB6642.  Pack factor 3  (NDC 0338-9575-03),Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2277,Amino Acids,Baxter Healthcare,888-229-0001,"CLINIMIX N9G15E-Solution for Infusion, 1000 mL (2.75% Amino Acid in 7.5% Glucose with Electrolytes). Product code FKB6669C - Pack factor of 8 (NDC 0338-9570-08)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2278,Amino Acids,Baxter Healthcare,888-229-0001,"CLINIMIX N9G20E-Solution for Infusion, 1000 mL  (2.75% Amino Acid in 10% Glucose with Electrolytes) Product code FKB6670C - Pack factor of 8 
(NDC 0338-9566-08)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2279,Amino Acids,Baxter Healthcare,888-229-0001,"CLINIMIX N14G30E-Solution for Infusion, 2000 mL (4.25% Amino Acid in 15% Dextrose with Electrolytes) Product code FKB6654V - Pack factor of 4 (NDC 0338-9587-04)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
2280,"Aminophylline Injection, USP","Hospira, Inc.",844-646-4398,250 mg/10mL (25 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-5921-01),Reverified,11/20/20,Available,,,Other,Pulmonary/Allergy,Current,,
2281,"Aminophylline Injection, USP","Hospira, Inc.",844-646-4398,500 mg/20mL (25 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-5922-01),Reverified,11/20/20,Available,,,Other,Pulmonary/Allergy,Current,,
2282,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 60 count bottle (NDC 0185-0144-60)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2283,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 90 count bottle (NDC 0185-0144-09)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2284,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 500 count bottle (NDC 0185-0144-05)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2285,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 400 mg, 500 count bottle (NDC 0245-0145-15)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2286,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 400 mg, 30 count bottle (NDC 0245-0145-30)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2287,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100 count bottle (NDC 0378-2610-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
2288,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 1000 count bottle (NDC 0378-2610-10)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
2289,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 100 count bottle (NDC 0378-2625-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
2290,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 1000 count bottle (NDC 0378-2625-10)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
2291,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 100 count bottle (NDC 0378-2650-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
2292,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 1000 count bottle (NDC 0378-2650-10)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
2293,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"75 mg, 100 count bottle (NDC 0378-2675-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
2294,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg, 100 count bottle (NDC 0378-2685-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
2295,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"150 mg, 100 count bottle (NDC 0378-2695-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
2296,Amlodipine Besylate and Benazepril Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,2.5 mg/10 mg (NDC 0093-7370-01),New,6/5/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,6/5/19,6/5/19
2297,Amlodipine Besylate and Benazepril Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,5 mg/10 mg (NDC 0093-7371-01),New,6/5/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,6/5/19,6/5/19
2298,Amlodipine Besylate and Benazepril Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,5 mg/20 mg (NDC 0093-7372-01),New,6/5/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,6/5/19,6/5/19
2299,Amlodipine Besylate and Benazepril Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,5 mg/40 mg (NDC 0093-7670-01),New,6/5/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,6/5/19,6/5/19
2300,Amlodipine Besylate and Benazepril Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,10 mg/20 mg (NDC 0093-7373-01),New,6/5/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,6/5/19,6/5/19
2301,Amlodipine Besylate and Benazepril Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,10 mg/40 mg (NDC 0093-7671-01),New,6/5/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,6/5/19,6/5/19
2302,Amlodipine Besylate and Olmesartan Medoxomil Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,5 mg/20 mg tablets (NDCs 0093-7027-56 and 0093-7027-98),New,3/11/19,,This product discontinuation is a business related decision.,,,Cardiovascular,To be Discontinued,3/11/19,3/11/19
2303,Amlodipine Besylate and Olmesartan Medoxomil Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,5 mg/40 mg tablets (NDCs 0093-7028-56 and 0093-7028-98),New,3/11/19,,This product discontinuation is a business related decision.,,,Cardiovascular,To be Discontinued,3/11/19,3/11/19
2304,Amlodipine Besylate and Olmesartan Medoxomil Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,10 mg/20 mg tablets (NDCs 0093-7029-56 and 0093-7029-98),New,3/11/19,,This product discontinuation is a business related decision.,,,Cardiovascular,To be Discontinued,3/11/19,3/11/19
2305,Amlodipine Besylate and Olmesartan Medoxomil Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,10 mg/20 mg tablets (NDCs 0093-7030-56 and 0093-7030-98),New,3/11/19,,This product discontinuation is a business related decision.,,,Cardiovascular,To be Discontinued,3/11/19,3/11/19
2306,Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 tablets (NDC 0591-5714-01)",Reverified,11/19/20,Available,,,,Psychiatry,Current,3/9/20,
2307,Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"25 mg, 100 tablets (NDC 0591-5713-01)",Reverified,11/19/20,On backorder,Recovery March 2021,,Other,Psychiatry,Current,3/9/20,
2308,Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"100 mg, 100 tablets (NDC 0591-5715-01)",Reverified,11/19/20,Available,,,,Psychiatry,Current,3/9/20,
2309,Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"150 mg, 100 tablets (NDC 0591-5716-01)",Reverified,11/19/20,Available,,,,Psychiatry,Current,3/9/20,
2310,Amoxicillin Powder for Suspension,Teva Pharmaceuticals,800-545-8800,"125 mg/5 mL powder for suspension (NDCs 0093-4150-73, 0093-4150-79 and 0093-4150-80)",New,6/3/19,,This product discontinuation is a business related decision.,,,Anti-Infective,To be Discontinued,6/3/19,6/3/19
2311,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"5 mg, 100 Count Bottle (NDC 68382-950-01)",Reverified,10/13/20,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
2312,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"7.5 mg, 100 Count Bottle (NDC 68382-951-01)",Reverified,10/13/20,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
2313,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"10 mg, 100 Count Bottle (NDC 68382-952-01)",Reverified,10/13/20,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
2314,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"12.5 mg, 100 Count Bottle (NDC 68382-953-01)",Reverified,10/13/20,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
2315,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"15 mg, 100 Count Bottle (NDC 68382-954-01)",Reverified,10/13/20,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
2316,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"20 mg, 100 Count Bottle (NDC 68382-955-01)",Reverified,10/13/20,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
2317,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"30 mg, 100 Count Bottle (NDC 68382-956-01)",Reverified,10/13/20,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
2318,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"30 mg, 100 Count Bottle (NDC 0185-0864-01)",Reverified,11/13/20,Available,,,Demand increase for the drug,Psychiatry,Current,,
2319,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"20 mg, 100 Count Bottle (NDC 0185-0853-01)",Reverified,11/13/20,Available,,,Demand increase for the drug,Psychiatry,Current,,
2320,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"10 mg, 100 Count Bottle (NDC 0185-0842-01)",Reverified,11/13/20,Available,,,Demand increase for the drug,Psychiatry,Current,,
2321,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"5 mg, 100 Count Bottle (NDC 0185-0831-01)",Reverified,11/13/20,Available,,,Demand increase for the drug,Psychiatry,Current,,
2322,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 10mg 100 (NDC 57844-0110-01),Reverified,11/19/20,Available,,,,Psychiatry,Current,,
2323,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 12.5mg 100 (NDC 57844-0112-01),Reverified,11/19/20,Available,,,,Psychiatry,Current,,
2324,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 15mg 100 (NDC 57844-0115-01),Reverified,11/19/20,Available,,,,Psychiatry,Current,,
2325,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 20mg 100 (NDC 57844-0120-01),Reverified,11/19/20,Available,,,,Psychiatry,Current,,
2326,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 30mg 100 (NDC 57844-0130-01),Reverified,11/19/20,Available,,,Other,Psychiatry,Current,,
2327,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 5mg 100 (NDC 57844-0105-01),Reverified,11/19/20,Available,,,,Psychiatry,Current,,
2328,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 7.5mg 100 (NDC 57844-0117-01),Reverified,11/19/20,Available,,,Other,Psychiatry,Current,,
2329,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,5mg [1.25/1.25/1.25/1.25mg] 100s (NDC 0378-4541-01),Reverified,11/10/20,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
2330,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,7.5mg [1.875/1.875/1.875/1.875mg] 100s (NDC 0378-4542-01),Reverified,11/10/20,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
2331,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10mg [2.5/2.5/2.5/2.5mg] 100s (NDC 0378-4543-01),Reverified,11/10/20,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
2332,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,12.5mg [3.125/3.125/3.125/3.125mg] 100s (NDC 0378-4544-01),Reverified,11/10/20,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
2333,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,15mg [3.75/3.75/3.75/3.75mg] 100s (NDC 0378-4545-01),Reverified,11/10/20,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
2334,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,20mg [5/5/5/5mg] 100s (NDC 0378-4546-01),Reverified,11/10/20,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
2335,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,30mg [7.5/7.5/7.5/7.5mg] 100s (NDC 0378-4547-01),Reverified,11/10/20,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
2336,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 5 mg, 100 (NDC 13107-0068-01)",Reverified,9/25/20,Available,,,Demand increase for the drug,Psychiatry,Current,,
2337,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 10 mg, 100 (NDC 13107-0070-01)",Reverified,9/25/20,Available,,,Demand increase for the drug,Psychiatry,Current,,
2338,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 15 mg, 100 (NDC 13107-0072-01)",Reverified,9/25/20,Available,,,Demand increase for the drug,Psychiatry,Current,,
2339,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 20 mg, 100 (NDC 13107-0073-01)",Reverified,9/25/20,Available,,,Demand increase for the drug,Psychiatry,Current,,
2340,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 30 mg, 100 (NDC 13107-0074-01)",Reverified,9/25/20,Available,,,Demand increase for the drug,Psychiatry,Current,,
2341,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,12.5  mg 100 count (NDC 0555-0776-02),Reverified,11/19/20,Available,,,,Psychiatry,Current,,
2342,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,15  mg 100 count (NDC 0555-0777-02),Reverified,11/19/20,Available,,,,Psychiatry,Current,,
2343,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,7.5  mg 100 count (NDC 0555-0775-02),Reverified,11/19/20,Available,,,,Psychiatry,Current,,
2344,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,10  mg 100 count (NDC 0555-0972-02),Reverified,11/19/20,Available,,,,Psychiatry,Current,,
2345,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,20 mg 100 count (NDC 0555-0973-02),Reverified,11/19/20,Available,,,,Psychiatry,Current,,
2346,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,30 mg 100 count (NDC 0555-0974-02),Reverified,11/19/20,Available,,,,Psychiatry,Current,,
2347,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,5 mg 100 count (NDC 0555-0971-02),Reverified,11/19/20,Available,,,,Psychiatry,Current,,
2348,Anagrelide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,1 MG 100 Capsules (NDC 0172-5240-60),Reverified,11/19/20,"Limited inventory, on allocation",,,Requirements related to complying with good manufacturing practices,Hematology,Current,,
2349,Anagrelide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,0.5 MG 100 Capsules (NDC 0172-5241-60),Reverified,11/19/20,"Limited inventory, on allocation",,,Requirements related to complying with good manufacturing practices,Hematology,Current,,
2350,Anagrelide Hydrochloride Capsules,Shire US Inc. now part of Takeda,800-828-2088,"AGRYLIN 0.5 mg Capsule,100 capsules in 1 bottle (NDC 54092-063-01)",Reverified,10/27/20,Available,Takeda is actively working to mitigate a recent unexpected increase in demand for the product.,,Demand increase for the drug,Hematology,Current,,
2351,Anagrelide Hydrochloride Capsules,Torrent Pharma Inc.,908-280-3333,0.5 mg per capsule Bottles of 100 (NDC 13668-453-01),Reverified,9/14/20,Available and shipping,,,Requirements related to complying with good manufacturing practices,Hematology,Current,,
2352,Anagrelide Hydrochloride Capsules,Torrent Pharma Inc.,908-280-3333,"1 mg per capsule, Bottles of 100 (NDC 13668-462-01)",Reverified,9/14/20,Available and shipping,,,Requirements related to complying with good manufacturing practices,Hematology,Current,,
2353,Anastrozole Tablets,Apotex Corp.,800-706-5575,1 mg tablets (NDC 60505-2985-3),New,1/21/20,,,,,Oncology,To be Discontinued,1/21/20,1/21/20
2354,Argatroban Injection,Novartis,888-669-6682,"250 mg/2.5 mL (100 mg/mL), single dose vial (NDC 0078-0930-61)",New,1/15/20,,"Novartis Pharmaceuticals has made a business decision to permanently discontinue the product Argatroban Injection, Vial 250 mg/2.5 mL.",,,Hematology,To be Discontinued,1/15/20,1/15/20
2355,Asparaginase Erwinia Chrysanthemi (Erwinaze),"Jazz Pharmaceuticals, Inc.",800-520-5568,"ERWINAZE 10,000 IU lyophilized powder supplied in a clear 3 mL glass vial 5 vial carton (NDC 57902-249-05)",Revised,11/6/20,Available,,,Other,Hematology;Oncology;Pediatric,Current,,
2356,Asparaginase Erwinia Chrysanthemi (Erwinaze),"Jazz Pharmaceuticals, Inc.",800-520-5568,"ERWINAZE 10,000 IU lyophilized powder supplied in a clear 3 mL glass vial 1 vial (NDC 57902-249-01)",Revised,11/6/20,Available,,,Other,Hematology;Oncology;Pediatric,Current,,
2357,Aspirin/Dipyridamole (Aggrenox) Extended Release Capsules,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,25mg/200mg capsules (NDC 0597-0001-60),New,5/26/20,,"Business decision made by the applicant, BIPI. BIPI will no longer be supplying the market with AGGRENOX capsules after June 11, 2020.",,,Cardiovascular,To be Discontinued,5/26/20,5/26/20
2358,"Atracurium Besylate Injection, USP",Mylan Institutional,800-796-9526,"10 mg/mL, 10 mL, 10PK (NDC 67457-698-10)",New,9/24/19,,,,,Anesthesia,To be Discontinued,9/24/19,9/24/19
2359,"Atracurium Besylate Injection, USP",Mylan Institutional,800-796-9526,"10 mg/mL, 5 mL, 10 PK (NDC 67457-699-05)",New,9/24/19,,,,,Anesthesia,To be Discontinued,9/24/19,9/24/19
2360,Atropine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,8 mg per 20 mL (0.4 mg per mL); MDV; (NDC 63323-580-20),Reverified,11/16/20,Available,Check wholesaler inventory,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
2361,Atropine Sulfate Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"0.1 mg/mL; 10 mL Luer-Jet Prefilled Syringe (NDC 76329-3339-1, Old NDC 0548-3339-00)",Reverified,10/30/20,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
2362,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,"1 mg/10 mL (0.1 mg/mL); Ansyr Plastic Syringe
(NDC 0409-1630-10)",Reverified,11/20/20,Limited Supply Available. Next Delivery: December 2020; Estimated Recovery: March 2021,,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
2363,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,"0.25 mg/5 mL (0.05 mg/mL); Ansyr Plastic Syringe
(NDC 0409-9630-05)",Reverified,11/20/20,Available,,,Other,Anesthesia;Neurology;Pediatric,Current,,
2364,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,0.5 mg/5 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4910-34),Reverified,11/20/20,Available,,,Other,Anesthesia;Neurology;Pediatric,Current,,
2365,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,"1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4911-34, pack of 10; NDC 0409-4911-11, individual)",Reverified,11/20/20,Available,,,Other,Anesthesia;Neurology;Pediatric,Current,,
2366,Atropine Sulfate Injection,American Regent/Luitpold,800-645-1706,"1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-1010-25)",Revised,7/10/20,Limited Availability,"American Regent is currently releasing the 1mg/mL, 1 mL vial, (NDC 00517-1010-25)",,Other,Anesthesia;Neurology;Pediatric,Current,,
2367,Atropine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.4 mg/mL, 20 mL vial (NDC 0641-6006-10)",Revised,8/20/20,Available,,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
2368,Atropine Sulfate Injection,American Regent/Luitpold,800-645-1706,"0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-0401-25)",Revised,7/10/20,Limited availability,"American Regent is currently releasing the 0.4mg/mL, 1 mL vial, NDC 00517-0401-25",,Other,Anesthesia;Neurology;Pediatric,Current,,
2369,Atropine Sulfate Ophthalmic Ointment,Bausch Health,800-321-4576,"1% (10 mg/g), 3.5 g tube (NDC 24208-825-55)",Revised,7/22/20,Availability limited to product already in pharmacies until resumption of manufacturing in the second half of 2020,Currently qualifying alternate supplier of inactive ingredient,,Shortage of an inactive ingredient,Ophthalmology,Current,,
2370,Avelox® (moxifloxacin HCl) Tablets,Bayer,888-842-2937,Bottles of 30 Tablets (NDC 50419-530-01),New,2/1/19,,Business decision to discontinue marketing in the US.,,,Anti-Infective,To be Discontinued,2/1/19,2/1/19
2371,"AVYCAZ® (ceftazidime and avibactam) for Injection, 2 grams/0.5 grams",Allergan Sales LLC,800-678-1605,"2 g/1, .5 g/1 powder for solution 1 Single-use vials (NDC 0456-2700-01)",New,2/26/20,Currently unavailable.  Duration of the shortage is yet to be determined.,,,Other,Anti-Infective,Current,,
2372,"AVYCAZ® (ceftazidime and avibactam) for Injection, 2 grams/0.5 grams",Allergan Sales LLC,800-678-1605,"2 g/1, .5 g/1 powder for solution Carton containing 10 vials  (NDC 0456-2700-10)",New,2/26/20,Currently unavailable.  Duration of the shortage is yet to be determined.,,,Other,Anti-Infective,Current,,
2373,Azacitidine Injection,Teva Pharmaceuticals,800-545-8800,100 mg/1 unit (NDC 0591-2897-49),New,10/30/19,,The product has not been marketed for an extended period of time. Teva made a business decision to discontinue this product.,,,Oncology,To be Discontinued,10/30/19,10/30/19
2374,Azithromycin (Azasite) Ophthalmic Solution 1%,Akorn Pharmaceuticals,800-932-5676,Azasite (Azithromycin Ophthalmic Solution) 1% 2.5 mL in 5 mL bottle (NDC 17478-307-03),Revised,9/11/19,,,,,Ophthalmology,Resolved,9/11/19,
2375,Azithromycin Tablets,Aurobindo Pharma,732-839-9400,250mg 6x3 Blister Pack/ Carton (NDC 65862064163),Reverified,10/2/20,Available,,,,Anti-Infective,Current,,
2376,Azithromycin Tablets,Lupin,866-587-4617,250 mg – Carton of 3 Blister Cards (6 Tablets per Blister Card) (NDC  6818016013),Reverified,10/2/20,Available,,,,Anti-Infective,Current,,
2377,Azithromycin Tablets,Pfizer Pharmaceuticals,800-533-4535,Zithromax 250 mg tablets; Unit Dose package of 50 (NDC 0069-4061-89),Reverified,11/20/20,Available,,,Demand increase for the drug,Anti-Infective,Current,,
2378,Azithromycin Tablets,Pfizer Pharmaceuticals,800-533-4535,Zithromax 500 mg tablets; Unit Dose package of 50 (NDC 0069-3070-86),Reverified,11/20/20,Available,,,Demand increase for the drug,Anti-Infective,Current,,
2379,Azithromycin Tablets,Pfizer Pharmaceuticals,800-533-4535,Zithromax 250 mg tablets; bottle of 30 (NDC 0069-3060-30),Reverified,11/20/20,Available,,,Demand increase for the drug,Anti-Infective,Current,,
2380,Azithromycin Tablets,Pfizer Pharmaceuticals,800-533-4535,Zithromax 250 mg tablets; boxes of 3 (Z-PAKS of 6) (NDC 0069-3060-75),Reverified,11/20/20,Available,,,Demand increase for the drug,Anti-Infective,Current,,
2381,Azithromycin Tablets,Pfizer Pharmaceuticals,800-533-4535,Zithromax 500 mg tablets; bottles of 30 (NDC 0069-3070-30),Reverified,11/20/20,Available,,,Demand increase for the drug,Anti-Infective,Current,,
2382,Azithromycin Tablets,Pfizer Pharmaceuticals,800-533-4535,Zithromax 500 mg tablets; boxes of 3 (TRI-PAKS of 3 tablets) (NDC 0069-3070-75),Reverified,11/20/20,Available,,,Demand increase for the drug,Anti-Infective,Current,,
2383,Azithromycin Tablets,Pfizer Pharmaceuticals,800-533-4535,250 mg tablets; Blister of 3x6 (NDC 59762-2198-3),Reverified,11/20/20,Available,,,Demand increase for the drug,Anti-Infective,Current,,
2384,Azithromycin Tablets,Pfizer Pharmaceuticals,800-533-4535,250 mg tablets; Bottle of 30 (NDC 59762-2198-7),Reverified,11/20/20,Available,,,Demand increase for the drug,Anti-Infective,Current,,
2385,Azithromycin Tablets,Sandoz,800-525-8747,600 mg 30 count bottle (NDC 0781-5793-31),Reverified,11/13/20,Available,,,,Anti-Infective,Current,,
2386,Azithromycin Tablets,Sandoz,800-525-8747,500 mg 30 count bottle (NDC 0781-8090-31),Reverified,11/13/20,Available,,,,Anti-Infective,Current,,
2387,Azithromycin Tablets,Sandoz,800-525-8747,500 mg 3 count unit dose (NDC 0781-8090-03),Reverified,11/13/20,Available,,,,Anti-Infective,Current,,
2388,Azithromycin Tablets,Sandoz,800-525-8747,250 mg 30 count bottle (NDC 0781-8089-31),Reverified,11/13/20,Available,,,,Anti-Infective,Current,,
2389,Azithromycin Tablets,Sandoz,800-525-8747,250 mg 6 count unit dose (NDC 0781-8089-26),Reverified,11/13/20,Available,,,,Anti-Infective,Current,,
2390,Azithromycin Tablets,CSPC Ouyi Pharmaceutical Co. Ltd.,609-356-0210,"600 mg, 30/bottle (NDC 51224-222-30)",Revised,8/20/20,Available,"Distributed by TAGI Pharma Inc at 1-815-624-7685, or Toll-free 1-855-225-8244",,Demand increase for the drug,Anti-Infective,Current,,
2391,Azithromycin Tablets,CSPC Ouyi Pharmaceutical Co. Ltd.,609-356-0210,"500 mg, 30/bottle (NDC 51224-122-30)",Revised,8/20/20,Available,"Distributed by TAGI Pharma Inc at 1-815-624-7685, or Toll-free 1-855-225-8244",,Demand increase for the drug,Anti-Infective,Current,,
2392,Azithromycin Tablets,CSPC Ouyi Pharmaceutical Co. Ltd.,609-356-0210,"250 mg, 30/bottle (NDC 51224-022-30)",Revised,8/20/20,Available,"Distributed by TAGI Pharma Inc at 1-815-624-7685, or Toll-free 1-855-225-8244",,Demand increase for the drug,Anti-Infective,Current,,
2393,Azithromycin Tablets,CSPC Ouyi Pharmaceutical Co. Ltd.,609-356-0210,"500 mg, Cartons of 1 blister card, 3 tablets per blister card (NDC 51224-122-03)",Revised,8/20/20,Available,"Distributed by TAGI Pharma Inc at 1-815-624-7685, or Toll-free 1-855-225-8244",,Demand increase for the drug,Anti-Infective,Current,,
2394,Azithromycin Tablets,CSPC Ouyi Pharmaceutical Co. Ltd.,609-356-0210,"500 mg, Cartons of 3 blister card, 3 tablets per blister card (NDC 51224-122-09)",Revised,8/20/20,Available,"Distributed by TAGI Pharma Inc at 1-815-624-7685, or Toll-free 1-855-225-8244",,Demand increase for the drug,Anti-Infective,Current,,
2395,Azithromycin Tablets,CSPC Ouyi Pharmaceutical Co. Ltd.,609-356-0210,"250 mg, Cartons of 1 blister card, 6 tablets per blister card (NDC 51224-022-06)",Revised,8/20/20,Available,"Distributed by TAGI Pharma Inc at 1-815-624-7685, or Toll-free 1-855-225-8244",,Demand increase for the drug,Anti-Infective,Current,,
2396,Azithromycin Tablets,CSPC Ouyi Pharmaceutical Co. Ltd.,609-356-0210,"250 mg, Cartons of 3 blister cards, 6 tablets per blister card (NDC 51224-022-18)",Revised,8/20/20,Available,"Distributed by TAGI Pharma Inc at 1-815-624-7685, or Toll-free 1-855-225-8244",,Demand increase for the drug,Anti-Infective,Current,,
2397,Azithromycin Tablets,Teva Pharmaceuticals,800-545-8800,250  mg 30 count (NDC 50111-787-10),Reverified,11/19/20,Available,,,,Anti-Infective,Current,,
2398,Azithromycin Tablets,Teva Pharmaceuticals,800-545-8800,250  mg 6 x 1 blister pack (NDC 50111-787-51),Reverified,11/19/20,Available,,,,Anti-Infective,Current,,
2399,Azithromycin Tablets,Teva Pharmaceuticals,800-545-8800,500  mg 3 x 1 blister pack (NDC 50111-788-55),Reverified,11/19/20,Available,,,,Anti-Infective,Current,,
2400,Azithromycin Tablets,Teva Pharmaceuticals,800-545-8800,500  mg 30 count (NDC 50111-788-10),Reverified,11/19/20,Available,,,,Anti-Infective,Current,,
2401,Azithromycin Tablets,Teva Pharmaceuticals,800-545-8800,600  mg 30 count (NDC 50111-789-10),Reverified,11/19/20,Available,,,,Anti-Infective,Current,,
2402,Azithromycin Tablets,Teva Pharmaceuticals,800-545-8800,250  mg 18 3 x 6 blister pack (NDC 50111-787-66),Reverified,11/19/20,Available,,,Demand increase for the drug,Anti-Infective,Current,,
2403,Azithromycin Tablets,Teva Pharmaceuticals,800-545-8800,500  mg 3 x 3 blister pack (NDC 50111-788-67),Reverified,11/19/20,Available,,,,Anti-Infective,Current,,
2404,Azithromycin Tablets,Wockhardt,800-346-6859,250 MG 3X6T (NDC 64679-0961-05),Reverified,4/23/20,Unavailable,,,Requirements related to complying with good manufacturing practices & demand increase for the drug,Anti-Infective,Current,,
2405,Azithromycin Tablets,Wockhardt,800-346-6859,250 mg 30T (NDC 64679-961-01),Reverified,4/23/20,Unavailable,,,Requirements related to complying with good manufacturing practices & demand increase for the drug,Anti-Infective,Current,,
2406,Azithromycin Tablets,Wockhardt,800-346-6859,250 mg Unit dose package of 100  (NDC 64679-961-02),Reverified,4/23/20,Unavailable,,,Requirements related to complying with good manufacturing practices & demand increase for the drug,Anti-Infective,Current,,
2407,Azithromycin Tablets,Wockhardt,800-346-6859,250 mg Cartons of 3 blister cards (6 tablets per blister card) (NDC 64679-961-05),Reverified,4/23/20,Unavailable,,,Requirements related to complying with good manufacturing practices & demand increase for the drug,Anti-Infective,Current,,
2408,Azithromycin Tablets,Wockhardt,800-346-6859,250 mg 500-ct bottle (NDC 64679-961-07),Reverified,4/23/20,Unavailable,,,Requirements related to complying with good manufacturing practices & demand increase for the drug,Anti-Infective,Current,,
2409,Azithromycin Tablets,Wockhardt,800-346-6859,"500 mg 500 mg, 30T (NDC 64679-0964-01)",Reverified,4/23/20,Unavailable,,,Requirements related to complying with good manufacturing practices & demand increase for the drug,Anti-Infective,Current,,
2410,Azithromycin Tablets,Wockhardt,800-346-6859,"500 mg 500 mg, 3X3T (NDC 64679-0964-05)",Reverified,4/23/20,Unavailable,,,Requirements related to complying with good manufacturing practices & demand increase for the drug,Anti-Infective,Current,,
2411,Azithromycin Tablets,Wockhardt,800-346-6859,500 mg Unit dose package of 100  (NDC 64679-964-02),Reverified,4/23/20,Unavailable,,,Requirements related to complying with good manufacturing practices & demand increase for the drug,Anti-Infective,Current,,
2412,Azithromycin Tablets,Wockhardt,800-346-6859,500 mg Cartons of 3 blister cards (3 tablets per blister card) (NDC 64679-964-05),Reverified,4/23/20,Unavailable,,,Requirements related to complying with good manufacturing practices & demand increase for the drug,Anti-Infective,Current,,
2413,Azithromycin Tablets,Wockhardt,800-346-6859,500 mg 500-ct bottle (NDC 64679-964-07),Reverified,4/23/20,Unavailable,,,Requirements related to complying with good manufacturing practices & demand increase for the drug,Anti-Infective,Current,,
2414,Azithromycin Tablets,Wockhardt,800-346-6859,600 mg Bottles of 30 (NDC 64679-962-01),Reverified,4/23/20,Unavailable,,,Requirements related to complying with good manufacturing practices & demand increase for the drug,Anti-Infective,Current,,
2415,Azithromycin Tablets,Bionpharma Inc.,888-611-2466,250 mg bottles of 30 (NDC 69452-171-13),Revised,8/20/20,Available,,,,Anti-Infective,Current,,
2416,Azithromycin Tablets,Bionpharma Inc.,888-611-2466,250 mg Carton of 6 (1 Card of 6 Tablets) (NDC 69452-171-04),Revised,8/20/20,Available,,,,Anti-Infective,Current,,
2417,Azithromycin Tablets,Bionpharma Inc.,888-611-2466,250 mg Carton of 18 (3 Cards of 6 Tablets) (NDC 69452-171-73),Revised,8/20/20,Available,,,,Anti-Infective,Current,,
2418,Azithromycin Tablets,Bionpharma Inc.,888-611-2466,500 mg bottles of 30 (NDC 69452-172-13),Revised,8/20/20,Available,,,,Anti-Infective,Current,,
2419,Azithromycin Tablets,Bionpharma Inc.,888-611-2466,500 mg Carton of 3 (1 Card of 3 Tablets) (NDC 69452-172-74),Revised,8/20/20,Available,,,,Anti-Infective,Current,,
2420,Azithromycin Tablets,Bionpharma Inc.,888-611-2466,500 mg Carton of 9 (3 Cards of 3 Tablets) (NDC 69452-172-72),Revised,8/20/20,Available,,,,Anti-Infective,Current,,
2421,Azithromycin Tablets,Alembic Pharmaceuticals,908-393-9604,250 mg bottles of 30 (NDC 62332-251-30),Revised,8/21/20,Available,,,Other,Anti-Infective,Current,,
2422,Azithromycin Tablets,Alembic Pharmaceuticals,908-393-9604,250 mg carton of 3 blister cards (6 tablets per blister card) (NDC 62332-251-06),Revised,8/21/20,Available,,,Other,Anti-Infective,Current,,
2423,Azithromycin Tablets,Alembic Pharmaceuticals,908-393-9604,500 mg bottle of 30 (NDC 62332-252-30),Revised,8/21/20,Available,,,Other,Anti-Infective,Current,,
2424,Azithromycin Tablets,Alembic Pharmaceuticals,908-393-9604,500 mg carton of 3 blister cards (3 tablets per blister card) (NDC 62332-252-03),Revised,8/21/20,Available,,,Other,Anti-Infective,Current,,
2425,Azithromycin Tablets,HEC Pharm USA Inc.,267-348-3664,500 mg carton of 1 blister card (3 tablets per blister card) (NDC 0527-2750-17),New,4/22/20,Available,"HEC and its distributor Lannett Company, Inc. in conjunction with FDA has initiated a temporary importation of German approved Azithromycin tablets into the U.S. market to address drug shortage. To place an order, please contact Lannett at (215) 333-9000.",,,Anti-Infective,Current,,
2426,Azithromycin Tablets,Aurobindo Pharma,732-839-9400,500mg 1x3 Blister Pack/Carton (NDC 65862064264),Revised,8/20/20,Available,,,,Anti-Infective,Current,,
2427,Azithromycin Tablets,Lupin,866-587-4617,250 mg Bottle of 30’s (NDC 6818016006),Reverified,10/2/20,Available,,,,Anti-Infective,Current,,
2428,Azithromycin Tablets,Lupin,866-587-4617,500 mg Carton of 3 Blister Cards (3 Tablets per Blister Card) (NDC 6818016113),Reverified,10/2/20,Available,,,,Anti-Infective,Current,,
2429,Azithromycin Tablets,Lupin,866-587-4617,"Azithromycin Tablets, 500 mg Bottle of 30's (NDC 6818016106)",Reverified,10/2/20,Available,,,,Anti-Infective,Current,,
2430,Azithromycin Tablets,Lupin,866-587-4617,"Azithromycin Tablets, 600 mg Bottle of 30’s (NDC 6818016206)",Reverified,10/2/20,Available,,,,Anti-Infective,Current,,
2431,Azithromycin Tablets,Aurobindo Pharma,732-839-9400,250mg 30 count bottles (NDC 65862064130),Reverified,10/2/20,Available,,,,Anti-Infective,Current,,
2432,Azithromycin Tablets,Aurobindo Pharma,732-839-9400,250mg 1x6 Blister Pack/ Carton (NDC 65862064169),Reverified,10/2/20,Available,,,,Anti-Infective,Current,,
2433,Azithromycin Tablets,Aurobindo Pharma,732-839-9400,500mg 3x3 Blister Pack/ Carton (NDC 65862064290),Revised,8/20/20,Available,,,,Anti-Infective,Current,,
2434,Azithromycin Tablets,Aurobindo Pharma,732-839-9400,500mg 30 count bottles (NDC 65862064230),Revised,8/20/20,Available,,,,Anti-Infective,Current,,
2435,Bacitracin Ophthalmic Ointment,Perrigo Pharmaceuticals,866-634-9120,Bacitracin Ophthalmic Ointment 3.5 g (NDC 0574-4022-35),Revised,4/29/20,,,Available,,Ophthalmology,Resolved,4/29/20,
2436,Belatacept (Nulojix) Lyophilized Powder for Injection,Bristol Myers Squibb Co.,800-721-5072 ; 877-417-1523,20cc vial 250mg lyophilized powder per vial for IV infusion (NDC 0003-0371-13),Reverified,12/16/19,"No disruption to existing patients is anticipated. Until further notice, BMS will continue to limit distribution of NULOJIX via the US NULOJIX Distribution Program, initiated 15-Feb-2017. Starting in August 2018, the restrictions of the NDP will be eased to allow for expansion of use to appropriate new patients if the treating physician determines that Nulojix is the best treatment option for the patient.  For further information, contact BMS Medical Information.",Increased demand for the drug exacerbated by a delay in transition to a more efficient manufacturing process.,,Demand increase for the drug,Transplant,Current,,
2437,Benzyl Alcohol (Ulesfia) Lotion 5%,Shionogi Inc.,800-849-9707,Ulesfia (benzyl alcohol) lotion 5% (50 mg/g of lotion) Bottles (NDC 69202-780-08),New,9/18/19,,"Business decision to discontinue marketing in the US. This product discontinuation is not related to product quality, safety, or efficacy.",,,Dermatology,To be Discontinued,9/18/19,9/18/19
2438,Benzyl Alcohol (Ulesfia) Lotion 5%,Shionogi Inc.,800-849-9707,Ulesfia (benzyl alcohol) lotion 5% (50 mg/g of lotion) Bottles (NDC 69202-780-88),New,9/18/19,,"Business decision to discontinue marketing in the US. This product discontinuation is not related to product quality, safety, or efficacy.",,,Dermatology,To be Discontinued,9/18/19,9/18/19
2439,Benzyl Alcohol (Ulesfia) Lotion 5%,Shionogi Inc.,800-849-9707,Ulesfia (benzyl alcohol) lotion 5% (50 mg/g of lotion) Bottles (NDC 23594-780-08),New,9/18/19,,"Business decision to discontinue marketing in the US. This product discontinuation is not related to product quality, safety, or efficacy.",,,Dermatology,To be Discontinued,9/18/19,9/18/19
2440,Benzyl Alcohol (Ulesfia) Lotion 5%,Shionogi Inc.,800-849-9707,Ulesfia (benzyl alcohol) lotion 5% (50 mg/g of lotion) Bottles (NDC 23594-780-88),New,9/18/19,,"Business decision to discontinue marketing in the US. This product discontinuation is not related to product quality, safety, or efficacy.",,,Dermatology,To be Discontinued,9/18/19,9/18/19
2441,Bethanechol Chloride Tablets,Teva Pharmaceuticals,800-545-8800,10 mg  (NDC 50111-324-01),New,5/1/20,,,,,Urology,To be Discontinued,5/1/20,5/1/20
2442,Bethanechol Chloride Tablets,Teva Pharmaceuticals,800-545-8800,5 mg  (NDC 50111-323-01),New,5/1/20,,,,,Urology,To be Discontinued,5/1/20,5/1/20
2443,Bethanechol Chloride Tablets,Teva Pharmaceuticals,800-545-8800,25 mg  (NDC 50111-325-01),New,5/1/20,,,,,Urology,To be Discontinued,5/1/20,5/1/20
2444,Bethanechol Chloride Tablets,Teva Pharmaceuticals,800-545-8800,50 mg  (NDC 50111-326-01),New,5/1/20,,,,,Urology,To be Discontinued,5/1/20,5/1/20
2445,Bethanechol Chloride Tablets,Teva Pharmaceuticals,800-545-8800,5 mg capsules (NDC 51285-697-02),New,1/13/20,,,,,Urology,To be Discontinued,1/13/20,1/13/20
2446,Bethanechol Chloride Tablets,Teva Pharmaceuticals,800-545-8800,10 mg capsules (NDC 51285-690-02),New,1/13/20,,,,,Urology,To be Discontinued,1/13/20,1/13/20
2447,Betrixaban (Bevyxxa) Capsules,"Portola Pharmaceuticals, Inc.",866-777-5947,40 mg capsules (NDC 69853-0202-1),New,5/1/20,,,,,Hematology,To be Discontinued,5/1/20,5/1/20
2448,Betrixaban (Bevyxxa) Capsules,"Portola Pharmaceuticals, Inc.",866-777-5947,80 mg capsules (NDC 69853-0201-1),New,5/1/20,,,,,Hematology,To be Discontinued,5/1/20,5/1/20
2449,Bosentan Tablets,"Janssen Research and Development, LLC",800-526-7736,62.5 mg tablets (NDC 10148-625-60),New,10/15/19,,,,,Cardiovascular,To be Discontinued,10/15/19,10/15/19
2450,Bosentan Tablets,"Janssen Research and Development, LLC",800-526-7736,125 mg tablets (NDC 10148-125-60),New,10/15/19,,,,,Cardiovascular,To be Discontinued,10/15/19,10/15/19
2451,Budesonide Capsules,Teva Pharmaceuticals,800-545-8800,3 mg capsules (NDC 0093-7445-01),New,12/23/19,,,,,Gastroenterology,To be Discontinued,12/23/19,12/23/19
2452,"Bumetanide Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.25 mg/mL, 4 mL vial (NDC 0641-6008-10)",Revised,7/22/20,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing in the July - August 2020 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
2453,"Bumetanide Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.25 mg/mL, 10 mL vial (NDC 0641-6007-10)",Revised,7/22/20,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing in the July - August 2020 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
2454,"Bumetanide Injection, USP","Hospira, Inc.",844-646-4398,1 mg/4 mL (0.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1412-04),Revised,11/20/20,Limited Supply Available. Next Delivery: November 2020; Estimated Recovery: December 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
2455,"Bumetanide Injection, USP","Hospira, Inc.",844-646-4398,2.5 mg/10 mL (0.25 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1412-10),Revised,11/20/20,Available,,,Other,Cardiovascular,Current,,
2456,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine w/EPI 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-461-57),Revised,11/16/20,Backordered.  Next release November 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2457,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine w/EPI 0.5% (250 mg per 50 mL) (5 mg per mL) MDV (NDC 63323-463-57),Revised,11/16/20,Backordered. Next release November 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2458,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.25% (25 mg per 10 mL) (2.5 mg per mL) SDV (NDC 63323-468-17),Revised,11/16/20,Backordered. Next release November 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2459,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI .25% (75 mg per 30 mL) (2.5 mg per mL) SDV (NDC 63323-468-37),Revised,11/16/20,Backordered. Next release November 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2460,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.5% (50 mg per 10 mL) (5 mg per mL) SDV (NDC 63323-462-17),Revised,11/16/20,Backordered. Next release November 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2461,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) SDV (NDC 63323-462-37),Revised,11/16/20,Backordered. Next release November 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2462,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) Sterile-Pak, SDV (NDC 63323-462-31)",Revised,11/16/20,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,
2463,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.75% (225 mg per 30 mL) (7.5 mg per mL)  SDV  (NDC 63323-460-37),Revised,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2464,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9042-01),Reverified,11/20/20,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
2465,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9042-17),Reverified,11/20/20,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
2466,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9043-01),Reverified,11/20/20,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
2467,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9045-01),Reverified,11/20/20,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
2468,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9045-17),Reverified,11/20/20,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
2469,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9046-01),Reverified,11/20/20,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
2470,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1746-10)",Reverified,11/20/20,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
2471,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1746-30)",Reverified,11/20/20,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
2472,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1749-10)",Reverified,11/20/20,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
2473,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1749-29)",Reverified,11/20/20,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
2474,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-1752-50)",Reverified,11/20/20,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
2475,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-1755-50)",Reverified,11/20/20,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
2476,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-465-57),Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2477,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine 0.5% (250 mg per 50 mL) (5 mg per mL)                    MDV (NDC 63323-467-57),Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2478,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.25% (25 mg per 10 mL) (2.5 mg per mL) MPF,         SDV (NDC 63323-464-17)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2479,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine MPF 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF, SDV (NDC 63323-464-37)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2480,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF,             Sterile-Pak, SDV (NDC 63323-464-31)",Reverified,11/16/20,Backordered.  Next release date not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2481,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (50 mg per 10 mL) (5 mg per mL)  MPF,                 SDV  (NDC 63323-466-17)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2482,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF,                 SDV (NDC 63323-466-37)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2483,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF,                Sterile-Pak, SDV (NDC 63323-466-31)",Reverified,11/16/20,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,
2484,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.75% (75 mg per 10 mL) (7.5 mg per mL) MPF,             SDV (NDC 63323-472-17)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2485,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.75% (225 mg per 30 mL) (7.5 mg per mL) MPF,     SDV (NDC 63323-472-37)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2486,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.25% 10 mL Single Dose Vials (NDC 55150-167-10),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
2487,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.25% 30 mL Single Dose Vials (NDC 55150-168-30),Revised,11/20/20,Currently on backorder - next shipment TBD,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
2488,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 10 mL Single Dose Vials (NDC 55150-169-10),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
2489,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 30 mL Single Dose Vials (NDC 55150-170-30),Revised,11/20/20,Currently on backorder - next shipment anticipated end of Nov 20,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
2490,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.75% 10 mL Single Dose Vials (NDC 55150-171-10),Revised,11/20/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
2491,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.75% 30 mL Single Dose Vials (NDC 55150-172-30),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
2492,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.25% 50 mL Multiple Dose Vials (NDC 55150-249-50),Revised,11/20/20,Available,Check wholesaler for inventory,,Demand increase for the drug,Anesthesia,Current,,
2493,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 50 mL Multiple Dose Vials (NDC 55150-250-50),Revised,11/20/20,Currently on backorder - next shipment TBD,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
2494,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-01),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2495,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-02),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2496,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1160-01),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2497,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-01),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2498,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-02),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2499,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1163-01),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2500,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,75 mg/10 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-01),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2501,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,225 mg/30 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-02),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2502,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose); Glass Ampul (NDC 00409-3613-01),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2503,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 25 mg/10 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-10),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2504,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 75 mg/30 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-30),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2505,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1587-50),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2506,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-10),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2507,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 150 mg/30 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-29),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2508,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1610-50),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2509,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 75 mg/10 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-10),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2510,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 225 mg/30 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-29),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2511,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose); Glass Ampul (NDC 00409- 1761-02),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
2512,"Bupivacaine Hydrochloride Injection, USP","Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.25% 5 mL single-dose ampules (NDC 59923-717-05),New,9/12/19,Available,"Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage.  Importation will begin mid-September 2019.  Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers.  Please call Areva Pharmaceutical Customer Service at  812-399-3599,  Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.",,,Anesthesia,Current,,
2513,"Bupivacaine Hydrochloride Injection, USP","Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.25% 10 mL single-dose ampules (NDC 59923-719-10),New,9/12/19,Available,"Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage.  Importation will begin mid-September 2019.  Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers.  Please call Areva Pharmaceutical Customer Service at  812-399-3599,  Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.",,,Anesthesia,Current,,
2514,"Bupivacaine Hydrochloride Injection, USP","Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.5% 5 mL single-dose ampules (NDC 59923-718-05),New,9/12/19,Available,"Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage.  Importation will begin mid-September 2019.  Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers.  Please call Areva Pharmaceutical Customer Service at  812-399-3599,  Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.",,,Anesthesia,Current,,
2515,"Bupivacaine Hydrochloride Injection, USP","Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.5% 10 mL single-dose ampules (NDC 59923-720-10),New,9/12/18,Available,"Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage.  Importation will begin mid-September 2019.  Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers.  Please call Areva Pharmaceutical Customer Service at  812-399-3599,  Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.",,,Anesthesia,Current,,
2516,"Bupivacaine Hydrochloride Injection, USP",Baxter Healthcare,888-229-0001,"Bupivacaine Spinal, USP (7.5 mg/mL in 8.25% dextrose) 2 mL Single Dose Ampule (10 x 2 mL)(NDC 36000-092-10)",Reverified,10/28/20,Stocked out - recovery TBD,SPINAL 0.75% - Sterile Hyperbaric Solution for Spinal Anesthesia,,Manufacturing Delay,Anesthesia,Current,,
2517,Buprenorphine Hydrochloride Sublingual Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"2 mg, 30 count bottle (NDC 0378-0923-93)",New,5/2/19,,,,,Analgesia/Addiction,To be Discontinued,5/2/19,5/2/19
2518,Buprenorphine Hydrochloride Sublingual Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"8 mg, 30 count bottle (NDC 0378-0924-93)",New,5/2/19,,,,,Analgesia/Addiction,To be Discontinued,5/2/19,5/2/19
2519,Bupropion Hydrochloride (Zyban) Tablets,GlaxoSmithKline,888-825-5249,150 mg  (NDC 0173-0556-01),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of the product is approximately July 2019.,,,Psychiatry,To be Discontinued,6/28/19,6/28/19
2520,Bupropion Hydrochloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"150 mg, 90 count bottle (NDC 0378-2008-77)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
2521,Bupropion Hydrochloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"300 mg, 500 count bottle (NDC 0378-2009-05)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
2522,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"10mg, 100 (NDC 69238-1117-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2523,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"10mg, 500 (NDC 69238-1117-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2524,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"15mg, 100 (NDC 69238-1118-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2525,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"15mg, 500 (NDC 69238-1118-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2526,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"15mg, 60 (NDC 69238-1118-06)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2527,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"30mg, 60 (NDC 69238-1119-06)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2528,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"5mg, 100 (NDC 69238-1115-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2529,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"5mg, 500 (NDC 69238-1115-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2530,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"7.5mg, 100 (NDC 69238-1116-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2531,Buspirone HCl Tablets,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,"5 mg, 100 count bottle (NDC 23155-023-01",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2532,Buspirone HCl Tablets,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,"5 mg, 500 count bottle (NDC 23155-023-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2533,Buspirone HCl Tablets,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,"10 mg, 100 count bottle (NDC 23155-024-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2534,Buspirone HCl Tablets,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,"10 mg, 500 count bottle (NDC 23155-024-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2535,Buspirone HCl Tablets,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,"15 mg, 60 count bottle (NDC 23155-025-06)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2536,Buspirone HCl Tablets,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,"15 mg, 100 count bottle (NDC 23155-025-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2537,Buspirone HCl Tablets,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,"15 mg, 180 count bottle (NDC 23155-025-08)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2538,Buspirone HCl Tablets,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,"15 mg, 500 count bottle (NDC 23155-025-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2539,Buspirone HCl Tablets,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,"30 mg, 60 count bottle (NDC 23155-097-06)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2540,Buspirone HCl Tablets,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,"30 mg, 500 count bottle (NDC 23155-097-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2541,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"15 mg, 60 count bottle (NDC 64380-743-03)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2542,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"15 mg, 180 count bottle (NDC 64380-743-18)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2543,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"5 mg, 100 count bottle (NDC 16729-200-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2544,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"5 mg, 500 count bottle (NDC 16729-200-16)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2545,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"7.5 mg, 100 count bottle (NDC 16729-201-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2546,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"10 mg, 100 count bottle (NDC 16729-202-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2547,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"10 mg, 500 count bottle (NDC 16729-202-16)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2548,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"15 mg, 60 count bottle (NDC 16729-203-12)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2549,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"15 mg, 100 count bottle (NDC 16729-203-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2550,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"30 mg, 60 count bottle (NDC 16729-289-12)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2551,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"7.5 mg, 100 count bottle (NDC 49884-725-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2552,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"7.5 mg, 500 count bottle (NDC 49884-725-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2553,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count bottle (NDC 0378-1140-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2554,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 500 count bottle (NDC 0378-1140-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2555,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, unit-dose blister pack, 100 count (NDC 51079-985-20)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2556,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"7.5 mg, 100 count bottle (NDC 0378-1145-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2557,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100 count bottle (NDC 0378-1150-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2558,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 500 count bottle (NDC 0378-1150-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2559,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, unit-dose blister pack, 100 count (NDC 51079-986-20)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2560,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 60 count bottle (NDC 0378-1165-91)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2561,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 180 count bottle (NDC 0378-1165-80)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2562,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 500 count bottle (NDC 0378-1165-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2563,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, unit-dose blister pack, 100 count (NDC 51079-960-20)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2564,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"30 mg, 60 count bottle (NDC 0378-1175-91)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2565,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"30 mg, unit-dose blister pack, 100 count (NDC 51079-994-20)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2566,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"5 mg, 100 count bottle (NDC 64380-741-06)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2567,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"5 mg, 500 count bottle (NDC 64380-741-07)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2568,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"5 mg, 1000 count bottle (NDC 64380-741-08)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2569,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"7.5 mg, 100 count bottle (NDC 64380-787-06)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2570,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"10 mg, 100 count bottle (NDC 64380-742-06)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2571,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"10 mg, 500 count bottle (NDC 64380-742-07)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2572,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"10 mg, 1000 count bottle (NDC 64380-742-08)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2573,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"30 mg, 60 count bottle (NDC 64380-744-03)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2574,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"5 mg, 100 count bottle (NDC 0093-0053-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2575,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"5 mg, 500 count bottle (NDC 0093-0053-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2576,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"10 mg, 100 count bottle (NDC 0093-0054-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2577,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"10 mg, 500 count bottle (NDC 0093-0054-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2578,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"15 mg, 100 count bottle (NDC 0093-1003-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2579,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"15 mg, 500 count bottle (NDC 0093-1003-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2580,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"30 mg, 60 count bottle (NDC 0093-5200-06)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2581,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"30 mg, 500 count bottle (NDC 0093-5200-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2582,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"5 mg, 100 count bottle (NDC 68382-180-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2583,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"5 mg, 500 count bottle (NDC 68382-180-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2584,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"10 mg, 100 count bottle (NDC 68382-181-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2585,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"10 mg, 500 count bottle (NDC 68382-181-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2586,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"15 mg, 100 count bottle (NDC 68382-182-01)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2587,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"15 mg, 500 count bottle (NDC 68382-182-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2588,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"30 mg, 60 count bottle (NDC 68382-183-14)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2589,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"30 mg, 500 count bottle (NDC 68382-183-05)",Revised,1/16/20,,,Available,,Psychiatry,Resolved,1/16/20,
2590,Busulfan Injection,Teva Pharmaceuticals,800-545-8800,6 mg/mL  (NDC 45963-640-77),New,5/6/20,,,,,Hematology,To be Discontinued,5/6/20,5/6/20
2591,Calcitriol Injection USP 1MCG /ML,Akorn Pharmaceuticals,800-932-5676,"Calcitriol Injection USP, 1 mcg/mL, 1 mL ampule  (NDC 17478-931-01)",Revised,12/2/19,Available,,,Other,Endocrinology/Metabolism,Current,,
2592,"Calcium Chloride Injection, USP","Hospira, Inc.",844-646-4398,1 g/10 mL (100 mg/mL); Ansyr Plastic Syringe (NDC 00409-1631-10),Reverified,11/20/20,Limited Supply Available. Next Delivery and Estimated Recovery: November 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Pediatric,Current,,
2593,"Calcium Chloride Injection, USP","Hospira, Inc.",844-646-4398,1 g/10 mL (100 mg/mL); LifeShield Abboject Glass Syringe (NDC 00409-4928-34),Reverified,11/20/20,Available,,,Other,Gastroenterology;Pediatric,Current,,
2594,"Calcium Chloride Injection, USP","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"Calcium Chloride Inj. USP, 10%, 10mL Luer-Jet Prefilled Syringe, (NDC 0548-3304-00), new (NDC 76329-3304-1)",Reverified,10/30/20,Available,,,Demand increase for the drug,Gastroenterology;Pediatric,Current,,
2595,"Calcium Chloride Injection, USP","Medefil, Inc.",630-682-4600,"Calcium Chloride Inj. USP, 10%, 10mL Prefilled Syringe, (NDC 64253-900-36)",Reverified,5/8/20,Available,Check wholesaler for inventory,,Other,Gastroenterology;Pediatric,Current,,
2596,"Calcium Chloride Injection, USP",American Regent/Luitpold,800-645-1706,"10% Calcium Chloride Injection, USP, 1 gram/10mL (100mg/mL), single dose vial, (NDC 0517-6710-10)",Reverified,9/29/20,Available,,,,Gastroenterology;Pediatric,Current,,
2597,"Capreomycin Injection, USP",Akorn Pharmaceuticals,800-932-5676,"Capastat Sulfate (Capreomycin for Injection USP) Eq to 1 g Capreomycin activity, 10mL (NDC 17478-080-50)",Revised,7/15/20,Available,"Available until 2Q 2021. After that, no further supply will be available",,Shortage of an active ingredient,Anti-Infective,Current,,
2598,Carbamazepine Extended Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,100 mg capsules (NDC 29033-019-12),New,6/19/19,,,,,Neurology,To be Discontinued,6/19/19,6/19/19
2599,Carbamazepine Extended Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,200 mg capsules (NDC 29033-020-12),New,6/19/19,,,,,Neurology,To be Discontinued,6/19/19,6/19/19
2600,Carbamazepine Extended Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,300 mg capsules (NDC 29033-004-12),New,6/19/19,,,,,Neurology,To be Discontinued,6/19/19,6/19/19
2601,Carbidopa and Levodopa Extended Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"Carbidopa and Levodopa Extended Release Tablets, 25/100 mg (NDC 0378-0088-01)",Revised,7/12/19,,,,,Neurology,Resolved,7/12/19,
2602,Carbidopa and Levodopa Extended Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"Carbidopa and Levodopa Extended Release Tablets, 50/200 mg (NDC 0378-0094-01)",Revised,7/12/19,,,,,Neurology,Resolved,7/12/19,
2603,Carbidopa and Levodopa Extended Release Tablets,Merck Sharp & Dohme Corp.,800-637-2579,"Carbidopa levodopa (50 mg of carbidopa and 200 mg of levodopa)  (SINEMET CR 50-200) sustained-release tablets, (NDC 0006-3919-68)bottles of 100",New,7/17/19,,To be discontinued on or near November 2019.,,,Neurology,To be Discontinued,7/17/19,7/17/19
2604,Carbidopa and Levodopa Extended Release Tablets,Merck Sharp & Dohme Corp.,800-637-2579,"Carbidopa levodopa  (25 mg of carbidopa and 100 mg of levodopa) (SINEMET CR 25-100 ) sustained-release tablets, (NDC 0006-3918-68) bottles of 100",New,7/17/19,,To be discontinued on or near February 2020.,Available,,Neurology,To be Discontinued,7/17/19,
2605,Carbidopa and Levodopa Extended Release Tablets,Accord Healthcare Inc.,"866-941-7875, Option 1 or 3",CARBIDOPA & LEVODOPA ER TABLETS 50MG/200MG 100CT; (NDC 1672907901),Revised,7/12/19,,,Stocks available to support current customer demand,,Neurology,Resolved,7/12/19,
2606,Carbidopa and Levodopa Extended Release Tablets,Sun Pharmaceutical Industries Inc.,800-810-4555,Carbidopa and Levodopa Extended Release Tablets  25-100 mg (NDC  62756-461-88 ),Revised,7/12/19,,,Available,,Neurology,Resolved,7/12/19,
2607,Carbidopa and Levodopa Extended Release Tablets,Accord Healthcare Inc.,"866-941-7875, Option 1 or 3",CARBIDOPA & LEVODOPA ER TABLETS 50MG/200MG 1000CT; (NDC 1672907917),Revised,7/12/19,,,Stocks available to support current customer demand,,Neurology,Resolved,7/12/19,
2608,Carbidopa and Levodopa Extended Release Tablets,Accord Healthcare Inc.,"866-941-7875, Option 1 or 3",CARBIDOPA & LEVODOPA ER TABLETS 25MG/100MG 100CT; (NDC 1672907801),Revised,7/12/19,,,Due to manufacturing constraints; we estimate the delay to continue until January 2020,,Neurology,Resolved,7/12/19,
2609,Carbidopa and Levodopa Extended Release Tablets,Accord Healthcare Inc.,"866-941-7875, Option 1 or 3",CARBIDOPA & LEVODOPA ER TABLETS 25MG/100MG 1000CT; (NDC 1672907817),Revised,7/12/19,,,Due to manufacturing constraints; we estimate the delay to continue until January 2020,,Neurology,Resolved,7/12/19,
2610,Carbidopa and Levodopa Extended Release Tablets,Sun Pharmaceutical Industries Inc.,800-810-4555,Carbidopa and Levodopa Extended Release Tablets  50-200 (NDC 62756-457-88),Revised,7/12/19,,,Available,,Neurology,Resolved,7/12/19,
2611,Carbinoxamine Maleate,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",4 mg/5 mL oral solution (NDCs 64376-612-16 and 64376-612-40),Revised,9/11/19,,,,,Pulmonary/Allergy,To be Discontinued,9/11/19,9/11/19
2612,Carbinoxamine Maleate,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",4 mg tablets (NDC 64376-605-01),Revised,9/11/19,,,,,Pulmonary/Allergy,To be Discontinued,9/11/19,9/11/19
2613,Cardene IV (nicardipine hydrochloride) 0.2 mg/mL in 5% Dextrose,"Chiesi USA, Inc.",888-466-6505 x6511,Cardene IV (nicardipine hydrochloride) 0.2 mg/mL in 5% Dextrose (NDC 10122-326-10),New,3/20/18,,The decision to discontinue the 0.2 mg/mL in 5% Dextrose formulation was business related.  Other formulations of Cardene IV remain available.,,,Cardiovascular,To be Discontinued,3/20/18,3/20/18
2614,"Carisoprodol Tablets, USP","Endo Pharmaceuticals, Inc.",800-828-9393,100’s count bottle (NDC 00603-2582-21),New,3/18/19,,Endo has made a business decision to permanently discontinue Carisoprodol 350mg tablets.,,,Musculoskeletal,To be Discontinued,3/18/19,3/18/19
2615,"Carisoprodol Tablets, USP","Endo Pharmaceuticals, Inc.",800-828-9393,500's count bottle (NDC 00603-2582-28),New,3/18/19,,Endo has made a business decision to permanently discontinue Carisoprodol 350mg tablets.,,,Musculoskeletal,To be Discontinued,3/18/19,3/18/19
2616,"Carisoprodol Tablets, USP","Endo Pharmaceuticals, Inc.",800-828-9393,100's count bottle (NDC 00603-2582-32),New,3/18/19,,Endo has made a business decision to permanently discontinue Carisoprodol 350mg tablets.,,,Musculoskeletal,To be Discontinued,3/18/19,3/18/19
2617,"Carisoprodol Tablets, USP",Mylan Specialty,800-796-9526,"Soma, 250 mg 30 count bottle (NDC 0037-2250-30)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2618,"Carisoprodol Tablets, USP",Ingenus Pharmaceuticals LLC,866-321-5031,"350 mg, 100 count tablets (NDC 50742-656-01)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2619,"Carisoprodol Tablets, USP",Teva Pharmaceuticals,800-545-8800,"350 mg, 100 count (NDC 0591-5513-01)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2620,"Carisoprodol Tablets, USP",Teva Pharmaceuticals,800-545-8800,"350 mg, 500 count (NDC 0591-5513-05)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2621,"Carisoprodol Tablets, USP",Teva Pharmaceuticals,800-545-8800,"350 mg, 1000 count (NDC 0591-5513-10)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2622,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 100 count (NDC 50228-109-01)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2623,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 500 count (NDC 50228-109-05)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2624,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 1000 count (NDC 50228-109-10)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2625,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 1000 count (NDC 60429-508-10)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2626,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 100 count (NDC 42543-700-01)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2627,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 500 count (NDC 42543-700-05)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2628,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 1000 count (NDC 42543-700-10)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2629,"Carisoprodol Tablets, USP","Endo Pharmaceuticals, Inc.",800-828-9393,100’s count bottle (NDC 00603-2582-21),Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2630,"Carisoprodol Tablets, USP","Endo Pharmaceuticals, Inc.",800-828-9393,500's count bottle (NDC 00603-2582-28),Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2631,"Carisoprodol Tablets, USP","Endo Pharmaceuticals, Inc.",800-828-9393,100's count bottle (NDC 00603-2582-32),Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2632,"Carisoprodol Tablets, USP",Mylan Specialty,800-796-9526,"Soma, 250 mg, 30 count bottle (NDC 0037-2250-30); 100 count bottle (NDC 0037-2250-10)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2633,"Carisoprodol Tablets, USP",Mylan Specialty,800-796-9526,"Soma, 350 mg, 100 count bottle (NDC 0037-2001-01)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2634,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 100 tablets (NDC 16714-510-01)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2635,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 500 tablets (NDC 16714-510-02)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2636,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 1000 tablets (NDC 16714-510-03)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2637,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 100 tablets (NDC 61442-451-01)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2638,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 500 tablets (NDC 61442-451-05)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2639,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 1000 tablets (NDC 61442-451-10)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2640,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 100 tablets (NDC 59746-705-01)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2641,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 500 tablets (NDC 59746-705-05)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2642,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 1000 tablets (NDC 59746-705-05)",Revised,5/19/20,,,,,Analgesia/Addiction;Musculoskeletal,Resolved,5/19/20,
2643,"Carisoprodol, Aspirin, and Codeine Phosphate Tablets USP",Ingenus Pharmaceuticals LLC,866-321-5031,200 mg/325 mg/16 mg (NDC 50742-256-01),New,9/1/20,,,,,Musculoskeletal,To be Discontinued,9/1/20,9/1/20
2644,Caspofungin Acetate Injection,Mylan Institutional,800-796-9526,50 mg (NDC 67457-831-50),New,7/23/20,,,,,Anti-Infective;Pediatric,To be Discontinued,7/23/20,7/23/20
2645,Cefazolin Injection,"Hospira, Inc.",844-646-4398,1g Single-dose ADD-Vantage Vial (NDC 00409-2585-01,Reverified,11/20/20,Limited Supply Available. Next Delivery and Estimated Recovery: February 2021,,,Demand increase for the drug,Anti-Infective,Current,,
2646,Cefazolin Injection,Apotex Corp.,800-706-5575,Cefazolin for Injection 10 g (10 vials) (NDC 60505-6143-04),Reverified,11/13/20,Available,,,,Anti-Infective,Current,,
2647,Cefazolin Injection,"Samson Medical Technologies, L.L.C.",856-751-5051,100 gram SmartPak® Pharmacy Bulk Package (NDC 66288-1100-1),Reverified,11/20/20,Available,,,,Anti-Infective,Current,,
2648,Cefazolin Injection,"Samson Medical Technologies, L.L.C.",856-751-5051,300 gram SmartPak® Pharmacy Bulk Package (NDC 66288-1300-1),Reverified,11/20/20,Available,,,,Anti-Infective,Current,,
2649,Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,1g 25 vials (NDC 25021-101-10),Reverified,10/22/20,Available,,,,Anti-Infective,Current,,
2650,Cefazolin Injection,Baxter Healthcare,888-229-0001,"Cefazolin Injection, USP, 1 gram/50 mL, in GALAXY Plastic Container. Frozen Premix. (Product code 2G3503)(NDC 0338-3503-41)",Revised,10/28/20,Available,,,,Anti-Infective,Current,,
2651,Cefazolin Injection,Baxter Healthcare,888-229-0001,"Cefazolin Injection, USP, 2 gram/100 mL, in GALAXY Plastic Container. Frozen Premix. (Product code 2G3508)(NDC 0338-3508-41)",Revised,10/28/20,Product on allocation for existing customers,,,Other,Anti-Infective,Current,,
2652,Cefazolin Injection,Apotex Corp.,800-706-5575,Cefazolin for Injection 1 g (25 vials) (NDC 60505-6142-05),Reverified,11/13/20,Available,,,,Anti-Infective,Current,,
2653,Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,10g 10 vials (NDC 25021-102-99),Reverified,10/22/20,Available,,,,Anti-Infective,Current,,
2654,Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,500mg 25 vials (NDC 25021-100-10),Reverified,10/22/20,Available,,,,Anti-Infective,Current,,
2655,Cefazolin Injection,B. Braun Medical Inc.,800-227-2862,Cefazolin Injection 2 gram/50 mL in DUPLEX Catalog 3105-11 (NDC 00264-3105-11),Reverified,9/8/20,Product on allocation to contracted customers,,,Other,Anti-Infective,Current,,
2656,Cefazolin Injection,B. Braun Medical Inc.,800-227-2862,Cefazolin Injection 1 gram/50 mL in DUPLEX Catalog 3103-11 (NDC 0264-3103-11),Reverified,9/8/20,Product on allocation to contracted customers,,,Other,Anti-Infective,Current,,
2657,Cefazolin Injection,WG Critical Care,888-493-0861,500mg Cefazolin SDV (NDC 44567-706-25),Reverified,11/18/20,Available,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
2658,Cefazolin Injection,WG Critical Care,888-493-0861,1g Cefazolin SDV (NDC 44567-707-25),Reverified,11/18/20,Available,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
2659,Cefazolin Injection,WG Critical Care,888-493-0861,10g Cefazolin PBP (NDC 44567-708-10),Reverified,11/18/20,Available,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
2660,Cefazolin Injection,"Hospira, Inc.",844-646-4398,1g Single Dose Glass Fliptop Vial (NDC 00409-0805-01),Reverified,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Anti-Infective,Current,,
2661,Cefazolin Injection,"Hospira, Inc.",844-646-4398,1g Single Dose Glass Fliptop Vial (NDC 00409-0805-01),Revised,10/2/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/2/20,10/2/20
2662,Cefazolin Injection,"Hospira, Inc.",844-646-4398,10 g Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-0806-01),Revised,10/2/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/2/20,10/2/20
2663,Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg/ 10 mL vial (NDC 0143-9923-90),Reverified,7/22/20,Inventory is currently available,Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
2664,Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1 g/ 10 mL vial (NDC 0143-9924-90),Reverified,7/22/20,Inventory is currently available,Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
2665,Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 mg/ 100 mL vial (NDC 0143-9983-03),Reverified,7/22/20,Inventory is currently available,Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
2666,Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 500 mg (NDC 0781-3450-95),Reverified,11/13/20,Available,,,,Anti-Infective,Current,,
2667,Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 1 g (NDC 0781-3451-96),Reverified,11/13/20,Available,,,,Anti-Infective,Current,,
2668,Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 10 g (NDC 0781-3452-95),Reverified,11/13/20,Available,,,,Anti-Infective,Current,,
2669,Cefdinir Capsules,Sandoz,800-525-8747,300 mg capsules  (NDC 0781-2176-60),New,7/9/20,,,,,Anti-Infective,To be Discontinued,7/9/20,7/9/20
2670,Cefepime Injection,"Hospira, Inc.",844-646-4396,1g; Single Dose Vial (NDC 00409-9566-01),Reverified,11/20/20,Available,,,Other,Anti-Infective;Pediatric,Current,,
2671,Cefepime Injection,"Hospira, Inc.",844-646-4396,2g; Single Dose Vial (NDC 00409-9735-01),Reverified,11/20/20,Available,,,Other,Anti-Infective;Pediatric,Current,,
2672,Cefepime Injection,Apotex Corp.,800-706-5575,Cefepime for Injection 1 g (10 vials) (NDC 60505-6146-04),Reverified,11/13/20,Available,,,,Anti-Infective;Pediatric,Current,,
2673,Cefepime Injection,Apotex Corp.,800-706-5575,Cefepime for Injection 1 g (1 vial) (NDC 60505-6146-00),Reverified,11/13/20,Available,,,,Anti-Infective;Pediatric,Current,,
2674,Cefepime Injection,Apotex Corp.,800-706-5575,Cefepime for Injection 2 g (10 vials) (NDC 60505-6147-04),Reverified,11/13/20,Available,,,,Anti-Infective;Pediatric,Current,,
2675,Cefepime Injection,Apotex Corp.,800-706-5575,Cefepime for Injection 2 g (1 vial) (NDC 60505-6147-00),Reverified,11/13/20,Available,,,,Anti-Infective;Pediatric,Current,,
2676,Cefepime Injection,Apotex Corp.,800-706-5575,Cefepime for Injection 1 g (1 vial) (NDC 60505-0834-00),Revised,3/1/19,,"Product was manufactured by Hospira, no longer distributed by Apotex",,,Anti-Infective;Pediatric,To be Discontinued,3/1/19,3/1/19
2677,Cefepime Injection,B. Braun Medical Inc.,800-227-2862,Cefepime 1 g (NDC 0264-3193-11),Reverified,9/9/20,Product on allocation to contracted custormers,,,Other,Anti-Infective;Pediatric,Current,,
2678,Cefepime Injection,B. Braun Medical Inc.,800-227-2862,Cefepime 2 g (NDC 0264-3195-11),Reverified,9/9/20,Product on allocation to contracted customers,,,Other,Anti-Infective;Pediatric,Current,,
2679,Cefepime Injection,Sagent Pharmaceuticals,866-625-1618,1 g vial (NDC 25021-121-20),Revised,10/22/20,Available.,,,,Anti-Infective;Pediatric,Current,,
2680,Cefepime Injection,Sagent Pharmaceuticals,866-625-1618,2 g vial (NDC 25021-122-50),Revised,10/22/20,On Allocation. Estimated availability Nov 2020,,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
2681,Cefepime Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 g single dose vial, sterile powder (NDC 63323-326-20)",Reverified,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
2682,Cefepime Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 g single dose vial, sterile powder (NDC 63323-340-20)",Reverified,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
2683,Cefepime Injection,Baxter Healthcare,888-229-0001,"Cefepime Injection, 1 gram/50mL, GALAXY Container (NDC 0338-1301-41)",Reverified,10/28/20,Available,,,,Anti-Infective;Pediatric,Current,,
2684,Cefepime Injection,Baxter Healthcare,888-229-0001,"Cefepime Injection, 2 gram/100mL, GALAXY Container (NDC 0338-1301-48)",Reverified,10/28/20,Available,,,,Anti-Infective;Pediatric,Current,,
2685,Cefepime Injection,"Hospira, Inc.",844-646-4398,Maxipime 2 g; Single Dose ADD-Vantage Glass Vial (NDC 00409-0218-01),Revised,8/25/20,,Discontinuation of the manufacture of the drug,,,Anti-Infective;Pediatric,To be Discontinued,8/25/20,8/25/20
2686,Cefepime Injection,"Hospira, Inc.",844-646-4398,Maxipime 1 g; Single Dose ADD-Vantage Glass Vial (NDC 00409-0217-01),Revised,8/25/20,,Discontinuation of the manufacture of the drug,,,Anti-Infective;Pediatric,To be Discontinued,8/25/20,8/25/20
2687,Cefepime Injection,"Hospira, Inc.",844-646-4398,Maxipime 1 g; Single Dose Glass Fliptop Vial (NDC 00409-0219-01),Revised,8/25/20,,Discontinuation of the manufacture of the drug,,,Anti-Infective;Pediatric,To be Discontinued,8/25/20,8/25/20
2688,Cefepime Injection,"Hospira, Inc.",844-646-4398,Maxipime 2 g; Single Dose Glass Fliptop Vial (NDC 00409-0220-01),Revised,8/25/20,,Discontinuation of the manufacture of the drug,,,Anti-Infective;Pediatric,To be Discontinued,8/25/20,8/25/20
2689,Cefepime Injection,WG Critical Care,888-493-0861,1 g vial (NDC 44567-0240-10),Reverified,11/18/20,Available,Please check wholesalers and distributors for inventory.,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
2690,Cefepime Injection,WG Critical Care,888-493-0861,2 g vial (NDC 44567-0241-10),Reverified,11/18/20,Available,Please check wholesalers and distributors for inventory.,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
2691,Cefepime Injection,"Samson Medical Technologies, L.L.C.",856-751-5051,100 gram SmartPak Pharmacy Bulk Package (NDC 66288-8100-1),Reverified,11/20/20,Available,,,,Anti-Infective;Pediatric,Current,,
2692,Cefotaxime Sodium Injection,"SteriMax, Inc.",800-881-3550,"2g/vial, (NDC 21586-012-2)",Revised,11/16/20,Available,"SteriMax in conjunction with FDA has initiated a temporary importation of Cefotaxime sodium for Injection, BP into the U.S. market to address drug shortage. To place an order, please contact FFF Enterprises at 1-800-843-7477",,Other,Anti-Infective;Pediatric,Current,,
2693,Cefotaxime Sodium Injection,"SteriMax, Inc.",800-881-3550,"1g/vial, (NDC 21586-011-2)",Revised,11/16/20,Available,"SteriMax in conjunction with FDA has initiated a temporary importation of Cefotaxime sodium for Injection, BP into the U.S. market to address drug shortage. To place an order, please contact FFF Enterprises at 1-800-843-7477",,Other,Anti-Infective;Pediatric,Current,,
2694,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg/ 10 mL vial (NDC 0143-9930-10),Revised,7/22/20,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
2695,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1 g/ 10 mL vial (NDC 0143-9931-25),Revised,7/22/20,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
2696,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,2 g/ 10 mL vial (NDC 0143-9933-25),Revised,7/22/20,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
2697,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 g/ 100 mL vial (NDC 0143-9935-01),Revised,7/22/20,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
2698,Cefotetan Disodium Injection,"Teligent Pharma, Inc.",856-697-1441,Cefotan 2g Vial 10 (NDC 52565-0053-10),Reverified,11/10/20,Available,,,,Anti-Infective,Current,,
2699,Cefotetan Disodium Injection,"Teligent Pharma, Inc.",856-697-1441,Cefotan 1g Vial 10 (NDC 52565-0052-10),Revised,3/31/20,,Low volume available; short-dated product; Teligent has made a business decision to discontinue manufacture of this presentation.,,,Anti-Infective,To be Discontinued,3/31/20,3/31/20
2700,Cefotetan Disodium Injection,B. Braun Medical Inc.,800-227-2862,1 gram/50 mL in DUPLEX (NDC 00264-3173-11),Revised,8/28/20,Product not available,,,Other,Anti-Infective,Current,,
2701,Cefotetan Disodium Injection,B. Braun Medical Inc.,800-227-2862,2 gram/50 mL in DUPLEX (NDC 00264-3175-11),Revised,8/28/20,Product not available,,,Other,Anti-Infective,Current,,
2702,Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,1 g SDV (NDC 63323-0385-10),Revised,11/16/20,8 mos expiry available by request. Next release December 2020.,Check wholesalers for inventory,,Manufacturing delay,Anti-Infective,Current,,
2703,Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,2 g SDV (NDC 63323-0386-20),Revised,11/16/20,Available,Check wholesalers for inventory,,Manufacturing delay,Anti-Infective,Current,,
2704,Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 g PBP (NDC 63323-0396-61),Revised,11/16/20,No release date available at this time.,,,Manufacturing delay,Anti-Infective,Current,,
2705,"Cefoxitin for Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1g vial (NDC 0143-9878-25),Revised,7/22/20,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
2706,"Cefoxitin for Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,2g vial (NDC 0143-9877-25),Revised,7/22/20,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
2707,"Cefoxitin for Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10g vial (NDC 0143-9876-10),Revised,7/22/20,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
2708,"Cefoxitin for Injection, USP",Apotex Corp.,800-706-5575,1 g (25 vials) (NDC 60505-0759-05),Reverified,11/13/20,Product is temporarily discontinued,Product manufactured by Hospira,,Discontinuation of the manufacture of the drug,Anti-Infective,Current,,
2709,"Cefoxitin for Injection, USP",Apotex Corp.,800-706-5575,2 g (25 vials) (NDC 60505-0760-05),Reverified,11/13/20,Product is temporarily discontinued,Product manufactured by Hospira,,Discontinuation of the manufacture of the drug,Anti-Infective,Current,,
2710,"Cefoxitin for Injection, USP",Apotex Corp.,800-706-5575,10 g (10 vials) (NDC 60505-0761-04),Reverified,11/13/20,Product is temporarily discontinued,Product manufactured by Hospira,,Discontinuation of the manufacture of the drug,Anti-Infective,Current,,
2711,"Cefoxitin for Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,1 g per vial; SDV; (NDC 63323-341-25),Revised,11/16/20,Available,Check wholesalers for inventory,,Manufacturing delays,Anti-Infective,Current,,
2712,"Cefoxitin for Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,2 grams per vial; SDV; (NDC 63323-342-25),Revised,11/16/20,Available,Check wholesalers for inventory,,Manufacturing delays,Anti-Infective,Current,,
2713,"Cefoxitin for Injection, USP",Sagent Pharmaceuticals,866-625-1618,"10 g, package of 10 vials (NDC 25021-111-99)",Revised,10/22/20,Available,,,,Anti-Infective,Current,,
2714,"Cefoxitin for Injection, USP",Sagent Pharmaceuticals,866-625-1618,"1 g, package of 10 vials (NDC 25021-109-10)",Revised,10/22/20,On backorder. Estimated availability Dec 2020,,,Manufacturing delay,Anti-Infective,Current,,
2715,"Cefoxitin for Injection, USP",Sagent Pharmaceuticals,866-625-1618,"2 g, package of 10 vials (NDC 25021-110-20)",Revised,10/22/20,On allocation. Estimated availability Nov 2020,,,Manufacturing delay,Anti-Infective,Current,,
2716,"Cefoxitin for Injection, USP",WG Critical Care,888-493-0861,1 g (NDC 44567-245-25),Reverified,11/18/20,Available,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
2717,"Cefoxitin for Injection, USP",WG Critical Care,888-493-0861,2 g (NDC 44567-246-25),Reverified,11/18/20,Available,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
2718,"Cefoxitin for Injection, USP",WG Critical Care,888-493-0861,10 g (NDC 44567-247-10),Reverified,11/18/20,Available,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
2719,"Cefoxitin for Injection, USP",B. Braun Medical Inc.,800-227-2862,Cefoxitin Injection 2 gram/50 mL in DUPLEX Catalog 3125-11 (NDC NDC 00264-3125-11),Revised,9/8/20,Available,,,Other,Anti-Infective,Current,,
2720,"Cefoxitin for Injection, USP",B. Braun Medical Inc.,800-227-2862,Cefoxitin Injection 1 gram/50 mL in DUPLEX Catalog 3123-11 (NDC 0264-3123-11),Revised,9/8/20,Available,,,Other,Anti-Infective,Current,,
2721,Ceftazidime (Fortaz) Injection,"Teligent Pharma, Inc.",856-697-1441,Ceftazidime (Fortaz) Premix Sol Frozen 1g Bag 24 x 50mL (NDC 24987-0412-00),New,3/20/18,,No longer manufacturing product,,,Anti-Infective;Pediatric,To be Discontinued,3/20/18,3/20/18
2722,Ceftazidime (Fortaz) Injection,"Teligent Pharma, Inc.",856-697-1441,Ceftazidime (Fortaz) Premix Sol Frozen 2g Bag 24 x 50mL (NDC 24987-0413-00),New,3/20/18,,No longer manufacturing product,,,Anti-Infective;Pediatric,To be Discontinued,3/20/18,3/20/18
2723,Cefuroxime Sodium (Zinacef) Injection,"Teligent Pharma, Inc.",856-697-1441,Cefuroxime Sodium (Zinacef) Premix Sol Frozen 1.5g Bag 24 x 50mL (NDC 24987-0425-00),New,3/20/18,,No longer manufacturing product,,,Anti-Infective;Pediatric,To be Discontinued,3/20/18,3/20/18
2724,Cetirizine Hydrochloride,Torrent Pharma Inc.,888-544-2299 option 4,5 mg/5 mL oral syrup (NDC 13668-596-07),New,4/24/19,,,,,Pulmonary/Allergy,To be Discontinued,4/24/19,4/24/19
2725,"Chlordiazepoxide Hydrochloride USP, Capsules",Bausch Health,800-321-4576,5 mg (NDC 43547-251-10),New,11/19/19,,"Product discontinuation as per business decision, non-safety related. Distributed by Solco Healthcare U.S., LLC. 
For additional information, please contact : 
Solco Healthcare US
email: chris.keith@solcohealthcare.com",,,Neurology;Psychiatry,To be Discontinued,11/19/19,11/19/19
2726,"Chlordiazepoxide Hydrochloride USP, Capsules",Bausch Health,800-321-4576,10 mg (NDC 43547-252-10),New,11/19/19,,"Product discontinuation as per business decision, non-safety related. Distributed by Solco Healthcare U.S., LLC. 
For additional information, please contact : 
Solco Healthcare US
email: chris.keith@solcohealthcare.com",,,Neurology;Psychiatry,To be Discontinued,11/19/19,11/19/19
2727,"Chlordiazepoxide Hydrochloride USP, Capsules",Bausch Health,800-321-4576,25 mg (NDC 43547-253-10),New,11/19/19,,"Product discontinuation as per business decision, non-safety related. Distributed by Solco Healthcare U.S., LLC. 
For additional information, please contact : 
Solco Healthcare US
email: chris.keith@solcohealthcare.com",,,Neurology;Psychiatry,To be Discontinued,11/19/19,11/19/19
2728,Chloroquine Phosphate Tablets,Natco Pharma Limited,+91 40 23547532,"250 mg, 50 count bottle (NDC 64980-177-50); distributed by Rising Pharmaceuticals, to order contact: 201-961-9000",Revised,5/8/20,,,Available,,Anti-Infective,Resolved,5/8/20,
2729,Chloroquine Phosphate Tablets,Natco Pharma Limited,+91 40 23547532,"500 mg, 25 count bottle (NDC 64980-178-02); distributed by Rising Pharmaceuticals, to order contact: 201-961-9000",Revised,5/8/20,,,Available,,Anti-Infective,Resolved,5/8/20,
2730,Chlorothiazide (Diuril) Oral Suspension,Bausch Health,877-361-8727,250 mg/5 mL (50 mg/mL) 237 mL (NDC 65649-311-12),New,8/12/20,Product availability is planned for 18-Sep-2020.,"Distributor-Salix Pharmaceuticals, Inc.: 1-800-321-4576",,Shortage of an inactive ingredient,Cardiovascular;Pediatric,Current,,
2731,Chlorothiazide Injection,Mylan Institutional,800-796-9526,500 mg (NDC 67457-263-30),New,4/8/20,,Expected discontinuation May 2020,,,Cardiovascular,To be Discontinued,4/8/20,4/8/20
2732,Chlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"250 mg, 100 count bottle (NDC 0378-0150-01)",New,5/2/19,,,,,Cardiovascular;Pediatric,To be Discontinued,5/2/19,5/2/19
2733,Chlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 100 count bottle (NDC 0378-0162-01)",New,5/2/19,,,,,Cardiovascular;Pediatric,To be Discontinued,5/2/19,5/2/19
2734,Chlorpheniramine Maleate; Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride Oral Solution,"Paddock Laboratories, LLC",800-775-2054,4 mg/5 mL; 5 mg/5 mL; 60 mg/5 mL (NDC 0574-1103-16),New,6/12/19,,,,,Pulmonary/Allergy,To be Discontinued,6/12/19,6/12/19
2735,Chlorpropamide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg, 100 count bottle (NDC 0378-0197-01)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
2736,Chlorpropamide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"250 mg, 100 count bottle (NDC 0378-0210-01)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
2737,Ciprofloxacin Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 50 count bottle (NDC 0378-1743-89)",New,5/2/19,,,,,Anti-Infective,To be Discontinued,5/2/19,5/2/19
2738,Ciprofloxacin Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"1000 mg, 50 count bottle (NDC 0378-1745-89)",New,5/2/19,,,,,Anti-Infective,To be Discontinued,5/2/19,5/2/19
2739,Cisatracurium Besylate Injection,Teva Pharmaceuticals,800-545-8800,200 mg/20 mL (10 mg/mL) Single-dose vials (NDC 0703-2045-03),Reverified,11/19/20,Product is available,"Teva is experiencing a significant increase in demand, due in part to the pandemic",,Demand increase for the drug,Anesthesia,Current,,
2740,Cisatracurium Besylate Injection,Teva Pharmaceuticals,800-545-8800,20 mg/10 mL (2 mg/mL) Multiple-dose vials (NDC 0703-2056-03),Reverified,11/19/20,Product is available,"Teva is experiencing a significant increase in demand, due in part to the pandemic",,Demand increase for the drug,Anesthesia,Current,,
2741,Cisatracurium Besylate Injection,Teva Pharmaceuticals,800-545-8800,10 mg/5 mL (2 mg/mL) Single-dose vials (NDC 0703-2033-03),Reverified,11/19/20,Product is available,"Teva is experiencing a significant increase in demand, due in part to the pandemic",,Demand increase for the drug,Anesthesia,Current,,
2742,Cisatracurium Besylate Injection,"Somerset Therapeutics, LLC",732-554-1019,2mg/mL 10 vials (NDC 70069-141-10),New,4/8/20,Limited supply available. Please contact wholesaler for availability. Somerset is ramping up production to meet increased demand.,,,Demand increase for the drug,Anesthesia,Current,,
2743,Cisatracurium Besylate Injection,"Somerset Therapeutics, LLC",732-554-1019,2mg/ml 10 vials (NDC 70069-161-10),New,4/8/20,Limited supply available. Please contact wholesaler for availability. Somerset is ramping up production to meet increased demand.,,,Demand increase for the drug,Anesthesia,Current,,
2744,Cisatracurium Besylate Injection,"Somerset Therapeutics, LLC",732-554-1019,10mg/mL 10 vials (NDC 70069-151-10),New,4/8/20,Limited supply available. Please contact wholesaler for availability. Somerset is ramping up production to meet increased demand.,,,Demand increase for the drug,Anesthesia,Current,,
2745,Cisatracurium Besylate Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,10 mg per 5 mL single dose vial (NDC 71288-712-06),Revised,7/22/20,"Backordered. Next Delivery: July 2020, August 2020 and November 2020.",Prioritized manufacturing and increased production due to overall demand.,,Demand increase for the drug,Anesthesia,Current,,
2746,Cisatracurium Besylate Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,200 mg per 20 mL single dose vial (NDC 71288-713-21),Revised,7/22/20,"Backordered. Next Delivery: July 2020, August 2020 and November 2020.",Prioritized manufacturing and increased production due to overall demand.,,Demand increase for the drug,Anesthesia,Current,,
2747,Cisatracurium Besylate Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,20 mg per 10 mL  multi dose vial (NDC 71288-712-11),Revised,7/22/20,"Backordered. Next Delivery: July 2020, August 2020 and November 2020.",Prioritized manufacturing and increased production due to overall demand.,,Demand increase for the drug,Anesthesia,Current,,
2748,Cisatracurium Besylate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg (base) per 5 mL (2 mg per mL), Single dose vial, PF, (NDC 63323-416-05)",Revised,11/16/20,Backordered. Next release Q2 - 2021.,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
2749,Cisatracurium Besylate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 10 mL (2 mg per mL), Multiple dose vial, (NDC 63323-417-10)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
2750,Cisatracurium Besylate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per 20 mL (10 mg per mL), Single dose vial, PF, (NDC 63323-418-20)",Revised,11/16/20,Backordered. Next release Q2 2021.,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
2751,Cisatracurium Besylate Injection,Sandoz,800-525-8747,2mg/ml; 5mL (NDC 0781-3150-95),Reverified,11/13/20,Available,,,,Anesthesia,Current,,
2752,Cisatracurium Besylate Injection,Sandoz,800-525-8747,2mg/mL; 10mL (NDC 0781-3152-95),Reverified,11/13/20,Available,,,,Anesthesia,Current,,
2753,Cisatracurium Besylate Injection,Sandoz,800-525-8747,1-mg/mL; 20mL (NDC 0781-3153-95_,Reverified,11/13/20,Available,,,,Anesthesia,Current,,
2754,Cisatracurium Besylate Injection,"Hospira, Inc.",844-646-4398,10mg/5mL (2mg/mL) Single Dose Vial (NDC 00409-1098-02),Revised,11/20/20,Limited Supply Available. Next Delivery and Estimated Recovery: December 2020,,,Demand increase for the drug,Anesthesia,Current,,
2755,Cisatracurium Besylate Injection,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL) Single Dose Vial (NDC 00409-1103-01),Revised,11/20/20,Limited Supply Available. Next Delivery: November 2020; Estimated Recovery: March 2021,,,Demand increase for the drug,Anesthesia,Current,,
2756,Cisatracurium Besylate Injection,"Hospira, Inc.",844-646-4398,20mg/10mL (2mg/mL) Multi-Dose Vial (NDC 00409-1208-01),Revised,11/20/20,Limited Supply Available. Next Delivery: November 2020; Estimated Recovery: March 2021,,,Demand increase for the drug,Anesthesia,Current,,
2757,Cisatracurium Besylate Injection,Abbvie,800-255-5162,"2 mg/mL, 5 mL Single-dose vial (NDC 0074-4378-05, 0074-4378-24, 0074-4378-36)",Revised,11/19/20,Product available,Please check with your wholesaler for available inventory,,Demand increase for the drug,Anesthesia,Current,,
2758,Cisatracurium Besylate Injection,Abbvie,800-255-5162,"2 mg/mL, 10 mL Multiple-dose vial (NDC 0074-4380-10, 0074-4380-79, 0074-4380-81)",Revised,11/19/20,Product available,Please check with your wholesaler for available inventory,,Demand increase for the drug,Anesthesia,Current,,
2759,Cisatracurium Besylate Injection,Abbvie,800-255-5162,"10 mg/mL, 20 mL Single-dose vial (NDC 0074-4382-20, 0074-4382-91, 0074-4382-93)",Revised,11/19/20,Limited availability,Please check with your wholesaler for available inventory,,Demand increase for the drug,Anesthesia,Current,,
2760,Cisatracurium Besylate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"20 mg / 10 mL Multiple-Dose Vial, Package of 10 vials (ndc 55150-286-10)",Reverified,11/20/20,Available,Check wholesaler for inventory,,Demand increase for the drug,Anesthesia,Current,,
2761,Cleocin-T 1%,Pfizer Pharmaceuticals,800-533-4535,Topical solution 1 x 60 pledgets (NDC 0009-3116-14),New,10/23/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/23/20,10/23/20
2762,Cleocin-T 1%,Pfizer Pharmaceuticals,800-533-4535,Topical solution 1 x 60 mL applicator bottle (NDC 0009-3116-02),New,10/23/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/23/20,10/23/20
2763,Cleocin-T 1%,Pfizer Pharmaceuticals,800-533-4535,Topical gel 1 x 60 g tube (NDC 0009-3331-01),New,10/23/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/23/20,10/23/20
2764,Cleocin-T 1%,Pfizer Pharmaceuticals,800-533-4535,Topical gel 1 x 30 g tube (NDC 0009-3331-02),New,10/23/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/23/20,10/23/20
2765,"Clindamycin Injection, USP",Mylan Institutional,800-796-9526,6 mL / vial (NDC 67457-816-06),New,10/23/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/23/20,10/23/20
2766,"Clindamycin Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,300 mg per 2 mL (150 mg per mL); SDV; (NDC 63323-282-02),New,5/10/19,,3 & 6 months dating available for direct or drop ship orders by request. Check wholesalers for inventory,,,Anti-Infective,To Be Discontinued,5/10/19,5/10/19
2767,"Clindamycin Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,600 mg per 4 mL (150 mg per mL); SDV; (NDC 63323-282-04),New,5/10/19,,6 & 8 months dating available for direct or drop ship orders by request. Check wholesalers for inventory,,,Anti-Infective,To Be Discontinued,5/10/19,5/10/19
2768,"Clindamycin Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,900 mg per 6 mL (150 mg per mL); SDV; (NDC 63323-282-06),New,5/10/19,,3 & 5 months dating available for direct or drop ship orders by request. Check wholesalers for inventory,,,Anti-Infective,To Be Discontinued,5/10/19,5/10/19
2769,"Clindamycin Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,9 grams per Pharmacy Bulk Package (150 mg per mL); (NDC 63323-282-60),New,5/10/19,,8 months dating available for direct or drop ship orders by request. Check wholesalers for inventory,,,Anti-Infective,To Be Discontinued,5/10/19,5/10/19
2770,Clindamycin Phosphate and Benzoyl Peroxide (Duac) Topical Gel,GlaxoSmithKline,888-825-5249,10 mg; 50 mg  (NDC 0145-2371-05),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of the product is approximately November 2019.,,,Dermatology,To be Discontinued,6/28/19,6/28/19
2771,Clomiphene Citrate,Teva Pharmaceuticals,800-545-8800,50 mg/1 unit tablet (NDC 0093-0041-65),New,6/10/19,,,,,Reproductive,To be Discontinued,6/10/19,6/10/19
2772,Clomiphene Citrate,Teva Pharmaceuticals,800-545-8800,50 mg/1 unit tablet (NDC 0093-0041-03),New,6/10/19,,,,,Reproductive,To be Discontinued,6/10/19,6/10/19
2773,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg  (90s)(NDC 0378-1910-77),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
2774,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg (100s)(NDC 0378-1910-01),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
2775,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg (1000s)(NDC 0378-1910-10),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
2776,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 1mg (90s)(NDC 0378-1912-77),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
2777,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 1mg (100s)(NDC 0378-1912-01),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
2778,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 1mg (1000s)(NDC 0378-1912-10),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
2779,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 2mg (100s)(NDC 0378-1914-01),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
2780,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 2mg (500s)(NDC 0378-1914-05),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
2781,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 0185-0063-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2782,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 0185-0063-05)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2783,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 1000 count bottle (NDC 0185-0063-10)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2784,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 0781-8018-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2785,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 0781-8018-05)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2786,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 1000 count bottle (NDC 0781-8018-10)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2787,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 16714-752-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Northstar Rx LLC",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2788,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 16714-752-02)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Northstar Rx LLC",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2789,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 16714-469-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Northstar Rx LLC",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2790,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 16714-469-02)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Northstar Rx LLC",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2791,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 100 count bottle (NDC 0185-0064-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2792,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 500 count bottle (NDC 0185-0064-05)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2793,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 1000 count bottle (NDC 0185-0064-10)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2794,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 100 count bottle (NDC 0781-5567-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2795,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 500 count bottle (NDC 0781-5567-05)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2796,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 1000 count bottle (NDC 0781-5567-10)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
2797,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"100 mg Tablet, 100 CT Bottle (NDC 18860-104-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
2798,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"12.5 mg tablet, 100 CT Bottle (NDC 18860-101-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
2799,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"25 mg tablets, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-102-01)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
2800,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"25 mg tablet, 100  CT bottle (NDC 18860-102-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
2801,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"100 mg tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-104-01)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
2802,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"150 mg Tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-105-01)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
2803,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"150 mg Tablet, 100 CT Bottle (NDC 18860-105-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
2804,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"200 mg Tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-106-01)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
2805,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"200 mg Tablets, 100 CT Bottle (NDC 18860-106-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
2806,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BK0/0/1.2 Replacement Solution for Continuous Renal Replacement Therapy, NON-PVC. (NDC 24571-113-06)",Reverified,10/28/20,Available,,,,Renal,Current,,
2807,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK0/2.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-108-06)",Reverified,10/28/20,Available,,,,Renal,Current,,
2808,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK4/0/1.2 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (DC 24571-114-06)",Reverified,10/28/20,Available,,,,Renal,Current,,
2809,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK4/2.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-105-06)",Reverified,10/28/20,Available,,,,Renal,Current,,
2810,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK2/3.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-103-06)",Reverified,10/28/20,Available,,,,Renal,Current,,
2811,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK2/0 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-102-06)",Reverified,10/28/20,Available,,,,Renal,Current,,
2812,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol B22GK4/0 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-111-06)",Reverified,10/28/20,Available,,,,Renal,Current,,
2813,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,PHOXILLUM BK4/2.5 Replacement Solution for Continuous Renal Replacement Therapy (NDC 24571-116-06),Reverified,10/28/20,Available,,,,Renal,Current,,
2814,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,PHOXILLUM B22K4/0 Replacement Solution for Continuous Renal Replacement Therapy (NDC 24571-117-06),Reverified,10/28/20,Available,,,,Renal,Current,,
2815,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,1 mg (NDC 0056-0169-70),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2816,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,1 mg (NDC 0056-0169-75),New,4/24/20,,Projection Cease of Commercialization: 1Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2817,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,2 mg (NDC 056-0170-70),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2818,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,2 mg (NDC 0056-0170-75),New,4/24/20,,Projection Cease of Commercialization: 1Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2819,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,2 1/2 mg (NDC 0056-0176-70),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2820,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,2 1/2 mg (NDC 0056-0176-75),New,4/24/20,,Projection Cease of Commercialization: 1Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2821,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,3 mg (NDC 0056-0188-70),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2822,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,3 mg (NDC 0056-0188-75),New,4/24/20,,Projection Cease of Commercialization: 1Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2823,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,4 mg (NDC 0056-0168-70),New,4/24/20,,Projection Cease of Commercialization: 1Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2824,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,4 mg (NDC 0056-0168-75),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2825,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,5 mg (NDC 0056-0172-70),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2826,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,5 mg (NDC 0056-0172-75),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2827,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,6 mg (NDC 0056-0189-70),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2828,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,6 mg (NDC 0056-0189-75),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2829,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,7 1/2  mg (NDC 0056-0173-70),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2830,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,7 1/2 mg (NDC 0056-0173-75),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2831,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,10 mg (NDC 0056-0174-70),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2832,Coumadin Tablets,Bristol Myers Squibb Co.,800-332-2056,10 mg (NDC 0056-0174-75),New,4/24/20,,Projection Cease of Commercialization: 2Q 2020,,,Hematology,To be Discontinued,4/24/20,4/24/20
2833,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,"CYCLOMYDRIL 0.2%, 1% 2ML (NDC 0065-0359-02)",New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
2834,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,"CYCLOMYDRIL 0.2%, 1% 5ML (NDC 0065-0359-05)",New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
2835,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 0.5% 15ML (NDC 0065-0395-15),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
2836,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 1% 2ML (NDC 0065-0396-02),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
2837,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 1% 5ML (NDC 0065-0396-05),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
2838,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 2% 2ML (NDC 0065-0397-02),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
2839,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 2% 5ML (NDC 0065-0397-05),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
2840,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 2% 15ML (NDC 0065-0397-15),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
2841,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOPENTOLATE HCL 1% 15ML (NDC 61314-396-01),New,11/9/20,Available,"Product distributed by Sandoz. Company Contact Information:
800-525-8747",,Shortage of an active ingredient,Ophthalmology,Current,,
2842,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOPENTOLATE HCL 1% 2ML (NDC 61314-396-03),New,11/9/20,Available,"Product distributed by Sandoz. Company Contact Information:
800-525-8747",,Shortage of an active ingredient,Ophthalmology,Current,,
2843,Cyclopentolate Ophthalmic Solution,Bausch & Lomb Incorporated,800-321-4576,"Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1%, 2 mL bottle (NDC 24208-735-01) and 15 mL bottle (NDC 24208-735-06)",New,11/9/20,Product available for existing clients/business,"Distributed by Bausch + Lomb, a division of Bausch Health US, LLC – 1-800-321-4576",,Other,Ophthalmology,Current,,
2844,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl 2% Oph Sol 20mg/mL, 15mL 1 Bottle (NDC 17478-097-12)",New,11/9/20,Not available/ Estimated availability March 2021,Manufacturing Delays,,Other,Ophthalmology,Current,,
2845,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl 2% Oph Sol 20mg/mL, 2mL, 1 Bottle (NDC 17478-097-02)",New,11/9/20,Not available/ Estimated availability March 2021,Manufacturing Delays,,Other,Ophthalmology,Current,,
2846,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl 2% Oph Sol 20mg/mL, 5mL 1 Bottle/EA (NDC 17478-097-10)",New,11/9/20,Not available/ Estimated availability March 2021,Manufacturing Delays,,Other,Ophthalmology,Current,,
2847,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl Opht Sol 1% 10mg/mL, 2mL, 1 Bottle (NDC 17478-100-02)",New,11/9/20,Not available/ Estimated availability March 2021,Manufacturing Delays,,Other,Ophthalmology,Current,,
2848,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl Ophth 1% 10mg/mL, 15mL, 1 Bottle (NDC 17478-100-12)",New,11/9/20,Not available/ Estimated availability March 2021,Manufacturing Delays,,Other,Ophthalmology,Current,,
2849,Cysteamine Hydrochloride Ophthalmic Solution,"Leadiant Biosciences, Inc.",866-634-2765,"0.44%, 15 mL bottle (NDC 54482-020-01)",New,10/27/20,Shortage anticipated from November 2020; Estimated shortage duration:  Unknown,"For more information please contact 1-866-634-2765, Leadiant@tmac.com, or go to  www.leadiant.com",,Delay in manufacturing,Ophthalmology,Current,,
2850,Cysteine Hydrochloride Injection,"Exela Pharma Sciences, LLC",828-758-5474 ext. 154 or 230,Elcys (Cysteine Hydrochloride injection) 500mg/10ml Single-dose vials (NDC 51754-1007-1) Packaged as 10 per carton (NDC 51754-1007-3),Revised,9/3/19,,,Available,,Other;Pediatric,Resolved,9/3/19,
2851,Darifenacin Extended-release Tablets,Teva Pharmaceuticals,800-545-8800,"7.5 mg, 30 count bottle (NDC 0591-4375-30)",New,6/26/20,,Discontinuation of manufacturing,,,Urology,To be Discontinued,6/26/20,6/26/20
2852,Darifenacin Extended-release Tablets,Teva Pharmaceuticals,800-545-8800,"15 mg, 30 count bottle (NDC 0591-4380-30)",New,6/26/20,,Discontinuation of manufacturing,,,Urology,To be Discontinued,6/26/20,6/26/20
2853,Darifenacin Hydrobromide Tablets,Teva Pharmaceuticals,800-545-8800,"Extended release, 7.5 mg, 90 count bottle (NDC 0591-4375-19)",New,6/17/20,,Discontinuance of Manufacturing,,,Urology,To be Discontinued,6/17/20,6/17/20
2854,Darifenacin Hydrobromide Tablets,Teva Pharmaceuticals,800-545-8800,"15 mg, 30 count bottle (NDC: 0591-4380-30)",New,6/17/20,,Discontinuance of Manufacturing,,,Urology,To be Discontinued,6/17/20,6/17/20
2855,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg, Bottle of 30 (NDC 0430-0171-15)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
2856,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg, Bottle of  90 (NDC 0430-0171-23)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
2857,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg , 337500 TABLETS in 1 DRUM (NDC 0430-0171-00)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
2858,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg, Bottle of 7 (NDC 0430-0171-96)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
2859,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg Bottle of 30 (NDC 0430-0170-15)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
2860,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg Bottle of  90 (NDC 0430-0170-23)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
2861,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg, 337500 TABLETS in 1 DRUM (NDC 0430-0170-00)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
2862,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg, Bottle of 7 (NDC 0430-0170-96)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
2863,Darifenacin Hydrobromide Tablets,Par Pharmaceutical,800-828-9393,"Extended-Release Tablet, 15 mg Bottle of 30, (NDC 10370-171-11)",New,10/30/19,,Par has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,10/30/19,10/30/19
2864,Darifenacin Hydrobromide Tablets,Par Pharmaceutical,800-828-9393,"Extended-Release Tablet, 15 mg Bottle of 90 (NDC 10370-171-09)",New,10/30/19,,Par has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,10/30/19,10/30/19
2865,Darifenacin Hydrobromide Tablets,Par Pharmaceutical,800-828-9393,"Extended-Release Tablet, 7.5 mg Bottle of 30 (NDC 10370-170-11)",New,10/30/19,,Par has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,10/30/19,10/30/19
2866,Darifenacin Hydrobromide Tablets,Par Pharmaceutical,800-828-9393,"Extended-Release Tablet, 7.5 mg Bottle of 90 (NDC 10370-170-09)",New,10/30/19,,Par has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,10/30/19,10/30/19
2867,Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir (Viekira XR) Tablets,Abbvie,800-255-5162,"200mg; 8.33mg; 50mg; 33.33 tablets, (NDC 0074-0063-28)",New,5/22/18,,"Estimated product availability until January 1, 2019. The product discontinuation is voluntary.",,,Antiviral,To be Discontinued,5/22/18,5/22/18
2868,Deferasirox Tablets,Teva Pharmaceuticals,800-545-8800,180 mg/1 (NDC 00093-3516-56),New,7/20/20,,Teva had evaluated the market and made a business decision to discontinue the product.,,,Hematology,To be Discontinued,7/20/20,7/20/20
2869,Deferasirox Tablets,Teva Pharmaceuticals,800-545-8800,90 mg/1 (NDC 00093-3517-56),New,7/20/20,,Teva had evaluated the market and made a business decision to discontinue the product.,,,Hematology,To be Discontinued,7/20/20,7/20/20
2870,Deferasirox Tablets,Teva Pharmaceuticals,800-545-8800,360 mg/1 (NDC 00093-3515-56),New,7/20/20,,Teva had evaluated the market and made a business decision to discontinue the product.,,,Hematology,To be Discontinued,7/20/20,7/20/20
2871,"Deferoxamine Mesylate for Injection, USP","ApoPharma USA, Inc.",866-931-0740,"500 mg per vial, Single use vial, Carton of 4 vials (NDC 52609-4505-6)",Revised,9/10/19,,,,,Hematology,Resolved,9/10/19,
2872,"Deferoxamine Mesylate for Injection, USP","ApoPharma USA, Inc.",866-931-0740,"2 g per vial, Single use vial, Carton of 4 vials (NDC 52609-4504-6)",Revised,9/10/19,,,,,Hematology,Resolved,9/10/19,
2873,"Deferoxamine Mesylate for Injection, USP","Hospira, Inc.",844-646-4398,500 mg; Single Dose Glass Fliptop Vial (NDC 00409-2336-10),Revised,9/10/19,,,,,Hematology,Resolved,9/10/19,
2874,"Deferoxamine Mesylate for Injection, USP","Hospira, Inc.",844-646-4398,2 g; Single Dose Glass Fliptop Vial (NDC 00409-2337-25),Revised,9/10/19,,,,,Hematology,Resolved,9/10/19,
2875,"Deferoxamine Mesylate for Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"500 mg per vial, 10 mL vial (NDC 63323-597-10)",Revised,9/10/19,,,,,Hematology,Resolved,9/10/19,
2876,Delavirdine Mesylate (RESCRIPTOR) Tablets,ViiV Healthcare,877-844-8872,200 mg tablets; bottles of 180 tablets (NDC 49702-225-17),New,6/26/19,,This decision is business-related and the anticipated final date for availability to patients is January 2020.,,,Antiviral,To be Discontinued,6/26/19,6/26/19
2877,"Demeclocycline Hydrochloride Tablets, USP",Teva Pharmaceuticals,800-545-8800,150 mg 100 count (NDC 0555-0701-02),New,4/21/20,,Teva had evaluated the market and decided to discontinue the product.,,,Anti-Infective,To be Discontinued,4/21/20,4/21/20
2878,"Demeclocycline Hydrochloride Tablets, USP",Teva Pharmaceuticals,800-545-8800,300 mg 48 count (NDC 0555-0702-84),New,4/21/20,,Teva had evaluated the market and decided to discontinue the product.,,,Anti-Infective,To be Discontinued,4/21/20,4/21/20
2879,Desloratadine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count bottle (NDC 0378-4017-01)",New,5/2/19,,,,,Pulmonary/Allergy,To be Discontinued,5/2/19,5/2/19
2880,Desloratadine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 500 count bottle (NDC 0378-4017-05)",New,5/2/19,,,,,Pulmonary/Allergy,To be Discontinued,5/2/19,5/2/19
2881,Desogestrel and Ethinyl Estradiol Tablets (ORTHO-CEPT),Janssen Pharmaceuticals,800-526-7736,ORTHO-CEPT (NDC 50458-196-15),Revised,10/8/14,,Product will be delisted. Last distribution March 2015.,,Discontinuation of the manufacture of the drug.,,To Be Discontinued,10/8/14,
2882,Dexamethasone Sodium Phosphate Injection,Mylan Institutional,800-796-9526,Dexamethasone Sodium Phosphate Injection SDV [4 mg / 1 ml] 25PK (NDC 67457-423-12),Reverified,11/10/20,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2883,Dexamethasone Sodium Phosphate Injection,Mylan Institutional,800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [20 mg / 5 ml] 25PK (NDC 67457-422-54),Reverified,11/10/20,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2884,Dexamethasone Sodium Phosphate Injection,Mylan Institutional,800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [120 mg / 30 ml] 25 PK (NDC 67457-421-30),Reverified,11/10/20,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2885,Dexamethasone Sodium Phosphate Injection,Mylan Institutional,800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [100 mg / 10 ml] 10PK (NDC 67457-420-10),Reverified,11/10/20,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2886,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,4 mg/1 mL SDV (NDC 55150-237-01),Revised,11/20/20,Backordered — next shipment TBD,Sporadic availability expected.,,Delay in shipping of the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2887,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,20 mg/5 mL MDV  (NDC 55150-238-05),Revised,11/20/20,Backordered — next shipment TBD,Sporadic availability expected.,,Delay in shipping of the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2888,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,120 mg/30 mL MDV (NDC 55150-239-30),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2889,Dexamethasone Sodium Phosphate Injection,"Somerset Therapeutics, LLC",732-554-1019,"Dexamethasone Sodium Phosphate Injection USP, 10 mg/mL, 1 mL Single Dose Vial (Preservative Free)(NDC 70069-021-25)",Reverified,9/11/20,Currently in Stock (we have capacity constraint but product available at this time). Estimated Release Dates: Released Product Available,,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2890,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,20 mg per 5 mL (4 mg per mL); MDV;  Amber vial (NDC 63323-165-05),Revised,11/16/20,"3, 4, 5 month expiry available by request.  Next release November 2020.",Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2891,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mg per 10 mL (10 mg per mL); MDV;  Amber Vial (NDC 63323-516-10),Revised,11/16/20,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2892,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,120 mg per 30 mL (4 mg per mL); MDV; Amber Vial (NDC 63323-165-30),Revised,11/16/20,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2893,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,4 mg per mL (4 mg per mL); SDV; Amber Vial (NDC 63323-165-01),Revised,11/16/20,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2894,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 mg per mL (10 mg per mL); SDV; Preservative Free; Amber Vial (NDC 63323-506-01),Revised,11/16/20,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2895,Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 1 mL vial (NDC 0641-6145-25)",Reverified,9/17/20,This presentation is temporarily on backorder.,Shortage duration is unknown at this time.,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2896,Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 5 mL vial (NDC 0641-6146-25)",Reverified,9/17/20,This presentation is temporarily on backorder.,Shortage duration is unknown at this time.,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2897,Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 1 mL vial (NDC 0641-0367-25)",Reverified,9/17/20,This presentation is temporarily on backorder.,Shortage duration is unknown at this time.,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2898,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,10 mg/1 mL SDV (NDC 55150-304-25),Revised,11/20/20,Initial availability targeted for end of November 2020,Sporadic availability expected.,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2899,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,100 mg/10 mL MDV (contains preservative)(NDC 55150-305-10),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2900,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single dose Simplist syringe, preservative free (NDC 76045-106-10)",Reverified,10/23/20,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2901,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single dose Simplist syringe, preservative free (NDC 76045-109-10)",Reverified,10/23/20,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
2902,Dexmedetomidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mcg/mL, 2 mL vial (NDC 0143-9532-25)",Revised,8/20/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
2903,Dexmedetomidine Injection,Sandoz,800-525-8747,"200 mcg/2 mL (100 mcg/mL) vial, box of 10 (NDC 0781-3297-95)",New,4/13/20,,Permanent Discontinuation,,,Anesthesia,To be Discontinued,4/13/20,4/13/20
2904,Dexmedetomidine Injection,Accord Healthcare Inc.,800-843-7477,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 16729-239-93)",Revised,11/3/20,Available,,,,Anesthesia,Current,,
2905,Dexmedetomidine Injection,Accord Healthcare Inc.,800-843-7477,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 16729-432-93), Novaplus",Revised,11/3/20,Available,,,,Anesthesia,Current,,
2906,Dexmedetomidine Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 55150-209-02)",Revised,11/20/20,Currently on backorder - next shipment anticipated end of Nov 20,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
2907,Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 24 (NDC 0338-9555-24)",Reverified,10/28/20,Available,,,,Anesthesia,Current,,
2908,Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 12 (NDC 0338-9557-12)",Reverified,10/28/20,Available,,,,Anesthesia,Current,,
2909,Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 24 (NDC 43066-555-24), Novaplus",Reverified,10/28/20,Available,,,,Anesthesia,Current,,
2910,Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 12 (NDC 43066-557-12), Novaplus",Reverified,10/28/20,Available,,,,Anesthesia,Current,,
2911,Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"80 mcg/20 mL (4 mcg/mL) in 0.9% sodium chloride, single dose vial, box of 10 (NDC 63323-671-20)",Reverified,11/16/20,Backordered. Next release December 2020.,,,Demand increase for the drug,Anesthesia,Current,,
2912,Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 25 (NDC 63323-671-50)",Reverified,11/16/20,Backordered. Next release December 2020.,,,Demand increase for the drug,Anesthesia,Current,,
2913,Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 63323-671-00)",Reverified,11/16/20,Backordered. Next release December 2020.,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
2914,Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 63323-421-02)",Reverified,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
2915,Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"400 mcg/4 mL (100 mcg/mL), multi-dose vial, box of 4 (NDC 44567-600-04)",Revised,11/18/20,Available,Distributed by WG Critical Care. Please contact WG Critical Care at 888-493-0861.,,Demand increase for the drug,Anesthesia,Current,,
2916,Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"1000 mcg/10 mL (100 mcg/mL), multi-dose vial, box of 4 (NDC 44567-601-04)",Revised,11/18/20,Available,Distributed by WG Critical Care. Please contact WG Critical Care at 888-493-0861.,,Demand increase for the drug,Anesthesia,Current,,
2917,Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"200 mcg/50 mL (4 mcg/mL), single dose bag, box of 24 (NDC 44567-602-24)",Revised,11/18/20,Available,Distributed by WG Critical Care. Please contact WG Critical Care at 888-493-0861.,,Demand increase for the drug,Anesthesia,Current,,
2918,Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"400 mcg/100 mL (4 mcg/mL), box of 24 (NDC 44567-603-24)",Revised,11/18/20,Available,Distributed by WG Critical Care. Please contact WG Critical Care at 888-493-0861.,,Demand increase for the drug,Anesthesia,Current,,
2919,Dexmedetomidine Injection,Jiangsu Hengrui Medicine Co. Ltd.,Athenex: 855-273-0154,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 70860-605-03)",Reverified,10/27/20,Available,"Distributed by Athenex. To order, contact Athenex at 855-273-0154.",,Demand increase for the drug,Anesthesia,Current,,
2920,Dexmedetomidine Injection,Mylan Institutional,800-RXMYLAN (1-800-796-9526),"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 67457-251-02)",Reverified,11/10/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
2921,Dexmedetomidine Injection,Par Pharmaceutical,800-828-9393,"100 mcg/mL, 2 mL single dose vial, box of 25 (NDC 42023-146-25)",Reverified,11/5/20,Available,Please check wholesalers for supply,,,Anesthesia,Current,,
2922,Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"80 mcg/20 mL (4 mcg/mL) in 0.9% sodium chloride, single dose vial, box of 10 (NDC 0409-1660-20)",Reverified,11/20/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
2923,Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 20 (NDC 0409-1660-50)",Reverified,11/20/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
2924,Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 0409-1660-10)",Reverified,11/20/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
2925,Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 0409-1638-02)",Reverified,11/20/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
2926,Dexmedetomidine Injection,Slayback Pharma,844-566-2505,"4 mcg/mL in 0.9% sodium chloride, 50 mL single dose bottle, box of 20 (NDC 71225-126-05)",Revised,10/27/20,"Currently on backorder, estimated to continue until Dec 2020.",,,Demand increase for the drug,Anesthesia,Current,,
2927,Dexmedetomidine Injection,Slayback Pharma,844-566-2505,"4 mcg/mL in 0.9% sodium chloride, 100 mL single dose bottle, box of 10 (NDC 71225-126-06)",Revised,10/27/20,"Currently on backorder, estimated to continue until Dec 2020.",,,Demand increase for the drug,Anesthesia,Current,,
2928,Dexmethylphenidate Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,10 mg 100 Count (NDC 0093-5277-01),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Neurology,To be Discontinued,5/17/19,5/17/19
2929,Dexmethylphenidate Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,2.5 mg 100 Count (NDC 0093-5275-01),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Neurology,To be Discontinued,5/17/19,5/17/19
2930,Dexmethylphenidate Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,5 mg 100 Count (NDC 0093-5276-01),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Neurology,To be Discontinued,5/17/19,5/17/19
2931,Dexrazoxane Injection,Gland Pharma,609-250-7990,500 mg per vial (NDC 72266-101-01); distributed by Fosun Pharma USA Inc.,Revised,2/26/20,,,Available,,Oncology;Pediatric,Resolved,2/26/20,
2932,Dexrazoxane Injection,Gland Pharma,609-250-7990,"500 mg per vial (NDC 51991-942-98); distributed by Breckenridge Pharmaceutical, Inc.",New,2/26/20,,,,,Oncology;Pediatric,Resolved,2/26/20,
2933,Dexrazoxane Injection,Gland Pharma,609-250-7990,"500 mg per vial (NDC 47781-578-07); distributed by Alvogen, Inc.",New,2/26/20,,,,,Oncology;Pediatric,Resolved,2/26/20,
2934,Dexrazoxane Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,250 mg per vial (NDC 0143-9247-01); distributed by West-Ward,Revised,2/26/20,,,Available,,Oncology;Pediatric,Resolved,2/26/20,
2935,Dexrazoxane Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg per vial (NDC 0143-9248-01); distributed by West-Ward,Revised,2/26/20,,,Available,,Oncology;Pediatric,Resolved,2/26/20,
2936,Dexrazoxane Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),250 mg Kit (NDC 67457-207-25),Revised,2/26/20,,,Available,,Oncology;Pediatric,Resolved,2/26/20,
2937,Dexrazoxane Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),500 mg Kit (NDC 67457-208-50),Revised,2/26/20,,,Available,,Oncology;Pediatric,Resolved,2/26/20,
2938,Dexrazoxane Injection,Pfizer Pharmaceuticals,844-646-4398,Zinecard 250 mg; Single Dose Vial (NDC 0013-8717-62),Revised,2/26/20,,,Available,,Oncology;Pediatric,Resolved,2/26/20,
2939,Dexrazoxane Injection,Clinigen Healthcare Ltd,615-255-0068,Totect® (Dexrazoxane) for injection; 1 vial (500 mg)(NDC 66220-110-01); distributed by Cumberland Pharmaceuticals,Revised,2/26/20,,,Available,,Oncology;Pediatric,Resolved,2/26/20,
2940,Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100s (NDC 0378-1070-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric;Psychiatry,To be Discontinued,5/8/18,5/8/18
2941,Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100s (NDC 0378-1071-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric;Psychiatry,To be Discontinued,5/8/18,5/8/18
2942,Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 100s (NDC 0378-1072-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric;Psychiatry,To be Discontinued,5/8/18,5/8/18
2943,Dextrose 25% Injection,"Hospira, Inc.",844-646-4398,250 mg/mL (25%); Ansyr Plastic Syringe (NDC 0409-1775-10),Reverified,11/20/20,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
2944,Dextrose 5% Injection Bags,Baxter Healthcare,800-229-0001,"5% Dextrose Injection, USP, in VIAFLO container Product codes:  UE0062D (250mL, NDC 0338-0062-30); UE0063D (500mL, NDC 0338-0066-20); UE0064D (1000mL, NDC 0338-0070-10)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2945,Dextrose 5% Injection Bags,Baxter Healthcare,800-229-0001,"5% Dextrose Injection, USP, 25 mL, in VIAFLEX Plastic Container. Quad Pack.  Product code 2B0080  (NDC 0338-0017-10)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2946,Dextrose 5% Injection Bags,Baxter Healthcare,800-229-0001,"5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, in VIAFLEX Plastic Container.  Single Pack. Product code EZPB0041 (NDC 0338-9147-30)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2947,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 250 mL VIAFLEX Plastic Container.  Product code 2B0062Q  (NDC 0338-0017-02)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2948,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 500 mL VIAFLEX Plastic Container.  Product code 2B0063Q  (NDC 0338-0017-03)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2949,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 1000 mL VIAFLEX Plastic Container. Product code 2B0064X  (NDC 0338-0017-04)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2950,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 250 mL AVIVA Container.  Product code 6E0062 (NDC 0338-6346-02)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2951,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 500 mL AVIVA Container. Product code 6E0063  (NDC 0338-6346-03)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2952,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,250 mL (NDC 0409-7922-02),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2953,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,500 mL (NDC 0409-7922-03),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2954,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,1000 mL (NDC 0409-7922-09),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2955,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,250 mL VisIV™ Container (NDC 0409-7922-25),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2956,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,250 mL (NDC 0409-7922-53),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2957,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,500 mL (NDC 0409-7922-55),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2958,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,150 mL (NDC 0409-7922-61),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2959,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,50 mL VisIV™ Container (NDC 0409-7923-06),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2960,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,100 mL VisIV™ Container (NDC 0409-7923-11),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2961,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,50 mL (NDC 0409-7923-13),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2962,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,"25 mL, Quad Pack (NDC 0409-7923-20)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2963,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,100 mL (NDC 0409-7923-23),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2964,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,"50 mL, Quad Pack (NDC 0409-7923-36)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2965,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,"100 mL, Quad Pack (NDC 0409-7923-37)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2966,Dextrose 5% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, USP, 100mL 
(NDC 63323-624-61)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2967,Dextrose 5% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, USP, 250mL 
(NDC 63323-624-74)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2968,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 50 mL, in VIAFLEX Plastic Container: Single Pack (NDC 0338-0017-41)
Quad Pack (NDC 0338-0017-11)
Multi Pack (NDC 0338-0017-31)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2969,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 100 mL, in VIAFLEX Plastic Container: Single Pack (NDC 0338-0017-48)
Quad Pack (NDC 0338-0017-18
Multi Pack (NDC 0338-0017-38)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2970,Dextrose 5% Injection Bags,"Hospira, Inc.",844-646-4398,50 mL (5%); ADD-Vantage Flexible Container (NDC 00409-7100-66),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2971,Dextrose 5% Injection Bags,"Hospira, Inc.",844-646-4398,100 mL (5%); ADD-Vantage Flexible Container (NDC 00409-7100-67),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2972,Dextrose 5% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, USP, 500mL 
(NDC 63323-624-75)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2973,Dextrose 5% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, USP, 1000mL 
(NDC 63323-624-10)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2974,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, in MINI-BAG Plus container, 50 mL,  Product code 2B0040 (NDC 0338-0551-11)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2975,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, in MINI-BAG Plus container, 100 mL,  Product code 2B0041 (NDC 0338-0551-18)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
2976,Dextrose 50% Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"DEXTROSE INJECTION, USP, 50%, [500 mg / mL](NDC 76329-3301-1)",Reverified,10/30/20,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,9/23/19,
2977,Dextrose 50% Injection,"Hospira, Inc.",844-646-4398,25 g/50 mL (50%; 0.5 g/mL); LifeShield Abboject Glass Syringe (NDC 0409-4902-34),Revised,11/20/20,Limited Supply Available. Next Delivery and Estimated Recovery: November 2020,Shortage per Manufacturer: Manufacturing Delay,,,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,9/23/19,
2978,Dextrose 50% Injection,"Hospira, Inc.",844-646-4398,25 g/50 mL (50%; 0.5 g/mL); Single Dose Glass Fliptop Vial (NDC 0409-6648-02),Revised,11/20/20,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,9/23/19,
2979,Dextrose 50% Injection,"Hospira, Inc.",844-646-4398,25 g/50 mL (50%; 0.5 g/mL); Ansyr Plastic Syringe (NDC 0409-7517-16),Revised,11/20/20,Limited Supply Available. Next Delivery and Estimated Recovery: November 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
2980,"Diazepam Injection, USP","Hospira, Inc.",844-646-4398,10 mg/2 mL (5 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1273-32),Revised,12/17/19,,,,,Neurology,Resolved,12/17/19,
2981,"Diazepam Injection, USP","Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-3213-12),Revised,12/17/19,,,,,Neurology,Resolved,12/17/19,
2982,"Diazepam Injection, USP","Beloteca, Inc.",512-669-8765,"Diazepam Injection, USP 10 mg/2 mL (5 mg/mL) Prefilled Single-dose Syringe with Luer Lock (NDC 69339-136-32)",Revised,12/17/19,,,,,Neurology,Resolved,12/17/19,
2983,Diclofenac Sodium Extended Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,100 mg (NDC 0378-0355-01),New,4/4/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction;Rheumatology,To be Discontinued,4/4/18,4/4/18
2984,Diclofenac Sodium Topical Gel,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",1% topical gel (NDC 49884-935-47),New,2/13/20,,,,,Analgesia/Addiction,To be Discontinued,2/13/20,2/13/20
2985,Diclofenac Sodium Topical Solution,Apotex Corp.,800-706-5575,2% topical solution (NDC 60505-0399-5),New,5/6/20,,,,,Analgesia/Addiction,To be Discontinued,5/6/20,5/6/20
2986,Dicyclomine Hydrochloride (BENTYL®) Capsule & Tablet,Allergan Sales LLC,800-678-1605,10 mg capsules in bottles of 100 (NDC 58914-012-10),New,3/29/19,,Product discontinued October 2017,,,Gastroenterology,To be Discontinued,3/29/19,3/29/19
2987,Dicyclomine Hydrochloride (BENTYL®) Capsule & Tablet,Allergan Sales LLC,800-679-1605,20 mg tablets in bottles of 100 (NDC 58914-013-10),New,3/29/19,,Product discontinued December 2016,,,Gastroenterology,To be Discontinued,3/29/19,3/29/19
2988,Dicyclomine Oral Tablets/Capsules,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Dicyclomine HCl Caps, USP, 10mg 1000s (NDC 0143-3126-10)",Reverified,7/22/20,Available,,,,Gastroenterology,Current,,
2989,Dicyclomine Oral Tablets/Capsules,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Dicyclomine HCl Caps, USP, 10mg 100s (NDC 0143-3126-01)",Reverified,7/22/20,Available,,,,Gastroenterology,Current,,
2990,Dicyclomine Oral Tablets/Capsules,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Dicyclomine HCl Tabs, USP, 20mg 1000s (NDC 0143-1227-10)",Reverified,7/22/20,Available,,,,Gastroenterology,Current,,
2991,Dicyclomine Oral Tablets/Capsules,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Dicyclomine HCl Tabs, USP, 20mg 100s (NDC 0143-1227-01)",Reverified,7/22/20,Available,,,,Gastroenterology,Current,,
2992,Dicyclomine Oral Tablets/Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Dicyclomine HCl 10mg C 100s (NDC 0378-1610-01),Reverified,11/10/20,Available,,,Other,Gastroenterology,Current,,
2993,Dicyclomine Oral Tablets/Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Dicyclomine HCl 10mg C 500s (NDC 0378-1610-05),Reverified,11/10/20,Available,,,Other,Gastroenterology,Current,,
2994,Dicyclomine Oral Tablets/Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Dicyclomine HCl 20mg T 100s (NDC 0378-1620-01),Reverified,11/10/20,Out of Stock. Resupply TBD.,,,Other,Gastroenterology,Current,,
2995,Dicyclomine Oral Tablets/Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Dicyclomine HCl 20mg T 500s (NDC 0378-1620-05),Reverified,11/10/20,Out of Stock. Resupply TBD.,,,Other,Gastroenterology,Current,,
2996,Dicyclomine Oral Tablets/Capsules,"Lannett Company, Inc.",215-333-9000,"Dicyclomine Hydrochloride Capsules USP, 10 mg (100 count bottles) (NDC 0527-0586-01)",Reverified,11/12/20,Available,,,,Gastroenterology,Current,,
2997,Dicyclomine Oral Tablets/Capsules,"Lannett Company, Inc.",215-333-9000,"Dicyclomine Hydrochloride Capsules USP, 10 mg (1000 count bottles) (NDC 0527-0586-10)",Reverified,11/12/20,Available,,,,Gastroenterology,Current,,
2998,Dicyclomine Oral Tablets/Capsules,"Lannett Company, Inc.",215-333-9000,"Dicyclomine Hydrochloride Tablets USP, 20 mg (100 count bottles) (NDC 0527-1282-01)",Reverified,11/12/20,Available,,,,Gastroenterology,Current,,
2999,Dicyclomine Oral Tablets/Capsules,"Lannett Company, Inc.",215-333-9000,"Dicyclomine Hydrochloride Tablets USP, 20 mg (1000 count bottles) (NDC 0527-1282-10)",Reverified,11/12/20,Available,,,,Gastroenterology,Current,,
3000,Dicyclomine Oral Tablets/Capsules,Teva Pharmaceuticals,800-545-8800,DICYCLOMINE HCL 10MG CAPSULES 100 count (NDC 0591-0794-01),Reverified,11/19/20,Available,,,,Gastroenterology,Current,,
3001,Dicyclomine Oral Tablets/Capsules,Teva Pharmaceuticals,800-545-8800,DICYCLOMINE HCL 10MG CAPSULES 1000 count (NDC 0591-0794-10),Reverified,11/19/20,Available,,,,Gastroenterology,Current,,
3002,Dicyclomine Oral Tablets/Capsules,Teva Pharmaceuticals,800-545-8800,DICYCLOMINE HCL 20MG TABLETS 100 count (NDC 0591-0795-01),Reverified,11/19/20,Available,,,,Gastroenterology,Current,,
3003,Dicyclomine Oral Tablets/Capsules,Teva Pharmaceuticals,800-545-8800,DICYCLOMINE HCL 20MG TABLETS 1000 count (NDC 0591-0795-10),Reverified,11/19/20,Available,,,,Gastroenterology,Current,,
3004,Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 200 mg, 30 count bottles (NDC 0555-0588-01)",New,5/9/18,,This was a business-related decision to discontinue manufacturing these products,,,Antiviral,To be Discontinued,5/9/18,5/9/18
3005,Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 250 mg, 30 count bottles (NDC 0555-0589-01)",New,5/9/18,,This was a business-related decision to discontinue manufacturing these products,,,Antiviral,To be Discontinued,5/9/18,5/9/18
3006,Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 400 mg, 30 count bottles (NDC 0555-0590-01)",New,5/9/18,,This was a business-related decision to discontinue manufacturing these products,,,Antiviral,To be Discontinued,5/9/18,5/9/18
3007,Didanosine Delayed-Release Capsules USP,Bristol Myers Squibb Co.,800-332-2056,"VIDEX EC Cpasules, 125 mg (NDC 0087-6671-17)",New,2/24/20,,"This discontinnuation is due to a marketing decision. Discontinuation date: March 31, 2020",,,Antiviral,To be Discontinued,2/24/20,2/24/20
3008,Didanosine Delayed-Release Capsules USP,Bristol Myers Squibb Co.,800-332-2056,"VIDEX EC Capsules, 200 mg (NDC 0087-6672-17)",New,2/24/20,,"This discontinuation is due to a marketing decision. Discontinuation date: February 14, 2020",,,Antiviral,To be Discontinued,2/24/20,2/24/20
3009,Didanosine Delayed-Release Capsules USP,Bristol Myers Squibb Co.,800-332-2056,"VIDEX EC Capsules, 250 mg (NDC 0087-6673-17)",New,2/24/20,,"This discontinuation is due to a marketing decision. Discontinuation date: March 31, 2020",,,Antiviral,To be Discontinued,2/24/20,2/24/20
3010,Didanosine Delayed-Release Capsules USP,Bristol Myers Squibb Co.,800-332-2056,"VIDEX EC Capsules, 400 mg (NDC 0087-6674-17)",New,2/24/20,,"This discontinuation is due to a marketing decision. Discontinuation date: November 20, 2019",,,Antiviral,To be Discontinued,2/24/20,2/24/20
3011,Didanosine Delayed-Release Capsules USP,Bristol Myers Squibb Co.,800-332-2056,VIDEX PED PWD 2 g (1 bottle) 4 oz (NDC 0087-6632-41),New,2/24/20,,"This discontinuation is due to a marketing decision. Discontinuation date: March 31, 2020",,,Antiviral,To be Discontinued,2/24/20,2/24/20
3012,Didanosine Delayed-Release Capsules USP,Bristol Myers Squibb Co.,800-332-2056,VIDEX PED PWD 4 g (1 bottle) 8 oz (NDC 0087-6633-41),New,2/24/20,,"This discontinuation is due to a marketing decision. Discontinuation date: May 31, 2019",,,Antiviral,To be Discontinued,2/24/20,2/24/20
3013,Diethylpropion Hydrochloride Controlled-Release Tablets,Teva Pharmaceuticals,800-545-8800,75 mg tablets (NDC 0591-0782-01),New,6/11/19,,This product discontinuation is a business related decision.,,,Endocrinology/Metabolism,To be Discontinued,6/11/19,6/11/19
3014,Diethylpropion Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,25 mg tablets (NDC 0591-0783-01),New,6/11/19,,This product discontinuation is a business related decision.,,,Endocrinology/Metabolism,To be Discontinued,6/11/19,6/11/19
3015,Difluprednate (Durezol) Ophthalmic Emulsion,Novartis,888-669-6682,0.05% 5mL in 8mL bottle (NDC 0065-9204-07),Revised,10/15/19,,,,,Ophthalmology,Resolved,10/15/19,
3016,Diltiazem Hydrochloride,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,25 mg/5mL vial (NDC 70860-301-05),Reverified,10/27/20,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,,Cardiovascular,Current,,
3017,Diltiazem Hydrochloride,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,50 mg/10mL vial (NDC 70860-301-10),Reverified,10/27/20,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,,Cardiovascular,Current,,
3018,Diltiazem Hydrochloride,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,125 mg/25mL vial (NDC 70860-301-25),Reverified,10/27/20,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,,Cardiovascular,Current,,
3019,Diltiazem Hydrochloride,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 5 mL vial  (NDC 0641-6013-10)",Revised,7/22/20,Inventory is currently available.,Additional lots will be scheduled for manufacturing.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
3020,Diltiazem Hydrochloride,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 10 mL vial (NDC 0641-6014-10)",Revised,7/22/20,Product is currently on allocation.,Additional lots will be scheduled for manufacturing.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
3021,Diltiazem Hydrochloride,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 30 mL vial (NDC 0641-6015-10)",Revised,7/22/20,This presentation is temporarily on backorder,Additional lots will be scheduled for manufacturing.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
3022,Diltiazem Hydrochloride,"Hospira, Inc.",844-646-4398,100 mg; Single Dose ADD-Vantage Vial (NDC 00409-4350-03),Reverified,11/20/20,Available,,,Other,Cardiovascular,Current,,
3023,Diltiazem Hydrochloride,"Hospira, Inc.",844-646-4398,25 mg/5 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1171-01),Reverified,11/20/20,Next Delivery and Estimated Recovery: February 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
3024,Diltiazem Hydrochloride,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1171-02),Reverified,11/20/20,Available,,,Other,Cardiovascular,Current,,
3025,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 10 mL, 10 vials (NDC 17478-0937-10)",Revised,2/7/20,Backorder. Estimated recovery March 2020.,,,Demand increase for the drug,Cardiovascular,Current,,
3026,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection (Premier) 25 mg / 5 mL, 10 mL, 10 vials (NDC 17478-0817-10)",Revised,2/7/20,,This product discontinuation is a business related decision.,,,Cardiovascular,To be Discontinued,2/7/20,2/7/20
3027,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection (Premier) 5 mg / mL, 25 mL, 1 vial (NDC 17478-0817-25)",Revised,2/7/20,,This product discontinuation is a business related decision.,,,Cardiovascular,To be Discontinued,2/7/20,2/7/20
3028,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection (Premier) 5 mg / mL, 25 mL, 10 vials (NDC 17478-0817-26)",Revised,2/7/20,,This product discontinuation is a business related decision.,,,Cardiovascular,To be Discontinued,2/7/20,2/7/20
3029,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 1 vial (NDC 17478-0937-25)",Revised,2/7/20,Backorder. Estimated recovery March 2020.,,,Demand increase for the drug,Cardiovascular,Current,,
3030,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 10 vials (NDC 17478-0937-26)",Revised,2/7/20,Backorder. Estimated recovery March 2020,,,Demand increase for the drug,Cardiovascular,Current,,
3031,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 5 mL, 10 vials (NDC 17478-0937-05)",Revised,2/7/20,Backorder. Estimated recovery March 2020.,,,Demand increase for the drug,Cardiovascular,Current,,
3032,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection (Premier) 0.5 mg / mL, 30 gram, 10 vials (NDC 17478-0817-05)",Revised,2/7/20,,This product discontinuation is a business related decision.,,,Cardiovascular,To be Discontinued,2/7/20,
3033,Diltiazem Hydrochloride ER (Twice-a-Day) Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,60 mg (NDC 0378-6060-01),Revised,2/20/20,,,,,Cardiovascular,Resolved,2/20/20,
3034,Diltiazem Hydrochloride ER (Twice-a-Day) Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,90 mg (NDC 0378-6090-01),Revised,2/20/20,,,,,Cardiovascular,Resolved,2/20/20,
3035,Diltiazem Hydrochloride ER (Twice-a-Day) Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,120 mg (NDC 0378-6120-01),Revised,2/20/20,,,,,Cardiovascular,Resolved,2/20/20,
3036,Diltiazem Hydrochloride Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"120 mg, 100 count bottle (NDC 0378-5220-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
3037,Diltiazem Hydrochloride Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"120 mg, 500 count bottle (NDC 0378-5220-05)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
3038,Diltiazem Hydrochloride Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"180 mg, 100 count bottle (NDC 0378-5280-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
3039,Diltiazem Hydrochloride Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"180 mg, 500 count bottle (NDC 0378-5280-05)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
3040,Diltiazem Hydrochloride Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"240 mg, 100 count bottle (NDC 0378-5340-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
3041,Diltiazem Hydrochloride Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"240 mg, 500 count bottle (NDC 0378-5340-05)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
3042,Dimercaprol (Bal in Oil) Injection USP,Akorn Pharmaceuticals,800-932-5676,"3 mL (100 mg/mL) ampules, box of 10 (NDC 17478-526-03)",Revised,11/10/20,Product is currently on backorder. Estimated shortage duration is until Jan 2021,Estimated recovery 1Q2021,,Other,Hematology;Other,Current,,
3043,Diphenhydramine Injection,"Hospira, Inc.",844-646-4398,50 mg/mL Carpuject™ Luer Lock Glass Syringe (NDC 00409-2290-31),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Pediatric;Pulmonary/Allergy,Current,,
3044,Diphenhydramine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 1 mL vial (NDC 0641-0376-25)",Revised,7/22/20,Inventory is currently available,Additional lots will be scheduled for manufacturing Product will be made available as it is released.,,Demand increase for the drug,Pediatric;Pulmonary/Allergy,Current,,
3045,Diphenhydramine Injection,Mylan Institutional,800-796-9526,500 mg / 10mL(NDC 67457-124-10),Reverified,11/10/20,Available,,,Demand increase for the drug,Pediatric;Pulmonary/Allergy,Current,,
3046,Diphenhydramine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"50 mg per vial, Single dose, Amber vial (NDC 63323-664-01)",Reverified,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Pediatric;Pulmonary/Allergy,Current,,
3047,Disulfiram Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"250 mg, 100s (NDC 0378-4140-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
3048,Disulfiram Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 100s (NDC 0378-4141-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
3049,Disulfiram Tablets,Teva Pharmaceuticals,800-545-8800,"250 mg, 100 count (NDC 0093-5035-01)",New,11/20/20,,Teva made a business decision to discontinue the product.,,,Analgesia/Addiction,To be Discontinued,11/20/20,11/20/20
3050,Disulfiram Tablets,Teva Pharmaceuticals,800-545-8800,"500 mg, 100 count (NDC 0093-5036-01)",New,11/20/20,,Teva made a business decision to discontinue the product.,,,Analgesia/Addiction,To be Discontinued,11/20/20,11/20/20
3051,Disulfiram Tablets,"Alvogen, Inc.",866-770-3024,"250 mg, 30 count (NDC 47781-607-30)",Revised,8/24/20,,,,,Analgesia/Addiction,Resolved,8/24/20,8/24/20
3052,Divalproex Sodium Extended-Release Tablets,Par Pharmaceutical,800-828-9393,500 mg Bottle of 500 (NDC 10370-511-50),New,10/31/19,,Par has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,10/31/19,10/31/19
3053,Divalproex Sodium Extended-Release Tablets,Par Pharmaceutical,800-828-9393,500 mg Bottle of 100 (NDC 10370-511-10),New,10/31/19,,Par has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,10/31/19,10/31/19
3054,Divalproex Sodium Extended-Release Tablets,Par Pharmaceutical,800-828-9393,250 mg Bottle of 100 (NDC 10370-510-10),New,10/31/19,,Par has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,10/31/19,10/31/19
3055,Divalproex Sodium Extended-Release Tablets,Par Pharmaceutical,800-828-9393,250 mg Bottle of 500 (NDC 10370-510-50),New,10/31/19,,Par has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,10/31/19,10/31/19
3056,Dobutamine Hydrochloride Injection,Pfizer Pharmaceuticals,800-533-4535,500 mg/40 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-54),New,4/3/20,,Discontinuation of the manufacture of the drug.,,,Cardiovascular;Pediatric;Renal,To be Discontinued,4/3/20,4/3/20
3057,Dobutamine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"250 mg/250 mL (NDC 0338-1073-02) Product code 2B0791, 500 mg/250 mL (NDC 0338-1075-02) Product code 2B0792, 1000 mg/250 mL (NDC 0338-1077-02) Product code 2B0793",Reverified,10/28/20,Available,,,,Cardiovascular;Pediatric;Renal,Current,,
3058,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/250 mL (1 mg/mL); Flexible Container (NDC 00409-2346-32),Revised,11/20/20,Next Delivery: January 2021; Estimated Recovery: June 2021,Check Wholesaler for Availablility Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,
3059,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/250 mL (2 mg/mL); Flexible Container (NDC 00409-2347-32),Revised,11/20/20,Next Delivery: November 2020; Estimated Recovery: October 2021,Check Wholesaler for Availablility Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,
3060,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,1000 mg/250 mL (4 mg/mL); Flexible Container (NDC 00409-3724-32),Revised,11/20/20,Next Delivery: November 2020; Estimated Recovery: May 2021,Check Wholesaler for Availablility Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,
3061,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-20),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular;Pediatric;Renal,Current,,
3062,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/40 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-54),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular;Pediatric;Renal,Current,,
3063,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-01),Revised,11/20/20,Available,,,Other,Cardiovascular;Pediatric;Renal,Current,,
3064,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-02),Revised,11/20/20,Available,,,Other,Cardiovascular;Pediatric;Renal,Current,,
3065,Docetaxel Injection,Teva Pharmaceuticals,800-545-8800,20 mg/mL  (NDC 45963-790-56),New,3/31/20,,,,,Oncology,To be Discontinued,3/31/20,3/31/20
3066,"Docusate Sodium Capsules, USP",Par Pharmaceutical,800-828-9393,"100mg, count bottle (NDC 0603-0150-21)",New,4/9/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Gastroenterology,To be Discontinued,4/9/19,4/9/19
3067,"Docusate Sodium Capsules, USP",Par Pharmaceutical,800-828-9393,"100mg, count bottle (NDC 0603-0150-32)",New,4/9/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Gastroenterology,To be Discontinued,4/9/19,4/9/19
3068,Donepezil Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,23mg tablets (NDCs 0228-4529-03 and 0228-4529-09),New,2/13/20,,,,,Neurology,To be Discontinued,2/13/20,2/13/20
3069,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,"400 mg/250 mL (1,600 mcg/mL); Flexible Container (NDC 00409-7809-22)",Revised,11/20/20,Next Delivery: February 2021; Estimated Recovery: September 2021,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
3070,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,"800 mg/500 mL (1,600 mcg/mL); Flexible Container (NDC 00409-7809-24)",Revised,11/20/20,Next Delivery: November 2020; Estimated Recovery: May 2021,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
3071,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,"800 mg/250 mL (3,200 mcg/mL); Flexible Container (NDC 00409-7810-22)",Revised,11/20/20,Limited Supply Available. Next Delivery: March 2021; Estimated Recovery: September 2021,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
3072,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/5 mL (40 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-5820-01),Revised,11/20/20,Available,,,Other,Cardiovascular,Current,,
3073,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,400 mg/10 mL (40 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9104-20),Revised,11/20/20,Available,,,Other,Cardiovascular,Current,,
3074,Dopamine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"800 mcg/mL (250 mL bag) Product code 2B0832 (NDC 0338-1005-02), 800 mcg/mL (500 mL bag)  Product code 2B0833 (NDC 0338-1005-03), 1600 mcg/mL (250 mL bag) Product code 2B0842 (NDC 0338-1007-02), 1600 mcg/mL (500 mL bag) Product code 2B0843 (NDC 0338-1007-03), 3200 mcg/mL (250 mL bag) Product code 2B0846 (NDC 0338-1009-02)",Reverified,10/28/20,Available,,,,Cardiovascular,Current,,
3075,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cosopt® dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 17478-605-10)",Revised,6/8/20,Available,,,,Ophthalmology,Current,,
3076,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 50383-233-10)",Revised,6/8/20,Limit availability / Recovery expected July 2020.,"Manufacturer interruption production issues.  Marketed by Hi-Tech Pharmacal Co., Inc. To order, contact Akorn Customer Service (1-800-932-5676)",,Other,Ophthalmology,Current,,
3077,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cosopt-PF® dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 0.2 mL single use, 60 count (NDC 17478-604-30)",Revised,6/8/20,Available,"Marketed by Akorn, Inc. To order, contact Akorn Customer Service (1-800-932-5676)",,Other,Ophthalmology,Current,,
3078,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Sandoz,800-525-8747,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 61314-030-02)",Reverified,11/13/20,Supply Available,"Labeled under Sandoz Inc. To order, contact Sandoz Inc. at 1-800-525-8747",,Demand increase for the product,Ophthalmology,Current,,
3079,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Bausch Health,800-321-4576,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 24208-486-10)",Revised,6/9/20,Available,"Marketed by Bausch & Lomb Inc. To order, contact Bausch & Lomb, a division of Valeant Pharmaceuticals North America at pharcs@valeant.com",,Other,Ophthalmology,Current,,
3080,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 0591-2482-79)",Reverified,11/19/20,Unavailable,This was a business-related decision to discontinue manufacturing these products.,,Discontinuation of the manufacture of the drug,Ophthalmology,Current,,
3081,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide Hydrochloride and Timolol Maleate 20 mg and 5 mg/mL, 10 mL (0591-2482-79)",New,4/20/18,,This was a business-related decision to discontinue manufacturing this product.,,,Ophthalmology,To be Discontinued,4/20/18,4/20/18
3082,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Aurobindo Pharma,866-850-2876,"Dorzolamide HCl and Timolol Maleate (Cosopt® PF) Ophthalmic Solution 2%/0.5% Preservative Free, 2mL single use container (NDC 65862-0947-60)",Reverified,9/25/20,Available,Available,,Other,Ophthalmology,Current,,
3083,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 0591-2481-79)",New,4/20/18,,This was a business-related decision to discontinue manufacturing these products,,,Ophthalmology,To be Discontinued,4/20/18,4/20/18
3084,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 0093-7618-43)",New,4/20/18,,This was a business-related decision to discontinue manufacturing these products,,,Ophthalmology,To be Discontinued,4/20/18,4/20/18
3085,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide Hydrochloride 22.3 mg/mL, 10 mL (NDC 0591-2481-79)",Reverified,11/19/20,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Ophthalmology,Current,4/20/18,4/20/18
3086,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide Hydrochloride 22.3 mg/mL, 10 mL (NDC 0093-7618-43)",Reverified,11/19/20,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Ophthalmology,Current,4/20/18,4/20/18
3087,Dorzolamide Hydrochloride Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 50383-232-10)",Revised,10/14/20,Available,"Manufacturer interruption production issues. Distributed by Hi-Tech Pharmacal Co., Inc. To order, contact Akorn Customer Service (1-800-932-5676)",,,Ophthalmology,Current,,
3088,Dorzolamide Hydrochloride Ophthalmic Solution,Merck Sharp & Dohme Corp.,800-637-2579,"TRUSOPT® dorzolamide hydrochloride ophthalmic solution 2%, 10 mL in an 18 mL capacity bottle (NDC 0006-3519-36)",Reverified,6/1/18,Product is available,"For additional information please contact: Merck National Service Center, Telephone Number: 1-800-672-6372",,Demand increase for the drug,Ophthalmology,Current,,
3089,Dorzolamide Hydrochloride Ophthalmic Solution,Bausch Health,800-321-4576,"Dorzolamide hydrochloride USP 2%, 10 mL (NDC 24208-485-10)",Revised,12/13/19,Currently on backorder. Estimated availability: January 2020,"Marketed by Bausch & Lomb Inc. To order, contact Bausch & Lomb, a division of Bausch Health US, LLC at pharcs@bauschhealth.com",,Other,Ophthalmology,Current,,
3090,Dorzolamide Hydrochloride Ophthalmic Solution,Sandoz,800-525-8747,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 61314-019-10)",Reverified,11/13/20,Supply available,"Labeled under Sandoz Inc. To order, contact Sandoz Inc. at 1-800-525-8747",,Demand increase for the product,Ophthalmology,Current,,
3091,Doxorubicin Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg/mL, 10 mL single-dose vial (NDC 63323-883-10)",New,3/5/20,,Product available. Check wholesalers for inventory or contact Customer Service to place a direct order. 10 mL will be discontinued when inventory is depleted.,,,Oncology;Pediatric,To Be Discontinued,3/5/20,3/5/20
3092,Doxycycline Capsules,Teva Pharmaceuticals,800-545-8800,50 mg capsules (NDC 0591-0410-01),New,4/29/19,,This product discontinuation is a business related decision.,,,Anti-Infective,To be Discontinued,4/29/19,4/29/19
3093,Doxycycline Capsules,Teva Pharmaceuticals,800-545-8800,75 mg capsules (NDC 0591-2404-01),New,4/29/19,,This product discontinuation is a business related decision.,,,Anti-Infective,To be Discontinued,4/29/19,4/29/19
3094,Doxycycline Capsules,Teva Pharmaceuticals,800-545-8800,100 mg capsules (NDC 0591-0411-50),New,4/29/19,,This product discontinuation is a business related decision.,,,Anti-Infective,To be Discontinued,4/29/19,4/29/19
3095,Doxycycline Hyclate Capsules,Teva Pharmaceuticals,800-545-8800,50 mg  (NDC 0591-5535-50),New,10/15/19,,This product is being discontinued due to a business decision.,,,Anti-Infective,To be Discontinued,10/15/19,10/15/19
3096,Doxycycline Hyclate Capsules,Teva Pharmaceuticals,800-545-8800,100 mg (NDCs 0591-5440-50 and 0591-5440-05),New,10/15/19,,This product is being discontinued due to a business decision.,,,Anti-Infective,To be Discontinued,10/15/19,10/15/19
3097,Doxycycline Hyclate Delayed Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,150 mg tablets (NDC 0378-3030-01),New,9/9/19,,,,,Anti-Infective,To be Discontinued,9/9/19,9/9/19
3098,Doxycycline Hyclate Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mg per vial; amber vial; preservative free; lyophilized powder (NDC 63323-130-11),Revised,10/23/20,Backordered.  Next release expected November 2020.,Check wholesalers for inventory,,Demand increase for the drug,Anti-Infective,Current,,
3099,Doxycycline Hyclate Injection,Mylan Institutional,800-796-9526,100 mg (Lyophilizate in Vials)(NDC 67457-437-10),Revised,11/10/20,Available,Increased supply in 2020 to meet increased demand,,Demand increase for the drug,Anti-Infective,Current,,
3100,Dronabinol Capsules,"Endo Pharmaceuticals, Inc.",800-462-3636,"2.5 mg capsules (NDC 498840-867-02), 5 mg capsules (NDC 498840-868-02), 10 mg capsules (NDC 498840-869-02)",New,2/7/19,,,,,Gastroenterology,To be Discontinued,2/7/19,2/7/19
3101,Dutasteride Capsules,Apotex Corp.,800-706-5575,0.5 mg capsules (NDCs 60505-3877-9 and 60505-3877-3),New,1/7/20,,,,,Urology,To be Discontinued,1/7/20,1/7/20
3102,Echothiophate Iodide (Phospholine Iodide) Ophthalmic Solution,Pfizer Pharmaceuticals,800-533-4535,6.25 mg package for 0.125% (NDC 0046-1065-05),Reverified,11/20/20,Available,,,Other,Ophthalmology,Current,,
3103,Echothiophate Iodide (Phospholine Iodide) Ophthalmic Solution,Pfizer Pharmaceuticals,800-533-4535,6.25 mg package for 0.125% (NDC 0046-1065-05),New,10/27/20,,"Pfizer anticipates stock available through May 1st, 2021.",,,Ophthalmology,To be Discontinued,10/27/20,10/27/20
3104,"Enalaprilat Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2.5mg/2mL, vial (NDC 0143-9786-10)",Revised,7/22/20,Inventory is currently available.,Additional lots will be scheduled for manufacturing Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
3105,"Enalaprilat Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1.25mg/mL, vial  (NDC 0143-9787-10)",Revised,7/22/20,Inventory is currently available.,Additional lots will be scheduled for manufacturing Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
3106,"Enalaprilat Injection, USP","Hospira, Inc.",844-646-4398,1.25 mg/mL; Single Dose Glass Fliptop Vial (NDC 00409-2122-01),New,3/24/20,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,,3/24/20
3107,"Enalaprilat Injection, USP","Hospira, Inc.",844-646-4398,2.5 mg/2 mL (1.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2122-02),New,3/24/20,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,,3/24/20
3108,Entecavir Tablets,Teva Pharmaceuticals,800-545-8800,0.5mg tablets (NDCs 0093-5786-98 and 0093-5786-56),New,2/14/20,,,,,Antiviral,To be Discontinued,2/14/20,2/14/20
3109,Entecavir Tablets,Teva Pharmaceuticals,800-545-8800,1mg tablets (NDC 0093-5787-56),New,2/14/20,,,,,Antiviral,To be Discontinued,2/14/20,2/14/20
3110,Epinastine Hydrochloride (Elestat®) Ophthalmic Solution,Allergan,800-678-1605,5 mL in 10 mL bottle (NDC 00023-9201-05),New,8/19/19,,,,,Ophthalmology,To be Discontinued,8/19/19,8/19/19
3111,"Epinephrine Injection, 0.1 mg/mL","Hospira, Inc.",844-646-4398,"1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 00409-4921-34, pack of 10; NDC 0409-4921-20, individual)",Revised,11/20/20,Available,,,,Cardiovascular;Pulmonary/Allergy,Current,,
3112,"Epinephrine Injection, 0.1 mg/mL","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"1:10,000, 10mL Luer-Jet Prefilled Syringe
(NDC 76329-3316-1)(old NDC 0548-3316-00)",Reverified,10/30/20,Available,,,,Cardiovascular;Pulmonary/Allergy,Current,,
3113,"Epinephrine Injection, Auto-Injector",Teva Pharmaceuticals,800-545-8800,"0.3 mg/mL epinephrine injection, USP, auto-injector (NDC 0093-5986-27)",Reverified,11/19/20,Available,,,,Pulmonary/Allergy,Current,,
3114,"Epinephrine Injection, Auto-Injector",Mylan Specialty,800-RXMYLAN (1-800-796- 9526),"0.3 mg (EpiPen® NDC 49502-500-02, pack of 2; NDC 49502-500-01, individual) (Authorized Generic NDC 49502-102-02, pack of 2; NDC 49502-102-01, individual)",Reverified,11/10/20,Available,"Production output from Mylan’s manufacturing partner Meridian Medical Technologies, a Pfizer company, has improved in recent months. Supplies are routinely shipping and, as a result, are more consistently available at the pharmacy level. In the event patients experience difficulty accessing product, they can continue to contact Mylan Customer Relations at 800-796-9526 for assistance in locating alternative pharmacies.",,,Pulmonary/Allergy,Current,,
3115,"Epinephrine Injection, Auto-Injector",Mylan Specialty,800-RXMYLAN (1-800-796- 9526),0.15 mg (EpiPen® NDC 49502-501-02) (Authorized Generic NDC 49502-101-02),Reverified,11/10/20,Available,"Production output from Mylan’s manufacturing partner Meridian Medical Technologies, a Pfizer company, has improved in recent months. Supplies are routinely shipping and, as a result, are more consistently available at the pharmacy level. In the event patients experience difficulty accessing product, they can continue to contact Mylan Customer Relations at 800-796-9526 for assistance in locating alternative pharmacies.",,,Pulmonary/Allergy,Current,,
3116,"Epinephrine Injection, Auto-Injector",Impax Laboratories,877-99-Impax(46729); option 2,"0.15 mg/0.15 mL epinephrine injection, USP, pre-filled auto-injector (two pack)(NDC 0115-1695-49)",Revised,6/1/20,On allocation to current customers.,,,Manufacturing delays,Pulmonary/Allergy,Current,,
3117,"Epinephrine Injection, Auto-Injector",Impax Laboratories,877-99-Impax(46729); option 2,"0.3 mg/0.3 mL epinephrine injection, USP, pre-filled auto-injector (two pack)(NDC 0115-1694-49)",Revised,6/1/20,On allocation to current customers.,,,Manufacturing delays,Pulmonary/Allergy,Current,,
3118,"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.3 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-023-01)",Reverified,6/15/20,Available,AUVI-Q is readily available and not currently in shortage.,,,Pulmonary/Allergy,Current,,
3119,"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.15 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-022-01)",Reverified,6/15/20,Available,AUVI-Q is readily available and not currently in shortage.,,,Pulmonary/Allergy,Current,,
3120,"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.1 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-021-01)",Reverified,6/15/20,Available,AUVI-Q is readily available and not currently in shortage.,,,Pulmonary/Allergy,Current,,
3121,"Epinephrine Injection, Auto-Injector",Adamis Pharmaceuticals Corporation,800-230-3935,"Carton containing two SYMJEPI (epinephrine injection, USP) 0.3 mg single-dose, pre-filled syringes (NDC 0781-3442-20)",Reverified,12/17/19,Available,,,,Pulmonary/Allergy,Current,,
3122,"Epinephrine Injection, Auto-Injector",Adamis Pharmaceuticals Corporation,800-230-3935,"Carton containing two SYMJEPI (epinephrine injection, USP) 0.15 mg single-dose, pre-filled syringes (NDC 0781-3448-20)",Reverified,12/17/19,Available,,,,Pulmonary/Allergy,Current,,
3123,"Epinephrine Injection, Auto-Injector",Teva Pharmaceuticals,800-545-8800,"0.15 MG Epinephrine Injection, USP auto-injector (NDC 0093-5985-27)",Reverified,11/19/20,Available,,,,Pulmonary/Allergy,Current,,
3124,Epirubicin Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,2 mg/1 mL  (NDCs 45963-608-60 and 45963-608-68),New,7/17/19,,This product discontinuation is a business related decision.  Anticipated discontinuance time is first quarter of the year 2020.,,,Oncology,To be Discontinued,7/17/19,7/17/19
3125,Epirubicin Hydrochloride Injection,Cipla Limited,844-247-5287,2 mg/1 mL  (NDCs 25021-203-25 and 59923-701-25),New,7/17/19,,Anticipated unavailability of product is September 2019.,,,Oncology,To be Discontinued,7/17/19,7/17/19
3126,Eprosartan Mesylate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Eprosartan Mesylate 600mg T 30s (NDC 0378-6629-93),Revised,3/16/20,,Mylan has made a business decision to discontinue this product.,,,Cardiovascular,To be Discontinued,3/16/20,3/16/20
3127,Eptifibatide (Integrilin) Injection,Merck Sharp & Dohme Corp.,800-672-6372,0.75 mg/mL (NDCs 0085-1136-02 and 0085-1136-03),New,11/18/19,,The following presentation will continue to be available: 0.75 mg/mL (NDC 0085-1136-01 ),,,Cardiovascular,To be Discontinued,11/18/19,11/18/19
3128,Eptifibatide (Integrilin) Injection,Merck Sharp & Dohme Corp.,800-672-6372,2 mg/mL (NDCs 0085-1177-03 and 0085-1177-05),New,11/18/19,,The following presentations will continue to be available: 2 mg/mL (NDCs 0085-1177-01 and 0085-1177-02),,,Cardiovascular,To be Discontinued,11/18/19,11/18/19
3129,Eptifibatide (Integrilin) Injection,Merck Sharp & Dohme Corp.,800-672-6372,20 mg/10ml (2 mg/ml)(NDC 0085-1177-01),New,10/21/20,,To be discontinued on or near October 2020.,,,Cardiovascular,To be Discontinued,10/21/20,10/21/20
3130,Eptifibatide (Integrilin) Injection,Merck Sharp & Dohme Corp.,800-672-6372,75 mg/100ml (0.75 mg/ml)(NDC 0085-1136-01),New,10/21/20,,To be discontinued on or near October 2020.,,,Cardiovascular,To be Discontinued,10/21/20,10/21/20
3131,Eptifibatide (Integrilin) Injection,Merck Sharp & Dohme Corp.,800-672-6372,200 mg/100ml (2 mg/ml)(NDC 0085-1177-02),New,10/21/20,,Discontinued,,,Cardiovascular,To be Discontinued,10/21/20,10/21/20
3132,Ergotamine Tartrate and Caffeine (Cafergot) Tablets,Sandoz,800-525-8747,1mg/100mg (NDC 0781-5405-01),New,7/2/20,,Discontinuation of drug manufacturing,,,Neurology,To be Discontinued,7/2/20,7/2/20
3133,Erlotinib Hydrochloride Tablets,"Astellas Pharma Global Development, Inc.",800-727-7003,25 mg tablets (NDC 50242-062-01),New,9/29/20,,,,,Oncology,To be Discontinued,9/29/20,9/29/20
3134,Erlotinib Hydrochloride Tablets,"Astellas Pharma Global Development, Inc.",800-727-7003,100 mg tablets (NDC 50242-063-01),New,9/29/20,,,,,Oncology,To be Discontinued,9/29/20,9/29/20
3135,Erlotinib Hydrochloride Tablets,"Astellas Pharma Global Development, Inc.",800-727-7003,150 mg tablets (NDC 50242-064-01),New,9/29/20,,,,,Oncology,To be Discontinued,9/29/20,9/29/20
3136,"Erythromycin Lactobionate for Injection, USP","Hospira, Inc.",844-646-4398,500 mg Single Dose Glass Fliptop Vial (NDC 00409-6482-01),Reverified,11/20/20,Available,,,Other,Anti-Infective,Current,,
3137,"Erythromycin Lactobionate for Injection, USP","Hospira, Inc.",844-646-4398,500 mg Single-dose ADD-Vantage® Vial (NDC 00409-6476-44),Reverified,11/20/20,Available,,,Other,Anti-Infective,Current,,
3138,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 3.5 g tube (NDC 17478-070-35),Revised,12/2/19,Limited availability.,"Expected availability Dec, 2019",,Requirements related to complying with good manufacturing practices,Ophthalmology,Current,,
3139,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 1 g  tube (unit dose) (NDC17478-070-01),Revised,12/2/19,On backorder,"Expected availability Oct 1, 2019",,Requirements related to complying with good manufacturing practices,Ophthalmology,Current,,
3140,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 3.5 g tube (NDC 17478-824-35)(Premier),Revised,12/2/19,No longer distributing,,,,Ophthalmology,Current,,
3141,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 1 g  tube (unit dose) (NDC 17478-824-01)(Premier),Revised,12/2/19,No longer distributing,,,,Ophthalmology,Current,,
3142,Erythromycin Ophthalmic Ointment,Bausch Health,800-321-4576,3.5 g in 1 Tube (NDC 24208-910-55),Reverified,12/13/19,Available,"Distributed by: Bausch & Lomb Incorporated, a division of  Bausch Health Americas, Inc, Bridgewater, NJ 08807 USA",,Demand increase for the drug,Ophthalmology,Current,,
3143,Erythromycin Ophthalmic Ointment,Bausch Health,800-321-5676,1 g in cartons of 50 (NDC 24208-910-19),Reverified,12/13/19,Available,"Distributed by: Bausch & Lomb Incorporated, a division of  Bausch Health Americas, Inc, Bridgewater, NJ 08807 USA",,Demand increase for the drug,Ophthalmology,Current,,
3144,Erythromycin Ophthalmic Ointment,Perrigo Company PLC,269-673-8451,"1 gram, 50-count (NDC 00574-4024-50)",Revised,12/10/19,Available and shipping,,,Demand increase for the drug,Ophthalmology,Current,,
3145,Erythromycin Ophthalmic Ointment,Perrigo Company PLC,269-673-8451,"3.5 gram, 1-count (NDC 00574-4024-35)",Revised,12/10/19,Available and shipping,,,Demand increase for the drug,Ophthalmology,Current,,
3146,Erythromycin Ophthalmic Ointment,Perrigo Company PLC,269-673-8451,"3.5 gram, 24-count (NDC 00574-4024-39)",Revised,12/10/19,Available and shipping,,,Demand increase for the drug,Ophthalmology,Current,,
3147,Escitalopram (Lexapro) 5 mg/5 mL Oral Solution,Allergan Sales LLC,800-678-1605,Lexapro oral solution 240 mL bottle 5 mg/5mL (NDC 0456-2101-08),New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3148,Escitalopram (Lexapro) 5 mg/5 mL Oral Solution,Allergan Sales LLC,800-678-1605,Escitalopram Oxalate oral solution 240 mL bottle (NDC 0591-4151-38),New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3149,Ethambutol Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,400 mg  (NDC 0555-0923-02),New,9/28/20,,,,,Anti-Infective,To be Discontinued,9/28/20,9/28/20
3150,Ethinyl Estradiol and Levonorgestrel (Myzilra),"Endo Pharmaceuticals, Inc.",800-462-3636,"0.03mg, 0.04mg, 0.03mg, 0.05mg, 0.075mg, 0.125mg; 6 blister pack in 1 carton (NDC 0603-7625-17)",New,5/10/19,,Discontinued due to business reasons.,,,Reproductive,To be Discontinued,5/10/19,5/10/19
3151,Ethinyl Estradiol and Levonorgestrel (Myzilra),"Endo Pharmaceuticals, Inc.",800-462-3636,"0.03mg, 0.04mg, 0.03mg, 0.05mg, 0.075mg, 0.125mg; 3 blister pack in 1 carton (NDC 0603-7625-49)",New,5/10/19,,Discontinued due to business reasons.,,,Reproductive,To be Discontinued,5/10/19,5/10/19
3152,Ethinyl Estradiol; Norgestrel Tablets,Teva Pharmaceuticals,800-545-8800,0.05 mg; 0.5mg  (NDC 52544-848-28),New,5/8/20,,,,,Reproductive,To be Discontinued,5/8/20,5/8/20
3153,Ethiodized Oil (Lipiodol) Injection,Guerbet LLC,877-729-6679,Box of one 10 mL ampoule (NDC 67684-1901-1),Revised,8/1/19,,,Available,,Medical Imaging;Oncology,Resolved,8/1/19,
3154,Ethiodized Oil (Lipiodol) Injection,Guerbet LLC,877-729-6679,Box of one 10 mL ampoule (NDC 67684-1901-1),Revised,7/31/19,,,,,Medical Imaging;Oncology,Resolved,7/31/19,
3155,"Ethosuximide Oral Solution, USP",Teva Pharmaceuticals,800-545-8800,"250 mg/5mL, 474 mL Bottle (NDC 0093-9660-16)",New,5/17/19,,Teva made a business decision to discontinue this product.,,,Neurology,To be Discontinued,5/17/19,5/17/19
3156,Etomidate (Amidate) Injection,"Hospira, Inc.",844-646-4398,40 mg/20 mL (2 mg/mL) Abboject Glass Syringe (NDC 00409-8060-29),New,3/24/20,,Discontinuation of the manufacture of the drug.,,,Analgesia/Addiction;Anesthesia,To be Discontinued,3/24/20,3/24/20
3157,Etomidate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"2 mg/mL, 10 mL vial (NDC 55150-221-10)",Revised,11/20/20,Currently on backorder - next shipment anticipated mid Dec 20,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
3158,Etomidate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"2 mg/mL, 20 mL vial (NDC 55150-222-10)",Revised,11/20/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
3159,Etomidate Injection,Gland Pharma Limited,Athenex: 855-273-0154; Fosun 833-291-9645,"2 mg/mL, 10 mL vial (NDC 70860-652-10)",Reverified,10/27/20,Unavailable,Distributed by Athenex Pharmaceutical. To contact: 855-273-0154.,,,Anesthesia,Current,,
3160,Etomidate Injection,Gland Pharma Limited,Athenex: 855-273-0154; Fosun 833-291-9645,"2 mg/mL, 20 mL vial (NDC 70860-652-20)",Reverified,10/27/20,Unavailable,Distributed by Athenex Pharmaceutical. To contact: 855-273-0154.,,,Anesthesia,Current,,
3161,Etomidate Injection,Gland Pharma Limited,Athenex: 855-273-0154; Fosun 833-291-9645,"2 mg/mL, 10 mL vial (NDC 72266-146-10)",Reverified,10/27/20,Available,Distributed by Fosun Pharma. To contact: 866-611-3762,,,Anesthesia,Current,,
3162,Etomidate Injection,Gland Pharma Limited,Athenex: 855-273-0154; Fosun 833-291-9645,"2 mg/mL, 20 mL vial (NDC 72266-147-10)",Reverified,10/27/20,Available,Distributed by Fosun Pharma. To contact: 866-611-3762,,,Anesthesia,Current,,
3163,Etomidate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 10 mL vial (NDC 0143-9506-10)",Revised,9/9/20,Available,,,,Anesthesia,Current,,
3164,Etomidate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9507-10)",Revised,9/9/20,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
3165,Etomidate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 10 mL vial (NDC 0143-9310-10), Novaplus",Revised,9/9/20,TBD,,,,Anesthesia,Current,,
3166,Etomidate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9311-10), Novaplus",Revised,9/9/20,TBD,,,,Anesthesia,Current,,
3167,Etomidate Injection,Mylan Institutional,800-RXMYLAN (1-800-796-9526),"2 mg/mL, 10 mL vial (NDC 67457-902-10)",Revised,11/10/20,Available,,,Other,Anesthesia,Current,,
3168,Etomidate Injection,Mylan Institutional,800-RXMYLAN (1-800-796-9526),"2 mg/mL, 20 mL vial (NDC 67457-903-20)",Revised,11/10/20,Available,,,,Anesthesia,Current,,
3169,Etomidate Injection,Pfizer Pharmaceuticals,800-533-4535,"Amidate, 2 mg/mL, 10 mL vial (NDC 0409-6695-01)",Reverified,11/20/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
3170,Etomidate Injection,Pfizer Pharmaceuticals,800-533-4535,"Amidate, 2 mg/mL, 20 mL vial (NDC 0409-6695-02)",Reverified,11/20/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
3171,Etomidate Injection,Pfizer Pharmaceuticals,800-533-4535,"Amidate, 2 mg/mL, 20 mL syringe (NDC 0409-8060-29)",Reverified,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia,Current,,
3172,Exenatide (BYDUREON) Extended Release for Injectable Suspension,AstraZeneca,800-236-9933,"BYDUREON® (exenatide extended-release) for injectable suspension, for subcutaneous use;  Single Dose Tray presentation; (2 mg) (NDC 0310-6520-04)",New,4/3/18,,"The planned permanent discontinuance of the Bydureon Single Dose Tray inventory from the U.S. market is September 30, 2018.  There are currently 2 other delivery options for exenatide-extended-release:  the Bydureon® Dual Chamber Pen presentation (NDC 0310-6530-04) and Bydureon® BCise™ (NDC 0310-6540-04).",,,Endocrinology/Metabolism,To be Discontinued,4/3/18,4/3/18
3173,Ezetimibe Tablets,Apotex Corp.,800-706-5575,10 mg (NDC 60505-2945-9) || (NDC 60505-2945-3) || (NDC 60505-2945-5),New,7/31/20,,To be discontinued due to API supply issues.,,,Cardiovascular,To be Discontinued,7/31/20,7/31/20
3174,Famotidine Injection,Mylan Institutional,800-796-9526,Famotidine Injection (Solution in Single Dose Vials) [20 mg / 2 ml] 25PK (NDC 67457-433-22),Reverified,11/10/20,Available,,,Demand increase for the drug,Gastroenterology,Current,,
3175,Famotidine Injection,Baxter Healthcare,888-229-0001,"Famotidine Injection premix, 20mg/50 mL in GALAXY Plastic Container (NDC 0338-5197-41)",Reverified,10/28/20,Available,,,,Gastroenterology,Current,,
3176,Famotidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 2 mL vial (NDC 0641-6022-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Gastroenterology,Current,,
3177,Famotidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 4 mL vial (NDC 0641-6023-25)",Revised,7/22/20,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Gastroenterology,Current,,
3178,Famotidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 20 mL vial (NDC 0641-6021-10)",Revised,7/22/20,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Gastroenterology,Current,,
3179,Famotidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 2 mL (10 mg per mL), single dose vial, PF, (NDC 63323-739-12)",Revised,11/16/20,Backordered. Next release November 2020.,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
3180,Famotidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"40 mg per 4 mL (10 mg per mL), mutilple dose vial, (NDC 63323-738-09)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
3181,Famotidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per 20 mL(10 mg per mL), multiple dose vial, (NDC 63323-738-20)",Revised,11/16/20,Backordered. Next release Q4 2020.,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
3182,Famotidine Injection,Mylan Institutional,800-796-9526,Famotidine Injection (Solution in Multi Dose Vials : Containing Preservatives) [40 mg / 4 ml] 10PK (NDC 67457-448-43),Reverified,11/10/20,Available,,,Demand increase for the drug,Gastroenterology,Current,,
3183,Famotidine Injection,Mylan Institutional,800-796-9526,Famotidine Injection (Solution in Multi Dose Vials : Containing Preservatives) [200 mg / 20 ml] 10PK (NDC 67457-457-20),Reverified,11/10/20,Available,,,Demand increase for the drug,Gastroenterology,Current,,
3184,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,20 MG 100 Count (NDC 0172-5728-60),Reverified,11/19/20,"On backorder, expected recovery in Q4, 2020","This product is on allocation, however we are satisfying historical committed customer demand.",,Demand increase for the drug,Gastroenterology,Current,,
3185,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,20 MG 1000 Count (NDC 0172-5728-80),Reverified,11/19/20,"On backorder, expected recovery in Q4, 2020","This product is on allocation, however we are satisfying historical committed customer demand.",,Demand increase for the drug,Gastroenterology,Current,,
3186,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,20 MG 500 Count (NDC 0172-5728-70),Reverified,11/19/20,"On backorder, expected recovery in Q4, 2020","This product is on allocation, however we are satisfying historical committed customer demand.",,Demand increase for the drug,Gastroenterology,Current,,
3187,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,40 MG 100 Count (NDC 0172-5729-60),Reverified,11/19/20,"On backorder, expected recovery in Q4, 2020","This product is on allocation, however we are satisfying historical committed customer demand.",,Demand increase for the drug,Gastroenterology,Current,,
3188,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,40 MG 500 Count (NDC 0172-5729-70),Reverified,11/19/20,"On backorder, expected recovery in Q4, 2020","This product is on allocation, however we are satisfying historical committed customer demand.",,Demand increase for the drug,Gastroenterology,Current,,
3189,Famotidine Tablets,Aurobindo Pharma,732-839-9400,20 mg - 100/Bottle (NDC 65862-859-01),Reverified,9/25/20,Available,,,,Gastroenterology,Current,,
3190,Famotidine Tablets,Aurobindo Pharma,732-839-9400,40 mg - 100/Bottle (NDC 65862-860-01),Reverified,9/25/20,Available,,,,Gastroenterology,Current,,
3191,Famotidine Tablets,Alembic Pharmaceuticals,908-393-9604,20 mg Bottle of 100 counts (NDC 62332-001-31),New,5/4/20,Available,,,,Gastroenterology,Current,,
3192,Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,20 mg Bottle of 1000 counts (NDC 62332-001-91),New,5/4/20,Available,,,,Gastroenterology,Current,,
3193,Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,40 mg Bottle of 100 counts (NDC 62332-002-31),New,5/4/20,Available,,,,Gastroenterology,Current,,
3194,Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,40 mg Bottle of 500 counts (NDC 62332-002-71),New,5/4/20,Available,,,,Gastroenterology,Current,,
3195,Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,40 mg Bottle of 1000 counts (NDC 62332-002-91),New,5/4/20,Available,,,,Gastroenterology,Current,,
3196,Famotidine Tablets,"Carlsbad Technology, Inc.",,20mg 100 count (NDC 61442-121-01),New,5/4/20,"We do have some stock, however, due to such high demand, we cannot send to all customers. We send as much as we can.","We are still shipping products. However, we are limited due to manufacturing capabilities, as well as limited resources such as active ingredient.",,Demand increase for the drug and shortage of an active ingredient,Gastroenterology,Current,,
3197,Famotidine Tablets,"Carlsbad Technology, Inc.",,20 mg 1000 count (NDC 61442-121-10),New,5/4/20,"We do have some stock, however, due to such high demand, we cannot send to all customers. We send as much as we can.","We are still shipping products. However, we are limited due to manufacturing capabilities, as well as limited resources such as active ingredient.",,Demand increase for the drug and shortage of an active ingredient,Gastroenterology,Current,,
3198,Famotidine Tablets,"Carlsbad Technology, Inc.",,40 mg 100 count (NDC 61442-122-01),New,5/4/20,"We do have some stock, however, due to such high demand, we cannot send to all customers. We send as much as we can.","We are still shipping products. However, we are limited due to manufacturing capabilities, as well as limited resources such as active ingredient.",,Demand increase for the drug and shortage of an active ingredient,Gastroenterology,Current,,
3199,Famotidine Tablets,"Carlsbad Technology, Inc.",,40 mg 1000 count (NDC 61442-122-10),New,5/4/20,"We do have some stock, however, due to such high demand, we cannot send to all customers. We send as much as we can.","We are still shipping products. However, we are limited due to manufacturing capabilities, as well as limited resources such as active ingredient.",,Demand increase for the drug and shortage of an active ingredient,Gastroenterology,Current,,
3200,Fenofibric Acid Delayed-Release Capsules,Par Pharmaceutical,800-828-9393,Fenofibric Acid Delayed-Release Capsules 45mg 90s (NDC 10370-209-09),New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Endocrinology/Metabolism,To be Discontinued,4/15/19,4/15/19
3201,Fenofibric Acid Delayed-Release Capsules,Par Pharmaceutical,800-828-9393,Fenofibric Acid Delayed-Release Capsules 135mg 90s (NDC 10370-210-09),New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Endocrinology/Metabolism,To be Discontinued,4/15/19,4/15/19
3202,Fenofibric Acid Delayed-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"45 mg, 90 count bottle (NDC 0378-2589-77)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
3203,Fenofibric Acid Delayed-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"135 mg, 90 count bottle (NDC 0378-2590-77)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
3204,"Fenoldopam Mesylate (Corlopam) Injection, USP","Hospira, Inc.",844-646-4398,20 mg/2 mL (10 mg/mL); Glass Ampul (NDC 00409-2304-02),New,11/16/20,,"Discontinuation of the manufacture of the ampul, equivalent vial available.",,,Cardiovascular,To be Discontinued,11/16/20,11/16/20
3205,"Fenoldopam Mesylate (Corlopam) Injection, USP","Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); Glass Ampul (NDC 00409-2304-01),New,11/16/20,,"Discontinuation of the manufacture of the ampul, equivalent vial available.",,,Cardiovascular,To be Discontinued,11/16/20,11/16/20
3206,"Fentanyl (Duragesic 100, 12, 25, 37, 50, 75) Extended-Release Film",Janssen Pharmaceuticals,800-526-7736,100 ug/1 h (NDC 50458-094-05),New,4/1/20,,"The Company has made a business decision to permanently discontinue all Duragesic/fentanyl transdermal system. Product should be maintained on the formularies until the last batch produced expires (31 July 2021), in order to maintain continuity of the reimbursement process.",,,Analgesia/Addiction,To be Discontinued,4/1/20,4/1/20
3207,"Fentanyl (Duragesic 100, 12, 25, 37, 50, 75) Extended-Release Film",Janssen Pharmaceuticals,800-526-7736,75 ug/1 h (NDC 50458-093-05),New,4/1/20,,"The Company has made a business decision to permanently discontinue all Duragesic/fentanyl transdermal system. Product should be maintained on the formularies until the last batch produced expires (31 July 2021), in order to maintain continuity of the reimbursement process.",,,Analgesia/Addiction,To be Discontinued,4/1/20,4/1/20
3208,"Fentanyl (Duragesic 100, 12, 25, 37, 50, 75) Extended-Release Film",Janssen Pharmaceuticals,800-526-7736,50 ug/1 h (NDC 50458-092-05),New,4/1/20,,"The Company has made a business decision to permanently discontinue all Duragesic/fentanyl transdermal system. Product should be maintained on the formularies until the last batch produced expires (31 July 2021), in order to maintain continuity of the reimbursement process.",,,Analgesia/Addiction,To be Discontinued,4/1/20,4/1/20
3209,"Fentanyl (Duragesic 100, 12, 25, 37, 50, 75) Extended-Release Film",Janssen Pharmaceuticals,800-526-7736,25 ug/1 h (NDC 50458-091-05),New,4/1/20,,"The Company has made a business decision to permanently discontinue all Duragesic/fentanyl transdermal system. Product should be maintained on the formularies until the last batch produced expires (31 July 2021), in order to maintain continuity of the reimbursement process.",,,Analgesia/Addiction,To be Discontinued,4/1/20,4/1/20
3210,"Fentanyl (Duragesic 100, 12, 25, 37, 50, 75) Extended-Release Film",Janssen Pharmaceuticals,800-526-7736,100 ug/1 unit (NDC 50458-106-05),New,4/1/20,,"The Company has made a business decision to permanently discontinue all Duragesic/fentanyl transdermal system. Product should be maintained on the formularies until the last batch produced expires (31 July 2021), in order to maintain continuity of the reimbursement process.",,,Analgesia/Addiction,To be Discontinued,4/1/20,4/1/20
3211,"Fentanyl (Duragesic 100, 12, 25, 37, 50, 75) Extended-Release Film",Janssen Pharmaceuticals,800-526-7736,75 ug/1 unit (NDC 50458-105-05),New,4/1/20,,"The Company has made a business decision to permanently discontinue all Duragesic/fentanyl transdermal system. Product should be maintained on the formularies until the last batch produced expires (31 July 2021), in order to maintain continuity of the reimbursement process.",,,Analgesia/Addiction,To be Discontinued,4/1/20,4/1/20
3212,"Fentanyl (Duragesic 100, 12, 25, 37, 50, 75) Extended-Release Film",Janssen Pharmaceuticals,800-526-7736,50 ug/1 unit (NDC 50458-104-05),New,4/1/20,,"The Company has made a business decision to permanently discontinue all Duragesic/fentanyl transdermal system. Product should be maintained on the formularies until the last batch produced expires (31 July 2021), in order to maintain continuity of the reimbursement process.",,,Analgesia/Addiction,To be Discontinued,4/1/20,4/1/20
3213,"Fentanyl (Duragesic 100, 12, 25, 37, 50, 75) Extended-Release Film",Janssen Pharmaceuticals,800-526-7736,25 ug/1 unit (NDC 50458-102-05),New,4/1/20,,"The Company has made a business decision to permanently discontinue all Duragesic/fentanyl transdermal system. Product should be maintained on the formularies until the last batch produced expires (31 July 2021), in order to maintain continuity of the reimbursement process.",,,Analgesia/Addiction,To be Discontinued,4/1/20,4/1/20
3214,"Fentanyl (Duragesic 100, 12, 25, 37, 50, 75) Extended-Release Film",Janssen Pharmaceuticals,800-526-7736,12.5 ug/1 unit (NDC 50458-101-05),New,4/1/20,,"The Company has made a business decision to permanently discontinue all Duragesic/fentanyl transdermal system. Product should be maintained on the formularies until the last batch produced expires (31 July 2021), in order to maintain continuity of the reimbursement process.",,,Analgesia/Addiction,To be Discontinued,4/1/20,4/1/20
3215,"Fentanyl (Duragesic 100, 12, 25, 37, 50, 75) Extended-Release Film",Janssen Pharmaceuticals,800-526-7736,12.5 ug/1 h (NDC 50458-090-05),New,4/1/20,,"The Company has made a business decision to permanently discontinue all Duragesic/fentanyl transdermal system. Product should be maintained on the formularies until the last batch produced expires (31 July 2021), in order to maintain continuity of the reimbursement process.",,,Analgesia/Addiction,To be Discontinued,4/1/20,4/1/20
3216,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1,000 mcg per 20 mL (50 mcg per mL) (0.05 mg per mL)  SDV (NDC 63323-806-20)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
3217,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2,500 mcg per 50 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-50)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
3218,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,50 mcg per 1 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-01),Reverified,11/16/20,Available,Check wholesalers for inventory.,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
3219,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mcg per 2 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-02),Reverified,11/16/20,Available,Check wholesalers for inventory.,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
3220,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,250 mcg per 5 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-05),Reverified,11/16/20,Available,Check wholesalers for inventory.,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
3221,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,100 mcg/2 mL (50 mcg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1276-32),Revised,11/20/20,Next Delivery and Estimated Recovery: January 2023,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
3222,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,100 mcg/2 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-32),Revised,11/20/20,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
3223,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,250 mcg/5 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-35),Revised,11/20/20,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
3224,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,1000 mcg/20 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-38),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Pediatric,Current,,
3225,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,100 mcg/2 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-22),Revised,11/20/20,Available,,,,Analgesia/Addiction;Pediatric,Current,,
3226,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,250 mcg/5 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-25),Revised,11/20/20,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
3227,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,500 mcg/10 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-28),Revised,11/20/20,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
3228,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,"1,000 mcg/20 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-31)",Revised,11/20/20,Limited Supply Available.,,,Other,Analgesia/Addiction;Pediatric,Current,,
3229,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,"2,500 mcg/50 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-61)",Revised,11/20/20,Limited Supply Available. Next Delivery: November 2020; Estimated Recovery: February 2021,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
3230,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 2 mL ampul (NDC 0641-6024-10),Revised,7/22/20,Currently not available,Inventory available in vial presentations.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
3231,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 5 mL ampul (NDC 0641-6025-10),Revised,7/22/20,Currently not available,Inventory available in vial presentations.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
3232,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 20 mL ampul (NDC 0641-6026-05),Revised,7/22/20,Currently not available,Inventory available in vial presentations.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
3233,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL 2 mL vial
(NDC 0641-6027-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled for manufacturing in the July - August 2020 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
3234,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL 5 mL vial
(NDC 0641-6028-25)",Revised,7/22/20,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing in the July - August 2020 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
3235,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 20 mL vial (NDC 0641-6029-25),Revised,7/22/20,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing in the July - August 2020 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
3236,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL  50 mL vial
(NDC 0641-6030-01)",Revised,7/22/20,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing in the July - August 2020 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
3237,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,2 mL ampule 10 pack (NDC 17478-0030-02),Revised,12/2/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
3238,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,2 mL ampule; 25 pack (NDC 17478-0030-25),Revised,12/2/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
3239,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,5 mL ampule 10 pack (NDC 17478-0030-05),Revised,12/2/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
3240,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,20 mL ampule (NDC 17478-0030-20),Revised,12/2/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
3241,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,5 mL ampule 25 pack (NDC 17478-0030-55),Revised,12/2/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
3242,Finasteride Tablets,Mylan Pharmaceuticals Inc.,800-RXMYLAN (1-800-796- 9526),5 mg tablet (NDC 0378-5036-05)(NDC 0378-5036-77)(NDC 0378-5036-93),New,5/23/18,,The discontinuation of this product is a business decision,,,Urology,To be Discontinued,5/23/18,5/23/18
3243,Finasteride Tablets,Teva Pharmaceuticals,800-545-8800,"1mg tablet (NDC 45963-600-03, 45963-600-09)",New,9/18/20,,This product discontinuation is a business related decision.,,,Urology,To be Discontinued,9/18/20,9/18/20
3244,Finasteride Tablets,Teva Pharmaceuticals,800-545-8800,5mg tablet (NDC 45963-500-02),New,9/18/20,,This product discontinuation is a business related decision.,,,Urology,To be Discontinued,9/18/20,9/18/20
3245,Finasteride Tablets,Teva Pharmaceuticals,800-545-8800,5 mg 30 CT (NDC 45963-500-30),New,9/18/20,,"Teva’s Finasteride 5 mg Tablets marketed under NDC 0093-7355-56, NDC 0093-7355-05 & NDC 0093-7355-98 are not affected by this discontinuation.",,,Urology,To be Discontinued,9/18/20,9/18/20
3246,Finasteride Tablets,Teva Pharmaceuticals,-,5 mg 90 CT (NDC 45963-500-08),New,9/18/20,,"Teva’s Finasteride 5 mg Tablets marketed under NDC 0093-7355-56, NDC 0093-7355-05 & NDC 0093-7355-98 are not affected by this discontinuation.",,,Urology,To be Discontinued,9/18/20,9/18/20
3247,"Floxuridine for Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,500 mg per vial (NDC 63323-145-07_,New,9/30/20,,"Discontinued: May 30, 2019",,,Oncology,To be Discontinued,9/30/20,9/30/20
3248,"Floxuridine for Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg per vial (NDC 0143-9270-01),Reverified,10/9/20,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing and will be available in the Late October 2020 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Oncology,Current,,
3249,"Fludarabine Phosphate for Injection, USP","Hospira, Inc.",844-646-4398,50 mg Single Dose Glass Fliptop Vial (NDC 61703-0344-18),New,2/10/20,,Discontinuation of the manufacture of the drug due to Active Pharmaceutical Ingredient Supplier market exit. Current supply expected to exhaust August 2020.,,,Oncology,To be Discontinued,2/10/20,2/10/20
3250,Fludrocortisone Acetate Tablets,Teva Pharmaceuticals,800-545-8800,"0.1 mg, 100 count bottle (NDC 0555-0997-02)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,8/7/19,
3251,Fludrocortisone Acetate Tablets,Impax Laboratories,877-835-5472,"0.1 mg, 100 count bottle (NDC 0115-7033-01)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,8/7/19,
3252,Fludrocortisone Acetate Tablets,Impax Laboratories,877-835-5472,"0.1 mg, 500 count bottle (NDC 0115-7033-02)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,8/7/19,
3253,Flumazenil Injection,Mylan,800-796-9526,"0.5 mg in 5 mL (0.1 mg/mL), multi-dose vial, 10 vials (NDC 67457-447-53)",New,12/16/19,,Expected Discontinuation April 2020,,,Analgesia/Addiction;Neurology;Pediatric,To be Discontinued,12/16/19,12/16/19
3254,Flumazenil Injection,Mylan,800-796-9526,"1 mg in 10 mL (0.1 mg/mL), multi-dose vial, 10 vials (NDC 67457-444-10)",Revised,7/19/19,,Discontinuation of the manufacture of the drug.,,,Analgesia/Addiction;Neurology;Pediatric,To be Discontinued,7/19/19,7/19/19
3255,Fluorescein Injection,Akorn Pharmaceuticals,800-932-5676,"AK-FLUOR® (fluorescein injection, USP) 10%, 100 mg/mL in a 5 mL single use vial (NDC 17478-253-10)",Revised,12/2/19,Available,Continue to allocate available inventory,,Shortage of an active ingredient,Ophthalmology,Current,,
3256,Fluorescein Injection,Akorn Pharmaceuticals,800-932-5676,"AK-FLUOR® (fluorescein injection, USP) 25%, 250 mg/mL in a 2 mL single use vial (NDC 17478-250-20)",Revised,12/2/19,Available,Continue to allocate available inventory,,Shortage of an active ingredient,Ophthalmology,Current,,
3257,Fluorescein Injection,Novartis,888-669-6682,Fluorescite (fluorescein injection) 10% 5 mL vial (NDC 0065-0092-65),Reverified,12/11/19,Available,,,Other,Ophthalmology,Current,,
3258,Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution,Altaire,631-722-5988 ext. 27,"Altafluor Solution Fluorescein sodium 0.25% and Benoxinate HCl 0.4%, 5 mL bottle (NDC 59390-0218-05)",Revised,12/10/19,,,,,Ophthalmology,Resolved,12/10/19,
3259,Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution,Altaire,631-722-5988 ext.27,"Flurox Solution  Fluorescein sodium 2.5mg (0.25%), benoxinate hydrochloride 4mg (0.4%), 5mL bottle (NDC 54799-508-05)",Revised,12/11/19,,,,,Ophthalmology,Resolved,12/11/19,
3260,Fluorescein Strips,HUB Pharmaceuticals,800-EYE-DROP,BIOGLO Fluorescein Sodium Ophthalmic Strips USP 100 Strips per box (ndc 17238-900-11),Reverified,2/13/20,Available,,,,Ophthalmology,Current,,
3261,Fluorescein Strips,HUB Pharmaceuticals,800-EYE-DROP,BIOGLO Fluorescein Sodium Ophthalmic Strips USP 300 Strips per box (NDC 17238-900-30),Reverified,2/12/20,Available,,,,Ophthalmology,Current,,
3262,Fluorescein Strips,Akorn Pharmaceuticals,800-932-5676,Ful-Glo 1.0 mg 100 sterile strips (NDC 17478-404-01),Revised,12/2/19,On backorder,Availability Q12020,,Other,Ophthalmology,Current,,
3263,Fluorescein Strips,Akorn Pharmaceuticals,800-932-5676,Ful-Glo 0.6 mg 300 sterile strips (NDC 17478-403-03),Revised,12/2/19,On backorder,Availability Q12020,,Other,Ophthalmology,Current,,
3264,Fluorouracil Injection,Teva Pharmaceuticals,800-545-8800,5g/100mL injection (NDC 0703-3019-12),Revised,2/20/20,,,,,Oncology,To be Discontinued,2/20/20,2/20/20
3265,Fluorouracil Injection,Teva Pharmaceuticals,800-545-8800,2.5g/50mL injection (NDC 0703-3018-12),Revised,2/20/20,,Actively selling. Remaining inventory estimated to last until April 2020,,,Oncology,To be Discontinued,2/20/20,2/20/20
3266,Fluorouracil Injection,Teva Pharmaceuticals,800-545-8800,50mg/1mL injection (NDC 0703-3015-13),Revised,2/20/20,,Actively selling. Remaining inventory estimated to last until April 2020,,,Oncology,To be Discontinued,2/20/20,2/20/20
3267,Fluoxetine Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 28 count bottle (NDC 0378-5410-28)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3268,Fluoxetine Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"20 mg, 28 count bottle (NDC 0378-5420-28)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3269,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 10 mg, 100 count bottle (NDC 0781-2823-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
3270,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 10 mg, 1000 count bottle (NDC 0781-2823-10)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
3271,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 20 mg, 100 count bottle (NDC 0781-2822-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
3272,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 20 mg, 1000 count bottle (NDC 0781-2822-10)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
3273,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 100 count bottle (NDC 0781-2824-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
3274,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 1000 count bottle (NDC 0781-2824-10)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
3275,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 30 count bottle (NDC 0781-2824-31)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
3276,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"1 mg, 100 count bottle (NDC 0378-6004-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3277,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"1 mg, 500 count bottle (NDC 0378-6004-05)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3278,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"2.5 mg, 100 count bottle (NDC 0378-6009-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3279,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"2.5 mg, 500 count bottle (NDC 0378-6009-05)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3280,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count bottle (NDC 0378-6074-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3281,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 500 count bottle (NDC 0378-6074-05)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3282,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100 count bottle (NDC 0378-6097-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3283,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 500 count bottle (NDC 0378-6097-05)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3284,Flurazepam Hydrochloride Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Flurazepam HCl 15mg C 100s (NDC 0378-4415-01),Reverified,11/10/20,Available,,,Other,Psychiatry,Current,,
3285,Flurazepam Hydrochloride Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Flurazepam HCl 30mg C 100s (NDC 0378-4430-01),Reverified,11/10/20,Available,,,Other,Psychiatry,Current,,
3286,Flurbiprofen Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 100 count bottle (NDC 0378-0076-01)",New,5/2/19,,,,,Rheumatology,To be Discontinued,5/2/19,5/2/19
3287,Flurbiprofen Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg, 100 count bottle (NDC 0378-0093-01)",New,5/2/19,,,,,Rheumatology,To be Discontinued,5/2/19,5/2/19
3288,"Flutamide Capsules, USP",Teva Pharmaceuticals,800-545-8800,125 mg 180 count (NDC 0591-2466-18),New,6/10/19,,Discontinuation of the manufacture of the drug.,,,Oncology,To be Discontinued,6/10/19,6/10/19
3289,Fluvastatin Sodium Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"80 mg, 30 count bottle (NDC 0378-5121-93)",New,5/2/19,,,,,Endocrinology/Metabolism;Pediatric,To be Discontinued,5/2/19,5/2/19
3290,Fluvastatin Sodium Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"80 mg, 100 count bottle (NDC 0378-5121-01)",New,5/2/19,,,,,Endocrinology/Metabolism;Pediatric,To be Discontinued,5/2/19,5/2/19
3291,Fluvoxamine ER Capsules,Par Pharmaceutical,"800-828-9393, option 5 then option 2",100 mg. 30’s count (NDC 10370-175-11),Revised,4/7/20,On backorder. Estimated availability end of April 2020,,,Delay in shipping of the drug,Psychiatry,Current,,
3292,Fluvoxamine ER Capsules,Par Pharmaceutical,"800-828-9393, option 5 then option 2",150 mg. 30’s count (NDC 10370-176-11),Revised,4/7/20,On backorder. Estimated availability end of April 2020,,,Delay in shipping of the drug,Psychiatry,Current,,
3293,Fluvoxamine ER Capsules,Teva Pharmaceuticals,800-545-8800,"Fluvoxamine 100 mg Extended Release Capsules, 30 count (NDC 0228-2848-03)",Reverified,11/19/20,Available,,,Other,Psychiatry,Current,,
3294,Fluvoxamine ER Capsules,Teva Pharmaceuticals,800-545-8800,"Fluvoxamine 150 mg Extended Release Capsules, 30 count (NDC 0228-2849-03)",Reverified,11/19/20,Available,,,Other,Psychiatry,Current,,
3295,"Folic Acid Tablets, USP",Par Pharmaceutical,800-828-9393,"1 mg, bottle of 100 (NDC 0603-3162-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Gastroenterology;Reproductive,To be Discontinued,4/19/19,4/19/19
3296,"Folic Acid Tablets, USP",Par Pharmaceutical,800-828-9393,"1 mg, bottle of 1000 (NDC 0603-3162-32)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Gastroenterology;Reproductive,To be Discontinued,4/19/19,4/19/19
3297,"Folic Acid Tablets, USP",Par Pharmaceutical,800-828-9393,"1 mg, bottle of 2500 (NDC 0603-3162-30)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Gastroenterology;Reproductive,To be Discontinued,4/19/19,4/19/19
3298,"Furosemide Injection, USP",Baxter Healthcare,888-229-0001,"Furosemide Injection, USP, 10 mg/mL - 10 mL Single Dose Glass Vial (25 x 10 mL) (NDC 36000-284-25)",Reverified,10/28/20,Available,,,,Cardiovascular,Current,,
3299,"Furosemide Injection, USP",Baxter Healthcare,888-229-0001,"Furosemide Injection, USP, 10 mg/mL - 2 mL Single Dose Glass Vial (25 x 2 mL)(NDC 36000-282-25)",Reverified,10/28/20,Available,,,,Cardiovascular,Current,,
3300,"Furosemide Injection, USP",Baxter Healthcare,888-229-0001,"Furosemide Injection, USP, 10 mg/mL - 4 mL Single Dose Glass Vial (25 x 4 mL)(NDC 36000-283-25)",Reverified,10/28/20,Available,,,,Cardiovascular,Current,,
3301,"Furosemide Injection, USP",Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,20 mg/mL (NDC 23155-473-41),Reverified,11/6/20,Available,,,,Cardiovascular,Current,,
3302,"Furosemide Injection, USP",Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,40 mg/4mL (NDC 23155-473-42),Reverified,11/6/20,Available,,,,Cardiovascular,Current,,
3303,"Furosemide Injection, USP",Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,100 mg/10mL (NDC 23155-473-44),Reverified,11/6/20,Available,,,,Cardiovascular,Current,,
3304,"Furosemide Injection, USP","Hospira, Inc.",844-646-4398,20 mg/2 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-02),Reverified,11/20/20,Available,,,Other,Cardiovascular,Current,,
3305,"Furosemide Injection, USP","Hospira, Inc.",844-646-4398,40 mg/4 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-04),Reverified,11/20/20,Available,,,Other,Cardiovascular,Current,,
3306,"Furosemide Injection, USP","Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL): Single Dose Glass Fliptop Vial (NDC 0409-6102-10),Reverified,11/20/20,Available,,,Other,Cardiovascular,Current,,
3307,"Furosemide Injection, USP","Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL; Ansyr Plastic syringe (NDC 0409-1639-10),Reverified,11/20/20,Available,,,Other,Cardiovascular,Current,,
3308,"Furosemide Injection, USP","Hospira, Inc.",844-646-4398,40 mg/4 mL (10 mg/mL); Ansyr Plastic syringe (NDC 0409-9631-04),Reverified,11/20/20,Available,,,Other,Cardiovascular,Current,,
3309,"Furosemide Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 2 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-02)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Cardiovascular,Current,,
3310,"Furosemide Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"40 mg per 4 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-04)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Cardiovascular,Current,,
3311,"Furosemide Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"100 mg per 10 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-10)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Cardiovascular,Current,,
3312,"Furosemide Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,20 mg/2 mL single-dose vial (NDC 55150-322-25),Reverified,11/20/20,Backordered — next shipments anticipated Jan 21,Intermittent availability expected.,,Delay in shipping of the drug,Cardiovascular,Current,,
3313,"Furosemide Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,40 mg/4 mL single-dose vial (NDC 55150-323-25),Reverified,11/20/20,Backordered — next shipments anticipated Jan 21,Intermittent availability expected.,,Delay in shipping of the drug,Cardiovascular,Current,,
3314,"Furosemide Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,100 mg/10 mL single-dose vial (NDC 55150--324-25),Reverified,11/20/20,Backordered — next shipments anticipated Jan 21,Intermittent availability expected.,,Delay in shipping of the drug,Cardiovascular,Current,,
3315,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Vials 5 mL single-dose vials, rubber stoppered, in individual cartons of 10, 2 cartons per Box (NDC 50419-188-81)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
3316,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Vials 10 mL single-dose vials, rubber stoppered, in individual cartons of 10, 2 cartons per Box (NDC 50419-188-82)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
3317,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Vials 15 mL single-dose vials, rubber stoppered, in individual cartons of 10, 2 cartons per Box (NDC 50419-188-83)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
3318,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Vials 20 mL single-dose vials, rubber stoppered, in individual cartons of 10, 2 cartons per Box (NDC 50419-188-84)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
3319,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Pre-Filled Syringes 10 mL pre-filled disposable syringe, Boxes of 5 (NDC 50419-188-36)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
3320,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Pre-Filled Syringes 15 mL pre-filled disposable syringe, Boxes of 5 (NDC 50419-188-37)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
3321,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Pre-Filled Syringes 20 mL pre-filled disposable syringe, Boxes of 5 (NDC 50419-188-38)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
3322,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Pharmacy Bulk Package 50 mL Pharmacy Bulk Package, rubber stoppered, 10 per box (NDC 50419-188-58)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
3323,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Pharmacy Bulk Package 100 mL Pharmacy Bulk Package, rubber stoppered, 10 per box (NDC 50419-188-11)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
3324,Gemcitabine Hydrochloride Injection,Apotex Corp.,800-706-5575,"200 mg/5.26 mL (38 mg/mL), single dose vial (NDC 60505-6113-6)",New,1/8/20,,Apotex made a business decision to discontinue this product.,,,Oncology,To be Discontinued,1/8/20,1/8/20
3325,Gemcitabine Hydrochloride Injection,Apotex Corp.,800-706-5575,"1 g/26.3 mL (38 mg/mL), single dose vial (NDC 60505-6114-0)",New,1/8/20,,Apotex made a business decision to discontinue this product.,,,Oncology,To be Discontinued,1/8/20,1/8/20
3326,Gemcitabine Hydrochloride Injection,Apotex Corp.,800-706-5575,"2 g/52.6 mL (38 mg/mL), single dose vial (NDC 60505-6115-2)",New,1/8/20,,Apotex made a business decision to discontinue this product.,,,Oncology,To be Discontinued,1/8/20,1/8/20
3327,Gemcitabine Hydrochloride Injection,Mylan Institutional,800-796-9526,"1 g, single dose vial (NDC 67457-462-01)",New,12/16/19,,Expected Discontinuation March/April 2020,,,Oncology,To be Discontinued,12/16/19,12/16/19
3328,Gemcitabine Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"1 g, single dose vial (NDC 45963-619-59)",New,1/16/20,,Actively selling; Remaining inventory estimated to last through April 2020,,,Oncology,To be Discontinued,1/16/20,1/16/20
3329,Gemcitabine Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"200 mg/5.26 mL (38 mg/mL), single dose vial (NDC 45963-623-57)",New,1/16/20,,Actively selling; Remaining inventory estimated to last through March 2020,,,Oncology,To be Discontinued,1/16/20,1/16/20
3330,Gemcitabine Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"1 g/26.3 mL (38 mg/mL), single dose vial (NDC 45963-624-58)",New,1/16/20,,Actively selling; Remaining inventory estimated to last through July 2020,,,Oncology,To be Discontinued,1/16/20,1/16/20
3331,Gemcitabine Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"2 g/52.6 mL (38 mg/mL), single dose vial (NDC 45963-636-60)",New,1/16/20,,Actively selling; Remaining inventory estimated to last through March 2020,,,,To be Discontinued,1/16/20,1/16/20
3332,Gemcitabine Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"200 mg, single dose vial (NDC 45963-612-57)",New,1/7/20,,,,,Oncology,To be Discontinued,1/7/20,1/7/20
3333,Gemcitabine Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"2 g, single dose vial (NDC 45963-620-60)",New,1/7/20,,,,,Oncology,To be Discontinued,1/7/20,1/7/20
3334,Gemcitabine Hydrochloride Injection,Mylan Institutional,800-796-9526,"200 mg, single dose vial (NDC 67457-464-20)",New,6/26/20,,Expected discontinuation December 2020,,,Oncology,To be Discontinued,6/26/20,6/26/20
3335,Gemifloxacin Mesylate (Factive) Tablets,"LG Chem, Ltd.",866-686-6174,"320mg, 7 Tablets in 1 Blister Pack (NDC 44004-321-07)",Reverified,11/5/20,Estimated recovery to be determined.,License to manufacture and distribute FACTIVE is under legal dispute.,,Other,Anti-Infective,Current,,
3336,Gemifloxacin Mesylate (Factive) Tablets,"LG Chem, Ltd.",866-686-6174,"320mg, 5 Tablets in 1 Blister Pack (NDC 44004-321-05)",Reverified,11/5/20,Estimated recovery to be determined.,License to manufacture and distribute FACTIVE is under legal dispute.,,Other,Anti-Infective,Current,,
3337,Glimepiride Tablets,Teva Pharmaceuticals,800-545-8800,1 mg 100 Count (NDC 0093-7254-01),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Endocrinology/Metabolism,To be Discontinued,5/17/19,5/17/19
3338,Glimepiride Tablets,Teva Pharmaceuticals,800-545-8800,2 mg 100 Count (NDC 0093-7255-01),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Endocrinology/Metabolism,To be Discontinued,5/17/19,5/17/19
3339,Glimepiride Tablets,Teva Pharmaceuticals,800-545-8800,4 mg 100 Count (NDC 0093-7256-01),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Endocrinology/Metabolism,To be Discontinued,5/17/19,5/17/19
3340,Glimepiride Tablets,Teva Pharmaceuticals,800-545-8800,4 mg 250 Count (NDC 0093-7256-52),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Endocrinology/Metabolism,To be Discontinued,5/17/19,5/17/19
3341,Glipizide Tablets,Teva Pharmaceuticals,800-545-8800,"5mg tablets (NDC 0591-0460-10), (NDC 0591-0460-05), (NDC 0591-0460-01)",New,5/28/20,,"Teva had evaluated the market and made decision to discontinue the product. No inventory remains for Glipizide 5 mg tablets 100 count NDC: 0591-0460-01. For the remaining presentations, allocations are being made based on customer Rx trends.",,,Endocrinology/Metabolism,To be Discontinued,5/28/20,5/28/20
3342,Glipizide Tablets,Teva Pharmaceuticals,800-545-8800,"10mg tablets, (NDC 0591-0461-10), (NDC 0591-0461-01), (NDC 0591-0461-05)",New,5/28/20,,"Teva had evaluated the market and made decision to discontinue the product. No inventory remains for Glipizide 5 mg tablets 100 count NDC: 0591-0460-01. For the remaining presentations, allocations are being made based on customer Rx trends.",,,Endocrinology/Metabolism,To be Discontinued,5/28/20,5/28/20
3343,Glycopyrrolate (Seebri Neohaler) Inhalation Powder,Sunovion Pharmaceuticals Inc.,888-669-6682,"15.6mcg  (NDCs 63402-815-06, 63402-815-12, and 63402-815-60)",New,3/10/20,,,,,Pulmonary/Allergy,To be Discontinued,3/10/20,3/10/20
3344,Guanfacine Hydrochloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"1 mg, 100 count bottle (NDC 0378-1061-01)",New,5/2/19,,,,,Neurology;Pediatric,To be Discontinued,5/2/19,5/2/19
3345,Guanfacine Hydrochloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"2 mg, 100 count bottle (NDC 0378-1062-01)",New,5/2/19,,,,,Neurology;Pediatric,To be Discontinued,5/2/19,5/2/19
3346,Guanfacine Hydrochloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"3 mg, 100 count bottle (NDC 0378-1063-01)",New,5/2/19,,,,,Neurology;Pediatric,To be Discontinued,5/2/19,5/2/19
3347,Guanfacine Hydrochloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"4 mg, 100 count bottle (NDC 0378-1065-01)",New,5/2/19,,,,,Neurology;Pediatric,To be Discontinued,5/2/19,5/2/19
3348,Guanfacine Hydrochloride Tablets,"Epic Pharma, LLC",203-564-0568,"Guanfacine Tablets 1 mg, 100 Count (NDC 42806-048-01)",New,6/12/19,Available,,,Other,Cardiovascular,Current,,
3349,Guanfacine Hydrochloride Tablets,"Epic Pharma, LLC",203-564-0568,"Guanfacine Tablets 2 mg, 100 Count (NDC 42806-296-01)",New,6/12/19,Available,,,Other,Cardiovascular,Current,,
3350,Guanfacine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg (NDC 0378-1160-01),Reverified,11/10/20,Unavailable. Estimated recovery TBD.,,,Other,Cardiovascular,Current,,
3351,Guanfacine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-1190-01),Reverified,11/10/20,Unavailable. Estimated recovery TBD.,,,Other,Cardiovascular,Current,,
3352,Guanfacine Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,1mg tablets 100 count bottle (NDC 0591-0444-01),Reverified,11/19/20,Available,,,Other,Cardiovascular,Current,,
3353,Guanfacine Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,2 mg tablets 100 count bottle (NDC 0591-0453-01),Reverified,11/19/20,Available,,,,Cardiovascular,Current,,
3354,Guanfacine Hydrochloride Tablets,Amneal Pharmaceutical,877-835-5472,1 mg bottles of 30 (NDC 65162-711-03); 1 mg bottles of 100 (NDC 65162-711-10),Reverified,8/17/20,Available,,,Other,Cardiovascular,Current,,
3355,Guanfacine Hydrochloride Tablets,Amneal Pharmaceutical,877-835-5472,2 mg bottles of 30 (NDC 65162-713-03); 2 mg bottles of 100 (NDC 65162-713-10); 2 mg bottles of 500 (NDC 65162-713-50),Reverified,8/17/20,Available,,,Other,Cardiovascular,Current,,
3356,Guanidine Hydrochloride Tablets,Merck Sharp & Dohme Corp.,800-672-6372,125 mg tablets (NDC 0085-0492-01),New,9/28/20,,To be discontinued on or near October 2020.,,,Neurology,To be Discontinued,9/28/20,9/28/20
3357,Haloperidol Lactate (Haldol) Injection,"Janssen Biotech, Inc.",800-526-7736,"5 mg/mL, 10 ampule in 1 box, > 1 mL in 1 ampule, (NDC 50458-255-01)",New,11/13/20,,Product discontinuation as per business decision,,,Psychiatry,To be Discontinued,11/13/20,11/13/20
3358,Haloperidol Lactate Injection,Patriot Pharmaceuticals,215-325-7676,"5 mg/mL, 10 ampule in 1 box,> 1 mL in 1 ampule, (NDC 10147-0911-1)",New,11/13/20,,Product discontinuation as per business decision,,,Psychiatry,To be Discontinued,11/13/20,11/13/20
3359,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,0.5 mg (NDC 0378-0351-01) and (NDC 0378-0351-10),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3360,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg (NDC 0378-0257-01) and (NDC 0378-0257-10),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3361,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-0214-01) and (NDC 0378-0214-10),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3362,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,5 mg (NDC 0378-0327-01) and (NDC 0378-0327-10),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3363,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-0334-01),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3364,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,20 mg (NDC 0378-0355-01),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3365,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 5MG 100 CT (NDC 68382-079-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,11/20/19,
3366,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 5MG 1000 CT (NDC 68382-079-10),Revised,11/20/19,,,Available,,Psychiatry,Resolved,11/20/19,
3367,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 10MG 100 CT (NDC 68382-080-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,11/20/19,
3368,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 20MG 100 CT (NDC 68382-081-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,11/20/19,
3369,Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-13-9101),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3370,Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-83-9101),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3371,Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count unit dose (NDC 0781-13-9113),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3372,Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-13-9201),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3373,Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-83-9201),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3374,Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count unit dose (NDC 0781-13-9213),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3375,Haloperidol Tablets,Sandoz,800-525-8747,2 mg 100 count bottle (NDC 0781-13-9801),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3376,Haloperidol Tablets,Sandoz,800-525-8747,2 mg 100 count unit dose (NDC 0781-13-9213),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3377,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 1000 count bottle (NDC 0781-13-9610),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3378,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 1000 count bottle (NDC 0781-83-9610),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3379,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-13-9601),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3380,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-83-9601),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3381,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count unit dose (NDC 0781-13-9613),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3382,Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0781-13-9701),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3383,Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0781-83-9701),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3384,Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count unit dose (NDC 0781-13-9713),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3385,Haloperidol Tablets,Sandoz,800-525-8747,20 mg 100 count bottle (NDC 0781-83-9301),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
3386,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 2,000 USP units in 1000 mL.  Product code 2B0944  (NDC 0338-0433-04)",Reverified,10/28/20,Available,,,,Hematology,Current,,
3387,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 1,000 USP units in 500 mL.  Product code 2B0953 (NDC 0338-0431-03)",Reverified,10/28/20,Unavailable,Product code 2B0953 was replaced with code AHB0953U,,Other,Hematology,Current,,
3388,Heparin Sodium and Sodium Chloride 0.9% Injection,"Hospira, Inc.",844-646-4398,"1,000 Units/500 mL (2 Units/mL); Flexible Container (NDC 00409-7620-03)",Revised,11/20/20,Limited Supply Available. Next Delivery: November 2020; Estimated Recovery: July 2021,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Hematology,Current,,
3389,Heparin Sodium and Sodium Chloride 0.9% Injection,"Hospira, Inc.",844-646-4398,"2,000 Units/1000 mL (2 Units/mL); Flexible Container (NDC 00409-7620-59)",Revised,11/20/20,Available,,,Other,Hematology,Current,,
3390,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection, 1,000 units / 500 mL (2 units / mL) in VIAFLEX Plastic Container.  Product code AHB0953U (NDC 0338-0424-18)",Reverified,10/28/20,Available,Product code AHB0953U replaces code 2B0953,,,Hematology,Current,,
3391,Heparin Sodium and Sodium Chloride 0.9% Injection,Sagent Pharmaceuticals,866-625-1618,1000 units/mL 10mL pack 25 (NDC 25021-400-10),Reverified,10/22/20,Available.,,,,Hematology,Current,,
3392,Heparin Sodium and Sodium Chloride 0.9% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1,000 Units/500 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-77)",Reverified,10/23/20,Expected availability February 2021,,,Other,Hematology,Current,,
3393,Heparin Sodium and Sodium Chloride 0.9% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2,000 Units/1000 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-10)",Reverified,10/23/20,Expected availability February 2021,,,Other,Hematology,Current,,
3394,"Hydralazine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"20 mg per mL, SDV (NDC 63323-614-01)",Revised,10/23/20,Backordered.  Next release expected November 2020.,Check wholesaler for inventory,,Manufacturing Delay,Cardiovascular,Current,,
3395,"Hydralazine Hydrochloride Injection, USP",Akorn Pharmaceuticals,800-932-5676,"20 mg/mL, 1mL single dose vial  (box of 10) (NDC 17478-934-01)",Revised,11/3/20,Not available,Not available,,Other,Cardiovascular,Current,,
3396,"Hydralazine Hydrochloride Injection, USP",Akorn Pharmaceuticals,800-932-5676,"20 mg/mL, 1mL single dose vial  (box of 25) (NDC 17478-934-15)",Revised,11/3/20,On allocation / Recovery expected March 2021,Manufacturer interruption production issues.,,Other,Cardiovascular,Current,,
3397,"Hydralazine Hydrochloride Injection, USP",Mylan Institutional,800-796-9526,20 mg / 1 ml] 25PK (NDC 67457-291-01),Reverified,11/10/20,Intermittent supply,,,Demand increase for the drug,Cardiovascular,Current,,
3398,"Hydralazine Hydrochloride Injection, USP","X-GEN Pharmaceuticals, Inc.",866-390-4411,20 mg/mL per vial (NDC 39822-0500-4),Revised,9/9/20,Not available and no plans to manufacture at this time.,,,Other,Cardiovascular,Current,,
3399,Hydrochlorothiazide (Microzide) Capsules,Allergan Sales LLC,800-678-1605,12.5 mg (NDC 52544-622-01),New,10/22/19,,"The authorized generic, Hydrochlorothiazide Capsules, USP, 12.5 mg remains commercially available.",,,Cardiovascular,To be Discontinued,10/22/19,10/22/19
3400,Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,20 mg/25 mg (NDC 0378-2025-01),New,5/22/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/22/18,5/22/18
3401,Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,12.5 mg/ 20 mg (NDC 0378-2012-01),New,5/22/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/22/18,5/22/18
3402,Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg/ 12.5 mg (NDC 0378-1012-01),New,5/22/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/22/18,5/22/18
3403,Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution,Perrigo Pharmaceuticals,269-673-8451,Hydrocodone Bitartrate (5 mg/5 mL) and Homatropine Methylbromide (1.5 mg/5 mL)(NDC 0574-1105-16),New,6/5/18,,The discontinuation of this product is a business decision,,,Pediatric;Pulmonary/Allergy,To be Discontinued,6/5/18,6/5/18
3404,Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 12 suppositories (NDC 59741-301-12),New,11/25/19,,,,,Other;Urology,To be Discontinued,11/25/19,11/25/19
3405,Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 24 suppositories (NDC 59741-301-24),New,11/25/19,,,,,Other;Urology,To be Discontinued,11/25/19,11/25/19
3406,Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 100 suppositories (NDC 59741-301-01),New,11/25/19,,,,,Other;Urology,To be Discontinued,11/25/19,11/25/19
3407,"Hydrocortisone Tablets, USP",Pfizer Pharmaceuticals,800-533-4535,5 mg tablet; bottle of 50 (NDC 59762-0073-1),Revised,11/20/20,Next Delivery: December 2020; Estimated Recovery: TBD,Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism,Current,,
3408,"Hydrocortisone Tablets, USP",Pfizer Pharmaceuticals,800-533-4535,10 mg tablet; bottle of 100 (NDC 59762-0074-1),Revised,11/20/20,Next Delivery: December 2020; Estimated Recovery: TBD,Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism,Current,,
3409,"Hydrocortisone Tablets, USP",Pfizer Pharmaceuticals,800-533-4535,20 mg tablet; bottle of 100 (NDC 59762-0075-1),Revised,11/20/20,Next Delivery: December 2020; Estimated Recovery: TBD,Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism,Current,,
3410,"Hydrocortisone Tablets, USP",Pfizer Pharmaceuticals,800-533-4535,Cortef 20 mg tablet; bottle of 100 (NDC 0009-0044-01),Revised,11/20/20,Available,,,Other,Endocrinology/Metabolism,Current,,
3411,"Hydrocortisone Tablets, USP",Pfizer Pharmaceuticals,800-533-4535,Cortef 5 mg tablet; bottle of 50 (NDC 0009-0012-01),Revised,11/20/20,Next Delivery and Estimated Recovery: October 2020,,,Other,Endocrinology/Metabolism,Current,,
3412,"Hydrocortisone Tablets, USP",Pfizer Pharmaceuticals,800-533-4535,Cortef 10 mg tablet; bottle of 100 (NDC 0009-0031-01),Revised,11/20/20,Available,,,Demand increase for the drug,Endocrinology/Metabolism,Current,,
3413,"Hydrocortisone Tablets, USP","Vensun Pharmaceuticals, Inc.",855-273-0146,"5 mg, 50 count bottles (NDC 42543-140-50)",Reverified,10/5/20,Available,ANDA Holder: Strides Pharma,,Other,Endocrinology/Metabolism,Current,,
3414,"Hydrocortisone Tablets, USP","Vensun Pharmaceuticals, Inc.",855-273-0146,"10 mg, 100 count bottles (NDC 42543-141-01)",Reverified,10/5/20,Available,ANDA Holder: Strides Pharma,,Other,Endocrinology/Metabolism,Current,,
3415,"Hydrocortisone Tablets, USP","Vensun Pharmaceuticals, Inc.",855-273-0146,"20 mg, 100 count bottles (NDC 42543-142-01)",Reverified,10/5/20,Available,ANDA Holder: Strides Pharma,,Other,Endocrinology/Metabolism,Current,,
3416,"Hydrocortisone Tablets, USP",Par Pharmaceutical,800-828-9393,"5 mg, bottle of 50 (NDC 0603-3899-19)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Pulmonary/Allergy,To be Discontinued,4/19/19,4/19/19
3417,"Hydrocortisone Tablets, USP",Par Pharmaceutical,800-828-9393,"10 mg, bottle of 100 (NDC 0603-3900-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Pulmonary/Allergy,To be Discontinued,4/19/19,4/19/19
3418,"Hydrocortisone Tablets, USP",Par Pharmaceutical,800-828-9393,"20 mg, bottle of 100 (NDC 0603-3901-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Pulmonary/Allergy,To be Discontinued,4/19/19,4/19/19
3419,"Hydrocortisone Tablets, USP","Vensun Pharmaceuticals, Inc.",855-273-0146,"5 mg, 50 count bottles (NDC 64380-970-25)",New,10/5/20,Available,,,,Endocrinology/Metabolism,Current,,
3420,"Hydrocortisone Tablets, USP","Vensun Pharmaceuticals, Inc.",855-273-0146,"10 mg, 100 count bottles (NDC 64380-971-06)",New,10/5/20,Available,,,,Endocrinology/Metabolism,Current,,
3421,"Hydrocortisone Tablets, USP","Vensun Pharmaceuticals, Inc.",855-273-0146,"20 mg, 100 count bottles (NDC 64380-972-06)",New,10/5/20,Available,,,,Endocrinology/Metabolism,Current,,
3422,"Hydrocortisone Tablets, USP",Amneal Pharmaceutical,866-525-7270,100mg/100 count (NDC 00115-1697-01),New,5/15/20,Unavailable,,,Limited API availability,Endocrinology/Metabolism,Current,,
3423,"Hydrocortisone Tablets, USP",Amneal Pharmaceutical,866-525-7270,20mg/100 count (NDC 00115-1700-01),New,5/15/20,Limited availability,,,Limited API availability,Endocrinology/Metabolism,Current,,
3424,"Hydromorphone Hydrochloride Extended-Release Tablets, CII",Teva Pharmaceuticals,800-545-8800,"32 mg, 100 count (NDC 0591-3631-01)",New,6/20/19,,This was a business-related decision to discontinue manufacturing these products.,,,Analgesia/Addiction,To be Discontinued,6/20/19,6/20/19
3425,"Hydromorphone Hydrochloride Extended-Release Tablets, CII",Teva Pharmaceuticals,800-545-8800,"16 mg, 100 count (NDC 0591-3630-01)",New,6/20/19,,This was a business-related decision to discontinue manufacturing these products.,,,Analgesia/Addiction,To be Discontinued,6/20/19,6/20/19
3426,"Hydromorphone Hydrochloride Extended-Release Tablets, CII",Teva Pharmaceuticals,800-545-8800,"12 mg, 100 count (NDC 0591-3739-01)",New,6/20/19,,This was a business-related decision to discontinue manufacturing these products.,,,Analgesia/Addiction,To be Discontinued,6/20/19,6/20/19
3427,"Hydromorphone Hydrochloride Extended-Release Tablets, CII",Teva Pharmaceuticals,800-545-8800,"8 mg, 100 count (NDC 0591-3629-01)",New,6/20/19,,This was a business-related decision to discontinue manufacturing these products.,,,Analgesia/Addiction,To be Discontinued,6/20/19,6/20/19
3428,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 0.5 mg per 0.5 mL, prefilled syringe (NDC 76045-009-06)                                                                                           Microvault",Revised,11/16/20,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
3429,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-11)                                                                                                                                                                                     Microvault",Revised,11/16/20,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
3430,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"1 mg per 1 mL, Single dose vial, (NDC 63323-852-25)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
3431,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single dose vial, (NDC 63323-853-25)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
3432,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single dose vial, (NDC 63323-854-10)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
3433,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-10)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
3434,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"50 mg per 5 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-15)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
3435,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 50 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-50)",Revised,11/16/20,Backorderd. Next release December 2020.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
3436,"Hydromorphone Hydrochloride Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 1 mL vial (NDC 0641-0121-25)",Revised,7/22/20,Inventory is currently available.,Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
3437,"Hydromorphone Hydrochloride Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0641-2341-41)",Revised,7/22/20,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing in the July - August 2020 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
3438,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 0.5 mg per 0.5 mL, prefilled syringe (NDC 76045-009-05)",Revised,11/16/20,Check wholesalers for inventory,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
3439,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-10)                                                                                                                                       Blister pack",Revised,11/16/20,Check wholesalers for inventory,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
3440,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 2 mg per 1 mL, prefilled syringe (NDC 76045-010-10)",Revised,11/16/20,Backordered. Next release date not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
3441,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 4 mg per 1 mL, prefilled syringe (NDC 76045-011-10)",Revised,11/16/20,Backordered. Next release date not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
3442,"Hydromorphone Hydrochloride Injection, USP",Teva Pharmaceuticals,800-545-8800,10 MG/1ML (NDC0703-0110-03),Reverified,11/19/20,Available,,,,Analgesia/Addiction,Current,,
3443,"Hydromorphone Hydrochloride Injection, USP",Teva Pharmaceuticals,800-545-8800,10 MG/1ML (NDC 0703-0113-03),Reverified,11/19/20,Available,,,,Analgesia/Addiction,Current,,
3444,"Hydromorphone Hydrochloride Injection, USP",Teva Pharmaceuticals,800-545-8800,10 MG/1 ML (NDC 0703-0018-01),Reverified,11/19/20,Available,,,,Analgesia/Addiction,Current,,
3445,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,0.5 mg/0.5 mL (1 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1283-05),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
3446,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,1 mg/1 mL (1 mg/1 mL); iSecure Luer Lock Glass Syringe (NDC 00409-1283-10),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
3447,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1312-10),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
3448,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,1 mg/1 mL (1 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1283-31),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
3449,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1312-30),Revised,11/20/20,Next Delivery and Estimated Recovery: November 2020,,,Demand increase for the drug,Analgesia/Addiction,Current,,
3450,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,4 mg/1 mL (4 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1304-31),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
3451,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,1 mg/1 mL (1 mg/mL); Glass Ampul (NDC 00409-2552-01),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
3452,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); Glass Ampul (NDC 00409-3356-01),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
3453,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,4 mg/1 mL (4 mg/mL); Glass Ampul (NDC 00409-2540-01),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
3454,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3365-01),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
3455,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-01),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
3456,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,50 mg/5 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-05),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
3457,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-50),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
3458,"Hydromorphone Hydrochloride Injection, USP",Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 1 mL ampule, 10 count (NDC 17478-0540-01)",Revised,12/2/19,Unavailable. Estimataed recovery Dec 2019,"Expected availability Dec, 2019",,Demand increase for the drug,Analgesia/Addiction,Current,,
3459,"Hydromorphone Hydrochloride Injection, USP",Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 5 mL ampule, 10 count (NDC 17478-0540-05)",Revised,12/2/19,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
3460,"Hydromorphone Hydrochloride Injection, USP",Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 50 mL vial, 10 count (NDC 17478-0540-50)",Revised,12/2/19,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
3461,Hydroxychloroquine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,"200 mg, 500 count bottle (NDC 0591-3041-05)",Revised,6/26/20,,,"Distributed by Actavis Pharma (Teva);  500 count bottle: on backorder, recovery to be determined.",,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3462,Hydroxychloroquine Sulfate Tablets,Sandoz,800-525-8747,"200 mg, 100 count bottle (NDC 16714-753-01)",Revised,6/26/20,,,Northstar Rx label; Available,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3463,Hydroxychloroquine Sulfate Tablets,Alkaloida Chemical Co. Zrt.,800-818-4555,"200 mg, 100 count bottle (NDC 57664-761-88); 500 count bottle (NDC 57664-761-13)",Revised,6/26/20,,,Distributed by Sun Pharmaceutical. Available,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3464,Hydroxychloroquine Sulfate Tablets,Amneal Pharmaceutical,866-525-7270,"200 mg, 100 count bottle (NDC 69238-1544-1)",Revised,6/26/20,,,Available,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3465,Hydroxychloroquine Sulfate Tablets,Appco Pharma LLC,855-672-7726,"200 mg, 100 count bottle (NDC 43598-721-01); 500 count bottle (NDC 43598-721-05)",Revised,6/26/20,,,Distributed by Dr. Reddy’s Laboratories Inc.; Limited supply subject to allocation; duration to be determined,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3466,Hydroxychloroquine Sulfate Tablets,Concordia Pharmaceuticals Inc.,877-370-1142,"200 mg, 100 count bottle (NDC 66993-057-02); 500 count bottle (NDC 66993-057-04)",Revised,6/26/20,,,Distributed by Prasco Laboratories; Available,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3467,Hydroxychloroquine Sulfate Tablets,Concordia Pharmaceuticals Inc.,877-370-1142,"Plaquenil 200 mg, 100 count bottle (NDC 59212-562-10)",Revised,6/26/20,,,Available,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3468,Hydroxychloroquine Sulfate Tablets,Laurus Labs Limited,833-352-8787,"200 mg, 100 count bottle (NDC42385-927-01); 500 count bottle (NDC 42385-927-05)",Revised,6/26/20,,,Distributed by Rising Pharmaceuticals; Available,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3469,Hydroxychloroquine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg, 100 count bottle (NDC 0378-0373-01)",Revised,6/26/20,,,Available,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3470,Hydroxychloroquine Sulfate Tablets,Sandoz,800-525-8747,"200 mg, 100 count bottle (NDC 0781-5994-01); 500 count bottle (NDC 0781-5994-05)",Revised,6/26/20,,,Available,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3471,Hydroxychloroquine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,"200 mg, 100 count bottle (NDC 0591-3041-01)",Revised,6/26/20,,,Distributed by Actavis Pharma (Teva); 100 count bottle: Limited supply subject to allocation; duration to be determined.,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3472,Hydroxychloroquine Sulfate Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"200 mg, 100 count bottle (NDC 68382-096-01); 500 count bottle (NDC 68382-096-05)",Revised,6/26/20,,,Available,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3473,Hydroxychloroquine Sulfate Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"200 mg, 100 count bottle (NDC 16714-110-01)",Revised,6/26/20,,,Northstar Rx label; Available,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3474,Hydroxychloroquine Sulfate Tablets,Ipca Laboratories Limited,,"200 mg, 100 count bottle (NDC 76385-144-01)",New,6/26/20,,,Distributed by Bayshore Pharmaceuticals; Available,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3475,Hydroxychloroquine Sulfate Tablets,Accord Healthcare Inc.,800-843-7477,"200 mg, 500 count bottle (NDC 16729-485-16)",New,6/26/20,,,Available,,Anti-Infective;Other;Rheumatology,Resolved,6/26/20,
3476,Hydroxyprogesterone Caproate Injection,AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,Hydroxyprogesterone Caproate Injection USP 250 mg/1 mL single-dose vial (NDC 55150-309-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
3477,Hydroxyprogesterone Caproate Injection,AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,"Hydroxyprogesterone Caproate Injection USP 1,250 mg/5 mL multiple-dose vial (NDC 55150-310-01)",Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
3478,Hydroxyprogesterone Caproate Injection,Slayback Pharma,844-566-2505,Hydroxyprogesterone Caproate Injection 250 mg/ 1 ml (NDC 71225-105-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
3479,Hydroxyprogesterone Caproate Injection,American Regent/Luitpold,800-645-1706,"Hydroxyprogesterone Caproate Injection, USP 250mg/mL 1mL Single Dose Vial (NDC 0517-1767-01)",Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
3480,Hydroxyprogesterone Caproate Injection,Slayback Pharma,844-566-2505,"Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 ml (NDC 71225-104-01)",Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
3481,Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Single dose auto-injector 1.1mL for subcutaneous injection: (NDC 64011-247-02),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
3482,Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Single-dose vial 1mL for intramuscular injection: (NDC 66993-038-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
3483,Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Multi-dose vial 5mL for intramuscular injection: (NDC 64011-243-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
3484,Hydroxyprogesterone Caproate Injection,Prasco Laboratories,866-525-0688,Single-dose vial 1mL for intramuscular injection: (NDC 66993-038-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
3485,Hydroxypropyl (Lacrisert) Cellulose Ophthalmic Insert,"Bausch Health Americas, Inc.",800-321-4576,"Lacrisert, 5 mg per ophthalmic insert, 60 unit dose blister pack (NDC 24208-800-60)",Reverified,10/1/20,"Product is on back order, estimated release not sooner than December 2020",Product is on back order due to manufacturing interruptions; capacity impacted due to COVID-19 Pandemic,,Other,Ophthalmology,Current,,
3486,Hydroxyzine Pamoate Oral Capsules,Pfizer Pharmaceuticals,800-533-4535,Vistaril (Hydroxyzine Pamoate Oral Capsules) 25 mg Capsules; 100 count bottle (NDC 0069-5410-66),Revised,11/20/20,Next delivery and Estimated recovery: January 2021,Shortage per manufacturer: Manufacturing Delay,,Other,Psychiatry,Current,,
3487,Hydroxyzine Pamoate Oral Capsules,Pfizer Pharmaceuticals,800-533-4535,Vistaril (Hydroxyzine Pamoate Oral Capsules) 50 mg Capsules; 100 count bottle (NDC 0069-5420-66),Revised,11/20/20,Available,,,Other,Psychiatry,Current,,
3488,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 25 mg 100 count (NDC 14539-674-01),Reverified,11/6/20,Available,,,,Psychiatry,Current,,
3489,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 25 mg 500 count (NDC 14539-674-05),Reverified,11/6/20,Available,,,,Psychiatry,Current,,
3490,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 50 mg 100 count (NDC 14539-675-01),Reverified,11/6/20,Available,,,,Psychiatry,Current,,
3491,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 50 mg 500 count (NDC 14539-675-05),Reverified,11/6/20,Available,,,,Psychiatry,Current,,
3492,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,100 mg 100 count (NDC 0555-0324-02),Reverified,11/19/20,Available,,,Other,Psychiatry,Current,,
3493,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,25 mg 100 count (NDC 0555-0323-02),Reverified,11/19/20,Available,,,Other,Psychiatry,Current,,
3494,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,25 mg 500 count (NDC 0555-0323-04),Reverified,11/19/20,Available,,,Other,Psychiatry,Current,,
3495,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,50 mg 100 count (NDC 0555-0302-02),Reverified,11/19/20,Available,,,Other,Psychiatry,Current,,
3496,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,50 mg 500 count (NDC 0555-0302-04),Reverified,11/19/20,Available,,,Other,Psychiatry,Current,,
3497,Hydroxyzine Pamoate Oral Capsules,Sandoz,800-525-8747,25 mg 100 count (NDC 0185-0674-01),Reverified,11/13/20,Supply Available,,,Demand increase for the drug,Psychiatry,Current,,
3498,Hydroxyzine Pamoate Oral Capsules,Sandoz,800-525-8747,25 mg 500 count (NDC 0185-0674-05),Reverified,11/13/20,Supply Available,,,Demand increase for the drug,Psychiatry,Current,,
3499,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 25mg Cap 100ct (NDC 00115-1803-01),Reverified,2/20/20,Expected to be on allocation until sometime in 1Q20.,,,Other,Psychiatry,Current,,
3500,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 25mg Cap 500ct (NDC 00115-1803-02),Reverified,2/20/20,Expected to be on allocation until sometime in 1Q20.,,,OIther,Psychiatry,Current,,
3501,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 50mg Cap 100ct (NDC 00115-1804-01),Reverified,2/20/20,Expected to be on allocation until sometime in 1Q20.,,,Other,Psychiatry,Current,,
3502,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 50mg Cap 500ct (NDC 00115-1804-02),Reverified,2/20/20,Expected to be on allocation until sometime in 1Q20.,,,Other,Psychiatry,Current,,
3503,Ifosfamide/Mesna Kit,Teva Pharmaceuticals,800-545-8800,1 gram/20 mL; 1 gram/10 mL  (NDCs 0703-4100-48 and 0703-4100-58),New,10/18/19,,This product is being discontinued due to a business decision.,,,Oncology,To be Discontinued,10/18/19,10/18/19
3504,Ifosfamide/Mesna Kit,Teva Pharmaceuticals,800-545-8800,3 gram/60 mL; 1 gram/10 mL (NDC 0703-4100-68 ),New,10/18/19,,This product is being discontinued due to a business decision.,,,Oncology,To be Discontinued,10/18/19,10/18/19
3505,"Imipenem and Cilastatin for Injection, USP",Merck Sharp & Dohme Corp.,800-672-6372,500 mg  imipenem  equivalent  and  500 mg  cilastatin  equivalent  and  20 mg  sodium bicarbonate as a buffer in trays of 25 vials (NDC 0006-3516-59),Revised,12/18/17,Product is available,"For additional information, please contact: Merck National Service Center at 1-800-672-6372",,Demand increase for the drug,Anti-Infective,Current,,
3506,"Imipenem and Cilastatin for Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"250 mg/250 mg per vial, single dose vial, sterile powder (NDC 63323-349-25)",Reverified,11/16/20,Available,Check wholesalers for inventory,,Delay in shipping of the drug,Anti-Infective,Current,,
3507,"Imipenem and Cilastatin for Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"500 mg/500 mg per vial, single dose vial, sterile powder (NDC  63323-322-25)",Reverified,11/16/20,Available,Check wholesaler for inventory,,Delay in shipping of the drug,Anti-Infective,Current,,
3508,Indacterol Maleate (Arcapta Neohaler) Inhalation Powder,Sunovion Pharmaceuticals Inc.,888-669-6682,75mcg  (NDCs 63402-675-06 and 63402-675-30),New,3/10/20,,,,,Pulmonary/Allergy,To be Discontinued,3/10/20,3/10/20
3509,Indacterol Maleate and Glycopyrrolate (Utibron Neohaler) Inhalation Powder,Sunovion Pharmaceuticals Inc.,888-669-6682,"15.6mcg; 27.5mcg  (NDCs 63402-681-06, 63402-681-12, and 63402-681-60)",New,3/10/20,,,,,Pulmonary/Allergy,To be Discontinued,3/10/20,3/10/20
3510,Indinavir (CRIXIVAN) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"400 mg capsules, unit-of-use bottles of 180 (with desiccant)(NDC 0006-0573-62)",New,3/31/20,,To be discontinued on or near August 2020.,,,Antiviral,To be Discontinued,3/31/20,3/31/20
3511,Indinavir (CRIXIVAN) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,200 mg capsules (NDC 0006-0571-43),New,9/21/20,,,,,Antiviral,To be Discontinued,9/21/20,9/21/20
3512,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 100s (NDC 0378-0143-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
3513,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 1000s (NDC 0378-0143-10)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
3514,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 100s (NDC 0378-0147-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
3515,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 500s (NDC 0378-0147-05)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
3516,INTRON A (Interferon alfa-2b) Recombinant for Injection,Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Powder for Injection (Interferon alfa-2b) 10 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4350-01),New,9/12/19,,To be discontinued in 2022,,,Antiviral;Oncology,To be Discontinued,9/12/19,9/12/19
3517,INTRON A (Interferon alfa-2b) Recombinant for Injection,Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Powder for Injection (Interferon alfa-2b) 18 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent ((NDC 0085-4351-01)),New,9/12/19,,To be discontinued in 2022,,,Antiviral;Oncology,To be Discontinued,9/12/19,9/12/19
3518,INTRON A (Interferon alfa-2b) Recombinant for Injection,Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Powder for Injection (Interferon alfa-2b) 50 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4352-01),New,9/12/19,,To be discontinued in 2022,,,Antiviral;Oncology,To be Discontinued,9/12/19,9/12/19
3519,INTRON A (Interferon alfa-2b) Recombinant for Injection,Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Solution for Injection (Interferon alfa-2b) 25 million IU multidose vial (32 million IU per 3.2 mL per vial); boxes containing 1 vial of INTRON A Solution for Injection (NDC 0085-1168-01),New,9/12/19,,To be discontinued in 2021,,,Antiviral;Oncology,To be Discontinued,9/12/19,9/12/19
3520,INTRON A (Interferon alfa-2b) Recombinant for Injection,Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Solution for Injection (Interferon alfa-2b) 25 million IU multidose vial (32 million IU per 3.2 mL per vial); boxes containing 1 vial of INTRON A Solution for Injection (NDC 0085-1133-01),New,9/12/19,,To be discontinued in 2021,,,Antiviral;Oncology,To be Discontinued,9/12/19,9/12/19
3521,Isocarboxazid Tablets,Validus Pharmaceuticals LLC,866-982-5438 (1-866-9VALIDUS),10mg (NDC 30698-032-01),Revised,1/10/20,,,,,Psychiatry,Resolved,1/10/20,
3522,Isoniazid Tablets,Teva Pharmaceuticals,800-545-8800,300 mg 1000 count (NDC 0555-0071-05),New,10/27/20,,Teva made a business decision to discontinue the 1000 count presentation. The other presentations of Isoniazid Tablets product remain active.,,,Anti-Infective,To be Discontinued,10/27/20,10/27/20
3523,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"30 mg, bottle of 100 (NDC 0603-4110-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
3524,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"30 mg, bottle of 500 (NDC 0603-4110-28)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
3525,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"30 mg, bottle of 1000 (NDC 0603-4110-32)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
3526,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"60 mg, bottle of 100 (NDC 0603-4111-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
3527,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"60 mg, bottle of 500 (NDC 0603-4111-28)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
3528,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"60 mg, bottle of 1000 (NDC 0603-4111-32)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
3529,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"120 mg, bottle of 100 (NDC 0603-4112-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
3530,Ketamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mg/mL, 5 mL vial (NDC 0143-9509-10)",Revised,7/22/20,This presentation is temporarily on backorder.,Additional lots are scheduled to be manufactured in the July - August 2020 timeframe.  Product will be made available as it is released.,,,Anesthesia,Current,,
3531,Ketamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 10 mL vial (NDC 0143-9508-10)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
3532,Ketamine Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),200 mg / 20 mL (NDC 67457-181-20),Reverified,11/10/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
3533,Ketamine Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),500 mg / 10 mL (NDC 67457-001-10),Reverified,11/10/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
3534,Ketamine Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),1000 mg / 10 mL (NDC 67457-108-10),Reverified,11/10/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
3535,Ketamine Injection,"Hospira, Inc.",844-646-4398,500 mg/5 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2051-05),Reverified,11/20/20,Available,,,Other,Anesthesia,Current,,
3536,Ketamine Injection,"Hospira, Inc.",844-646-4398,500 mg/10 mL (50 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2053-10),Reverified,11/20/20,Next Delivery and Estimated Recovery: January 2021,,,Demand increase for the drug,Anesthesia,Current,,
3537,Ketamine Injection,Par Pharmaceutical,201-802-4000,"10 mg/mL, 20 mL MDV (NDC 42023-113-10)",Revised,7/28/20,Backordered due to increased demand.  Expected recovered date is September 2020.,,,Demand increase for the drug,Anesthesia,Current,,
3538,Ketamine Injection,Par Pharmaceutical,201-802-4000,"100 mg/mL, 5 mL MDV (NDC 42023-115-10)",Revised,7/28/20,Available,Please check wholesalers for supply,,Demand increase for the drug,Anesthesia,Current,,
3539,Ketamine Injection,Par Pharmaceutical,201-802-4000,"50 mg/mL, 10 mL MDV (NDC 42023-114-10)",Revised,7/28/20,Available,Please check wholesalers for supply,,Demand increase for the drug,Anesthesia,Current,,
3540,Ketoconazole Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg, 100 count bottle (NDC 0378-0261-01)",New,5/2/19,,,,,Anti-Infective,To be Discontinued,5/2/19,5/2/19
3541,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 1000 count bottle (NDC 23155-020-10)",New,11/25/19,,Avet is no longer marketing the 25 mg strength,,,Analgesia/Addiction;Rheumatology,To be Discontinued,11/25/19,11/25/19
3542,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 100 count bottle (NDC 69336-127-10)",Reverified,9/28/20,Available,"Marketed by Sterling Knight Pharmaceuticals, LLC. Contact information: 662-661-3232.",,,Analgesia/Addiction;Rheumatology,Current,,
3543,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 1000 count bottle (NDC 69336-127-11)",Reverified,9/28/20,Available,"Marketed by Sterling Knight Pharmaceuticals, LLC. Contact information: 662-661-3232.",,,Analgesia/Addiction;Rheumatology,Current,,
3544,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 100 count bottle (NDC 23155-020-01)",Reverified,9/28/20,Unavailable - Discontinuation of the manufacture of the drug,,,,Analgesia/Addiction;Rheumatology,Current,,
3545,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 1000 count bottle (NDC 23155-020-10)",Reverified,9/28/20,Unavailable - Discontinuation of the manufacture of the drug,,,,Analgesia/Addiction;Rheumatology,Current,,
3546,Ketoprofen Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg Extended-Release Capsules, bottle of 100 (NDC 0378-8200-01)",Reverified,11/10/20,Available,,,Other,Analgesia/Addiction;Rheumatology,Current,12/23/16,
3547,Ketoprofen Capsules,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 count bottle (NDC 0093-3193-01)",Reverified,11/19/20,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Rheumatology,Current,,
3548,Ketoprofen Capsules,Teva Pharmaceuticals,800-545-8800,"75 mg, 100 count bottle (NDC 0093-3195-01)",Reverified,11/19/20,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Rheumatology,Current,,
3549,Ketoprofen Capsules,Teva Pharmaceuticals,800-545-8800,"75 mg, 500 count bottle (NDC 0093-3195-05)",Reverified,11/19/20,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Rheumatology,Current,,
3550,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 100 count bottle (NDC 23155-020-01)",New,11/25/19,,Avet is no longer marketing the 25 mg strength,,,Analgesia/Addiction;Rheumatology,To be Discontinued,11/25/19,11/25/19
3551,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"50 mg, 100 count bottle (NDC 23155-021-01)",Reverified,9/28/20,Available,,,,Analgesia/Addiction;Rheumatology,Current,,
3552,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"75 mg, 100 count bottle (NDC 23155-022-01)",Reverified,9/28/20,Available,,,,Analgesia/Addiction;Rheumatology,Current,,
3553,Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"15 mg/mL, 1 mL vial (NDC 0641-6041-25)",Reverified,7/22/20,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,
3554,Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"30 mg/mL, 1 mL vial (NDC 0641-6042-25)",Reverified,7/22/20,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,
3555,Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"30 mg/mL, 2 mL vial (NDC 0641-6043-25)",Reverified,7/22/20,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,
3556,Ketorolac Tromethamine Injection,Virtus Pharmaceuticals,888-843-3593,30MG/ML (NDC 69543-0386-25),New,3/26/18,Available,,,Other,Analgesia/Addiction,Current,,
3557,Ketorolac Tromethamine Injection,Gland Pharma Limited,855-273-0154,15 mg/mL vial (NDC 70860-700-01 and 70860-700-02),Reverified,9/28/20,"Backordered, next shipment in November","Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Demand increase for the drug,Analgesia/Addiction,Current,,
3558,Ketorolac Tromethamine Injection,Gland Pharma Limited,855-273-0154,30 mg/mL vial (NDC 70860-701-01 and 70860-701-03),Reverified,9/28/20,"Backordered, next shipment in November","Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Demand increase for the drug,Analgesia/Addiction,Current,,
3559,Ketorolac Tromethamine Injection,Gland Pharma Limited,855-273-0154,60 mg/mL vial (NDC 70860-701-02 and 70860-701-04),Reverified,9/28/20,"Backordered, next shipment in November","Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Demand increase for the drug,Analgesia/Addiction,Current,,
3560,Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 15MG/ML 25X1ML (NDC 25021-700-01),Reverified,10/22/20,Backordered. Estimated availability TBD,,,Manufacturing delays,Analgesia/Addiction,Current,,
3561,Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 30MG/ML 25X2ML (NDC 25021-701-02),Reverified,10/22/20,Backordered. Estimated availability TBD,,,Manufacturing delay,Analgesia/Addiction,Current,,
3562,Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 30MG/ML 25X1ML (NDC 25021-701-01),Reverified,10/22/20,Backordered. Estimated availability TBD,,,Manufacturing delay,Analgesia/Addiction,Current,,
3563,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,30 mg/mL (30 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-2287-23),Reverified,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
3564,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,30 mg/mL (30 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2287-31),Reverified,11/20/20,Next Delivery and Estimated Recovery: January 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
3565,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,60 mg/2 mL (30 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2287-61),Reverified,11/20/20,Next Delivery and Estimated Recovery: January 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
3566,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,15 mg/mL (15 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3793-01),Reverified,11/20/20,Limited Supply Available. Next Delivery and Estimated Recovery: November 2020,,,Demand increase for the drug,Analgesia/Addiction,Current,,
3567,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,30 mg/mL (30 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3795-01),Reverified,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
3568,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,60 mg/2 mL (30 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3796-01),Reverified,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
3569,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"15 mg per mL, Single Dose Amber Vial, (NDC 63323-161-01)",Revised,11/16/20,Backordered. Next release November 2020.,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,12/4/15,
3570,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-01)",Revised,11/16/20,Backordered. Next release November 2020.,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,12/4/15,
3571,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-02)",Revised,11/16/20,Backordered. Next release November 2020.,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,12/4/15,
3572,Ketorolac Tromethamine Injection,Baxter Healthcare,888-229-0001,"Ketorolac Tromethamine Injection, USP, 30 mg/ mL.  Single dose glass flip top vial - 25 units per carton (NDC 0338-0072-25)",Revised,10/28/20,Available,FOR INTRAVENOUS AND INTRAMUSCULAR USE. 30mg/mL (1 mL fill volume/ 2 mL container),,,Analgesia/Addiction,Current,,
3573,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"15 mg per mL, Single Dose, Simplist Syringe, (NDC 76045-107-10)",Revised,11/16/20,Available,Check wholesaler for inventory,,,Analgesia/Addiction,Current,,
3574,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"30 mg per mL, Single Dose, Simplist Syringe, (NDC 76045-104-10)",Revised,11/16/20,Available,Check wholesaler for inventory,,,Analgesia/Addiction,Current,,
3575,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"60 mg per 2 mL, Single Dose, Simplist Syringe, (NDC 76045-105-20)",Revised,11/16/20,Available,Check wholesaler for inventory,,,Analgesia/Addiction,Current,,
3576,Ketorolac Tromethamine Injection,Baxter Healthcare,888-229-0001,"Ketorolac Tromethamine Injection, USP, 15 mg/mL. Single dose glass flip top vial. 10 units per carton (NDC 0338-0069-10)",Revised,10/28/20,"Stocked out, Recovery mid-November 2020",FOR INTRAVENOUS AND INTRAMUSCULAR USE. 15 mg/mL (1 mL fill volume/ 2 mL container),,Demand increase for the drug,Analgesia/Addiction,Current,,
3577,Ketorolac Tromethamine Injection,Gland Pharma Limited,609-250-7990,"30 mg/mL, 1 mL vial (NDC 72266-118-25)",Reverified,9/28/20,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Demand increase for the drug,Analgesia/Addiction,Current,,
3578,Ketorolac Tromethamine Injection,Gland Pharma Limited,609-250-7990,"30 mg/mL, 2 mL vial (NDC 72266-119-25)",Reverified,9/28/20,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Available,Analgesia/Addiction,Current,,
3579,Labetalol Hydrochloride Injection,Gland Pharma,609-250-7990,"5mg/mL, 20 mL vial (NDC 72266-102-01)",Reverified,12/11/19,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Available,Cardiovascular,Current,,
3580,Labetalol Hydrochloride Injection,Gland Pharma,609-250-7990,"5 mg/mL, 40 mL vial (NDC 72266-103-01)",Reverified,12/11/19,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Available,Cardiovascular,Current,,
3581,Labetalol Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg/20 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2267-20),Reverified,11/20/20,Available,,,Other,Cardiovascular,Current,,
3582,Labetalol Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/40 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2267-54),Reverified,11/20/20,Available,,,Other,Cardiovascular,Current,,
3583,Labetalol Hydrochloride Injection,"Hospira, Inc.",844-646-4398,20 mg/4 mL (5 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2339-34),Reverified,11/20/20,Available,,,Other,Cardiovascular,Current,,
3584,Labetalol Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,5mg/mL (100mg/20mL) Multi-Dose vial (NDC 17478-420-20),Revised,12/2/19,Available,,,Other,Cardiovascular,Current,,
3585,Labetalol Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,5mg/mL (200mg/40mL) Multi-Dose vial (NDC 17478-420-40 ),Revised,12/2/19,Available,,,Other,Cardiovascular,Current,,
3586,Labetalol Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 20 mL multidose vial (NDC 0143-9622-01)",Revised,7/22/20,This presentation is temporarily on backorder.,Additional lots are scheduled to be manufactured in the July - August 2020 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
3587,Labetalol Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 40 mL multidose vial (NDC 0143-9623-01)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled for manufacturing.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
3588,Lamivudine and Zidovudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine and Zidovudine Tablets 150mg and 300mg (NDC 0378-5180-91),New,3/16/18,,,,,Antiviral,To be Discontinued,3/16/18,3/16/18
3589,Lamivudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine Tablets 100mg (NDC 0378-5168-93),New,3/16/18,,,,,Antiviral,To be Discontinued,3/16/18,3/16/18
3590,Lamivudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine Tablets 150mg (NDC 0378-5169-91),New,3/16/18,,,,,Antiviral,To be Discontinued,3/16/18,3/16/18
3591,Lamivudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine Tablets 300mg (NDC 0378-5170-93),New,3/16/18,,,,,Antiviral,To be Discontinued,3/16/18,3/16/18
3592,Lamotrigine Tablets,Teva Pharmaceuticals,800-545-8800,100 mg (NDCs 0093-0463-01 and 0093-0463-05),New,10/15/19,,This product is being discontinued due to a business decision.,,,Neurology,To be Discontinued,10/15/19,10/15/19
3593,Lamotrigine Tablets,Cipla Limited,844-247-5287,25 mg bottles of 100 (NDC 69097-148-07),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
3594,Lamotrigine Tablets,Cipla Limited,844-247-5287,25 mg bottles of 500 (NDC NDC 69097-148-12),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
3595,Lamotrigine Tablets,Cipla Limited,844-247-5287,25 mg bottles of 1000 (NDC 69097-148-15),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
3596,Lamotrigine Tablets,Cipla Limited,844-247-5287,100 mg bottles of 100 (NDC 69097-149-07),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
3597,Lamotrigine Tablets,Cipla Limited,844-247-5287,100 mg bottles of 500 (NDC 69097-149-12),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
3598,Lamotrigine Tablets,Cipla Limited,844-247-5287,100 mg bottles of 1000 (NDC 69097-149-15),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
3599,Lamotrigine Tablets,Cipla Limited,844-2547-5287,150 mg bottles of 60 (NDC 69097-151-03),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
3600,Lamotrigine Tablets,Cipla Limited,844-247-5287,150 mg bottles of 500 (NDC 69097-151-12),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
3601,Lamotrigine Tablets,Cipla Limited,844-247-5287,150 mg bottles of 1000 (NDC 69097-151-15),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
3602,Lamotrigine Tablets,Cipla Limited,844-247-5287,200 mg bottles of 60 (NDC 69097-152-03),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
3603,Lamotrigine Tablets,Cipla Limited,844-247-5287,200 mg bottles of 500 (NDC 69097-152-12),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
3604,Lamotrigine Tablets,Cipla Limited,844-247-5287,200 mg bottles of 1000 (NDC 69097-152-15),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
3605,Lanoxin (digoxin) Tablets,Concordia Pharmaceuticals Inc.,866-243-5382,Lanoxin (digoxin) 187.5 mcg (0.1875 mg) tablets; 100-count bottles (NDC 59212-245-55),New,5/22/18,,"A business decision was made to discontinue manufacture and supply of the Lanoxin 187.5 mcg (0.1875 mg) strength tablets.  All existing lots on the market are good through expiry. The anticipated final date of availability for sale is June 30, 2018 (NDC 59212-245-55).",,,Cardiovascular,To be Discontinued,5/22/18,5/22/18
3606,Latanoprost Ophthalmic Solution 0.005%,Sandoz,800-525-8747,2.5 mL Bottle (NDC 61314-547-01),Revised,4/6/20,,,,,Ophthalmology,Resolved,4/6/20,
3607,Latanoprost Ophthalmic Solution 0.005%,Pfizer Pharmaceuticals,800-533-4535,"2.5 mL fill, 0.005% (50 mcg/mL): Package of 1 bottle (NDC 59762-0333-2)",Revised,4/6/20,,,,,Ophthalmology,Resolved,4/6/20,
3608,Latanoprost Ophthalmic Solution 0.005%,Bausch Health,800-321-4576,"2.5 mL fill, 0.005% (50 mcg/mL): Package of 1 bottle (NDC 24208-463-25)",Revised,4/6/20,,,,,Ophthalmology,Resolved,4/6/20,
3609,Lesinurad (ZURAMPIC) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,ZURAMPIC® (lesinurad) 200 mg tablets 5 count bottle (NDC 70785-011-05),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Zurampic.",,,Endocrinology/Metabolism,To be Discontinued,4/15/19,4/15/19
3610,Lesinurad (ZURAMPIC) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,ZURAMPIC® (lesinurad) 200 mg tablets 30 count bottle (NDC 70785-011-30),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Zurampic.",,,Endocrinology/Metabolism,To be Discontinued,4/15/19,4/15/19
3611,Lesinurad/Allopurinol (DUZALLO®) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,200/200mg tablets 5 count bottle (NDC 70785-021-05),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.",,,Endocrinology/Metabolism,To be Discontinued,4/15/19,4/15/19
3612,Lesinurad/Allopurinol (DUZALLO®) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,200/200 mg tablets 30 count bottle (NDC 70785-021-30),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.",,,Endocrinology/Metabolism,To be Discontinued,4/15/19,4/15/19
3613,Lesinurad/Allopurinol (DUZALLO®) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,200/200 mg tablets 90 count bottle (NDC 70785-021-90),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.",,,,To be Discontinued,4/15/19,4/15/19
3614,Lesinurad/Allopurinol (DUZALLO®) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,200/300 mg tablets 5 count bottle (NDC 70785-022-05),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.",,,,To be Discontinued,4/15/19,4/15/19
3615,Lesinurad/Allopurinol (DUZALLO®) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,200/300 mg tablets 30 count bottle (NDC 70785-022-30),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.",,,,To be Discontinued,4/15/19,4/15/19
3616,Lesinurad/Allopurinol (DUZALLO®) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,200/300 mg tablets 90 count bottle (NDC 70785-022-90),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.",,,,To be Discontinued,4/15/19,4/15/19
3617,Letermovir (Prevymis) Injection,Merck Sharp & Dohme Corp.,800-672-6372,480 mg injection (NDC 0006-5004-01),Revised,12/2/19,Available,,,Other,Antiviral,Current,,
3618,Letermovir (Prevymis) Injection,Merck Sharp & Dohme Corp.,800-672-6372,240 mg injection (NDC 0006-5003-01),Revised,12/2/19,Available,,,Other,Antiviral,Current,,
3619,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,500mg vial (NDC 25021-828-50),Reverified,10/22/20,Backordered. Estimated availability Dec-2020,,,Manufacturing delay,Oncology;Pediatric,Current,,
3620,Leucovorin Calcium Lyophilized Powder for Injection,Teva Pharmaceuticals,800-545-8800,"100mg/vial, 20mL (NDC 0703-5140-01)",Reverified,11/19/20,Available,,,Demand increase for the drug,Oncology;Pediatric,Current,9/25/13,
3621,Leucovorin Calcium Lyophilized Powder for Injection,Teva Pharmaceuticals,800-545-8800,350mg/vial 30mL (NDC 0703-5145-01),Reverified,11/19/20,Available,,,Demand increase for the drug,Oncology;Pediatric,Current,9/25/13,
3622,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,200 mg SDV (NDC 63323-710-50),Reverified,11/16/20,Available,Check Wholesaler Inventory,,Demand increase for the drug,Oncology;Pediatric,Current,9/25/13,
3623,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,500 mg SDV (NDC 63323-711-00),Reverified,11/16/20,Available,Check Wholesaler Inventory,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
3624,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,50 mg vial (NDC 25021-813-10),Reverified,10/22/20,Backordered. Estimated availability Dec-2020,,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
3625,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,100mg vial (NDC 25021-814-30),Reverified,10/22/20,Backordered. Estimated availability Dec-2020,,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
3626,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,200mg vial (NDC 25021-815-30),Reverified,10/22/20,Backordered. Estimated availability Dec-2020,,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
3627,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,350mg vial (NDC 25021-816-30),Reverified,10/22/20,Backordered. Estimated availability Dec-2020,,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
3628,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 50 mL (10 mg per mL) Single dose amber vial, liquid (NDC 63323-631-50)",New,5/15/20,Backordered. Next release July 2020.,Check Wholesaler Inventory,,Manufacturing Delay,Oncology;Pediatric,Current,,
3629,Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg, 10 mL vial (NDC 0143-9555-01)",New,7/16/20,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,
3630,Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mg, 20 mL vial (NDC 0143-9554-01)",New,7/16/20,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,
3631,Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"200 mg, 30 mL vial (NDC 0143-9553-01)",New,7/16/20,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,
3632,Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"350 mg, 50 mL vial (NDC 0143-9552-01)",New,7/16/20,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,
3633,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-4273,Eligard 22.5 mg (NDC 62935-223-05),Reverified,11/18/20,Available,Call customer service: 1-877-ELIGARD,,,Endocrinology/Metabolism;Oncology,Current,,
3634,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-4273,Eligard 30 mg (NDC 62935-303-30),Reverified,11/18/20,Available,Call customer service: 1-877-ELIGARD,,,Endocrinology/Metabolism;Oncology,Current,,
3635,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-2473,Eligard 45 mg (NDC 62935-453-45),Reverified,11/18/20,Available,Call customer service: 1-877-ELIGARD,,,Endocrinology/Metabolism;Oncology,Current,,
3636,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-2473,Fensolvi 45 mg (NDC 62935-153-50),Reverified,11/18/20,Available,Call customer service: 1-888-FENSOLVI,,,Endocrinology/Metabolism;Oncology,Current,,
3637,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-2473,Eligard 7.5 mg Kit (NDC 62935-753-75),Reverified,11/18/20,Available,Call customer service: 1-877-ELIGARD,,,Endocrinology/Metabolism;Oncology,Current,,
3638,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 3 Months, 30mg (NDC 0074-9694-03)",Revised,11/3/20,On backorder. Units expected to be received by November. Further replenishment expected to be received in December,,,Delay in shipping of the drug,Endocrinology/Metabolism;Oncology,Current,,
3639,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 3 Months 22.5 mg PDS Kit (NDC 0074-3346-03)",Revised,11/3/20,On backorder; Additional lots coming in late November 2020,,,,Endocrinology/Metabolism;Oncology,Current,,
3640,Leuprolide Acetate Injection,Abbvie,800-621-1020,Lupron Depot 6 Months 45mg PDS Kit (NDC 0074-3473-03),Revised,11/3/20,On backorder. Units expected in October,,,Delay in shipping of the drug,Endocrinology/Metabolism;Oncology,Current,,
3641,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 1 Month 7.5 mg PDS Kit (NDC 0074-3642-03)",Revised,11/3/20,Available; Additional Units expected to release by mid-November,,,,Endocrinology/Metabolism;Oncology,Current,,
3642,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 4 Months 30 mg PDS Kit (NDC 0074-3683-03)",Revised,11/3/20,On backorder. Units expected to be released by mid-November,,,Delay in shipping of the drug,Endocrinology/Metabolism;Oncology,Current,,
3643,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 1 Month 3.75 mg PDS Kit (NDC 0074-3641-03)",Revised,11/3/20,Available; Additional units released early October 2020,,,,Endocrinology/Metabolism;Oncology,Current,,
3644,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 3 Months 11.25 mg PDS Kit (NDC 0074-3663-03)",Revised,11/3/20,On backorder. Next units expected to release by mid-November,,,Delay in shipping of the drug,Endocrinology/Metabolism;Oncology,Current,,
3645,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 1 Month 11.25 mg PDS Kit (NDC 0074-2282-03)",Revised,11/3/20,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
3646,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 1 Month 15 mg PDS Kit (NDC 0074-2440-03)",Revised,11/3/20,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
3647,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 1 Month 7.5 mg PDS Kit (NDC 0074-2108-03)",Revised,11/3/20,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
3648,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 3 Months, 11.25mg (NDC 0074-3779-03)",Revised,11/3/20,On backorder. Units expected to be released in December,,,Delay in shipping of the drug,Endocrinology/Metabolism;Oncology,Current,,
3649,"Levetiracetam Extended-Release Oral Tablets, USP",Teva Pharmaceuticals,800-545-8800,500mg (NDC 0591-3635-60),New,6/7/19,,This was a business-related decision to discontinue manufacturing these products.,,,Neurology,To be Discontinued,6/7/19,6/7/19
3650,"Levetiracetam Extended-Release Oral Tablets, USP",Teva Pharmaceuticals,800-545-8800,750mg (NDC 0591-3699-60),New,6/7/19,,This was a business-related decision to discontinue manufacturing these products.,,,Neurology,To be Discontinued,6/7/19,6/7/19
3651,"Levetiracetam Extended-Release Oral Tablets, USP",Apotex Corp.,800-706-5575,Levetiracetam Extended-Release Tablets 500 mg (60 ct. bottle)(NDC 60505-3280-06),Reverified,11/13/20,Available,,,Demand increase for the drug,Neurology,Current,,
3652,"Levetiracetam Extended-Release Oral Tablets, USP",Apotex Corp.,800-706-5575,Levetiracetam Extended-Release Tablets 750 mg (60 ct. bottle)(NDC 60505-3517-06),Reverified,11/13/20,Available,,,Demand increase for the drug,Neurology,Current,,
3653,"Levetiracetam Extended-Release Oral Tablets, USP",Sun Pharmaceutical Industries Inc.,800-818-4555,500mg tablet 60 count bottle (NDC 4733557386),Reveriifed,5/5/20,"Back-order, Estimated re-supply: TBD",,,Shortage of active ingredient,Neurology,Current,,
3654,"Levetiracetam Extended-Release Oral Tablets, USP",Sun Pharmaceutical Industries Inc.,800-818-4555,750mg tablet 60 count bottle (NDC 4733557686),Reveriifed,5/5/20,"Back-order, Estimated re-supply: TBD",,,Shortage of active ingredient,Neurology,Current,,
3655,"Levetiracetam Extended-Release Oral Tablets, USP",Lupin,866-587-4617,500mg  60 count bottle (NDC 68180-117-07),Reverified,4/30/20,Continuous production but will be on/off backorder,,,Shortage of active ingredient,Neurology,Current,,
3656,"Levetiracetam Extended-Release Oral Tablets, USP",Lupin,866-587-4617,750mg 60 count bottle (NDC 68180-118-07),Reverified,4/30/20,Continuous production but will be on/off backorder,,,Shortage of active ingredient,Neurology,Current,,
3657,"Levetiracetam Extended-Release Oral Tablets, USP",UCB Inc.,844-599-2273,500mg extended-release (NDC 50474-598-66),Revised,4/21/20,Available,,,,Neurology,Current,,
3658,"Levetiracetam Extended-Release Oral Tablets, USP",UCB Inc.,844-599-2273,750mg extended-release (NDC 50474-599-66),Revised,4/21/20,Available,,,,Neurology,Current,,
3659,"Levetiracetam Extended-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam ER Tablets, 500mg, 60’s (NDC 43547-0345-06)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
3660,"Levetiracetam Extended-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam ER Tablets, 500mg, 500’s (NDC 43547-0345-50)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
3661,"Levetiracetam Extended-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam ER Tablets, 750mg, 60’s (NDC 43547-0346-06)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
3662,"Levetiracetam Extended-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam ER Tablets, 750mg, 500’s (NDC 43547-0346-50)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
3663,"Levetiracetam Extended-Release Oral Tablets, USP",Lotus Pharmaceutical Co. Ltd.,866-770-3024,"Levetiracetam (Roweepra XR) Extended-Release Tablets, 500 mg 60 ct. bottle; (NDC 69102-200-60)",New,9/3/19,,The discontinuation of this product is a business decision.,,,Neurology,To be Discontinued,9/3/19,9/3/19
3664,"Levetiracetam Extended-Release Oral Tablets, USP",Lotus Pharmaceutical Co. Ltd.,866-770-3024,"Levetiracetam (Roweepra XR) Extended-Release Tablets, 750 mg 60 ct. bottle; (NDC 69102-201-60)",New,9/3/19,,The discontinuation of this product is a business decision.,,,Neurology,To be Discontinued,9/3/19,9/3/19
3665,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"250mg, 120 count bottle (NDC 13668-014-12)",Reverified,2/18/20,Available,,,,Neurology,Current,,
3666,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"500mg, 120 count bottle (NDC 13668-015-12)",Reverified,2/18/20,Available,,,,Neurology,Current,,
3667,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"750 mg, 120 count bottle (NDC 13668-016-12)",Reverified,2/18/20,Available,,,,Neurology,Current,,
3668,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"750 mg, 500 count bottle (NDC 13668-016-05)",Reverified,2/18/20,Available,,,,Neurology,Current,,
3669,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"1000 mg, 60 count bottle (NDC 13668-017-60)",Reverified,2/18/20,Available,,,Shortage of Active Ingredient,Neurology,Current,,
3670,"Levetiracetam Immediate-Release Oral Tablets, USP",UCB Inc.,844-599-2273,"250MG, (NDC 50474-594-40)",Revised,4/21/20,Available,,,,Neurology,Current,,
3671,"Levetiracetam Immediate-Release Oral Tablets, USP",UCB Inc.,844-599-2273,"500MG, (NDC 50474-595-40)",Revised,4/21/20,Available,,,,Neurology,Current,,
3672,"Levetiracetam Immediate-Release Oral Tablets, USP",UCB Inc.,844-599-2273,"750MG, (NDC 50474-596-40)",Revised,4/21/20,Available,,,,Neurology,Current,,
3673,"Levetiracetam Immediate-Release Oral Tablets, USP",UCB Inc.,844-599-2273,"1000MG, (NDC 50474-597-66)",Revised,4/21/20,Available,,,,Neurology,Current,,
3674,"Levetiracetam Immediate-Release Oral Tablets, USP",Aurobindo Pharma,866-850-2876,"250mg, 120 count (NDC 65862024508)",Reverified,9/25/20,Available,,,,Neurology,Current,,
3675,"Levetiracetam Immediate-Release Oral Tablets, USP",Aurobindo Pharma,866-850-2876,"500mg , 120 count (NDC 65862024608)",Reverified,9/25/20,Available,,,,Neurology,Current,,
3676,"Levetiracetam Immediate-Release Oral Tablets, USP",Aurobindo Pharma,866-850-2876,"1000mg, 60 count (NDC 65862031560)",Reverified,9/25/20,Available,,,,Neurology,Current,,
3677,"Levetiracetam Immediate-Release Oral Tablets, USP",Aurobindo Pharma,866-850-2876,"750mg, 120 count (NDC 65862024708)",Reverified,9/25/20,Available,,,,Neurology,Current,,
3678,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 250 mg – 90 Count Bottes (68180-112-09)",Reverified,4/30/20,Available,,,,Neurology,Current,,
3679,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 250 mg – 120 Count Bottes (68180-112-16)",Reverified,4/30/20,Available,,,,Neurology,Current,,
3680,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 250 mg – 500 Count Bottes (68180-112-02)",Reverified,4/30/20,Available,,,,Neurology,Current,,
3681,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 500 mg – 90 Count Bottes (68180-113-09)",Reverified,4/30/20,Available,,,,Neurology,Current,,
3682,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 750 mg – 90 Count Bottes (68180-114-09)",Reverified,4/30/20,Available,,,,Neurology,Current,,
3683,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 750 mg – 500 Count Bottes (68180-114-02)",Reverified,4/30/20,Available,,,,Neurology,Current,,
3684,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 500 mg – 120 Count Bottes (68180-113-16)",Reverified,4/30/20,Will remain on backorder for few months,"Due to shortage, API is being allocated between the different strengths",,Shortage of active Ingredient,Neurology,Current,,
3685,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 500 mg – 500 Count Bottes (68180-113-02)",Reverified,4/30/20,Will remain on backorder for few months,"Due to shortage, API is being allocated between the different strengths",,Shortage of active Ingredient,Neurology,Current,,
3686,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 750 mg – 120 Count Bottes (68180-114-16)",Reverified,4/30/20,Will remain on backorder for few months,"Due to shortage, API is being allocated between the different strengths",,Shortage of active Ingredient,Neurology,Current,,
3687,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 1000 mg – 60 Count Bottes (68180-115-07)",Reverified,4/30/20,Will remain on backorder for few months,"Due to shortage, API is being allocated between the different strengths",,Shortage of active Ingredient,Neurology,Current,,
3688,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"250mg, 120 count (NDC 31722053612)",Reverified,12/17/19,Available,,,,Neurology,Current,,
3689,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"250mg, 500 count (NDC 31722053605)",Reverified,12/17/19,Available,,,,Neurology,Current,,
3690,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"500mg, 120 count (NDC 31722053712)",Reverified,12/17/19,Available,,,,Neurology,Current,,
3691,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"500mg, 500 count (NDC 31722053705)",Reverified,12/17/19,Available,,,,Neurology,Current,,
3692,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"750mg, 120 count (NDC 31722053812)",Reverified,12/17/19,Available,,,,Neurology,Current,,
3693,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"750mg, 500 count (NDC 31722053805)",Reverified,12/17/19,Available,,,,Neurology,Current,,
3694,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 250mg – 120’s (NDC 43547-0221-15)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
3695,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 500mg – 120’s (NDC 43547-0222-15)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
3696,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 500mg – 1000’s (NDC 43547-0222-11)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
3697,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 750mg – 120’s (NDC 43547-0223-15)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
3698,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 1000mg – 60’s (NDC 43547-0224-06)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
3699,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 250 mg, 120 count (NDC 0378-5613-78)",Reverified,11/10/20,Available,,,Shortage of active ingredient,Neurology,Current,,
3700,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 250 mg, 500 count (NDC 0378-5613-05)",Reverified,11/10/20,Available,,,Shortage of active ingredient,Neurology,Current,,
3701,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 500 mg, 500 count (NDC 0378-5615-05)",Reverified,11/10/20,Available,,,Shortage of active ingredient,Neurology,Current,,
3702,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 500 mg, 120 count (NDC 0378-5615-78)",Reverified,11/10/20,Available,,,Shortage of active ingredient,Neurology,Current,,
3703,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 750 mg, 120 count (NDC 0378-5617-78)",Reverified,11/10/20,Available,,,Shortage of active ingredient,Neurology,Current,,
3704,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 750 mg, 500 count (NDC 0378-5617-05)",Reverified,11/10/20,Available,,,Shortage of active ingredient,Neurology,Current,,
3705,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 1000 mg, 60 count (NDC 0378-5619-91)",Reverified,11/10/20,Available,,,Shortage of active ingredient,Neurology,Current,,
3706,"Levetiracetam Oral Tablets, USP",Lotus Pharmaceutical Co. Ltd.,866-770-3024,"Levetiracetam (Roweepra) Tablets, 500 mg (120 count; (NDC 69102-104-01)",New,9/3/19,,The discontinuation of this product is a business decision.,,,Neurology,To be Discontinued,9/3/19,9/3/19
3707,"Levetiracetam Oral Tablets, USP",Lotus Pharmaceutical Co. Ltd.,866-770-3024,"Levetiracetam (Roweepra) Tablets, 750 mg (120 count; (NDC 69102-102-01)",New,9/3/19,,The discontinuation of this product is a business decision.,,,Neurology,To be Discontinued,9/3/19,9/3/19
3708,"Levetiracetam Oral Tablets, USP",Lotus Pharmaceutical Co. Ltd.,866-770-3024,"Levetiracetam (Roweepra) Tablets, 1000 mg 60 count; (NDC  69102-103-01)",New,9/3/19,,The discontinuation of this product is a business decision.,,,Neurology,To be Discontinued,9/3/19,9/3/19
3709,Levocetirizine Dihydrochloride Tablets,Apotex Corp.,800-706-5575,5 mg tablets (NDCs 60505-3713-9 and 60505-3713-5),New,1/21/20,,,,,Pulmonary/Allergy,To be Discontinued,1/21/20,1/21/20
3710,Levofloxacin Tablets,Sandoz,800-525-8747,250 mg 100 count bottle (NDC 0781-5790-01),New,2/26/20,,Sandoz Inc. has made a business decision to discontinue Levofloxacin Tablets.,,,Anti-Infective,To be Discontinued,2/26/20,2/26/20
3711,Levofloxacin Tablets,Sandoz,800-525-8747,250 mg 50 count bottle (NDC 0781-5790-50),New,2/26/20,,Sandoz Inc. has made a business decision to discontinue Levofloxacin Tablets.,,,Anti-Infective,To be Discontinued,2/26/20,2/26/20
3712,Levofloxacin Tablets,Sandoz,800-525-8747,500 mg 50 count bottle (NDC 0781-5791-50),New,2/26/20,,Sandoz Inc. has made a business decision to discontinue Levofloxacin Tablets.,,,Anti-Infective,To be Discontinued,2/26/20,2/26/20
3713,Levofloxacin Tablets,Sandoz,800-525-8747,500 mg 100 count bottle (NDC 0781-5791-01),New,2/26/20,,Sandoz Inc. has made a business decision to discontinue Levofloxacin Tablets.,,,Anti-Infective,To be Discontinued,2/26/20,2/26/20
3714,Levofloxacin Tablets,Sandoz,800-525-8747,750 mg 20 count bottle (NDC 0781-5792-20),New,2/26/20,,Sandoz Inc. has made a business decision to discontinue Levofloxacin Tablets.,,,Anti-Infective,To be Discontinued,2/26/20,2/26/20
3715,Levofloxacin Tablets,Sandoz,800-525-8747,750 mg 50 count bottle (NDC 0781-5792-50),New,2/26/20,,Sandoz Inc. has made a business decision to discontinue Levofloxacin Tablets.,,,Anti-Infective,To be Discontinued,2/26/20,2/26/20
3716,Levoleucovorin Calcium Injection,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg/1 mL (17.5 mL)(NDC 67457-600-20),New,6/25/19,,,,,Oncology,To be Discontinued,6/25/19,6/25/19
3717,Levoleucovorin Calcium Injection,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg/1 mL (25 mL)(NDC 67457-601-30),New,6/25/19,,,,,Oncology,To be Discontinued,6/25/19,6/25/19
3718,Levoleucovorin Calcium Injection,Teva Pharmaceuticals,800-545-8800,10 mg/ml (NDC 45963-762-57),New,5/20/20,,Teva made a business decision to discontinue the manufacturing of this product.,,,Oncology,To be Discontinued,5/20/20,5/20/20
3719,Lidocaine HCl Topical Jelly,Teva Pharmaceuticals,800-545-8800,"Lidocaine HCl Topical Jelly, 20 mg/1 mL (2%), 5 mL (NDC 0591-3012-26)",New,4/27/18,,This was a business-related decision to discontinue manufacturing these products,,,Anesthesia,To be Discontinued,4/27/18,4/27/18
3720,Lidocaine HCl Topical Jelly,Teva Pharmaceuticals,800-545-8800,"Lidocaine HCl Topical Jelly, 20 mg/1 mL (2%), 30 mL (NDC 0591-3012-30)",New,4/27/18,,This was a business-related decision to discontinue manufacturing these products,,,Anesthesia,To be Discontinued,4/27/18,4/27/18
3721,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,Baxter Healthcare,888-229-0001,"Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 gram/500 mL (4mg/mL) in VIAFLEX Plus container. Product code 2B0973 (NDC 0338-0409-03)",Reverified,9/23/20,Available,,,,Cardiovascular,Current,,
3722,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,Baxter Healthcare,888-229-0001,"Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 gram/250 mL (8mg/mL) in VIAFLEX Plus container. Product code 2B0962 (NDC 0338-0411-02)",Reverified,9/23/20,Available,,,,Cardiovascular,Current,,
3723,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.8% Lidocaine Hydrochloride and 5% Dextrose in 250mL Excel Plastic container P5982 (NDC 00264-9598-20),Revised,9/10/20,Product available,,,Other,Cardiovascular,Current,,
3724,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.4% Lidocaine Hydrochloride and 5% Dextrose in 250mL Excel Plastic container P5942 (NDC 00264-9594-20),Revised,9/10/20,Product available,,,Other,Cardiovascular,Current,,
3725,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.4% Lidocaine Hydrochloride and 5% Dextrose in 500mL Excel Plastic container P5941 (NDC 00264-9594-10),Revised,9/10/20,Product available,,,Other,Cardiovascular,Current,,
3726,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 2 mL Ampoule (NDC 55150-158-72),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
3727,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 5 mL Ampoule (NDC 55150-159-74),Revised,11/20/20,Available,Next shipment expected Jan. 2020,,Demand increase for the drug,Anesthesia,Current,,
3728,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 2 mL Ampoule (NDC 55150-160-72),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
3729,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 2 mL Single Dose Vial (NDC 55150-161-02),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
3730,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 5 mL Single Dose Vial (NDC 55150-162-05),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
3731,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 30 mL Single Dose Vial (NDC 55150-163-30),Revised,11/20/20,Currently on backorder - next shipment anticipated mid Dec 20,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
3732,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 2 mL Single Dose Vial (NDC 55150-164-02),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
3733,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 5 mL Single Dose Vial (NDC 55150-165-05),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
3734,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (10 mg/mL); Ansyr Plastic Syringe (NDC 0409-9137-05),Revised,11/20/20,Next Delivery and Estimated Recovery: August 2021,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
3735,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,1.5%; 20mL Sterile Pack Amp (NDC 0409-4056-01),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
3736,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,20 mg/2 mL (10 mg/mL); Glass Ampul (NDC 0409-4713-32),Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3737,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"200 mg/20 mL (10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-01, pack of 25; NDC 0409-4276-16, individual)",Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3738,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,300 mg/30 mL (10 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4279-02),Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3739,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-02),Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3740,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,1%; 30 mL Sterile Pack vial (NDC 0409-4270-01),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
3741,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,40 mg/2 mL (20 mg/mL); Glass Ampul (NDC 0409-4282-01),Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3742,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,200 mg/10 mL (20 mg/mL); Glass Ampul (NDC 0409-4282-02),Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3743,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (10 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4904-34),Revised,11/20/20,Limited Supply Available. Next Delivery: November 2020; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
3744,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,100 mg/5 mL (20 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4903-34),Revised,11/20/20,Limited Supply Available. Next Delivery: November 2020; Estimated Recovery: May 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
3745,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,100 mg/5 mL (20 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-2066-05),Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3746,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"400 mg/20 mL (20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-01, pack of 25; NDC 0409-4277-16, individual)",Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3747,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"1,000 mg/50 mL (20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-02)",Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3748,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,200 mg/5 mL (40 mg/mL); Glass Ampul (NDC 0409-4283-01),Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3749,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,Xylocaine Cardiac 100 mg/5 mL (20 mg/mL); Ansyr Plastic Syringe (NDC 0409-1323-05),Revised,11/20/20,Next Delivery and Estimated Recovery: July 2021,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
3750,Lidocaine Hydrochloride (Xylocaine) Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"2%, 5mL Luer-Jet Prefilled Syringe (NDC 76329-3390-1)
(old NDC 0548-3390-00)",Reverified,10/30/20,Available,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3751,Lidocaine Hydrochloride (Xylocaine) Injection,American Regent/Luitpold,800-645-1706,"1%, 50 mL vial package of 25 (NDC 00517-0625-25)",Reverified,7/8/20,Unavailable-No product available for release. No plan to manufacture.,"American Regent/Luitpold has discontinued manufacturing Lidocaine HCl Injection, USP",,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
3752,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 10 mL ampule (NDC 63323-0493-97)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3753,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 20 mL ampule (NDC 63323-0493-91)",Reverified,11/16/20,Backordered. Next release date not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3754,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 2 mL vial (NDC 63323-0202-02)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3755,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 2% injection 20 mg/mL, 5 mL SD Tear Top vial, preservative-free (NDC 63323-0208-05)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3756,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-17)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3757,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 20 mL vial (NDC 63323-0486-27)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3758,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-57)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3759,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-10)
discontinued",Reverified,11/16/20,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3760,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection NDC discontinued 20 mg/mL, 20 mL vial (NDC 63323-0486-20)-NDC discontinued",Reverified,11/16/20,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3761,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-50)-NDC discontinued",Reverified,11/16/20,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3762,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 2 mL vial (NDC 63323-0495-27)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3763,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 5 mL vial (NDC 63323-0495-07)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3764,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 10 mL ampule (NDC 63323-0496-97)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3765,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,250 mg/50 mL (5 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4275-01),Revised,11/20/20,Next Delivery: January 2021; Estimated Recovery: January 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
3766,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,100 mg/2 mL (50 mg/mL); Glass Ampul (NDC 0409-4712-01),Revised,11/20/20,Next Delivery: September 2022; Estimated Recovery: December 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
3767,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,250 mg/50 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4278-01),Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3768,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31)",Reverified,11/16/20,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3769,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 0.5% Xylocaine 0.5% injection 5 mg/mL, 50 mL vial (NDC 63323-0484-57)",Reverified,11/16/20,Not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3770,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 0.5% - MPF injection, APP 5 mg/mL, 50 mL vial (NDC 63323-0491-57)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3771,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 2 mL vial (NDC 63323-0201-02)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3772,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 10 mL vial (NDC 63323-0201-10)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3773,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% injection 10 mg/mL, 20 mL vial (NDC 63323-0485-27)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3774,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% injection 10 mg/mL, 50 mL vial (NDC 63323-0485-57)",Reverified,11/16/20,Backordered. Next release December 2019.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3775,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 2 mL vial (NDC 63323-0492-27)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3776,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80)",Reverified,11/16/20,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3777,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89)",Reverified,11/16/20,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3778,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 5 mL vial (NDC 63323-0492-57)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3779,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial (NDC 63323-0492-37)",Reverified,11/16/20,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3780,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (10 mg/mL); Glass Ampul (NDC 0409-4713-02),Revised,11/20/20,Next Delivery: November 2020; Estimated Recovery: December 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
3781,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,300 mg/20 mL (15 mg/mL); Glass Ampul (NDC 0409-4776-01),Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3782,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 10 mL Multi Dose Vial (NDC 55150-251-10),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
3783,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 20 mL Multi Dose Vial (NDC 55150-252-20),Revised,11/20/20,Currently on backorder - next shipment anticipated in Jan 21,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
3784,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 10 mL Multi Dose Vial (NDC 55150-254-10),Revised,11/20/20,Currently on backorder,Intermittent availability expected,,Demand increase for the drug,Anesthesia,Current,,
3785,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 20 mL Multi Dose Vial (NDC 55150-255-20),Revised,11/20/20,Currently on backorder - next shipment anticipated in Jan 21,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
3786,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1% 5 mL vial, Preservative Free (NDC 0143-9595-25)",Reverified,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
3787,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% 5 mL vial, Preservative Free (NDC 0143-9594-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
3788,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1% 50 mL vial, Preserved (NDC 0143-9577-10)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
3789,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% 50 mL vial, Preserved (NDC 0143-9575-10)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
3790,Lidocaine Hydrochloride (Xylocaine) Injection,"Spectra Medical Devices, Inc.",978-657-0889 ext. 5231,1% 5 mL ampule (NDC 65282-1605-1),New,6/14/18,"Currently available, in stock Production is ongoing",,,Other,Anesthesia,Current,,
3791,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% MDV 1000mg/50mL (NDC 55150-025-650),New,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
3792,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"0.5% w/EPI 1:100,000; 1.8 mL Carpule (NDC 00409-0996-01)",Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
3793,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"2.5 g/50 mL (0.5%; 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3177-01)",Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3794,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"200 mg/20 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-01)",Revised,11/20/20,Limited Supply Available. Next Delivery and Estimated Recovery: January 2021,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3795,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"300 mg/30 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-02)",Revised,11/20/20,Limited Supply Available. Next Delivery and Estimated Recovery: November 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
3796,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"500 mg/50 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3178-03)",Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3797,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"75 mg/5 mL (1.5%; 1:200,000); Glass Ampul (NDC 0409-1209-01)",Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3798,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"450 mg/30 mL (1.5%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3181-01)",Revised,11/20/20,Limited Supply Available.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
3799,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"400 mg/20 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-01)",Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3800,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"600 mg/30 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-02)",Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3801,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"1 g/50 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-03)",Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3802,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"400 mg/20 mL (2%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3183-01)",Revised,11/20/20,Available,,,Other,Anesthesia;Pediatric,Current,,
3803,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"2% w/EPI 1:50,000; 1.8mL syringe (NDC 00409-7263-01)",Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
3804,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 100 mg MDV (NDC 63323-0482-17)",Revised,11/16/20,Backordered. Next release date not available at this time.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
3805,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 100mg SDV, MPF (NDC 63323-0487-17)",Revised,11/16/20,Backordered. Next release December 2020.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
3806,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 150 mg, SDV, MPF (NDC 63323-0488-17)",Revised,11/16/20,Available,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
3807,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 200 mg, SDV, MPF (NDC 63323-0489-17)",Revised,11/16/20,Backorered. Next release December 2020.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
3808,Liothyronine Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Liothyronine Sodium 5mcg tablets (NDC 0378-3611-01),New,3/28/18,,The discontinuation of this product is a business decision,,,Endocrinology/Metabolism,To be Discontinued,3/28/18,3/28/18
3809,Liothyronine Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Liothyronine Sodium 25mcg tablets (NDC 0378-3612-01),New,3/28/18,,The discontinuation of this product is a business decision,,,Endocrinology/Metabolism,To be Discontinued,3/28/18,3/28/18
3810,Lisinopril (Prinivil) Tablets,Merck Sharp & Dohme Corp.,800-672-6372,"5-mg tablets, unit-of-use bottle/90 (NDC 0006-0019-54)",New,3/11/19,,To be discontinued on or near April 2019.,,,Cardiovascular,To be Discontinued,3/11/19,
3811,Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2.5 mg (NDC 0378-2072-01); 5 mg (NDC 0378-2073-01); 5 mg (NDC 0378-2073-10); 10 mg (NDC 0378-2074-01); 10 mg (NDC 0378-2074-10); 20 mg (NDC 0378-2075-01); 20 mg (NDC 0378-2075-10); 30 mg (NDC 0378-2077-01); 40 mg (NDC 0378-2076-01; 40 mg (NDC 0378-2076-05),New,4/11/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,4/11/18,4/11/18
3812,Lithium Oral Solution,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,8 mEq/5 mL 500 mL bottle (ndc 0054-3527-63),Revised,5/18/20,"Unavailable, Estimated Shortage: TBD",,,Shortage of an active ingredient,Psychiatry,Current,,
3813,"Lorazepam Injection, USP","Hospira, Inc.",844-646-4398,4 mg/mL; Carpuject Luer Lock Glass Syringe (NDC 00409-1539-31),Reverified,11/20/20,Next Delivery and Estimated Recovery: January 2021,Shortage per manufacturer: Manufacturing Delay,,Other,Neurology,Current,,
3814,"Lorazepam Injection, USP","Hospira, Inc.",844-646-4398,2 mg/mL; Carpuject Luer Lock Glass Syringe  (NDC 00409-1985-30),Reverified,11/20/20,Available,,,,Neurology,Current,,
3815,"Lorazepam Injection, USP","Hospira, Inc.",844-646-4398,2 mg/mL; 1 mL Multiple Dose Glass Fliptop Vial (NDC 00409-6778-02),Reverified,11/20/20,Available,,,Other,Neurology,Current,,
3816,"Lorazepam Injection, USP","Hospira, Inc.",844-646-4398,4 mg/mL; 1 mL Multiple Dose Glass Fliptop Vial (NDC 00409-6779-02),Reverified,11/20/20,Next Delivery and Estimated Recovery: February 2023,Shortage per manufacturer: Manufacturing Delay,,Other,Neurology,Current,,
3817,"Lorazepam Injection, USP","Hospira, Inc.",844-646-4398,20 mg/10 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-6780-02),Reverified,11/20/20,Next Delivery and Estimated Recovery: February 2023,Shortage per manufacturer: Manufacturing Delay,,Other,Neurology,Current,,
3818,"Lorazepam Injection, USP","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"LORAZEPAM INJECTION, USP, C IV [2 mg/ mL](NDC 76329-8261-1)",Reverified,10/30/20,Available,,,Other,Neurology,Current,,
3819,"Lorazepam Injection, USP",Akorn Pharmaceuticals,800-932-5676,Lorazepam Injection 2 mg/mL (NDC 17478-040-01),Revised,12/2/19,Available,,,Demand increase for the drug,Neurology,Current,,
3820,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 2 mg/mL, 1 mL vial (NDC 0641-6001-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
3821,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 2 mg/mL, 10 mL vial (NDC 0641-6000-10)",Revised,7/22/20,This presentation is temporarily on backorder,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
3822,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 4 mg/mL, 1 mL vial (NDC 0641-6003-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
3823,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 4 mg/mL, 10 mL vial ((NDC 0641-6002-10)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
3824,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 2 mg/mL, 1 mL vial (NDC 0641-6044-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
3825,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 2 mg/mL, 10 mL vial (NDC 0641-6046-10)",Revised,7/22/20,This presentation is temporarily on backorder.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
3826,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 4 mg/mL, 1 mL vial (NDC 0641-6045-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
3827,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 4 mg/mL, 10 mL vial (NDC 0641-6002-10)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
3828,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 1000 count bottle (NDC 0527-1394-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,11/25/19,11/25/19
3829,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 1000 count bottle (NDC 0527-1395-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,11/25/19,11/25/19
3830,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 1000 count bottle (NDC 0527-1396-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,11/25/19,11/25/19
3831,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 1000 count bottle (NDC 0527-1397-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,11/25/19,11/25/19
3832,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 100 count bottle (NDC 0527-1394-01)",Revised,11/12/20,Allocating Inventory. Additional lots are scheduled for release in the January timeframe. Product will be made available as it is released (allocating inventory).,Manufacturing capacity constraint,,Other,Psychiatry,Current,,
3833,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 1000 count bottle (NDC 0527-1394-10)",Revised,11/12/20,Unavailable,,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
3834,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 100 count bottle (NDC 0527-1395-01)",Revised,11/12/20,Allocating Inventory. Additional lots are scheduled for release in the December timeframe. Product will be made available as it is released (allocating inventory).,Manufacturing capacity constraint,,Other,Psychiatry,Current,,
3835,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 1000 count bottle (NDC 0527-1395-10)",Revised,11/12/20,Unavailable,,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
3836,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 100 count bottle (NDC 0527-1396-01)",Revised,11/12/20,Unavailable. Additional lots are scheduled for release in the December timeframe. Product will be made available as it is released (allocating inventory).,Manufacturing capacity constraint,,Other,Psychiatry,Current,,
3837,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 1000 count bottle (NDC 0527-1396-10)",Revised,11/12/20,Unavailable,,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
3838,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 100 count bottle (NDC 0527-1397-01)",Revised,11/12/20,Allocating Inventory. Additional lots are scheduled for release in the December timeframe. Product will be made available as it is released (allocating inventory).,Manufacturing capacity constraint,,Other,Psychiatry,Current,,
3839,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 1000 count bottle (NDC 0527-1397-10)",Revised,11/12/20,Unavailable,,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
3840,Loxapine Capsules,Mylan,800-796-9526,"5 mg, 100 count bottle (NDC 0378-7005-01)",Reverified,11/9/20,Unavailable. Re-supply TBD.,,,Other,Psychiatry,Current,,
3841,Loxapine Capsules,Mylan,800-796-9526,"10 mg, 100 count bottle (NDC 0378-7010-01)",Reverified,11/9/20,Unavailable. Re-supply TBD.,,,Other,Psychiatry,Current,,
3842,Loxapine Capsules,Mylan,800-796-9526,"25 mg, 100 count bottle (NDC 0378-7025-01)",Reverified,11/9/20,Unavailable. Re-supply TBD.,,,Other,Psychiatry,Current,,
3843,Loxapine Capsules,Mylan,800-796-9526,"50 mg, 100 count bottle (NDC 0378-7050-01)",Reverified,11/9/20,Unavailable. Re-supply TBD.,,,Other,Psychiatry,Current,,
3844,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"5 mg, 100 count bottle (NDC 0591-0369-01)",Reverified,11/19/20,"On backorder, (recovery expected Jan 2021)",Cannot support additional business currently.,,Other,Psychiatry,Current,,
3845,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"10 mg, 100 count bottle (NDC 0591-0370-01)",Reverified,11/19/20,Available,,,,Psychiatry,Current,,
3846,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, 100 count bottle (NDC 0591-0371-01)",Reverified,11/19/20,"On backorder, (recovery expected Jan 2021)",Cannot support additional business currently.,,Other,Psychiatry,Current,,
3847,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 count bottle (NDC 0591-0372-01)",Reverified,11/19/20,"On backorder, (recovery expected Jan 2021)",Cannot support additional business currently.,,Other,Psychiatry,Current,,
3848,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,718-276-8607,"12.5mg tablets, 100 count (NDC 42806-012-01)",New,2/28/18,,This discontinuation is due to a business decision.,,,Gastroenterology,To be Discontinued,2/28/18,2/28/18
3849,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"12.5mg tablets, 1000 count (NDC 42806-012-10)",New,2/28/18,,This discontinuation is due to a business decision.,,,Gastroenterology,To be Discontinued,2/28/18,2/28/18
3850,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"25mg tablets, 100 count (NDC 42806-014-01)",New,2/28/18,,This discontinuation is due to a business decision.,,,Gastroenterology,To be Discontinued,2/28/18,2/28/18
3851,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"25mg tablets, 1000 count (NDC 42806-014-10)",New,2/28/18,,This discontinuation is due to a business decision.,,,Gastroenterology,To be Discontinued,2/28/18,2/28/18
3852,"Medroxyprogesterone Acetate (Depo-Provera) Injection, Suspension",Pfizer Pharmaceuticals,800-533-4535,"400 mg/mL, 1 carton containing one 2.5 mL vial (NDC 0009-0626-01)",New,10/27/20,,Discontinuation of the manufacturing of the drug.,,,Reproductive,To be Discontinued,10/27/20,10/27/20
3853,Medroxyprogesterone Acetate (Provera) Tablet,Pfizer Pharmaceuticals,800-533-4535,"10 mg, bottles of 500 (NDC 0009-0050-11)",New,2/12/20,,Discontinuation of the manufacture of the drug.,,,Reproductive,To be Discontinued,2/12/20,2/12/20
3854,Megestrol Acetate (Megace) Oral Suspension,"Endo Pharmaceuticals, Inc.",800-462-3636,MEGACE®ES 625mg/5ml Suspension (NDC 63481-160-38),New,8/21/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Endocrinology/Metabolism,To be Discontinued,8/21/19,8/21/19
3855,Megestrol Acetate (Megace) Oral Suspension,Bristol Myers Squibb Co.,800-332-2056,40 mg/mL Oral Suspension (NDC 00015-508-42),New,5/6/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/6/19,5/6/19
3856,Mesalamine (CANASA®)  Suppositories,Allergan,800-678-1605,"1 gm, Rectal Suppositories, 42 suppositories in 1 box (NDC 58914-501-42)",New,7/30/20,,"Additional products remain available:   
NDC 58914-501-56 (30 suppositories in 1 box); NDC 58914-501-33 (3 suppositories in 1 box); NDC 59762-0118-3",,,Gastroenterology,To be Discontinued,7/30/20,7/30/20
3857,Mesna Injection,Teva Pharmaceuticals,800-545-8800,100 mg/mL (NDC 0703-4805-03),New,6/21/19,,This product discontinuation is a business related decision.,,,Oncology,To be Discontinued,6/21/19,6/21/19
3858,"Metaproterenol Sulfate Tablets, USP",Par Pharmaceutical,"800-828-9393 option 5, then option 2","10mg, 100 count (NDC 49884-0258-01)",New,7/12/19,,Business decision to discontinue marketing in the US.,,,Pulmonary/Allergy,To be Discontinued,7/12/19,7/12/19
3859,"Metaproterenol Sulfate Tablets, USP",Par Pharmaceutical,"800-828-9393 option 5, then option 2","20mg, 100 count (NDC 49884-0259-01)",New,7/12/19,,Business decision to discontinue marketing in the US.,,,Pulmonary/Allergy,To be Discontinued,7/12/19,7/12/19
3860,Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,"Metformin Hydrochloride Tablet Extended Release, 750 mg per tablet, (NDC 0093-7212-01), 100 count per bottle",New,7/22/19,,Teva made a business decision to discontinue the drug product.,,,Endocrinology/Metabolism,To be Discontinued,7/22/19,7/22/19
3861,Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,"Metformin Hydrochloride Tablet Extended Release, 500 mg per tablet, (NDC 0093-7267-01), 100 count per bottle",New,7/22/19,,Teva made a business decision to discontinue the drug product.,,,Endocrinology/Metabolism,To be Discontinued,7/22/19,7/22/19
3862,Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,"Metformin Hydrochloride Tablet Extended Release, 500 mg per tablet, (NDC 0093-7267-10), 1000 count per bottle",New,7/22/19,,Teva made a business decision to discontinue the drug product.,,,Endocrinology/Metabolism,To be Discontinued,7/22/19,7/22/19
3863,Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,750mg tablets (NDC 2037-577-10) and (NDC 62037-577-01 ),New,6/24/20,,Teva made a business decision to discontinue the product.,,,Endocrinology/Metabolism,To be Discontinued,6/24/20,6/24/20
3864,Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,500mg tablets (NDC 62037-571-01) and (NDC 62037-571-10),New,6/24/20,,Teva made a business decision to discontinue the product.,,,Endocrinology/Metabolism,To be Discontinued,6/24/20,6/24/20
3865,Metformin Hydrochloride Tablets,Sandoz,800-525-8747,"500 mg, bottle count 100 (NDC 42806-213-01)",New,4/15/20,,Business decision to discontinue.,,,Endocrinology/Metabolism,To be Discontinued,4/15/20,4/15/20
3866,Metformin Hydrochloride Tablets,Sandoz,800-525-8747,"500 mg, bottle count 500 (NDC 42806-213-05)",New,4/15/20,,Business decision to discontinue.,,,Endocrinology/Metabolism,To be Discontinued,4/15/20,4/15/20
3867,Metformin Hydrochloride Tablets,Sandoz,800-525-8747,"500 mg, bottle count 1000 (NDC 42806-213-10)",New,4/15/20,,Business decision to discontinue.,,,Endocrinology/Metabolism,To be Discontinued,4/15/20,4/15/20
3868,Metformin Hydrochloride Tablets,Sandoz,800-525-8747,"850 mg, bottle count 100 (NDC 42806-215-01)",New,4/15/20,,Business decision to discontinue.,,,Endocrinology/Metabolism,To be Discontinued,4/15/20,4/15/20
3869,Metformin Hydrochloride Tablets,Sandoz,800-525-8747,"850 mg, bottle count 500 (NDC 42806-215-05)",New,4/15/20,,Business decision to discontinue.,,,Endocrinology/Metabolism,To be Discontinued,4/15/20,4/15/20
3870,Metformin Hydrochloride Tablets,Sandoz,800-525-8747,"1000 mg, bottle count 500 (NDC 42806-221-05)",New,4/15/20,,Business decision to discontinue.,,,Endocrinology/Metabolism,To be Discontinued,4/15/20,4/15/20
3871,Methadone Hydrochloride Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),Methadone Hydrochloride Injection (Solution in Multi Dose Vials) [200 mg / 20 ml](NDC 67457-217-20),Reverified,11/10/20,Available,Short dated inventory,,Other,Analgesia/Addiction;Anesthesia,Current,,
3872,Methadone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Methadone Hydrochloride Injection USP, 200 mg/20 mL (10 mg/mL) , 20 mL multidose vials (NDC 17478-380-20)",Revised,2/18/20,Backordered. Estimated recovery March 2020,,,Other,Analgesia/Addiction;Anesthesia,Current,,
3873,"Methocarbamol Tablet, USP","Endo Pharmaceuticals, Inc.",800-462-3636,"Robaxin® 500mg, 100 Tablets (NDC 52244-429-10)",New,8/21/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Analgesia/Addiction;Musculoskeletal,To be Discontinued,8/21/19,8/21/19
3874,"Methocarbamol Tablet, USP","Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",750 mg tablets (NDC 52244-449-10),New,10/27/20,,,,,Analgesia/Addiction,To be Discontinued,10/27/20,10/27/20
3875,Methocarbamol Tablets,"Oxford Pharmaceuticals, LLC",256-759-6905,"500 mg, 100 ct (NDC 69584-611-10); 500 ct (NDC 69584-611-50); 1000 ct (NDC 69584-611-90)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
3876,Methocarbamol Tablets,"Oxford Pharmaceuticals, LLC",256-759-6905,"750 mg, 100 ct (NDC 69584-612-10); 500 ct (NDC 69584-612-50); 1000 ct (NDC 69584-612-90)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
3877,Methocarbamol Tablets,"Solco Healthcare US, LLC",866-931-9829,"500 mg, 100 ct (NDC 43547-0405-10); 500 ct (NDC 43547-0405-50)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
3878,Methocarbamol Tablets,"Solco Healthcare US, LLC",866-931-9829,"750 mg, 100 ct (NDC 43547-0226-10); 500 ct (NDC 43547-0226-50)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
3879,Methocarbamol Tablets,Granules Pharmaceuticals Inc.,877-770-3183,"500 mg, 100 ct (NDC 70010-754-01); 500 ct (NDC 70010-754-05)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
3880,Methocarbamol Tablets,Granules Pharmaceuticals Inc.,877-770-3183,"750 mg, 100 ct (NDC 70010-770-01); 500 ct (NDC 70010-770-05)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
3881,Methocarbamol Tablets,"AustarPharma, LLC",805-447-9866 ext. 259,"Distributed by Golden State Medical Supply, Inc.: 500 mg, 100 ct (NDC 60429-118-01); 500 ct (NDC 60429-118-05) Distributed by Virus Pharmaceuticals: 500 mg, 100 ct (NDC 69543-134-10); 500 ct (NDC 69543-134-50)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
3882,Methocarbamol Tablets,"AustarPharma, LLC",805-477-9866 ext. 259,"Distributed by Golden State Medical Supply, Inc.: 750 mg, 100 ct (NDC 60429-119-01); 500 ct (NDC 60429-119-05) Distributed by Virtus Pharmaceuticals: 750 mg, 100 ct (NDC 69543-135-10); 500 ct (NDC 69543-135-50)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
3883,Methocarbamol Tablets,Camber Pharmaceuticals Inc.,866-827-3647,"500 mg, 100 ct (NDC 31722-533-01); 500 ct (NDC 31722-533-05)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
3884,Methocarbamol Tablets,Camber Pharmaceuticals Inc.,866-827-3647,"750 mg, 100 ct (NDC 31722-534-01); 500 ct (NDC 31722-534-05)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
3885,Methocarbamol Tablets,Bayshore Pharmaceuticals,973-315-1819,"500 mg, 100 ct (NDC 76385-123-01); 500 ct (NDC 76385-123-50)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
3886,Methocarbamol Tablets,Bayshore Pharmaceuticals,973-315-1819,"750 mg, 100 ct (NDC 76385-124-01); 500 ct (NDC 76385-124-50)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
3887,Methotrexate Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg/mL, 2 mL vial (NDC 0143-9519-10)",Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3888,Methotrexate Sodium Injection,Teva Pharmaceuticals,800-545-8800,25MG/ML 1X40ML (NDC 00703-3678-01),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3889,Methotrexate Sodium Injection,Teva Pharmaceuticals,800-545-8800,25MG/ML 1X40ML Premier label  (NDC 00703-3678-81),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3890,Methotrexate Sodium Injection,Teva Pharmaceuticals,800-545-8800,25MG/ML 1X10ML (NDC 00703-3675-01),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3891,Methotrexate Sodium Injection,Teva Pharmaceuticals,800-545-8800,25MG/ML SDV 10X2ML (NDC 00703-3671-03),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3892,Methotrexate Sodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 gram per vial, 50 mL vial, SDV (NDC 63323-122-50)",Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3893,Methotrexate Sodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,"250 mg per 10 mL, vial (NDC 63323-123-10)",Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3894,Methotrexate Sodium Injection,"Hospira, Inc.",844-646-4398,50 mg/2 mL (25 mg/mL); Glass Fliptop Vial (NDC 61703-0350-38),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3895,Methotrexate Sodium Injection,"Hospira, Inc.",844-646-4398,1 g/40 mL (25 mg/mL); Single Dose Glass Fliptop Vial (NDC 61703-0408-41),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3896,Methotrexate Sodium Injection,Accord Healthcare Inc.,800-843-7477,25 mg/mL; 2mL (NDC 16729-277-30),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3897,Methotrexate Sodium Injection,Accord Healthcare Inc.,800-843-7477,25 mg/mL; 40 mL (NDC 16729-277-35),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3898,Methotrexate Sodium Injection,Accord Healthcare Inc.,800-843-7477,25 mg/mL; 10 mL (NDC 16729-277-03),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3899,Methotrexate Sodium Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),1000 mg/40 mL (NDC 67457-480-40),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
3900,Methotrexate Sodium Injection,Mylan,800-796-9526,"250 mg in 10 mL (25 mg/mL), single dose vial (NDC 67457-466-10)",Revised,3/3/20,,Expected Discontinuation March 2020,,,Dermatology;Oncology;Pediatric;Rheumatology,To be Discontinued,12/16/19,12/16/19
3901,"Methotrexate Tablets, USP","Endo Pharmaceuticals, Inc.",800-462-3636,"Methotrexate Sodium 2.5 mg Tablet, 36 count (NDC 67253-320-36)",New,9/13/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Dermatology;Oncology;Rheumatology,To be Discontinued,9/13/19,9/13/19
3902,"Methotrexate Tablets, USP","Endo Pharmaceuticals, Inc.",800-462-3636,"Methotrexate Sodium 2.5 mg Tablet, 100 count (NDC 67253-320-10)",New,9/13/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Dermatology;Oncology;Rheumatology,To be Discontinued,9/13/19,9/13/19
3903,Methscopolamine Bromide Tablets,Par Pharmaceutical,800-828-9393,"5 mg tablets, bottle of 60 (NDC 64376-604-61)",New,1/27/20,,Par has made a business decision to permanently discontinue the drug product.,,,Gastroenterology,To be Discontinued,1/27/20,1/27/20
3904,Methscopolamine Bromide Tablets,Par Pharmaceutical,800-828-9393,"2.5 mg tablets, bottle of 100 (NDC 64376-603-01)",New,1/27/20,,Par has made a business decision to permanently discontinue the drug product.,,,Gastroenterology,To be Discontinued,1/27/20,1/27/20
3905,"Methscopolamine Bromide, Tablets, USP",Par Pharmaceutical,800-828-9393,"2.5 mg, 100 count (NDC  64376-603-01)",New,7/18/19,,Par has made a business decision to permanently discontinue the drug product.,,,Gastroenterology,To be Discontinued,7/18/19,7/18/19
3906,"Methscopolamine Bromide, Tablets, USP",Par Pharmaceutical,800-828-9393,"5 mg, 60 count (NDC 64376-604-61)",New,7/18/19,,Par has made a business decision to permanently discontinue the drug product.,,,Gastroenterology,To be Discontinued,7/18/19,7/18/19
3907,Methyclothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count bottle (NDC 0378-0160-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
3908,Methyldopa Tablets,Teva Pharmaceuticals,800-545-8800,500 mg/1 unit (NDC 0093-2932-05),New,6/10/19,,"The discontinuation of these products is a business decision and not related to product quality, safety or efficacy.",,,Cardiovascular,To be Discontinued,6/10/19,6/10/19
3909,Methyldopa Tablets,Teva Pharmaceuticals,800-545-8800,500 mg/1 unit (NDC 0093-2932-01),New,6/10/19,,"The discontinuation of these products is a business decision and not related to product quality, safety or efficacy.",,,Cardiovascular,To be Discontinued,6/10/19,6/10/19
3910,Methyldopa Tablets,Teva Pharmaceuticals,800-545-8800,250 mg/1 unit (NDC 0093-2931-10),New,6/10/19,,"The discontinuation of these products is a business decision and not related to product quality, safety or efficacy.",,,Cardiovascular,To be Discontinued,6/10/19,6/10/19
3911,Methyldopa Tablets,Teva Pharmaceuticals,800-545-8800,250 mg/1 unit (NDC 0093-2931-01),New,6/10/19,,"The discontinuation of these products is a business decision and not related to product quality, safety or efficacy.",,,Cardiovascular,To be Discontinued,6/10/19,6/10/19
3912,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 250 mg 100s (16729-03-001),Reverified,12/13/19,Limited availability; Estimated shortage until March 2020,,,API procurement delay,Cardiovascular,Current,,
3913,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 250 mg 500s (16729-03-016),Reverified,12/13/19,Limited availability; Estimated shortage until March 2020,,,API procurement delay,Cardiovascular,Current,,
3914,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 500 mg 100s (16729-03-101),Reverified,12/13/19,Limited availability; Estimated shortage until March 2020,,,API procurement delay,Cardiovascular,Current,,
3915,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 500 mg 500s (16729-03-116),Reverified,12/13/19,Limited availability; Estimated shortage until March 2020,,,API procurement delay,Cardiovascular,Current,,
3916,Methyldopa Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,250 mg (NDC 0378-0611-01),Reverified,11/10/20,Unavailable. Estimated recovery TBD.,,,Other,Cardiovascular,Current,,
3917,Methyldopa Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,500 mg (NDC 0378-0421-01),Reverified,11/10/20,Unavailable. Estimated recovery TBD.,,,Other,Cardiovascular,Current,,
3918,Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension,"Tris Pharma, Inc.",732-940-0358,300 mg/60 mL (NDC 24478-321-02),Revised,10/7/20,,"Effective September 21, 2018, Tris Pharma, Inc. acquired NextWave Pharmaceuticals, previously a wholly owned subsidiary of Pfizer Inc., including this product",,,Pediatric;Psychiatry,Resolved,10/7/20,
3919,Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension,"Tris Pharma, Inc.",732-940-0358,600 mg/120mL (NDC 24478-322-04),Revised,10/7/20,,"Effective September 21, 2018, Tris Pharma, Inc. acquired NextWave Pharmaceuticals, previously a wholly owned subsidiary of Pfizer Inc., including this product",,,Pediatric;Psychiatry,Resolved,10/7/20,
3920,Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension,"Tris Pharma, Inc.",732-940-0358,750 mg/150 mL (NDC 24478-323-05),Revised,10/7/20,,"Effective September 21, 2018, Tris Pharma, Inc. acquired NextWave Pharmaceuticals, previously a wholly owned subsidiary of Pfizer Inc., including this product",,,Pediatric;Psychiatry,Resolved,10/7/20,
3921,Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension,"Tris Pharma, Inc.",732-940-0358,900 mg/180 mL (NDC 24478-324-06),Revised,10/7/20,,"Effective September 21, 2018, Tris Pharma, Inc. acquired NextWave Pharmaceuticals, previously a wholly owned subsidiary of Pfizer Inc., including this product",,,Pediatric;Psychiatry,Resolved,10/7/20,
3922,"Methylphenidate Hydrochloride Extended-Release Tablets, USP CII",Teva Pharmaceuticals,800-545-8800,36 mg 30 count (NDC 0591-2717-30),New,5/17/19,,Teva made a business related decision to discontinue the product.,,,Pediatric;Psychiatry,To be Discontinued,5/17/19,5/17/19
3923,"Methylphenidate Hydrochloride Extended-Release Tablets, USP CII",Teva Pharmaceuticals,800-545-8800,54 mg 30 count (NDC 0591-2718-30),New,5/17/19,,Teva made a business related decision to discontinue the product.,,,Pediatric;Psychiatry,To be Discontinued,5/17/19,5/17/19
3924,"Methylphenidate Hydrochloride Tablets, USP CII",Teva Pharmaceuticals,800-545-8800,5 mg 100 count (NDC 0591-5882-01),New,5/17/19,,Teva made a business decision to discontinue the product.,,,Pediatric;Psychiatry,To be Discontinued,5/17/19,5/17/19
3925,"Methylphenidate Hydrochloride Tablets, USP CII",Teva Pharmaceuticals,800-545-8800,10 mg 100 count (NDC 0591-5883-01),New,5/17/19,,Teva made a business decision to discontinue the product.,,,Pediatric;Psychiatry,To be Discontinued,5/17/19,5/17/19
3926,"Methylphenidate Hydrochloride Tablets, USP CII",Teva Pharmaceuticals,800-545-8800,20 mg 100 count (NDC 0591-5884-01),New,5/17/19,,Teva made a business decision to discontinue the product.,,,Pediatric;Psychiatry,To be Discontinued,5/17/19,5/17/19
3927,Methylprednisolone Tablets,Teva Pharmaceuticals,800-545-8800,4 mg tablets (NDC 0591-0790-01),New,12/5/19,,,,,Neurology,To be Discontinued,12/5/19,12/5/19
3928,Methylprednisolone Tablets,Teva Pharmaceuticals,800-545-8800,4 mg  (NDC 0591-0790-21),New,8/17/20,,,,,Rheumatology,To be Discontinued,8/17/20,8/17/20
3929,"Metoclopramide Injection, USP",Heritage Pharma,855-228-9470,10mg/2mL (NDC 23155-240-41),Revised,10/18/19,,,,,Gastroenterology,Resolved,10/18/19,
3930,"Metoclopramide Injection, USP","Hospira, Inc.",844-646-4398,10 mg/2 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3414-01),Revised,10/18/19,,,,,Gastroenterology,Resolved,10/18/19,
3931,"Metoclopramide Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 2 mL, single use, prefilled syringe (NDC 76045-101-20)",Revised,10/18/19,,,,,Gastroenterology,Resolved,10/18/19,
3932,"Metoclopramide Injection, USP",Teva Pharmaceuticals,800-545-8800,5 mg/ 1 ml (NDC 0703-4502-04),Revised,10/18/19,,,,,Gastroenterology,Resolved,10/18/19,
3933,"Metoclopramide Injection, USP",Teva Pharmaceuticals,800-545-8800,5 mg/ 1 ml (NDC 0703-4502-84),Revised,10/18/19,,,,,Gastroenterology,Resolved,10/18/19,
3934,"Metoprolol Tartrate Injection, USP",Gland Pharma Limited,609-250-7990,5 mg per 5 mL Single Dose Vial (NDC 47781-587-17),Reverified,10/27/20,Available,Distributed by Alvogen Inc. (Company Contact Information:  973-532-7840),,Available,Cardiovascular,Current,,
3935,"Metoprolol Tartrate Injection, USP",Baxter Healthcare,888-229-0001,1 mg/mL - 5 mL Sterile Single Use Glass Vial (10 x 5 mL). For Intravenous Use (NDC 36000-033-10),Reverified,9/23/20,Available,,,,Cardiovascular,Current,,
3936,"Metoprolol Tartrate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"5 mg per 5 mL, SDV, PF (NDC 63323-660-05)",Reverified,11/16/20,Available,Check wholesalers for inventory,,Manufacturing delays,Cardiovascular,Current,,
3937,"Metoprolol Tartrate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1mg/mL – 10mL vials, (NDC 0143-9660-10)",Reverified,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
3938,"Metoprolol Tartrate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1mg/mL – 5ml vials (NDC 0143-9873-25),Reverified,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
3939,"Metoprolol Tartrate Injection, USP","Hospira, Inc.",844-646-4398,5 mg/5 mL (1 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1778-05),Reverified,11/20/20,Available,,,Other,Cardiovascular,Current,,
3940,"Metoprolol Tartrate Injection, USP","Hospira, Inc.",844-646-4398,5 mg/5 mL (1 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1778-35),Reverified,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
3941,"Metoprolol Tartrate Injection, USP","Hospira, Inc.",844-646-4398,5 mg/5 mL (1 mg/mL); Glass Ampul (NDC 00409-2285-05),Reverified,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
3942,"Metoprolol Tartrate Injection, USP",Gland Pharma Limited,609-250-7990,"1 mg/mL, 5 mL vial (NDC 72266-122-25)",Reverified,10/27/20,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Available,Cardiovascular,Current,,
3943,"Metoprolol Tartrate Injection, USP",Gland Pharma Limited,609-250-7990,1 mg/mL 5mL vial (NDC 70860-300-05 and 70860-300-41),Reverified,10/27/20,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Available,Cardiovascular,Current,,
3944,Metoprolol Tartrate Tablets,Teva Pharmaceuticals,800-545-8800,50 mg tablets (NDCs 0591-0462-01 and 0591-0462-10),New,12/16/19,,,,,Cardiovascular,To be Discontinued,12/16/19,12/16/19
3945,Metoprolol Tartrate Tablets,Teva Pharmaceuticals,800-545-8800,100 mg tablets (NDCs 0591-0463-01 and 0591-0463-10),New,12/16/19,,,,,Cardiovascular,To be Discontinued,12/16/19,12/16/19
3946,Metronidazole (Flagyl) Tablets,Pfizer Pharmaceuticals,800-533-4535,250 mg tablets 1 x 100 bottle (NDC 0025-1831-31),New,10/20/20,,Discontinuation of the manufacture of the drug.,,,,To be Discontinued,10/20/20,10/20/20
3947,Metronidazole (Flagyl) Tablets,Pfizer Pharmaceuticals,800-533-4535,250 mg tablets 1 x 50 bottle (NDC 0025-1831-50),New,10/20/20,,Discontinuation of the manufacture of the drug.,,,,To be Discontinued,10/20/20,10/20/20
3948,"Metronidazole Injection, USP",Baxter Healthcare,888-229-0001,"Metronidazole Injection, USP, 500 mg/100 mL, in VIAFLEX Plus Container (NDC 0338-1055-48)",Reverified,9/23/20,Available,,,,Anti-Infective,Current,,
3949,"Metronidazole Injection, USP","Hospira, Inc.",844-646-4398,500 mg/100 mL (5 mg/mL); Flexible Container (NDC 00409-7811-24),Reverified,11/20/20,Available,,,Other,Anti-Infective,Current,,
3950,"Metronidazole Injection, USP","Hospira, Inc.",844-646-4398,500 mg/100 mL (5 mg/mL); Flexible Container (NDC 00409-7811-37),Reverified,11/20/20,Available,,,Other,Anti-Infective,Current,,
3951,"Metronidazole Injection, USP",B. Braun Medical Inc.,800-227-2862,Metronidazole Injection 500mg (5mg/mL) 100mL D5353-5224 (NDC 0264-5535-32),Reverified,9/8/20,Product available for contracted  customers,,,Manufacturing interruptions and demand increase,Anti-Infective,Current,,
3952,"Midazolam Injection, USP",Akorn Pharmaceuticals,800-932-5676,10 ML Vial - Pack of 10 (NDC 17478-0524-10),New,4/2/20,Limited supply. On allocation for 2020.,Cannot supply market demand.,,Other,Anesthesia;Neurology,Current,,
3953,"Midazolam Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 10 mL vial, 10 count (NDC 63323-0411-10)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3954,"Midazolam Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 2 mL prefilled syringe, 24 count (NDC 76045-0001-20)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3955,"Midazolam Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 2 mL vial, 25 count (NDC 63323-0411-12)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3956,"Midazolam Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 5 mL vial, 25 count (NDC 63323-0411-25)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3957,"Midazolam Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 1 mL fill in 2 mL vial, 25 count (NDC 63323-0412-25)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3958,"Midazolam Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 10 mL vial, 10 count (NDC 63323-0412-10)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3959,"Midazolam Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 1 mL prefilled syringe, 24 count (NDC 76045-0002-10)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3960,"Midazolam Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 2 mL vial, 25 count (NDC 63323-0412-02)",Revised,11/16/20,8 month dating (expiry 7/31/2021) available by request.,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3961,"Midazolam Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 5 mL vial, 10 count (NDC 63323-0412-05)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3962,"Midazolam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1 mg/mL, 10 mL vial, 10 count (NDC 00641-6056-10)",Revised,10/23/20,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3963,"Midazolam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1 mg/mL, 2 mL vial, 25 count (NDC 00641-6057-25)",Revised,10/23/20,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3964,"Midazolam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1 mg/mL, 5 mL vial, 10 count (NDC 0641-6059-25)",Revised,10/23/20,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3965,"Midazolam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 1 mL vial, 25 count (NDC 00641-6061-25)",Revised,10/23/20,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3966,"Midazolam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 10 mL vial, 10 count (NDC 00641-6060-10)",Revised,10/23/20,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3967,"Midazolam Injection, USP","Hospira, Inc.",844-646-4398,2 mg/2mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2305-17),Revised,11/20/20,Available,,,,Anesthesia;Neurology,Current,,
3968,"Midazolam Injection, USP","Hospira, Inc.",844-646-7398,5 mg/5 mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2305-05),Revised,11/20/20,Available,,,,Anesthesia;Neurology,Current,,
3969,"Midazolam Injection, USP","Hospira, Inc.",844-646-4398,5 mg/mL (5 mg/mL)  Single Dose Glass Fliptop Vial (NDC 00409-2308-01),Revised,11/20/20,Available,,,Other,Anesthesia;Neurology,Current,,
3970,"Midazolam Injection, USP","Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2596-05),Revised,11/20/20,Available,,,Other,Anesthesia;Neurology,Current,,
3971,"Midazolam Injection, USP","Hospira, Inc.",844-646-4398,10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2308-02),Revised,11/20/20,Available,,,Other,Anesthesia;Neurology,Current,,
3972,"Midazolam Injection, USP","Hospira, Inc.",844-646-4398,25 mg/5 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2596-03),Revised,11/20/20,Available,,,Other,Anesthesia;Neurology,Current,,
3973,"Midazolam Injection, USP","Hospira, Inc.",844-646-4398,10 mg/10 mL (1 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2587-05),Revised,11/20/20,Available,,,,Anesthesia;Neurology,Current,,
3974,"Midazolam Injection, USP","Hospira, Inc.",844-646-4398,2 mg/2 mL (1 mg/mL) CARPUJECT™ Luer Lock Glass Syringe (NDC 00409-2306-62),Revised,11/20/20,Next delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Neurology,Current,,
3975,"Midazolam Injection, USP","Hospira, Inc.",844-646-4398,5 mg/mL CARPUJECT™ Luer Lock Glass Syringe (NDC 00409-2307-60),Revised,11/20/20,Next delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Neurology,Current,,
3976,"Midazolam Injection, USP",Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,50 mg/10mL vial (NDC 23155-601-42),Revised,11/6/20,On backorder – increase demand due to Covid-19; resupply date end of November 2020,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3977,"Midazolam Injection, USP",Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,25 mg/5mL vial (NDC 23155-601-41),Revised,11/6/20,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3978,"Midazolam Injection, USP",Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,2 mg/2mL vial (NDC 23155-600-41),Revised,11/6/20,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3979,"Midazolam Injection, USP",Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,50 mg per 10 mL Multi-Dose Vial (NDC 70860-601-10),Revised,10/27/20,Available,"Marketing partner: Athenex Pharmaceutical Division, LLC.",,Demand increase for the drug,Anesthesia;Neurology,Current,,
3980,"Midazolam Injection, USP",Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,25 mg per 5 mL Multi-Dose Vial (NDC 70860-601-05),Revised,10/27/20,No stock available. Resupply December 2020,"Marketing partner: Athenex Pharmaceutical Division, LLC.",,Demand increase for the drug,Anesthesia;Neurology,Current,,
3981,"Midazolam Injection, USP",Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,25 mg per 5 mL Multi-Dose Vial (NDC 47781-589-17),Revised,10/27/20,"No stock available, Resupply July 2020",Marketing partner: Alvogen Inc.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3982,"Midazolam Injection, USP",Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,50 mg per 10 mL Multi-Dose Vial (NDC 47781-589-91),Revised,10/27/20,Available,Marketing partner: Alvogen Inc.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3983,"Midazolam Injection, USP",Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,2 mg per 2 mL Single Dose Vial (NDC 70860-600-02),Revised,10/27/20,"No stock available, Resupply December 2020","Marketing partner: Athenex Pharmaceutical Division, LLC.",,Demand increase for the drug,Anesthesia;Neurology,Current,,
3984,"Midazolam Injection, USP",Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,2 mg per 2 mL Single Dose Vial (NDC 47781-588-68),Revised,10/27/20,Stock available. Additional resupply June 2020,Marketing partner: Alvogen Inc.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
3985,Miglitol Tablets,"Hospira, Inc.",844-646-4398,25 mg (NDC 0009-5012-01),New,11/17/20,,,,,Endocrinology/Metabolism,To be Discontinued,11/17/20,11/17/20
3986,Miglitol Tablets,"Hospira, Inc.",844-646-4398,50 mg (NDC 0009-5013-01),New,11/17/20,,,,,Endocrinology/Metabolism,To be Discontinued,11/17/20,11/17/20
3987,Miglitol Tablets,"Hospira, Inc.",844-646-4398,100 mg (NDC 0009-5014-01),New,11/17/20,,,,,Endocrinology/Metabolism,To be Discontinued,11/17/20,11/17/20
3988,"Minocycline Hydrochloride Extended-Release Tablets, USP",Teva Pharmaceuticals,800-545-8800,55 mg 30 count (NDC 00093-7741-56),New,3/24/20,,Estimated Inventory Depletion: June 2020,,,Anti-Infective,To be Discontinued,3/24/20,3/24/20
3989,"Minocycline Hydrochloride Extended-Release Tablets, USP",Teva Pharmaceuticals,800-545-8800,115 mg 30 count (NDC 00093-2133-56),New,3/24/20,,Estimated Inventory Depletion: April 2020,,,Anti-Infective,To be Discontinued,3/24/20,3/24/20
3990,"Minocycline Hydrochloride Extended-Release Tablets, USP",Teva Pharmaceuticals,800-545-8800,65 mg 30 count (NDC 00093-2134-56),New,3/24/20,,Estimated Inventory Depletion: May 2020,,,Anti-Infective,To be Discontinued,3/24/20,3/24/20
3991,"Minocycline Hydrochloride Extended-Release Tablets, USP",Teva Pharmaceuticals,800-545-8800,105 mg 30 count (NDC 00093-7743-56),New,3/24/20,,No Inventory Remains,,,Anti-Infective,To be Discontinued,3/24/20,3/24/20
3992,"Minocycline Hydrochloride Extended-Release Tablets, USP",Teva Pharmaceuticals,800-545-8800,80 mg 30 count (NDC 00093-7742-56),New,3/24/20,,No Inventory Remains,,,Anti-Infective,To be Discontinued,3/24/20,3/24/20
3993,Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,15mg tablets (NDC 0591-2469-15),New,5/29/18,,This product discontinuation is a business related decision,,,Psychiatry,To be Discontinued,5/29/18,5/29/18
3994,Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,30mg tablets (NDC 0591-2470-15),New,5/29/18,,This product discontinuation is a business related decision,,,Psychiatry,To be Discontinued,5/29/18,5/29/18
3995,Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,45mg tablets (NDC 0591-2471-15),New,5/29/18,,This product discontinuation is a business related decision,,,Psychiatry,To be Discontinued,5/29/18,5/29/18
3996,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,15 mg 30 count bottle (NDC 0093-7206-56),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3997,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,15 mg 30 count bottle (NDC 0591-1117-30),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3998,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,15 mg 1000 count bottle (NDC 0591-1117-10),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
3999,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,30 mg 30 count bottle (NDC 0093-7207-56),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
4000,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,30 mg 30 count bottle (NDC 0591-1118-30),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
4001,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,30 mg 1000 count bottle (NDC 0591-1118-10),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
4002,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,45 mg 30 count bottle (NDC 0591-1119-30),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
4003,Misoprostol Tablets,Teva Pharmaceuticals,800-545-8800,"100 mcg, 120 count (NDC 0172-4430-59)",New,8/11/20,,Business decision to discontinue. The product has been unavailable since May 2011.,,,Gastroenterology,To be Discontinued,8/11/20,8/11/20
4004,Misoprostol Tablets,Teva Pharmaceuticals,800-545-8800,"100 mcg, 60 count (NDC 0172-4430-49)",New,8/11/20,,Business decision to discontinue. The product has been unavailable since May 2011.,,,Gastroenterology,To be Discontinued,8/11/20,8/11/20
4005,Misoprostol Tablets,Teva Pharmaceuticals,800-545-8800,"200 mcg, 100 count (NDC 0172-4431-60)",New,8/11/20,,Business decision to discontinue. The product has been unavailable since May 2011.,,,Gastroenterology,To be Discontinued,8/11/20,8/11/20
4006,Modafinil Tablets,Par Pharmaceutical,800-828-9393,"100 mg, bottle of 30 (NDC 49884-534-11)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,4/19/19,4/19/19
4007,Mometasone Furoate (Elocon) Topical Cream,Merck Sharp & Dohme Corp.,800-672-6372,0.1% 15 gram tube  (NDC 0085-3149-01),New,7/29/19,,,,,Dermatology,To be Discontinued,7/29/19,7/29/19
4008,Mometasone Furoate (Elocon) Topical Cream,Merck Sharp & Dohme Corp.,800-672-6372,0.1% 50 gram tube  (NDC 0085-3149-03),New,7/29/19,,,,,Dermatology,To be Discontinued,7/29/19,7/29/19
4009,Montelukast Sodium Chewable Tablet,Teva Pharmaceuticals,800-545-8800,4 mg  (NDCs 0093-7424-98 and 0093-7424-56),New,7/28/20,,,,,Pulmonary/Allergy,To be Discontinued,7/28/20,7/28/20
4010,Montelukast Sodium Chewable Tablet,Teva Pharmaceuticals,800-545-8800,5 mg  (NDCs 0093-7425-98 and 0093-7425-56),New,7/28/20,,,,,Pulmonary/Allergy,To be Discontinued,7/28/20,7/28/20
4011,Montelukast Sodium Chewable Tablet,Teva Pharmaceuticals,800-545-8800,"10 mg (NDCs 0093-7426-10, 0093-7426-56, and 0093-7426-98)",New,7/28/20,,,,,Pulmonary/Allergy,To be Discontinued,7/28/20,7/28/20
4012,Montelukast Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-5201-93),New,3/20/18,,The discontinuation of this product is a business decision,,,Pediatric;Pulmonary/Allergy,To be Discontinued,3/20/18,3/20/18
4013,Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules,Pfizer Pharmaceuticals,800-533-4535,20 mg/0.8 mg; 30 capsules per bottle (NDC 60793-430-20),New,10/7/19,,Stop sale date 15Nov2019.  Anticipated unavailability of product is early 2020.,,,Analgesia/Addiction,To be Discontinued,10/7/19,10/7/19
4014,Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules,Pfizer Pharmaceuticals,800-533-4535,30 mg/1.2 mg; 30 capsules per bottle (NDC 60793-431-20),New,10/7/19,,Stop sale date 15Nov2019.  Anticipated unavailability of product is early 2020.,,,Analgesia/Addiction,To be Discontinued,10/7/19,10/7/19
4015,Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules,Pfizer Pharmaceuticals,800-533-4535,50 mg/2 mg; 30 capsules per bottle (NDC 60793-433-20),New,10/7/19,,Stop sale date 15Nov2019.  Anticipated unavailability of product is early 2020.,,,Analgesia/Addiction,To be Discontinued,10/7/19,10/7/19
4016,Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules,Pfizer Pharmaceuticals,800-533-4535,60 mg/2.4 mg; 30 capsules per bottle (NDC 60793-434-20),New,10/7/19,,Stop sale date 15Nov2019.  Anticipated unavailability of product is early 2020.,,,Analgesia/Addiction,To be Discontinued,10/7/19,10/7/19
4017,Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules,Pfizer Pharmaceuticals,800-533-4535,80 mg/3.2 mg; 30 capsules per bottle (NDC 60793-435-20),New,10/7/19,,Stop sale date 15Nov2019.  Anticipated unavailability of product is early 2020.,,,Analgesia/Addiction,To be Discontinued,10/7/19,10/7/19
4018,Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules,Pfizer Pharmaceuticals,800-533-4535,100 mg/4 mg; 30 capsules per bottle (NDC 60793-437-20),New,10/7/19,,Stop sale date 15Nov2019.  Anticipated unavailability of product is early 2020.,,,Analgesia/Addiction,To be Discontinued,10/7/19,10/7/19
4019,Morphine Sulfate Extended-Release Tablets,Par Pharmaceutical,800-828-9393,"15 mg, bottle of 100 (NDC 60951-652-70)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Analgesia/Addiction,To be Discontinued,4/19/19,4/19/19
4020,Morphine Sulfate Extended-Release Tablets,Par Pharmaceutical,800-828-9393,"30 mg, bottle of 100 (NDC 60951-653-70)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Analgesia/Addiction,To be Discontinued,4/19/19,4/19/19
4021,Morphine Sulfate Extended-Release Tablets,Par Pharmaceutical,800-828-9393,"60 mg, bottle of 100 (NDC 60951-655-70)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Analgesia/Addiction,To be Discontinued,4/19/19,4/19/19
4022,Morphine Sulfate Extended-Release Tablets,Par Pharmaceutical,800-828-9393,"100 mg, bottle of 100 (NDC 60951-658-70)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Analgesia/Addiction,To be Discontinued,4/19/19,4/19/19
4023,Morphine Sulfate Extended-Release Tablets,Par Pharmaceutical,800-828-9393,"200 mg, bottle of 100 (NDC 60951-659-70)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Analgesia/Addiction,To be Discontinued,4/19/19,4/19/19
4024,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 100s (NDC 0378-2658-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
4025,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"30 mg, 100s (NDC 0378-2659-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
4026,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"60 mg, 100s (NDC 0378-2660-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
4027,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg, 100s (NDC 0378-2661-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
4028,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg, 100s (NDC 0378-2662-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
4029,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single dose vial, (NDC 63323-452-01)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
4030,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single dose vial, (NDC 63323-454-01)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
4031,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"5 mg per 1 mL, Single dose vial, (NDC 63323-455-01)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
4032,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"8 mg per 1 mL, Single dose vial, (NDC 63323-458-01)",Revised,11/16/20,Backordered. Next release December 2020.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
4033,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single dose vial, (NDC 63323-451-01)",Revised,11/16/20,Backordered. Next release December 2020.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
4034,"Morphine Sulfate Injection, USP","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,Morphine Sulfate 1 mg/mL 30 mg in 30 mL PUMP-JET®  SUITABLE FOR USE WITH COMPATIBLE I.V. INFUSION PUMPS (NDC 76329-1911-1),Reverified,10/30/20,Available,,,,Analgesia/Addiction,Current,,
4035,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 1 mL vial (NDC 0641-6125-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
4036,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"8 mg/mL, 1 mL vial (NDC 0641-6126-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
4037,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 1 mL vial (NDC 0641-6127-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
4038,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,250 mg/10 mL (25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1135-02),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
4039,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,2 mg/mL (2 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1890-01),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
4040,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,2 mg/mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1890-11),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
4041,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,4 mg/mL (4 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1891-01),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
4042,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,4 mg/mL (4 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1891-11),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
4043,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,8 mg/mL (8 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1892-01),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
4044,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,8 mg/mL (8 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1892-11),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
4045,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1893-01),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
4046,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1893-11),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
4047,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,5 mg/10 mL (0.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3814-12),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
4048,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,10 mg/10 mL (1 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3815-12),Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
4049,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,"1,000 mg/20 mL (50 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1134-03)",Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
4050,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,"2,500 mg/50 mL (50 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1134-05)",Revised,11/20/20,Available,,,Other,Analgesia/Addiction,Current,,
4051,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single-use prefilled syringe (NDC 76045-004-10)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
4052,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single-use prefilled syringe (NDC 76045-005-10)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
4053,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"5 mg per 1 mL, Single-use prefilled syringe (NDC 76045-006-10)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
4054,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"8 mg per 1 mL, Single-use prefilled syring (NDC 76045-007-10)",Revised,11/16/20,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
4055,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single-use prefilled syringe (NDC 76045-008-10)",Revised,11/16/20,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
4056,"Morphine Sulfate Injection, USP","ICU Medical, Inc.",877-946-7747,1mg/mL 30mL PCA glass vial (NDC 0409-2029-02),Revised,4/30/20,,,,,Analgesia/Addiction,To be Discontinued,4/30/20,4/30/20
4057,"Morphine Sulfate Injection, USP","ICU Medical, Inc.",877-946-7747,5mg/mL 30mL PCA GLASS VIAL (CII)(NDC 0409-6028-04),New,10/2/19,,Discontinuation of the manufacture of the drug,,,Analgesia/Addiction,To be Discontinued,10/2/19,10/2/19
4058,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Duramorph (Preservative-Free) 1 mg/mL, 10 mL ampul (NDC 0641-6019-10)",Revised,7/22/20,This presentation is temporarily on backorder .,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
4059,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Duramorph (Preservative-Free) 0.5 mg/mL, 10 mL ampul (NDC 0641-6020-10)",Revised,7/22/20,This presentation is temporarily on backorder .,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
4060,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Infumorph (Preservative-free Morphine Sulfate Sterile Solution) 10 mg/mL, 20 mL ampul (NDC 0641-6039-01)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
4061,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Infumorph (Preservative-free Morphine Sulfate Sterile Solution) 25 mg/mL, 20 mL ampul (NDC 0641-6040-01)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
4062,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single-use prefilled syringe (NDC 76045-004-11)",Revised,10/8/20,Backordered. Next release October 2020.,Check wholesalers for inventory,,Other,Analgesia/Addiction,Current,,
4063,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single-use prefilled syringe (NDC 76045-004-11)",Revised,10/8/20,Availble,Check wholesalers for inventory,,Available,Analgesia/Addiction,Current,,
4064,Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Adult; 10 mL Single Dose Dual Glass Fliptop Vials (NDC 61703-0434-82),Reverified,11/20/20,Next Delivery and Estimated Recovery: September 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
4065,Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Adult; 2 x 50 mL Pharmacy Bulk Package Dual Glass Fliptop Vials (NDC 61703-0422-83),Reverified,11/20/20,Next Delivery and Estimated Recovery: September 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
4066,Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Pediatric; Single Dose Glass Fliptop Vial (NDC 61703-0421-53),Reverified,11/20/20,Next Delivery and Estimated Recovery: September 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
4067,Multi-Vitamin Infusion (Adult and Pediatric),Baxter Healthcare,888-229-0001,"INFUVITE Pediatric, Multiple Vitamins for Injection. Single Dose package. (NDC 54643-5646-1)",Reverified,9/23/20,Available,"For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition.",,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
4068,Multi-Vitamin Infusion (Adult and Pediatric),Baxter Healthcare,888-229-0001,"INFUVITE Adult, Multiple Vitamins for Injection. Single dose package. (NDC 54643-5649-1)",Reverified,9/23/20,Available,"For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition.",,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
4069,Multi-Vitamin Infusion (Adult and Pediatric),Baxter Healthcare,888-229-0001,"INFUVITE Adult, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5650-2)",Reverified,9/23/20,Available,"For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition.",,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
4070,Multi-Vitamin Infusion (Adult and Pediatric),Baxter Healthcare,888-229-0001,"INFUVITE Pediatric, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5647-0)",Reverified,9/23/20,Available,"For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition.",,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
4071,Mupirocin Calcium Nasal Ointment,GlaxoSmithKline,908-293-5330,2% Nasal Ointment 1 gram tube Package of 10 (NDC 0029152611),Revised,12/13/19,,,,,Anti-Infective,To be Discontinued,12/13/19,12/13/19
4072,Mycophenolic Acid Delayed Release Tablets,Teva Pharmaceuticals,800-545-8800,180mg tablets (NDC 0093-7031-89),New,3/11/20,,,,,Transplant,To be Discontinued,3/11/20,3/11/20
4073,Mycophenolic Acid Delayed Release Tablets,Teva Pharmaceuticals,800-545-8800,360mg tablets (NDC 0093-7032-89),New,3/11/20,,,,,Transplant,To be Discontinued,3/11/20,3/11/20
4074,Nadolol Tablets,Ingenus Pharmaceuticals LLC,866-321-5031,20 mg (100 ct) (NDC 50742-178-01),New,9/11/20,,Product Discontinuation,,,Cardiovascular,To be Discontinued,9/11/20,9/11/20
4075,Nadolol Tablets,Ingenus Pharmaceuticals LLC,866-321-5031,20 mg (1000 ct) (NDC 50742-178-10 ),New,9/11/20,,Product Discontinuation,,,Cardiovascular,To be Discontinued,9/11/20,9/11/20
4076,Nadolol Tablets,Ingenus Pharmaceuticals LLC,866-321-5031,40 mg (100 ct) (NDC 50742-179-01 ),New,9/11/20,,Product Discontinuation,,,Cardiovascular,To be Discontinued,9/11/20,9/11/20
4077,Nadolol Tablets,Ingenus Pharmaceuticals LLC,866-321-5031,40 mg (1000 ct) (NDC 50742-179-10 ),New,9/11/20,,Product Discontinuation,,,Cardiovascular,To be Discontinued,9/11/20,9/11/20
4078,Nadolol Tablets,Ingenus Pharmaceuticals LLC,866-321-5031,80 mg (100 ct) (NDC 50742-180-01 ),New,9/11/20,,Product Discontinuation,,,Cardiovascular,To be Discontinued,9/11/20,9/11/20
4079,Nadolol Tablets,Ingenus Pharmaceuticals LLC,866-321-5031,80 mg (1000 ct) (NDC 50742-180-10 ),New,9/11/20,,Product Discontinuation,,,Cardiovascular,To be Discontinued,9/11/20,9/11/20
4080,Nadolol Tablets,Teva Pharmaceuticals,800-545-8800,"20 mg, 100 count (NDC 0591-2694-01)",New,8/11/20,,Business decision to discontinue. The 20 mg and 80 mg tablets have been unavailable since Mar 2016 and the 40 mg tablets have been unavailable since Dec 2015,,,Cardiovascular,To be Discontinued,8/11/20,8/11/20
4081,Nadolol Tablets,Teva Pharmaceuticals,800-545-8800,"40 mg, 100 count (NDC 0591-2697-01)",New,8/11/20,,Business decision to discontinue. The 20 mg and 80 mg tablets have been unavailable since Mar 2016 and the 40 mg tablets have been unavailable since Dec 2015,,,Cardiovascular,To be Discontinued,8/11/20,8/11/20
4082,Nadolol Tablets,Teva Pharmaceuticals,800-545-8800,"80 mg, 100 count (NDC 0591-2685-01)",New,8/11/20,,Business decision to discontinue. The 20 mg and 80 mg tablets have been unavailable since Mar 2016 and the 40 mg tablets have been unavailable since Dec 2015,,,Cardiovascular,To be Discontinued,8/11/20,8/11/20
4083,Nafcillin Sodium Injection,Sandoz,800-525-8747,1 gram vial packaged in 10s (NDC 0781-3124-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
4084,Nafcillin Sodium Injection,Sandoz,800-525-8747,2 gram vial packaged in 10s (NDC 0781-3125-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
4085,Nafcillin Sodium Injection,Sandoz,800-525-8747,Pharmacy Bulk Package bottle (NDC 0781-3126-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
4086,Nafcillin Sodium Injection,Sandoz,800-525-8747,1 gram vial packaged in 10s (NDC 0781-9124-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
4087,Nafcillin Sodium Injection,Sandoz,800-525-8747,"1 gram ADD-Vantage Vial, packed in 10s (NDC 0781-9224-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
4088,Nafcillin Sodium Injection,Sandoz,800-525-8747,"2 gram ADD-Vantage Vial, packed in 10s (NDC 0781-9225-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
4089,Nafcillin Sodium Injection,Sandoz,800-525-8747,"1 gram ADD-Vantage Vial, packed in 10s (NDC 0781-3128-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
4090,Nafcillin Sodium Injection,Sandoz,800-525-8747,"2 gram ADD-Vantage Vial, packed in 10s (NDC 0781-3129-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
4091,Naftifine Hydrochloride Cream,Mylan Pharmaceuticals Inc.,800-796-9526,Naftifine HCl Cream 1% 60 gm (NDC 40085-201-60),New,5/15/19,,Discontinuation of the manufacture of the drug,,,Dermatology,To be Discontinued,5/15/19,5/15/19
4092,Naftifine Hydrochloride Cream,Mylan Pharmaceuticals Inc.,800-796-9526,Naftifine HCl Cream 1% 90 gm (NDC 40085-201-90),New,5/15/19,,Discontinuation of the manufacture of the drug,,,Dermatology,To be Discontinued,5/15/19,5/15/19
4093,Naftifine Hydrochloride Cream,Mylan Pharmaceuticals Inc.,800-796-9526,Naftifine HCl Cream 2% 45 gm (NDC 40085-203-45),New,5/15/19,,Discontinuation of the manufacture of the drug,,,Dermatology,To be Discontinued,5/15/19,5/15/19
4094,Naftifine Hydrochloride Cream,Mylan Pharmaceuticals Inc.,800-796-9526,Naftifine HCl Cream 2% 60 gm (NDC 40085-203-60),New,5/15/19,,Discontinuation of the manufacture of the drug,,,Dermatology,To be Discontinued,5/15/19,5/15/19
4095,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,10 mg/mL; 1 mL Glass Ampul (NDC 00409-1463-01),Revised,11/20/20,Next Delivery: November 2020; Estimated Recovery: December 2020,Shortage of an active ingredient,,Other,Analgesia/Addiction,Current,,
4096,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,20 mg/mL; 1 mL Glass Ampul (NDC 00409-1465-01),Revised,11/20/20,Limited Supply Available. Next Delivery: November 2020; Estimated Recovery: December 2020,Shortage of an active ingredient,,Other,Analgesia/Addiction,Current,,
4097,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial (NDC 00409-1464-01),Revised,11/20/20,Limited Supply Available. Next Delivery and Estimated Recovery: November 2020,Shortage of an active ingredient,,Other,Analgesia/Addiction,Current,,
4098,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/10 mL (20 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial (NDC 00409-1467-01),Revised,11/20/20,Next Delivery: November 2020; Estimated Recovery: December 2020,Shortage of an active ingredient,,Other,Analgesia/Addiction,Current,,
4099,Naratriptan Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg  (NDC 0378-4450-59),New,7/17/19,,,,,Neurology,To be Discontinued,7/17/19,7/17/19
4100,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,50 mg 100 Tablets (NDC 0093-7178-01),Reverified,11/19/20,Availability is unknown at this time.,API availability,,Other,Psychiatry,Current,,
4101,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,100 mg 60 Tablets (NDC 0093-1024-06),Reverified,11/19/20,Availability is unknown at this time.,API availability,,Other,Psychiatry,Current,,
4102,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,150 mg 60 Tablets (NDC 0093-7113-06),Reverified,11/19/20,Availability is unknown at this time.,API availabliity,,Other,Psychiatry,Current,,
4103,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,200 mg 60 Tablets (NDC 0093-1025-06),Reverified,11/19/20,Availablity is unknown at this time.,API availability,,Other,Psychiatry,Current,,
4104,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,250 mg 60 Tablets (NDC 0093-1026-06),Reverified,11/19/20,Availability is unknown at this time.,API availability,,Other,Psychiatry,Current,,
4105,Nelarabine (Arranon) Injection,Novartis,888-669-6682,250 mg/50 mL (NDC 0078-0683-06),Revised,1/7/20,,,,,Hematology,Resolved,1/7/20,
4106,"Neomycin and Polymyxin B Sulfates Solution For Irrigation, USP",Teva Pharmaceuticals,800-545-8800,"40 mg and 200,000 units (1 mL ampule) (NDC 0591-2190-45)",New,6/10/19,,Discontinuation of the manufacture of the drug.,,,Anti-Infective;Urology,To be Discontinued,6/10/19,6/10/19
4107,Nesiritide Powder (NATRECOR) for Injection,Janssen Pharmaceuticals,800-526-7736,1.5 mg (NDC 65847-205-25),New,2/5/18,,Discontinuation of the manufacture of the drug,,,Cardiovascular,To be Discontinued,2/5/18,2/5/18
4108,Nevirapine (Viramune) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,200 mg tablets (NDC 0597-0046-60),New,5/29/20,,,,,Antiviral,To be Discontinued,5/29/20,5/29/20
4109,Nevirapine Extended Release Tablets,Sandoz,800-525-8747,"400 mg, bottle of 30 tablets (NDC 0781-5893-31)",New,1/24/20,,,,,Antiviral,To be Discontinued,1/24/20,1/24/20
4110,Nevirapine Extended Release Tablets,Sandoz,800-525-8747,"400 mg, bottle of 500 tablets (NDC 0781-5893-05)",New,1/24/20,,,,,Antiviral,To be Discontinued,1/24/20,1/24/20
4111,Nevirapine Extended Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,100 mg tablets (NDC 0378-6950-77),New,1/31/19,,,,,Antiviral,To be Discontinued,1/31/19,1/31/19
4112,"Nifedipine Extended-Release Tablet, USP",Teva Pharmaceuticals,800-545-8800,"Nifedipine extended-release tablets, 90 mg, 500 count (NDC 45963-152-50)",New,6/7/19,,This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,6/7/19,6/7/19
4113,"Nifedipine Extended-Release Tablet, USP",Teva Pharmaceuticals,800-545-8800,"Nifedipine extended-release tablets, 90 mg, 100 count (NDC 45963-152-02)",New,6/7/19,,This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,6/7/19,6/7/19
4114,"Nifedipine Extended-Release Tablet, USP",Par Pharmaceutical,800-828-9393,"30mg, 100 count bottle (NDC 10370-677-01)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/15/19,4/15/19
4115,"Nifedipine Extended-Release Tablet, USP",Par Pharmaceutical,800-828-9393,"30mg, 500 count bottle (NDC 10370-677-05)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/15/19,4/15/19
4116,"Nifedipine Extended-Release Tablet, USP",Par Pharmaceutical,800-828-9393,"60mg, 100 count bottle (NDC 10370-678-01)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/15/19,4/15/19
4117,"Nifedipine Extended-Release Tablet, USP",Par Pharmaceutical,800-828-9393,"60mg, 500 count bottle (NDC 10370-678-05)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/15/19,4/15/19
4118,"Nifedipine Extended-Release Tablet, USP",Par Pharmaceutical,800-828-9393,"90 mg, 100 count bottle (NDC 10370-679-01)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/15/19,4/15/19
4119,Nizatidine Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"150 mg, 60 count bottle (NDC 0378-5150-91)",New,5/2/19,,,,,Gastroenterology,To be Discontinued,5/2/19,5/2/19
4120,Nizatidine Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"300 mg, 30 count bottle (NDC 0378-5300-93)",New,5/2/19,,,,,Gastroenterology,To be Discontinued,5/2/19,5/2/19
4121,Nizatidine Capsules,Glenmark Pharmaceuticals,201-331-4282,"150 mg, 60 count bottle (NDC 68462-0425-60)",New,3/9/20,,,,,Gastroenterology,To be Discontinued,3/9/20,3/9/20
4122,Nizatidine Capsules,Glenmark Pharmaceuticals,201-331-4282,"300 mg, 30 count bottle (NDC 68462-0426-30)",New,3/9/20,,,,,Gastroenterology,To be Discontinued,3/9/20,3/9/20
4123,Nizatidine Capsules,Teva Pharmaceuticals,800-545-8800,"300 mg, 30 count bottle (NDC 0591-3138-30)",Reverified,11/19/20,Supply Interruption,Duration of the supply interruption is unknown at this time.,,Other,Gastroenterology,Current,3/27/20,
4124,Nizatidine Capsules,Teva Pharmaceuticals,800-545-8800,"150 mg, 60 count bottle (NDC 0591-3137-60)",Reverified,11/19/20,Supply Interruption,Duration of the supply interruption is unknown at this time.,,Other,Gastroenterology,Current,3/27/20,
4125,Nizatidine Capsules,Glenmark Pharmaceuticals,201-331-4282,"300 mg, 30 count bottle (NDC 68462-0426-30)",New,3/27/20,Unavailable,This was a business-related decision to discontinue manufacturing these products.,,,Gastroenterology,Current,3/27/20,
4126,Nizatidine Capsules,Glenmark Pharmaceuticals,201-331-4282,"150 mg, 60 count bottle (NDC 68462-0425-60)",New,3/27/20,Unavailable,This was a business-related decision to discontinue manufacturing these products.,,,Gastroenterology,Current,3/27/20,
4127,Norethindrone (NOR QD) Tablets,Allergan,800-678-1605,"Nor QD, 0.35 mg norethindrone, Tablets, (NDC  52544-235-28)",New,2/23/18,,"An authorized generic of the product is currently available as Nora-BE, NDC 52544-629-28.",,,Reproductive,To be Discontinued,2/23/18,2/23/18
4128,Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"0.02 mg norethindrone acetate / 1 mg ethinyl estradiol / 75 mg ferrous fumarate; 28 tablets per blister pack, 3 blisters per carton (NDC 0378-7301-53)",New,5/23/19,,,,,Reproductive,To be Discontinued,5/23/19,5/23/19
4129,"Nystatin Cream, USP",Par Pharmaceutical,800-828-9393,"100,000 USP units per gram, 15 g (NDC 0603-7818-74)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Dermatology,To be Discontinued,4/15/19,4/15/19
4130,"Nystatin Cream, USP",Par Pharmaceutical,800-828-9393,"100,000 USP units per gram, 30 g (NDC 0603-7818-78)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Dermatology,To be Discontinued,4/15/19,4/15/19
4131,"Nystatin Cream, USP",Par Pharmaceutical,800-828-9393,"100,000 USP units per gram, 60 g (NDC 0603-7818-88)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Dermatology,To be Discontinued,4/15/19,4/15/19
4132,"Nystatin Cream, USP",Teva Pharmaceuticals,800-545-8800,"100,000 USP units per gram, 15 g (NDC 0472-0163-15)",New,11/15/19,,Teva made a business decision to discontinue the product.,,,Dermatology,To be Discontinued,11/15/19,11/15/19
4133,"Nystatin Cream, USP",Teva Pharmaceuticals,800-545-8800,"100,000 units per gram, 30 g (NDC 0472-0163-30)",New,11/15/19,,Teva made a business decision to discontinue the product.,,,Dermatology,To be Discontinued,11/15/19,11/15/19
4134,Nystatin Oral Suspension,Wockhardt,800-346-6854 ext. 2,"Nystatin Oral Solution 100,000 units/1mL; 473 mL bottles (NDC 60432-0537-16)",Revised,5/6/20,,,,,Anti-Infective;Pediatric,Resolved,5/6/20,
4135,Nystatin Oral Suspension,Wockhardt,800-346-6854 ext. 2,"Nystatin Oral Solution 100,000 units/1mL; 60 mL bottles (NDC 60432-0537-60)",Revised,5/6/20,,,,,Anti-Infective;Pediatric,Resolved,5/6/20,
4136,Nystatin Oral Suspension,"VistaPharm, Inc.",877-530-1633,"Nystatin Oral Suspension, USP 500,000 units/5 ml; 5mL unit dose cup; 50 unit dose cups/ case (NDC 66689-037-50)",Revised,5/6/20,,,,,Anti-Infective;Pediatric,Resolved,5/6/20,
4137,Nystatin Oral Suspension,"VistaPharm, Inc.",877-530-1633,"Nystatin Oral Suspension, USP 500,000 units/5 ml; 5mL unit dose cup; 100 unit dose cups/ case (NDC 66689-037-99)",Revised,5/6/20,,,,,Anti-Infective;Pediatric,Resolved,5/6/20,
4138,Nystatin Oral Suspension,"VistaPharm, Inc.",877-530-1633,"Nystatin Oral Suspension, USP 100,000 units/ml; 60 mL Bottle (NDC 66689-008-02)",Revised,5/6/20,,,,,Anti-Infective;Pediatric,Resolved,5/6/20,
4139,Nystatin Oral Suspension,"VistaPharm, Inc.",877-530-1633,"Nystatin Oral Suspension, USP 100,000 units/ml; 480 mL Bottle (NDC 66689-008-16)",Revised,5/6/20,,,,,Anti-Infective;Pediatric,Resolved,5/6/20,
4140,Nystatin Oral Suspension,"Pharmaceutical Associates, Inc",800-845-8210,"Nystatin Oral Suspension, USP 500,000 Units/5 mL 5 mL Unit Dose Cups Case of 40 – 5 mL UDC (NDC 00121-4810-40); Case of 100 – 5 mL UDC (NDC 00121-4810-00); 2 oz. Bottles (NDC 00121-0810-02); 16 oz. Bottles (NDC 00121-0810-16)",Revised,5/6/20,,,,,Anti-Infective;Pediatric,Resolved,5/6/20,
4141,Ocriplasmin (Jetrea) Injection,"Thrombogenics, Inc.",855-879-5387,1.25 mg/ml (NDC 24856-002-01),New,4/24/20,,ThromboGenics has decided for business reasons to discontinue manufacture of the drug product for the United States.,,,Ophthalmology,To be Discontinued,4/24/20,4/24/20
4142,Olanzapine and Fluoxetine (Symbyax) Capsules,Eli Lilly and Co.,800-545-5979,12mg/50mg per capsule (NDC Package Code 0002-3234-30),New,7/15/20,,The product distribution will continue until end of December 2020.,,,Psychiatry,To be Discontinued,7/15/20,7/15/20
4143,Olanzapine and Fluoxetine (Symbyax) Capsules,Eli Lilly and Co.,800-545-5979,6mg/50mg per capsule (NDC Package Code 0002-3233-30),New,7/15/20,,The product distribution will continue until end of December 2020.,,,Psychiatry,To be Discontinued,7/15/20,7/15/20
4144,Olaratumab (Lartruvo) Injection,Eli Lilly and Co.,800-545-5979,500mg/50 ML x 1 vial (NDC 0002-8926-01),New,10/2/19,,Market withdrawal of Lartruvo. There is no safety or quality issue related to the withdrawal.,,,Oncology,To be Discontinued,10/2/19,10/2/19
4145,Olaratumab (Lartruvo) Injection,Eli Lilly and Co.,800-545-5979,190mg/19 ML x 1 vial (NDC 0002-7190-01),New,10/2/19,,Market withdrawal of Lartruvo. There is no safety or quality issue related to the withdrawal.,,,Oncology,To be Discontinued,10/2/19,10/2/19
4146,Olmesartan Medoxomil and Hydrochlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"20mg/12.5mg, 30 count bottle (NDC 0378-1413-93)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
4147,Olmesartan Medoxomil and Hydrochlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"20mg/12.5mg, 90 count bottle (NDC 0378-1413-77)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
4148,Olmesartan Medoxomil and Hydrochlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"40mg/12.5mg, 30 count bottle (NDC 0378-1422-93)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
4149,Olmesartan Medoxomil and Hydrochlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"40mg/12.5mg, 90 count bottle (NDC 0378-1422-77)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
4150,Olmesartan Medoxomil and Hydrochlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"40mg/25mg, 30 count bottle (NDC 0378-1425-93)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
4151,Olmesartan Medoxomil and Hydrochlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"40mg/25mg, 90 count bottle (NDC 0378-1425-77)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
4152,Olmesartan Medoxomil Tablets,Aurobindo Pharma,866-850-2876,"5mg, 30 ct. (NDC 65852-0741-30)",Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4153,Olmesartan Medoxomil Tablets,Aurobindo Pharma,866-850-2876,"20mg, 30 ct. (NDC 65862-0742-30)",Revised,3/5/20,,,,API Supply Issue,Cardiovascular,Resolved,3/5/20,
4154,Olmesartan Medoxomil Tablets,Aurobindo Pharma,866-850-2876,"20mg, 90 ct. (NDC 65862-0742-90)",Revised,3/5/20,,,,API Supply Issue,Cardiovascular,Resolved,3/5/20,
4155,Olmesartan Medoxomil Tablets,Aurobindo Pharma,866-850-2876,"40mg, 30 ct. (NDC 65862-0743-30)",Revised,3/5/20,,,,API Supply Issue,Cardiovascular,Resolved,3/5/20,
4156,Olmesartan Medoxomil Tablets,Aurobindo Pharma,866-850-2876,"40mg., 90 ct. (NDC 65862-0743-90)",Revised,3/5/20,,,,API Supply Issue,Cardiovascular,Resolved,3/5/20,
4157,Olmesartan Medoxomil Tablets,Alembic Pharmaceuticals,908-393-9604,"5mg, Bottle of 30 counts (NDC 62332-131-30)",Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4158,Olmesartan Medoxomil Tablets,Alembic Pharmaceuticals,908-393-9604,"20mg, Bottle of 30 counts (NDC 62332-132-30)",Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4159,Olmesartan Medoxomil Tablets,Alembic Pharmaceuticals,908-393-9604,"20mg, Bottle of 90 counts (NDC 62332-132-90)",Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4160,Olmesartan Medoxomil Tablets,Alembic Pharmaceuticals,908-393-9604,"40mg, Bottle of 30 counts (NDC 62332-133-30)",Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4161,Olmesartan Medoxomil Tablets,Alembic Pharmaceuticals,908-393-9604,"40mg, Bottle of 90 counts (NDC 62332-133-90)",Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4162,Olmesartan Medoxomil Tablets,Glenmark Pharmaceuticals,888-721-7115,5mg (NDC 68462-0436-30),Revised,3/5/20,,,,API shortage,Cardiovascular,Resolved,3/5/20,
4163,Olmesartan Medoxomil Tablets,Glenmark Pharmaceuticals,888-721-7115,20mg (NDC 68462-0437-30),Revised,3/5/20,,,,API shortage,Cardiovascular,Resolved,3/5/20,
4164,Olmesartan Medoxomil Tablets,Glenmark Pharmaceuticals,888-721-7115,20mg (NDC 68462-0437-90),Revised,3/5/20,,,,API shortage,Cardiovascular,Resolved,3/5/20,
4165,Olmesartan Medoxomil Tablets,Glenmark Pharmaceuticals,888-721-7115,40mg (NDC 68462-0438-30),Revised,3/5/20,,,,API shortage,Cardiovascular,Resolved,3/5/20,
4166,Olmesartan Medoxomil Tablets,Glenmark Pharmaceuticals,888-721-7115,40mg (NDC 68462-0438-90),Revised,3/5/20,,,,API shortage,Cardiovascular,Resolved,3/5/20,
4167,Olmesartan Medoxomil Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Olmesartan Medoxomil  5mg T 30s (NDC 0378-7012-93),Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4168,Olmesartan Medoxomil Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Olmesartan Medoxomil 20mg T 30s (NDC 0378-7112-93),Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4169,Olmesartan Medoxomil Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Olmesartan Medoxomil 20mg T 90s (NDC 0378-7112-77),Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4170,Olmesartan Medoxomil Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Olmesartan Medoxomil 40mg T 30s (NDC 0378-7124-93),Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4171,Olmesartan Medoxomil Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Olmesartan Medoxomil 40mg T 90s (NDC 0378-7124-77),Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4172,Olmesartan Medoxomil Tablets,Accord Healthcare Inc.,866-941-7875,"5mg, 30T (NDC 1672-9320-10)",Revised,3/5/20,,,,Limited API availability,Cardiovascular,Resolved,3/5/20,
4173,Olmesartan Medoxomil Tablets,Accord Healthcare Inc.,866-941-7875,"5mg, 90T (NDC 1672-9320-15)",Revised,3/5/20,,,,Limited API availability,Cardiovascular,Resolved,3/5/20,
4174,Olmesartan Medoxomil Tablets,Accord Healthcare Inc.,866-941-7875,"20mg, 30T (NDC 1672-9321-10)",Revised,3/5/20,,,,Limited API availability,Cardiovascular,Resolved,3/5/20,
4175,Olmesartan Medoxomil Tablets,Accord Healthcare Inc.,866-941-7875,"20mg, 90T (NDC 1672-9321-15)",Revised,3/5/20,,,,Limited API availability,Cardiovascular,Resolved,3/5/20,
4176,Olmesartan Medoxomil Tablets,Accord Healthcare Inc.,866-941-7875,"40mg, 30T (NDC 1672-9322-10)",Revised,3/5/20,,,,Limited API availability,Cardiovascular,Resolved,3/5/20,
4177,Olmesartan Medoxomil Tablets,Accord Healthcare Inc.,866-941-7875,"40mg, 90T (NDC 1672-9322-15)",Revised,3/5/20,,,,Limited API availability,Cardiovascular,Resolved,3/5/20,
4178,Olmesartan Medoxomil Tablets,Torrent Pharma Inc.,888-544-2299 option 4,5mg tablet (NDC 13668-248-30),Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4179,Olmesartan Medoxomil Tablets,Torrent Pharma Inc.,888-544-2299 option 4,20mg tablet (NDC 13668-249-30),Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4180,Olmesartan Medoxomil Tablets,Torrent Pharma Inc.,888-544-2299 option 4,20mg tablet (NDC 13668-249-90),Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4181,Olmesartan Medoxomil Tablets,Torrent Pharma Inc.,888-544-2299 option 4,40mg tablet (NDC 13668-250-30),Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4182,Olmesartan Medoxomil Tablets,Torrent Pharma Inc.,888-544-2299 option 4,40mg tablet (NDC 13668-250-90),Revised,3/5/20,,,,,Cardiovascular,Resolved,3/5/20,
4183,Olmesartan Medoxomil Tablets,"Daiichi Sankyo, Inc.",908-992-7001,"5mg, 30 Unit (NDC 65597-101-30)",Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4184,Olmesartan Medoxomil Tablets,"Daiichi Sankyo, Inc.",908-992-7001,"20mg, 30 Unit (NDC 65597-103-30)",Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4185,Olmesartan Medoxomil Tablets,"Daiichi Sankyo, Inc.",908-992-7001,"20mg, 90 Unit (NDC 65597-103-90)",Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4186,Olmesartan Medoxomil Tablets,"Daiichi Sankyo, Inc.",908-992-7001,"40mg, 30 Unit (NDC 65597-104-30)",Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4187,Olmesartan Medoxomil Tablets,"Daiichi Sankyo, Inc.",908-992-7001,"40mg, 90 Unit (NDC 65597-104-90)",Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4188,Olmesartan Medoxomil Tablets,Alkem Laboratories,201-476-9445,Olmesartan Medoxomil 20mg 30 Tabs (NDC 67877-0446-30),Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4189,Olmesartan Medoxomil Tablets,Alkem Laboratories,201-476-9445,Olmesartan Medoxomil 20mg 90 Tabs (NDC 67877-0446-90),Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4190,Olmesartan Medoxomil Tablets,Alkem Laboratories,201-476-9445,Olmesartan Medoxomil 40mg 30 Tabs (NDC 67877-0447-30),Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4191,Olmesartan Medoxomil Tablets,Alkem Laboratories,201-476-9445,Olmesartan Medoxomil 40mg 90 Tabs (NDC 67877-0447-90),Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4192,Olmesartan Medoxomil Tablets,Alkem Laboratories,201-476-9445,Olmesartan Medoxomil 5mg 30 Tabs (NDC 67877-0445-30),Revised,3/5/20,,,,Other,Cardiovascular,Resolved,3/5/20,
4193,Olopatadine Hydrochloride Ophthalmic Solution,Novartis,888-669-6682,Pataday 2mg/mL 5mL in 1 bottle (NDC 0065-0272-11),New,2/26/20,,The product will be available via OTC.,,,Ophthalmology,To be Discontinued,2/26/20,2/26/20
4194,Olopatadine Hydrochloride Ophthalmic Solution,Novartis,888-669-6682,Pataday 2mg/mL 2.5mL in 1 bottle (NDC 0065-0272-25),New,2/26/20,,The product will be available via OTC.,,,Ophthalmology,To be Discontinued,2/26/20,2/26/20
4195,Olopatadine Hydrochloride Ophthalmic Solution,Novartis,888-669-6682,Pataday 2mg/mL 2.5mL in 1 bottle (NDC 61314-272-25),New,2/26/20,,The product will be available via OTC.,,,Ophthalmology,To be Discontinued,2/26/20,2/26/20
4196,Olopatadine Hydrochloride Ophthalmic Solution,Novartis,888-669-6682,Pazeo Ophthalmic Solution 7mg/mL 2.5mL in 1 bottle (NDC 0065-4273-25),New,8/11/20,,"Discontinuation of this product is not due to manufacturing, product quality, safety, or efficacy concerns.",,,Ophthalmology,To be Discontinued,8/11/20,8/11/20
4197,Olopatadine Hydrochloride Ophthalmic Solution,Novartis,888-669-6682,Pazeo Ophthalmic Solution 7mg/mL 5mL in 1 bottle (NDC 0065-4273-27),New,8/11/20,,"Discontinuation of this product is not due to manufacturing, product quality, safety, or efficacy concerns.",,,Ophthalmology,To be Discontinued,8/11/20,8/11/20
4198,Ombitasvir; Paritaprevir; Ritonavir (Technivie) Tablets,Abbvie,800-255-5162,212.5mg; 75mg; 50mg (NDC 0074-3082-28),New,5/22/18,,"Estimated product availability until January 1, 2019. The product discontinuation is voluntary",,,Antiviral,To be Discontinued,5/22/18,5/22/18
4199,Omega-3-Acid Ethyl Esters,Par Pharmaceutical,800-828-9393,"900 mg/1 unit capsule, liquid filled (NDC 49884-019-08)",New,5/10/19,,Par has made a business decision to discontinue the drug product.,,,Gastroenterology,To be Discontinued,5/10/19,5/10/19
4200,Omega-3-Acid Ethyl Esters,Par Pharmaceutical,800-828-9393,900mg/1 unit capsule (NDC 0254-3010-08),New,5/10/19,,Par has made a business decision to discontinue the drug product.,,,Gastroenterology,To be Discontinued,5/10/19,5/10/19
4201,Omeprazole Delayed-Release 40 mg Capsules,Teva Pharmaceuticals,800-545-8800,"Omeprazole 40 mg Capsule, Delayed Release Pellets (NDC 0093-5294-56), (30 count Bottle)",New,7/17/19,,Teva made a business decision to discontinue product.,,,Gastroenterology,To be Discontinued,7/17/19,7/17/19
4202,Omeprazole Delayed-Release 40 mg Capsules,Teva Pharmaceuticals,800-545-8800,"Omeprazole 40 mg Capsule, Delayed Release Pellets (NDC (0093-5294-98) (90 count Bottle)",New,7/17/19,,Teva made a business decision to discontinue product.,,,Gastroenterology,To be Discontinued,7/17/19,7/17/19
4203,Omeprazole Delayed-Release 40 mg Capsules,Teva Pharmaceuticals,800-545-8800,"Omeprazole 40 mg Capsule, Delayed Release Pellets (NDC 0093-5294-10) (1000 count Bottle )",New,7/17/19,,Teva made a business decision to discontinue product.,,,Gastroenterology,To be Discontinued,7/17/19,7/17/19
4204,Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,"2 mg/mL, 2 mL vial (NDC 72266-123-25)",Reverified,10/27/20,Available,Distributed by Fosun Pharma USA Inc. Company Contact Information:  833-291-9645,,Available,Gastroenterology,Current,,
4205,Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,"2 mg/mL, 20 mL vial (NDC 72266-124-01)",Reverified,10/27/20,Available,Distributed by Fosun Pharma USA Inc. Company Contact Information:  833-291-9645,,Available,Gastroenterology,Current,,
4206,Ondansetron Hydrochloride Injection,Baxter Healthcare,800-229-0001,"Ondansetron Injection, USP (2 mg/mL) 2 mL Single Use Glass Vial (25 x 2 mL) (NDC 36000-012-25)",Reverified,9/23/20,Available,For IV or IM injection,,,Gastroenterology,Current,,
4207,Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,2 mg/mL 2mL vial (NDC 70860-776-02),Reverified,10/27/20,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Demand increase for the drug,Gastroenterology,Current,,
4208,Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,2 mg/mL 20mL vial (NDC 70860-777-20),Reverified,10/27/20,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Available,Gastroenterology,Current,,
4209,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"Inj4mg/2mL, 25 (NDC 23155-549-31)",Reverified,11/6/20,Product is available,,,Demand increase for the drug,Gastroenterology,Current,,
4210,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,PPRx4mg/2mL (NDC 23155-548-41),Reverified,11/6/20,Product is available,,,Demand increase for the drug,Gastroenterology,Current,,
4211,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,PPRx4mg/2mL (NDC 23155-548-42),Reverified,11/6/20,Product is available,,,Demand increase for the drug,Gastroenterology,Current,,
4212,Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, amber vial, 4 mg per 2 mL (NDC 63323-373-02)",Revised,11/16/20,7 months expiry (expiry 6/30/2021) dating available by request.,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
4213,Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Multi dose, amber vial, 40 mg per 20 mL (NDC 63323-374-20)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
4214,Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, Simplist syringe, 4 mg per 2 mL (NDC 76045-103-20)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
4215,Ondansetron Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9890-01)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Gastroenterology,Current,,
4216,Ondansetron Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"2 mg/mL, 2 mL vial, 25 count (NDC 55150-125-02)",Reverified,11/20/20,On long term backorder,On long term backorder,,Delay in shipping of the drug,Gastroenterology,Current,,
4217,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"4mg/2mL, 10 (NDC 23155-547-41 )",Reverified,11/6/20,Product is available,,,Demand increase for the drug,Gastroenterology,Current,,
4218,Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,40 mg/20 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-4759-01),Reverified,11/20/20,Available,,,Other,Gastroenterology,Current,,
4219,Ondansetron Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 2 mL vial (NDC 0641-6078-25)",Revised,7/22/20,This presentation is temporarily on backorder.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Gastroenterology,Current,,
4220,Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/2 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-4755-03),Reverified,11/20/20,Available,,,Other,Gastroenterology,Current,,
4221,Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/2 mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1120-12),Reverified,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Gastroenterology,Current,,
4222,Ondansetron Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"2 mg/mL, 20 mL vial, 1 count (NDC 55150-126-20)",Reverified,11/20/20,On long term backorder,On long term backorder,,Delay in shipping of the drug,Gastroenterology,Current,,
4223,Ondansetron Hydrochloride Injection,Apotex Corp.,800-706-5575,Ondansetron 2mg/mL 2mL vials Box of 25 vials (NDC 60505-6130-05),Reverified,11/13/20,Available,,,Available,Gastroenterology,Current,,
4224,Ondansetron Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,40mg/20mL EA 1 Vial (NDC 25021-782-20),Reverified,10/22/20,Available,,,,Gastroenterology,Current,,
4225,Ondansetron Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,4mg/2mL PK 25 Vials (NDC 25021-777-02),Reverified,10/22/20,Available,,,,Gastroenterology,Current,,
4226,Oxalaplatin Injection,Gland Pharma Limited,833-291-9645,"50 mg/10 mL, 10 vials per pack (NDC 72266-125-10)",New,9/28/20,,"50 mg/10 mL and 100 mg/20 mL, 1 vial per packs (NDCs 72266-161-01 and 72266-162-01, respectively) will continue to be available; Gland Pharma Limited, Distributed by Fosun Pharma USA Inc. (Company Contact Information: 833-291-9645)",,,Oncology,To be Discontinued,9/28/20,9/28/20
4227,Oxalaplatin Injection,Gland Pharma Limited,833-291-9645,"100 mg/20 mL, 10 vials per pack (NDC 72266-126-10)",New,9/28/20,,"50 mg/10 mL and 100 mg/20 mL, 1 vial per packs (NDCs 72266-161-01 and 72266-162-01, respectively) will continue to be available; Gland Pharma Limited, Distributed by Fosun Pharma USA Inc. (Company Contact Information: 833-291-9645)",,,Oncology,To be Discontinued,9/28/20,9/28/20
4228,Oxybutynin Chloride Extended-Release Tablets,Impax Laboratories,877-835-5472,"5 mg, 100 count bottle (NDC 0093-5206-01)",New,3/29/19,,"Distributed by Teva Pharmaceuticals, 1-800-545-8800. Teva made a business decision to discontinue product.",,,Neurology;Pediatric;Urology,To be Discontinued,3/29/19,3/29/19
4229,Oxybutynin Chloride Extended-Release Tablets,Impax Laboratories,877-835-5472,"10 mg, 100 count bottle (NDC 0093-5207-01)",New,3/29/19,,"Distributed by Teva Pharmaceuticals, 1-800-545-8800. Teva made a business decision to discontinue product.",,,Neurology;Pediatric;Urology,To be Discontinued,3/29/19,3/29/19
4230,Oxybutynin Chloride Extended-Release Tablets,Impax Laboratories,877-835-5472,"15 mg, 100 count bottle (NDC 0093-5208-01)",New,3/29/19,,"Distributed by Teva Pharmaceuticals, 1-800-545-8800. Teva made a business decision to discontinue product.",,,Neurology;Pediatric;Urology,To be Discontinued,3/29/19,3/29/19
4231,Oxybutynin Chloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count bottle (NDC 0378-6605-01)",New,5/2/19,,,,,Neurology;Pediatric;Urology,To be Discontinued,5/2/19,5/2/19
4232,Oxybutynin Chloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 500 count bottle (NDC 0378-6605-05)",New,5/2/19,,,,,Neurology;Pediatric;Urology,To be Discontinued,5/2/19,5/2/19
4233,Oxybutynin Chloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100 count bottle (NDC 0378-6610-01)",New,5/2/19,,,,,Neurology;Pediatric;Urology,To be Discontinued,5/2/19,5/2/19
4234,Oxybutynin Chloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 500 count bottle (NDC 0378-6610-05)",New,5/2/19,,,,,Neurology;Pediatric;Urology,To be Discontinued,5/2/19,5/2/19
4235,Oxybutynin Chloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 100 count bottle (NDC 0378-6615-01)",New,5/2/19,,,,,Neurology;Pediatric;Urology,To be Discontinued,5/2/19,5/2/19
4236,Oxycodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,30 mg/1 unit (NDC 0228-2879-11),New,11/7/19,,Teva made a business decision to discontinue manufacture of the drug product.,,,Analgesia/Addiction;Anesthesia,To be Discontinued,11/7/19,11/7/19
4237,Oxycodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,15 mg/1 unit (NDC 0228-2878-11),New,11/7/19,,Teva made a business decision to discontinue manufacture of the drug product.,,,Analgesia/Addiction;Anesthesia,To be Discontinued,11/7/19,11/7/19
4238,Oxycodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,5 mg/1 unit (NDC 0228-2876-11),New,11/7/19,,Teva made a business decision to discontinue manufacture of the drug product.,,,Analgesia/Addiction;Anesthesia,To be Discontinued,11/7/19,11/7/19
4239,Oxymorphone Hydrochloride,Teva Pharmaceuticals,800-545-8800,5 mg/1 unit (NDC 0093-5861-01),New,6/10/19,,Business related decision to discontinue these products,,,Analgesia/Addiction;Anesthesia,To be Discontinued,6/10/19,6/10/19
4240,Oxymorphone Hydrochloride,Teva Pharmaceuticals,800-545-8800,10 mg/1 unit (NDC 0093-5862-01),New,6/10/19,,Business related decision to discontinue these products,,,Analgesia/Addiction;Anesthesia,To be Discontinued,6/10/19,6/10/19
4241,"Oxytocin (Pitocin) Synthetic Injection, USP",Par Pharmaceutical,800-828-9393,Pitocin Single Pack 10 mL Vial (NDC 42023-116-01),New,11/1/19,,Par has made a business decision to permanently discontinue the drug product.,,,Reproductive,To be Discontinued,11/1/19,11/1/19
4242,"Oxytocin Injection, USP Synthetic","Fresenius Kabi USA, LLC",888-386-1300,100 USP Units per 10 mL (10 USP units per mL); Multiple dose vial;  (NDC 63323-012-10),Revised,11/16/20,Available,Check wholesalers for inventory.,,Delay in manufacturing,Reproductive,Current,,
4243,"Oxytocin Injection, USP Synthetic","Fresenius Kabi USA, LLC",888-386-1300,300 USP Units per 30 mL (10 USP Units per mL); Multiple dose vial; (NDC 63323-012-30),Revised,11/16/20,Available,Check wholesalers for inventory.,,Delay in manufacturing,Reproductive,Current,,
4244,"Oxytocin Injection, USP Synthetic","Fresenius Kabi USA, LLC",888-386-1300,10 USP Units per mL (10 USP units per mL); (NDC 63323-012-01)( NDC 63323-0012-11),Revised,11/16/20,8 month expiry dating available by request. Next release November 2020.,Check wholesalers for inventory.,,Delay in manufacturing,Reproductive,Current,,
4245,"Oxytocin Injection, USP Synthetic",Par Pharmaceutical,800-828-9393,"Packages of six 50 mL Pharmacy Bulk Packages, each containing 10 units of oxytocin per mL (total = 500 units of oxytocin per vial), (NDC 42023-130-06)",Revised,3/30/20,Available,,,,Reproductive,Current,,
4246,"Oxytocin Injection, USP Synthetic",Par Pharmaceutical,800-828-9393,"Packages of twenty-five oversized 1-mL vials, each containing 10 units of oxytocin, (NDC 42023-116-25)",Revised,3/30/20,Available,,,,Reproductive,Current,,
4247,"Oxytocin Injection, USP Synthetic",Par Pharmaceutical,800-828-9393,"Packages of twenty-five 10 mL multiple-dose vial, each containing 10 units of oxytocin per mL (total = 100 units of oxytocin per vial) (NDC 42023-116-02)",Revised,3/30/20,Available,,,,Reproductive,Current,,
4248,"Paclitaxel Injection, USP",HQ Specialty Pharma,201-857-8290,30 mg/5 mL (NDC 44567-504-1),New,7/3/19,,Distributed by WG Critical Care. Discontinuance: no longer commercially viable,,,Oncology,To be Discontinued,7/3/19,7/3/19
4249,"Paclitaxel Injection, USP",HQ Specialty Pharma,201-857-8290,100 mg/16.7 mL (NDC 44567-505-1),New,7/3/19,,Distributed by WG Critical Care. Discontinuance: no longer commercially viable,,,Oncology,To be Discontinued,7/3/19,7/3/19
4250,"Paclitaxel Injection, USP",HQ Specialty Pharma,201-857-8290,300 mg/50 mL (6 mg/mL)(NDC 44567-506-1),New,7/3/19,,Distributed by WG Critical Care. Discontinuance: no longer commercially viable,,,Oncology,To be Discontinued,7/3/19,7/3/19
4251,"Paclitaxel Injection, USP",Mylan Institutional,800-796-9526,"100 mg in 16.7 mL (6 mg/mL), multi-dose vial (NDC 67457-449-17)",New,11/22/19,,19-Dec,,,Oncology,To be Discontinued,11/22/19,11/22/19
4252,"Paclitaxel Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,30 mg/5 mL (6 mg/mL) MDV (NDC 63323-763-05),Revised,3/30/20,,Product available. Check wholesalers for inventory or contact Customer Service to place a direct order. Product will be discontinued when inventory is depleted.,,,Oncology,To be Discontinued,3/6/20,3/6/20
4253,"Paclitaxel Injection, USP",Mylan Institutional,800-796-9526,"30 mg in 5 mL (6 mg/mL), multi-dose vial (NDC 67457-471-52)",Revised,3/30/20,,Expected discontinuation October 2020 (short dating),,,Oncology,To be Discontinued,3/30/20,3/30/20
4254,"Paclitaxel Injection, USP",Mylan Institutional,800-796-9526,"300 mg in 50 mL (6 mg/mL), multi-dose vial (NDC 67457-434-51)",Revised,3/30/20,,Expected discontinuation October 2020 (short dating),,,Oncology,To be Discontinued,3/30/20,3/30/20
4255,Pantoprazole Sodium for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"40 mg, 10 vials (NDC 0143-9284-10)",Reverified,7/22/20,Inventory is currently available,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Gastroenterology,Current,,
4256,Pantoprazole Sodium for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,"40 mg, 10 vials (NDC 62756-129-44)",New,10/29/19,Available,,,,Gastroenterology,Current,,
4257,Pantoprazole Sodium for Injection,Aurobindo Pharma,888-238-7880,"40 mg, 10 vials (NDC 55150-202-10)",Reverified,9/25/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
4258,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 10 vials (NDC 0008-0923-55)",Revised,11/20/20,Limited Supply Available.  Next Delivery: November 2020; Estimated Recovery: December 2020,,,Other,Gastroenterology,Current,,
4259,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 25 vials (NDC 0008-0923-60)",Revised,11/20/20,Next Delivery: November 2020; Estimated Recovery: May 2021,,,Other,Gastroenterology,Current,,
4260,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 10 vials (NDC 0008-2001-10; Amerinet)",Revised,11/20/20,Available,,,Other,Gastroenterology,Current,,
4261,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 25 vials (NDC 0008-2001-25; Amerinet)",Revised,11/20/20,Available,,,Other,Gastroenterology,Current,,
4262,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 10 vials (NDC 0008-4001-10; PremierPro)",Revised,11/20/20,Next Delivery: November 2020; Estimated Recovery: November 2020,,,Other,Gastroenterology,Current,,
4263,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 25 vials (NDC 0008-4001-25; PremierPro)",Revised,11/20/20,Next Delivery: December 2020; Estimated Recovery: April 2021,,,Other,Gastroenterology,Current,,
4264,Pantoprazole Sodium for Injection,Sandoz,800-525-8747,"40 mg, 10 vials (NDC 0781-3232-95)",Reverified,11/13/20,Available,,,,Gastroenterology,Current,,
4265,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,25mcg Cartridge: (NDC 68875-0202-1); Carton: (NDC 68875-0202-2) (contains 2 cartridges),Reverified,1/28/20,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,Important Information Regarding a Temporary Special Use Program for Obtaining and Using NATPARA® (Parathyroid Hormone) for Injection,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
4266,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,50mcg   Cartridge: (NDC 68875-0203-1); Carton: (NDC 68875-0203-2) (contains 2 cartridges),Reverified,1/28/20,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,Important Information Regarding a Temporary Special Use Program for Obtaining and Using NATPARA® (Parathyroid Hormone) for Injection,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
4267,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,75mcg   Cartridge: (NDC 68875-0204-1); Carton: (NDC 68875-0204-2) (contains 2 cartridges),Reverified,1/28/20,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,Important Information Regarding a Temporary Special Use Program for Obtaining and Using NATPARA® (Parathyroid Hormone) for Injection,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
4268,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,100mcg   Cartridge: (NDC 68875-0205-1); Carton: (NDC 68875-0205-2) (contains 2 cartridges),Reverified,1/28/20,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,Important Information Regarding a Temporary Special Use Program for Obtaining and Using NATPARA® (Parathyroid Hormone) for Injection,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
4269,Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 200 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4347-01)",New,2/28/18,,This presentation will be discontinued on or near December 2019. For additional information please contact the Merck National Service Center Telephone Number: 1-800-672-6372,,,Oncology,To be Discontinued,2/28/18,2/28/18
4270,Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 300 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4348-01)",New,2/28/18,,This presentation will be discontinued on or near December 2019. For additional information please contact the Merck National Service Center Telephone Number: 1-800-672-6372,,,Oncology,To be Discontinued,2/28/18,2/28/18
4271,Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 600 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4349-01)",New,2/28/18,,This presentation will be discontinued on or near December 2018.  For additional information please contact the Merck National Service Center Telephone Number: 1-800-672-6372,,,Oncology,To be Discontinued,2/28/18,2/28/18
4272,PEGINTRON (peginterferon alfa-2b) Injection,Merck Sharp & Dohme Corp.,800-672-6372,"PEGINTRON injection (peginterferon alfa-2b) 50 mcg per 0.5 mL; box containing one 50 mcg per 0.5 mL vial of PEGINTRON Powder for Injection and one 5 mL vial of Diluent (Sterile Water for Injection USP), 2 BD Safety Lok syringes with a safety sleeve and 2 alcohol swabs (NDC 00085-4353-01)",New,9/12/19,,To be discontinued on or near May 2021,,,Antiviral;Oncology,To be Discontinued,9/12/19,9/12/19
4273,Penicillamine (Depen) Titratable Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"Penicillamine tablets, 250 mg (NDC 0037-4401-01)",Revised,10/1/19,,,,,Endocrinology/Metabolism;Gastroenterology;Inborn Errors;Pediatric;Renal;Rheumatology,Resolved,10/1/19,
4274,Penicillin V Potassium Tablets,Sandoz,800-525-8747,"500 mg, 100 tablets (NDC 0781-1655-01)",New,3/19/20,,,,,Anti-Infective,To be Discontinued,3/19/20,3/19/20
4275,Penicillin V Potassium Tablets,Sandoz,800-525-8747,"500 mg, 1000 tablets (NDC 0781-1655-10)",New,3/19/20,,,,,Anti-Infective,To be Discontinued,3/19/20,3/19/20
4276,Penicillin V Potassium Tablets,Sandoz,800-525-8747,"250 mg, 100 tablets (NDC 0781-1205-01)",New,3/19/20,,,,,Anti-Infective,To be Discontinued,3/19/20,3/19/20
4277,Penicillin V Potassium Tablets,Sandoz,800-525-8747,"250 mg, 1000 tablets (NDC 0781-1205-10)",New,3/19/20,,,,,Anti-Infective,To be Discontinued,3/19/20,3/19/20
4278,Pentamidine Isethionate (Nebupent) For Inhalation Solution,"Fresenius Kabi USA, LLC",888-386-1300,"300 mg per vial, SDV, PF (NDC 63323-877-15)",Revised,9/13/19,,,,,Anti-Infective,Resolved,9/13/19,
4279,Pentoxifylline Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"400 mg, 100s (NDC 0378-0357-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/8/18,5/8/18
4280,Pentoxifylline Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"400 mg, 500s (NDC 0378-0357-05)",New,5/8/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/8/18,5/8/18
4281,Peritoneal Dialysis Solutions,Baxter Healthcare,888-229-0001,Peritoneal Dialysis Solutions for Automated Peritoneal Dialysis (APD) therapy (Dianeal and Extraneal),Revised,3/2/20,,,,,Pediatric;Renal,Resolved,3/2/20,
4282,Peritoneal Dialysis Solutions,Fresenius Medical Care North America,800-323-5188,Peritoneal Dialysis Solutions (Delflex and Stay Safe),Revised,3/2/20,,,,,Pediatric;Renal,Resolved,3/2/20,
4283,Peritoneal Dialysis Solutions,Baxter Healthcare,888-229-0001,Peritoneal Dialysis Solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD) therapy (Dianeal and Extraneal),Revised,3/2/20,,,,,Pediatric;Renal,Resolved,3/2/20,
4284,Phenobarbital Oral Solution,Torrent Pharma Inc.,908-280-3333,1 pint 473mL (NDC 16571-330-16),New,11/25/19,,,,,Neurology,To be Discontinued,11/25/19,11/25/19
4285,"Phenytoin Sodium Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 2 mL vial (NDC 0641-0493-25)",Revised,9/3/19,,,Available,,Neurology,Resolved,9/3/19,
4286,"Phenytoin Sodium Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 5 mL vial (NDC 0641-2555-45)",Revised,9/3/19,,,Available,,Neurology,Resolved,9/3/19,
4287,"Physostigmine Salicylate Injection, USP",Akorn Pharmaceuticals,800-932-5676,"Physostigmine Salicylate Injection, USP  1mg/mL (10amps/box, 2mL each) (NDC 17478-510-02)",Revised,12/2/19,Available,,,Other,Neurology,Current,,
4288,Pindolol Tablets,"ANI Pharmaceuticals, Inc.",800-434-1121,"5 mg: Bottles of 100 tablets, (NDC 62559-560-01)",Revised,4/24/20,Currently Unavailable; Estimated Resupply: 2Q 2021,Finished Goods can be manufactured upon receipt of API.,,Shortage of an active ingredient,Cardiovascular,Current,,
4289,Pindolol Tablets,"ANI Pharmaceuticals, Inc.",800-434-1121,"10 mg; Bottles of 100 tablets, (NDC 62559-561-01)",Revised,4/24/20,Currently Unavailable; Estimated Resupply: 2Q 2021,Finished Goods can be manufactured upon receipt of API.,,Shortage of an active ingredient,Cardiovascular,Current,,
4290,Pindolol Tablets,Bayshore Pharmaceuticals,973-315-1819,5 mg/ 100 count (NDC 76385-131-01),Revised,11/18/20,Available,,,,Cardiovascular,Current,,
4291,Pindolol Tablets,Bayshore Pharmaceuticals,973-315-1819,10 mg/ 100 count (NDC 76385-132-01),Revised,11/18/20,Available,,,,Cardiovascular,Current,,
4292,Pindolol Tablets,Sun Pharmaceutical Industries Inc.,800-818-4555,"Pindolol Tablets, 5mg and 10mg (100 count bottles)(NDC 57664-655-88, 57664-656-88)",New,2/21/20,No product available. Product can be manufactured upon availability of API. Concrete estimated release dates cannot be provided at this moment.,,,Shortage of active ingredient,Cardiovascular,Current,,
4293,Pindolol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Pindolol 5mg Tabs 100s (NDC 0378-0052-01),Revised,11/17/20,Unavailable. Re-supply Q1 2021.,,,,Cardiovascular,Current,,
4294,Pindolol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Pindolol 10mg Tabs 100s (NDC 0378-0127-01),Revised,11/17/20,Unavailable. Re-supply Q1 2021.,,,,Cardiovascular,Current,,
4295,Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets,Sandoz,800-525-8747,500mg;15mg tablets (NDC 0781-5626-60),New,2/10/20,,,,,Endocrinology/Metabolism,To be Discontinued,2/10/20,2/10/20
4296,Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets,Sandoz,800-525-8747,850mg;15mg tablets (NDC 0781-5627-60),New,2/10/20,,,,,Endocrinology/Metabolism,To be Discontinued,2/10/20,2/10/20
4297,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"2.25 g, single dose vial, box of 10 (NDC 64679-034-01",Revised,2/21/20,,,,,Anti-Infective;Pediatric,Resolved,2/21/20,
4298,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"2.25 g, single dose vial, box of 10 (NDC 61990-0110-2)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4299,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"4.5 g, single dose vial, box of 10 (NDC 61990-0130-2)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4300,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"2.25 g, single dose vial, box of 10 (NDC 70860-120-20); distributed by Athenex",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4301,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"3.375 g, single dose vial, box of 10 (NDC 61990-0120-2)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4302,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"13.5 g, pharmacy bulk vial (NDC 61990-0140-1)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4303,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"40.5 g, pharmacy bulk vial (NDC 61990-0150-1)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4304,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"3.375 g, single dose vial, box of 10 (NDC 70860-121-30); distributed by Athenex",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4305,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"4.5 g, single dose vial, box of 10 (NDC 70860-122-50); distributed by Athenex",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4306,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"40.5 g, pharmacy bulk bottle (NDC 70860-123-99); distributed by Athenex",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4307,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"3.375 g, single dose vial, box of 10 (NDC 0409-3378-13) ADD-Vantage; distributed by Hospira",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4308,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"4.5 g, single dose vial, box of 10 (NDC 0409-3379-04) ADD-Vantage; distributed by Hospira",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4309,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"2.25 g, single dose vial, box of 10 (NDC 0409-3383-02); distributed by Hospira",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4310,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"3.375 g, single dose vial, box of 10 (NDC 0409-3385-13); distributed by Hospira",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4311,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"4.5 g, single dose vial, box of 10 (NDC 0409-3390-04); distributed by Hospira",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4312,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"13.5 g, pharmacy bulk bottle (NDC 0409-2999-14); distributed by Hospira",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4313,Piperacillin and Tazobactam (Zosyn) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2.25 g, single-dose vial (NDC 63323-981-21)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4314,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"3.375 g, single dose vial, box of 10 (NDC 64679-056-01)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4315,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"3.375 g, single dose vial (NDC 64679-056-02)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4316,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"40.5 g, pharmacy bulk vial, box of 10 (NDC 64679-679-02)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4317,Piperacillin and Tazobactam (Zosyn) Injection,"Qilu Tianhe Pharmaceutical Co., Ltd.",,"2.25 g, single dose vial, box of 10 (NDC 60505-6156-4); distributed by Apotex",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4318,Piperacillin and Tazobactam (Zosyn) Injection,"Qilu Tianhe Pharmaceutical Co., Ltd.",,"3.375 g, single dose vial, box of 10 (NDC 60505-6157-4); distributed by Apotex",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4319,Piperacillin and Tazobactam (Zosyn) Injection,"Qilu Tianhe Pharmaceutical Co., Ltd.",,"4.5 g, single dose vial, box of 10 (NDC 60505-6159-4); distributed by Apotex",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4320,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"2.25 g, single dose vial, box of 10 (NDC 0781-9210-95) Novaplus",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4321,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"4.5 g, single dose vial, box of 10 (NDC 0781-9214-95) Novaplus",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4322,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"3.375 g, single dose vial, box of 10 (NDC 0781-9213-95) Novaplus",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4323,Piperacillin and Tazobactam (Zosyn) Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),"3.375 g, single dose vial, box of 10 (NDC 67457-522-37)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4324,Piperacillin and Tazobactam (Zosyn) Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),"4.5 g, single dose vial, box of 10 (NDC 67457-523-45)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4325,Piperacillin and Tazobactam (Zosyn) Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),"2.25 g, single dose vial, box of 10 (NDC 67457-521-22)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4326,Piperacillin and Tazobactam (Zosyn) Injection,Pfizer Pharmaceuticals,800-533-4535,"Zosyn; 2.25 g/50 mL, frozen IV bag (NDC 0206-8860-02)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4327,Piperacillin and Tazobactam (Zosyn) Injection,Pfizer Pharmaceuticals,800-533-4535,"Zosyn; 3.375 g/50 mL, frozen IV bag (NDC 0206-8861-02)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4328,Piperacillin and Tazobactam (Zosyn) Injection,Pfizer Pharmaceuticals,800-533-4535,"Zosyn; 4.5 g/100 mL, frozen IV bag (NDC 0206-8862-02)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4329,Piperacillin and Tazobactam (Zosyn) Injection,Aurobindo Pharma,888-238-7880,"2.25 g, single dose vial, box of 10 (NDC 55150-119-30); distributed by AuroMedics Pharma LLC",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4330,Piperacillin and Tazobactam (Zosyn) Injection,Aurobindo Pharma,888-238-7880,"3.375 g, single dose vial, box of 10 (NDC 55150-120-30); distributed by AuroMedics Pharma LLC",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4331,Piperacillin and Tazobactam (Zosyn) Injection,Aurobindo Pharma,888-238-7880,"4.5 g, single dose vial, box of 10 (NDC 55150-121-50); distributed by AuroMedics Pharma LLC",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4332,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"2.25 g, single dose vial, box of 10 (NDC 63323-309-20); distributed by Fresenius Kabi",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4333,Piperacillin and Tazobactam (Zosyn) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"3.375 g, single dose vial, box of 10 (NDC 63323-983-21)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4334,Piperacillin and Tazobactam (Zosyn) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4.5 g, single dose vial, box of 10 (NDC 63323-982-52)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4335,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"40.5 g, pharmacy bulk bottle (NDC 63323-304-74); distributed by Fresenius Kabi",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4336,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"2.25 g, single dose vial, box of 10 (NDC 0409-3374-02) ADD-Vantage; distributed by Hospira",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4337,Piperacillin and Tazobactam (Zosyn) Injection,Aurobindo Pharma,888-238-7880,"2.25 g, single dose vial, box of 10 (NDC 25021-164-30); distributed by Sagent Pharmaceuticals",Reverified,10/9/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4338,Piperacillin and Tazobactam (Zosyn) Injection,Aurobindo Pharma,888-238-7880,"3.375 g, single dose vial, box of 10 (NDC 25021-165-30); distributed by Sagent Pharmaceuticals",Reverified,10/9/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4339,Piperacillin and Tazobactam (Zosyn) Injection,Aurobindo Pharma,888-238-7880,"4.5 g, single dose vial, box of 10 (NDC 25021-166-48); distributed by Sagent Pharmaceuticals",Reverified,10/9/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4340,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"2.25 g, single dose vial, box of 10 (NDC 44567-801-10); distributed by WG Critical Care",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4341,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"3.375 g, single dose vial, box of 10 (NDC 44567-802-10); distributed by WG Critical Care",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4342,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"4.5 g, single dose vial, box of 10 (NDC 44567-803-10); distributed by WG Critical Care",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4343,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"40.5 g, pharmacy bulk bottle (NDC 44567-804-01); distributed by WG Critical Care",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4344,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"4.5 g, single dose vial, box of 10 (NDC 0781-3114-95)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4345,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"3.375 g, single dose vial, box of 10 (NDC 0781-3113-95)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4346,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"2.25 g, single dose vial, box of 10 (NDC 0781-3110-95)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4347,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"4.5 g, single dose vial, box of 10 (NDC 64679-012-01)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4348,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"4.5 g, single dose vial (NDC 64679-012-02)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4349,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"40.5 g, pharmacy bulk vial (NDC 64679-679-01)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4350,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"2.25 g, single dose vial (NDC 64679-034-02)",Revised,2/21/20,,,Available,,Anti-Infective;Pediatric,Resolved,2/21/20,
4351,"Potassium Acetate Injection, USP","Hospira, Inc.",844-646-4398,"100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-3294-51)",Reverified,11/20/20,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
4352,"Potassium Acetate Injection, USP","Hospira, Inc.",844-646-4398,"40 mEq/mL (2 mEq/mL), Single Dose Plastic Fliptop Vial (NDC 00409-8183-01)",Reverified,11/20/20,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
4353,"Potassium Acetate Injection, USP","Hospira, Inc.",844-646-4398,"100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial NovaPlus (NDC 00409-3294-25)",Reverified,11/20/20,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
4354,"Potassium Acetate Injection, USP","Hospira, Inc.",844-646-4398,"40 mEq/mL (2 mEq/mL), Single Dose Plastic Fliptop Vial NovaPlus (NDC 00409-8183-25)",Reverified,11/20/20,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
4355,"Potassium Acetate Injection, USP","Exela Pharma Sciences, LLC",828-758-5474,Potassium Acetate Inj. 40mEq (2mEq/ml) 20mL (NDC 51754-2001-4),Revised,12/10/19,On allocation due to increased demand.,"Please check with wholesaler for availability. Additional production underway. Direct shipment to hospitals at 200 vials max per week are available from Exela. Customer Service # 828-758-5474, then press #2",,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
4356,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,10 mEq/50 mL (Legacy Hospira NDC 0409-7075-14) (ICU Medical NDC 0990-7075-14),Revised,6/21/19,,,Available,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
4357,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,30 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0673-04),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
4358,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,30 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 0409-7903-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
4359,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,40 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 0409-7904-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
4360,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,10 mEq/1000 mL in 5% dex & 0.45% NaCl (NDC 0409-7993-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
4361,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,20 mEq/1000 mL in 5% dex & 0.9% NaCl (NDC 0409-7107-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
4362,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,40 mEq/1000 mL in 5% dex & 0.9% NaCl (NDC 0409-7109-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
4363,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,20 mEq/1000 mL in 0.45% NaCl (NDC 0409-9257-39),Revised,6/21/19,,,Available,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
4364,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,"20 mEq/100 mL (Legacy Hospira NDC 0409-7075-26)
(ICU Medical NDC 0990-7075-26)",Revised,6/21/19,,,Available,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
4365,Potassium Chloride Injection,"Hospira, Inc.",844-646-4398,10 mEq/5 mL (2 mEq/mL); Single Dose Glass Fliptop Vial (NDC 00409-6635-01),Revised,6/21/19,,,Available,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
4366,Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",4.5 mg tablets (NDC 10370-255-11),New,1/27/20,,,,,Neurology,To be Discontinued,1/27/20,1/27/20
4367,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,5 mL in 10 mL bottle (Pred Forte) (NDC 11980-180-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
4368,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,10 mL in 15 mL bottle (Pred Forte) (NDC 11980-180-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
4369,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,10 mL in 15 mL bottle (NDC 60758-119-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
4370,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,15 mL in 15 mL bottle (NDC 60758-119-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
4371,Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 5mL in 1 bottle (NDC 61314-637-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
4372,Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 10mL in 1 bottle (NDC 61314-637-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
4373,Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 15mL in 1 bottle (NDC 61314-637-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
4374,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,15 mL in 15 mL bottle (Pred Forte) (NDC 11980-180-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
4375,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,5 mL in 10 mL bottle (NDC 60758-119-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
4376,"Primaquine Phosphate Tablet, EQ 15mg Base",Sanofi,800-633-1610,"Primaquine; Film-coated tablet, 15 mg/1 unit, bottles of 100, (NDC 0024-1596-01)",Revised,12/10/19,,,,,Anti-Infective,Resolved,12/10/19,
4377,"Primaquine Phosphate Tablet, EQ 15mg Base",Bayshore Pharmaceuticals,973-315-1819,"Primaquine Phosphate USP,  26.3 mg (15mg base)Tablets, (NDC 76385-102-01), 100 Count Bottle",Revised,12/10/19,,,,,Anti-Infective,Resolved,12/10/19,
4378,"Primidone Tablets, USP",Par Pharmaceutical,800-828-9393,"50mg, count bottle (NDC 0603-5371-21)",New,4/9/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,4/9/19,4/9/19
4379,"Primidone Tablets, USP",Par Pharmaceutical,800-828-9393,"50mg, count bottle (NDC 0603-5371-28)",New,4/9/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,4/9/19,4/9/19
4380,Prinivil Tablets,Merck Sharp & Dohme Corp.,800-672-6372,"10-mg tablets, unit-of-use bottle/90 (NDC0006-0106-54)",New,2/20/20,,To be discontinued on or near March 2020.,,,Cardiovascular,To be Discontinued,2/20/20,2/20/20
4381,Prinivil Tablets,Merck Sharp & Dohme Corp.,800-672-6372,"20-mg tablets, unit-of-use bottle/90 (NDC 0006-0207-54)",New,2/20/20,,To be discontinued on or near March 2020.,,,Cardiovascular,To be Discontinued,2/20/20,2/20/20
4382,"Procainamide Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,"1,000 mg/10 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1902-01)",Reverified,11/20/20,Available,,,Other,Cardiovascular;Renal,Current,,
4383,"Procainamide Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,"1,000 mg/2 mL (500 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1903-01)",Reverified,11/20/20,Available,,,Other,Cardiovascular;Renal,Current,,
4384,"Procainamide Hydrochloride Injection, USP","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,100 mg/1 mL injection; 10 mL Luer-Jet Prefilled Syringe (NDC 76329-3399-5),Reverified,10/30/20,Available,,,Other,Cardiovascular;Renal,Current,,
4385,"Procainamide Hydrochloride Injection, USP","Nexus Pharmaceuticals, Inc.",888-806-4606,"500 mg/mL, 2 mL (NDC 14789-900-02)",New,10/19/17,Available,,,Other,Cardiovascular;Renal,Current,,
4386,"Procainamide Hydrochloride Injection, USP","Nexus Pharmaceuticals, Inc.",888-806-4606,"100 mg/mL, 10 mL (NDC 14789-900-10)",New,10/19/17,Available,,,Other,Cardiovascular;Renal,Current,,
4387,"Progesterone Injection, USP",Teva Pharmaceuticals,800-545-8800,50MG 1X10ML (NDC 0591-3128-79),Revised,9/23/19,,,,,Endocrinology/Metabolism,Resolved,9/23/19,
4388,"Progesterone Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 10 mL, MDV (NDC 63323-0261-10)",Revised,9/23/19,,,,,Endocrinology/Metabolism,Resolved,9/23/19,
4389,"Progesterone Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 10 mL (NDC 0143-9725-01)",Revised,9/23/19,,,,,Endocrinology/Metabolism,Resolved,9/23/19,
4390,"Progesterone Injection, USP",AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,500 mg/10 mL multiple dose vial (NDC 55150-306-10),Revised,9/23/19,,,,,Endocrinology/Metabolism,Resolved,9/23/19,
4391,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg/mL, 1 mL vial (NDC 0641-0928-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
4392,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL ,1 mL vial (NDC 0641-0929-25)",Revised,7/22/20,Inventory is currently available,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
4393,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg/mL, 1 mL ampul (NDC 0641-1495-35)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
4394,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 1 mL ampul (NDC 0641-1496-35)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
4395,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 25 mg/mL, 1 mL vial (NDC 0641-6084-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
4396,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 50 mg/mL ,1 mL vial (NDC 0641-6085-25)",Revised,7/22/20,Inventory is currently available,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
4397,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 25 mg/mL, 1 mL ampul (NDC 0641-6082-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
4398,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 50 mg/mL, 1 mL ampul (NDC 0641-6083-25)",Revised,7/22/20,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
4399,Promethazine (Phenergan) Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"25 mg/mL, Carton of 25 ampuls (NDC 39822-5525-3)",Reverified,12/11/19,Available,,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
4400,Promethazine (Phenergan) Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"50 mg/mL, Carton of 25 ampuls (NDC 39822-5550-6)",Reverified,12/11/19,Available,,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
4401,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"25 mg/1 mL, 1 vial Single-Dose (NDC 0703-2191-01)",New,12/19/19,,Teva made a business decision to discontinue this product.,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,12/19/19,12/19/19
4402,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"50 mg/1 mL Injection, 1 Vial Single-Dose (NDC 0703-2201-01)",New,12/19/19,,Teva made a business decision to discontinue this product.,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,12/19/19,12/19/19
4403,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"25 mg/1 mL, 25 in 1 tray (NDC 0703-2191-04)",New,12/19/19,,Teva made a business decision to discontinue this product.,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,12/19/19,12/19/19
4404,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"50 mg/1 mL, 25 in 1 tray (NDC 0703-2201-04)",New,12/19/19,,Teva made a business decision to discontinue this product.,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,12/19/19,12/19/19
4405,Promethazine Suppository,Teva Pharmaceuticals,800-545-8800,"25 mg/1 unit, (NDC 0591-2992-39 )",New,4/28/20,,"Teva evaluated the market and decided to discontinue the product. For Promethazine Hydrochloride 25 mg/1 unit, NDC 0591-2992-39, allocations are being made based on customer Rx trends. Product availability is anticipated until May, 2020",,,Anesthesia;Pulmonary/Allergy,To be Discontinued,4/28/20,4/28/20
4406,Promethazine Suppository,Teva Pharmaceuticals,800-545-8800,"12.5 mg/1 unit, (NDC 0591-2985-39)",New,4/28/20,,"Teva evaluated the market and decided to discontinue the product. For Promethazine Hydrochloride 25 mg/1 unit, NDC 0591-2992-39, allocations are being made based on customer Rx trends. Product availability is anticipated until May, 2020",,,Anesthesia;Pulmonary/Allergy,To be Discontinued,4/28/20,4/28/20
4407,Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per 10 mL (10 mg per mL), single patient use only, 10 mL (NDC 63323-269-10)",Reverified,11/16/20,Shipping / Check wholesaler inventory,,,,Anesthesia,Current,,
4408,Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per 20 mL (10 mg per mL), single patient use only, 20 mL (NDC 63323-269-29)",Reverified,11/16/20,Shipping / Check wholesaler inventory,,,Demand increase for the drug,Anesthesia,Current,,
4409,Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 50 mL (10 mg per mL), single patient use only, 50 mL (NDC 63323-269-50)",Reverified,11/16/20,Allocating to wholesalers / Check wholesaler inventory,COVID-19 demand,,Demand increase for the drug,Anesthesia,Current,,
4410,Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"1000 mg per 100 mL (10 mg per mL), single patient use only, 100 mL (NDC 63323-269-65)",Reverified,11/16/20,Allocating to wholesalers / Check wholesaler inventory,COVID-19 demand,,Demand increase for the drug,Anesthesia,Current,,
4411,Propofol Injectable Emulsion,Sagent Pharmaceuticals,866-625-1618,200mg per 20ml (NDC 25021-608-20),Reverified,10/22/20,Available. On Allocation,,,Demand increase due to Covid-19,Anesthesia,Current,,
4412,Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 10X100ML VL (NDC 0591-2136-68),Reverified,11/19/20,Limited supply available. Next Delivery and Estimated Recovery: TBD,Supply chain has been impacted by shipping delays due to COVID-19,,Other,Anesthesia,Current,,
4413,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-30),Revised,11/20/20,Limited Supply Available. Next Delivery: November 2020; Estimated Recovery: March 2021,,,Demand increase for the drug,Anesthesia,Current,,
4414,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-33),Revised,11/20/20,Limited Supply Available. Next Delivery and Estimated Recovery: January 2021,,,Demand increase for the drug,Anesthesia,Current,,
4415,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,1000 mg/100 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-24),Revised,11/20/20,Limited Supply Available. Next Delivery: November 2020; Estimated Recovery: December 2020,,,Demand increase for the drug,Anesthesia,Current,,
4416,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,200mg/20mL  10ct (NDC 43598-265-58),Reverified,11/13/20,"Limited supply, resupply TBD",Manufacturer extended lead times,,Demand increase for the drug,Anesthesia,Current,,
4417,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"200mg/20mL vial, individual (NDC 43598-265-20)",Reverified,11/13/20,"Limited supply, resupply TBD",Manufacturer extended lead times,,Demand increase for the drug,Anesthesia,Current,,
4418,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,500mg/50mL  20ct (NDC 43598-548-21),Reverified,11/13/20,"Limited supply, resupply TBD",Manufacturer extended lead times,,Demand increase for the drug,Anesthesia,Current,,
4419,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"500mg/50mL vial, individual (NDC 43598-548-50)",Reverified,11/13/20,"Limited supply, resupply TBD",Manufacturer extended lead times,,Demand increase for the drug,Anesthesia,Current,,
4420,Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 20X50ML VL (NDC 0591-2136-51),Reverified,11/19/20,Limited supply available. Next Delivery and Estimated Recovery: TBD,Supply chain has been impacted by shipping delays due to COVID-19,,Other,Anesthesia,Current,,
4421,Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 25X20ML VL (NDC 0591-2136-95),Reverified,11/19/20,Limited supply available. Next Delivery and Estimated Recovery: TBD,Supply chain has been impacted by shipping delays due to COVID-19,,Other,Anesthesia,Current,,
4422,Propofol Injectable Emulsion,Sagent Pharmaceuticals,866-625-1618,500mg per 50ml (NDC 250-21-608-50),Reverified,10/22/20,Available. On Allocation,,,Demand increase due to Covid-19,Anesthesia,Current,,
4423,Propofol Injectable Emulsion,Sagent Pharmaceuticals,866-625-1618,1000mg per 100ml (NDC 25021-608-51),Reverified,10/22/20,Available. On Allocation,,,Demand increase due to Covid-19,Anesthesia,Current,,
4424,Propofol Injectable Emulsion,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 20 mL vial (NDC 0641-6194-10)",New,7/23/20,This presentation is currently available.,Additional lots are scheduled for manufacturing.   Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
4425,Propofol Injectable Emulsion,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 50 mL vial (NDC 0641-6195-20",New,7/23/20,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing in the August – September 2020 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
4426,Propofol Injectable Emulsion,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 100 mL vial (NDC 0641-6196-10",New,7/23/20,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing in the August – September 2020 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
4427,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"1000mg/100mL vial, 10ct (NDC 43598-549-10)",Reverified,11/13/20,"Limited supply, resupply TBD",Manufacturer extended lead times,,Demand increase for the drug,Anesthesia,Current,,
4428,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"1000mg/100mL vial, individual (NDC 43598-549-52)",Reverified,11/13/20,"Limited supply, resupply TBD",Manufacturer extended lead times.,,Demand increase for the drug,Anesthesia,Current,,
4429,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"200mg/20mL vial, 25ct (NDC 43598-265-25)",Reverified,11/13/20,"Limited supply, resupply TBD",Manufacturer extended lead times.,,Demand increase for the drug,Anesthesia,Current,,
4430,"Pyrazinamide Tablets, USP",DAVA Pharmaceuticals Inc.,"800-828-9393, Option 5, then Option 2","500 mg, Bottle of 100 (NDC 67253-660-10)",New,4/20/20,,Distributed by Par Pharmaceuticals.,,,Anti-Infective,To be Discontinued,4/20/20,4/20/20
4431,Quinapril Hydrochloride (Accupril) Tablets,Pfizer Pharmaceuticals,800-533-4535,5 mg tablets; 10 x 10 unit dose blisters (NDC 0071-0527-40),New,11/12/19,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,11/12/19,11/12/19
4432,Quinapril Hydrochloride (Accupril) Tablets,Pfizer Pharmaceuticals,800-533-4535,10 mg tablets; 10 x 10 unit dose blisters (NDC 0071-0530-40),New,11/12/19,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,11/12/19,11/12/19
4433,Quinapril Hydrochloride (Accupril) Tablets,Pfizer Pharmaceuticals,800-533-4535,20 mg tablets; 10 x 10 unit dose blisters (NDC 0071-0532-40),New,11/12/19,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,11/12/19,11/12/19
4434,Quinidine Gluconate Injection,Eli Lilly and Co.,800-545-5979,"QUINIDINE GLUCONATE, 80 mg/1 mL,10 mL/vial Injectable (NDC 0002-1407-01)",Revised,9/19/19,,Discontinuation of the manufacture of the drug. The product distribution has ceased given the product's labeled expiry of March 2019. FDA and CDC are developing a strategy to ensure continued access to essential medicine for the treatment of severe malaria in the United States.,,,Anti-Infective;Cardiovascular,To be Discontinued,9/19/19,9/19/19
4435,Rabeprazole Sodium Delayed-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"20 mg, 30 count bottle (NDC 0378-6709-93)",New,5/2/19,,,,,Gastroenterology,To be Discontinued,5/2/19,5/2/19
4436,Rabeprazole Sodium Delayed-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"20 mg, 90 count bottle (NDC 0378-6709-77)",New,5/2/19,,,,,Gastroenterology,To be Discontinued,5/2/19,5/2/19
4437,Rabeprazole Sodium Delayed-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"20 mg, 500 count bottle (NDC 0378-6709-05)",New,5/2/19,,,,,Gastroenterology,To be Discontinued,5/2/19,5/2/19
4438,"Ranitidine Injection, USP",Mylan Institutional,800-796-9526,"Ranitidine Injection 25 mg/mL, 2ml vial; 10 pack; (NDC 67457-397-99)",Revised,4/3/20,,,,,Gastroenterology,To be Discontinued,4/3/20,4/3/20
4439,"Ranitidine Injection, USP",Mylan Institutional,800-796-9526,"Ranitidine Injection 25 mg/mL, 6 mL vial; 1 pack; (NDC 67457-398-62)",Revised,4/3/20,,,,,Gastroenterology,To be Discontinued,4/3/20,4/3/20
4440,"Ranitidine Injection, USP",Zydus Pharmaceuticals USA Inc.,609-730-1900,Ranitidine HCl Injection 25mg/mL (10x2mL SD vials)(NDC 68382-422-02),Revised,4/3/20,,,,,Gastroenterology,To be Discontinued,4/3/20,4/3/20
4441,"Ranitidine Injection, USP",Zydus Pharmaceuticals USA Inc.,609-730-1900,Ranitidine HCl Injection 25mg/mL (6mL MD vial)(NDC 68382-423-06),Revised,4/3/20,,,,,Gastroenterology,To be Discontinued,4/3/20,4/3/20
4442,"Ranitidine Injection, USP","Teligent Pharma, Inc.",856-697-1441,ZANTAC INJECTABLE 25MG/ML 2ML VIAL (NDC 52565-101-01),Revised,4/3/20,,,,,Gastroenterology,To be Discontinued,4/3/20,4/3/20
4443,"Ranitidine Injection, USP","Teligent Pharma, Inc.",856-697-1441,ZANTAC INJECTABLE 25MG/ML 40ML VIAL (NDC 52565-096-01),Revised,4/3/20,,,,,Gastroenterology,To be Discontinued,4/3/20,4/3/20
4444,"Ranitidine Injection, USP","Teligent Pharma, Inc.",856-697-1441,ZANTAC INJECTABLE 25MG/ML 6ML VIAL (NDC 52565-102-01),Revised,4/3/20,,,,,Gastroenterology,To be Discontinued,4/3/20,4/3/20
4445,Ranitidine Tablets/Capsules,Glenmark Pharmaceuticals,888-721-7115,150mg 60 count bottle (NDC 68462-248-60),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4446,Ranitidine Tablets/Capsules,Glenmark Pharmaceuticals,888-721-7115,150mg 100 count bottle (NDC 68462-248-01),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4447,Ranitidine Tablets/Capsules,Glenmark Pharmaceuticals,888-721-7115,150mg 500 count bottle (NDC 68462-248-05),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4448,Ranitidine Tablets/Capsules,Glenmark Pharmaceuticals,888-721-7115,300mg 30 count bottle (NDC 68462-249-30),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4449,Ranitidine Tablets/Capsules,Glenmark Pharmaceuticals,888-721-7115,300mg 100 count bottle (NDC 68462-249-01),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4450,Ranitidine Tablets/Capsules,Glenmark Pharmaceuticals,888-721-7115,300mg 250 count bottle (NDC 68462-249-20),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4451,Ranitidine Tablets/Capsules,Appco Pharma LLC,732-253-7735,150mg 60 count bottle (NDC 62559-690-60),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4452,Ranitidine Tablets/Capsules,Appco Pharma LLC,732-253-7735,150mg 500 count bottle (NDC 62559-690-05),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4453,Ranitidine Tablets/Capsules,Appco Pharma LLC,732-253-7735,300mg 30 count bottle (NDC 62559-691-30),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4454,Ranitidine Tablets/Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,150mg 60 count bottle (NDC 5511112960),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4455,Ranitidine Tablets/Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,150mg 500 count bottle (NDC 5511112905),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4456,Ranitidine Tablets/Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,300mg 30 count bottle (NDC 5511113030),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4457,Ranitidine Tablets/Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,300mg 100 count bottle (NDC 5511113001),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4458,Ranitidine Tablets/Capsules,Novitium Pharma LLC,609-469-5920,"150 mg, Bottle of 60 capsules (NDC 70954-001-20)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4459,Ranitidine Tablets/Capsules,Novitium Pharma LLC,609-469-5920,"150 mg, Bottle of 500 capsules (NDC 70954-001-40)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4460,Ranitidine Tablets/Capsules,Novitium Pharma LLC,609-469-5920,"300 mg, Bottle of 30 capsules (NDC 70954-002-10)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4461,Ranitidine Tablets/Capsules,Novitium Pharma LLC,609-469-5920,"300 mg, Bottle of 100 capsule (NDC 70954-002-40)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4462,Ranitidine Tablets/Capsules,Ajanta Pharma USA Inc,855-664-7744,150 mg 60’s count bottle (NDC 27241-109-06),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4463,Ranitidine Tablets/Capsules,Ajanta Pharma USA Inc,855-664-7744,150 mg 500’s count bottle (NDC 27241-109-50),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4464,Ranitidine Tablets/Capsules,Ajanta Pharma USA Inc,855-664-7744,300 mg 30’s count bottle (NDC 27241-110-03),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4465,Ranitidine Tablets/Capsules,Ajanta Pharma USA Inc,855-664-7744,300 mg 100’s count bottle (NDC 27241-110-10),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4466,Ranitidine Tablets/Capsules,Strides Pharma Inc.,855-273-0146,"150 mg, 60 count bottle (NDC 64380-0803-03)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4467,Ranitidine Tablets/Capsules,Strides Pharma Inc.,855-273-0146,"150 mg, 100 count bottle (NDC 64380-0803-06)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4468,Ranitidine Tablets/Capsules,Strides Pharma Inc.,855-273-0146,"150 mg, 500 count bottle (NDC 64380-0803-07)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4469,Ranitidine Tablets/Capsules,Strides Pharma Inc.,855-273-0146,"150 mg, 1000 count bottle (NDC 64380-0803-08)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4470,Ranitidine Tablets/Capsules,Strides Pharma Inc.,855-273-0146,"300 mg, 30 count bottle (NDC 64380-0804-04)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4471,Ranitidine Tablets/Capsules,Strides Pharma Inc.,855-273-0146,"300 mg, 100 count bottle (NDC 64380-0804-06)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4472,Ranitidine Tablets/Capsules,Strides Pharma Inc.,855-273-0146,"300 mg, 250 count bottle (NDC 64380-0804-38)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4473,Ranitidine Tablets/Capsules,Amneal Pharmaceutical,866-525-7270,"150 mg, 60 count (NDC 65162-253-06)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4474,Ranitidine Tablets/Capsules,Amneal Pharmaceutical,866-525-7270,"150 mg, 100 count (NDC 65162-253-10)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4475,Ranitidine Tablets/Capsules,Amneal Pharmaceutical,866-525-7270,"150 mg, 180 count (NDC 65162-253-18)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4476,Ranitidine Tablets/Capsules,Amneal Pharmaceutical,866-525-7270,"150 mg, 500 count (NDC 65162-253-50)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4477,Ranitidine Tablets/Capsules,Amneal Pharmaceutical,866-525-7270,"150 mg, 1000 count (NDC 65162-253-11)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4478,Ranitidine Tablets/Capsules,Amneal Pharmaceutical,866-525-7270,"150 mg, 1000 count (NDC 65162-253-11)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4479,Ranitidine Tablets/Capsules,Amneal Pharmaceutical,866-525-7270,"300 mg, 30 count (NDC 65162-254-03)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4480,Ranitidine Tablets/Capsules,Amneal Pharmaceutical,866-525-7270,"300 mg, 100 count (NDC 65162-254-10)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4481,Ranitidine Tablets/Capsules,Amneal Pharmaceutical,866-525-7270,"300 mg, 250 count (NDC 65162-254-25)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4482,Ranitidine Tablets/Capsules,Amneal Pharmaceutical,866-525-7270,"300 mg, 250 count (NDC 53746-254-02)",Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4483,Ranitidine Tablets/Capsules,Sandoz,800-525-8747,150 mg 500 ct bottle (NDC 0781-2855-05),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4484,Ranitidine Tablets/Capsules,Sandoz,800-525-8747,150 mg 60 ct bottle (NDC 0781-2855-60),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4485,Ranitidine Tablets/Capsules,Sandoz,800-525-8747,300 mg 30 ct bottle (NDC 0781-2865-31),Revised,4/3/20,,,,,Gastroenterology;Pediatric,To be Discontinued,4/3/20,4/3/20
4486,Ranitidine Tablets/Capsules,Teva Pharmaceuticals,800-545-8800,150 mg / 300 mg (NDC 0172-4357-49) and (NDC 0172-4358-46),New,4/30/20,,Teva made a business decision to discontinue these products. Teva has not marketed the subject products for an extended period of time.,,,Gastroenterology;Pediatric,To be Discontinued,4/30/20,4/30/20
4487,Ranitidine Tablets/Capsules,Teva Pharmaceuticals,800-545-8800,150 mg/1 unit (NDC 0172-4357-70),New,4/30/20,,Teva made a business decision to discontinue these products. Teva has not marketed the subject products for an extended period of time.,,,Gastroenterology;Pediatric,To be Discontinued,4/30/20,4/30/20
4488,Ranitidine Tablets/Capsules,Teva Pharmaceuticals,800-545-8800,300 mg/1 unit (NDC 0172-4358-60),New,4/30/20,,Teva made a business decision to discontinue these products. Teva has not marketed the subject products for an extended period of time.,,,Gastroenterology;Pediatric,To be Discontinued,4/30/20,4/30/20
4489,Ranolazine Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,500 mg  (NDC 45963-418-50),New,7/6/20,,,,,Cardiovascular,To be Discontinued,7/6/20,7/6/20
4490,Ranolazine Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,1000 mg  (NDC 45963-419-50),New,7/6/20,,,,,Cardiovascular,To be Discontinued,7/6/20,7/6/20
4491,Remifentanil (Ultiva) Lyophilized Powder for Solution Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg per vial, SDV (NDC 63323-723-03)",Revised,3/2/20,,,,,Analgesia/Addiction;Pediatric,Resolved,3/2/20,
4492,Remifentanil (Ultiva) Lyophilized Powder for Solution Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per vial, SDV (NDC 63323-724-05)",Revised,3/2/20,,,,,Analgesia/Addiction;Pediatric,Resolved,3/2/20,
4493,Remifentanil (Ultiva) Lyophilized Powder for Solution Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per vial, SDV (NDC 63323-725-10)",Revised,3/2/20,,,,,Analgesia/Addiction;Pediatric,Resolved,3/2/20,
4494,Remifentanil (Ultiva) Lyophilized Powder for Solution Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),1 mg (NDC 67457-198-03),Revised,3/2/20,,,,,Analgesia/Addiction;Pediatric,Resolved,3/2/20,
4495,Remifentanil (Ultiva) Lyophilized Powder for Solution Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),2 mg (NDC 67457-198-05),Revised,3/2/20,,,,,Analgesia/Addiction;Pediatric,Resolved,3/2/20,
4496,Remifentanil (Ultiva) Lyophilized Powder for Solution Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),5 mg (NDC 67457-198-10),Revised,3/2/20,,,,,Analgesia/Addiction;Pediatric,Resolved,3/2/20,
4497,Repaglinide Tablets,Sandoz,800-525-8747,1mg tablets (NDC 0781-5149-01),New,2/2/18,,,,,Endocrinology/Metabolism,To be Discontinued,2/2/18,2/2/18
4498,Ribavirin (Rebetol) Oral Solution,Merck Sharp & Dohme Corp.,800-672-6372,40 mg/mL (NDC 0085-1318-01),New,4/16/19,,To be discontinued on or near June 2019.,,,Antiviral,To be Discontinued,4/16/19,4/16/19
4499,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,"200 mg (NDCs 66435-101-14, 66435-101-16, 66435-101-18, 66435-101-42, 66435-101-56, 66435-101-70, 66435-101-84, 66435-102-16, 66435-102-95, 54738-950-16)",New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
4500,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,400 mg (NDCs 66435-103-56 and 66435-103-95),New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
4501,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,"600 mg (NDCs 66435-104-56, 66435-104-92, 54738-952-56)",New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
4502,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,600 mg dose pack (NDCs 66435-108-56 and 66435-108-99),New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
4503,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,800 mg dose pack (NDCs 66435-105-56 and 66435-105-99),New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
4504,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,1000 mg dose pack (NDCs 66435-106-56 and 66435-106-99),New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
4505,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,1200 mg dose pack (NDCs 66435-107-56 and 66435-107-99),New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
4506,Rifampin (Rifadin) Capsules,Sanofi-Aventis,800-633-1610; Option 7,150 mg capsules (NDC 0068-0510-30),New,6/15/20,,,,,Anti-Infective,To be Discontinued,6/15/20,6/15/20
4507,Rifampin (Rifadin) Capsules,Sanofi-Aventis,800-633-1610; Option 7,300 mg capsules (NDC 0068-0508-60),New,6/15/20,,,,,Anti-Infective,To be Discontinued,6/15/20,6/15/20
4508,Rifampin/Isoniazid (Rifamate) Capsules,Sanofi-Aventis,800-633-1610; Option 7,150 mg/300 mg capsules (NDC 0068-0509-60),New,6/15/20,,,,,Anti-Infective,To be Discontinued,6/15/20,6/15/20
4509,Rifampin/Isoniazid/Pyrazinamide (Rifater) Tablets,Sanofi-Aventis,800-633-1610; Option 7,150 mg/300 mg/120 mg tablets (NDC 0088-0576-41),New,6/15/20,,,,,Anti-Infective,To be Discontinued,6/15/20,6/15/20
4510,Rifapentine Tablets,Sanofi,800-633-1610 Option 7,"Rifapentine (Piftin) Tablets, 150 mg (NDC 0088-2102-24)",New,3/25/20,On allocation with intermittent supply.,,,Demand increase for the drug,Anti-Infective,Current,3/25/20,
4511,Risedronate Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"150 mg, 1 count blister card (NDC 0378-4150-32)",New,5/2/19,,,,,Other,To be Discontinued,5/2/19,5/2/19
4512,Risedronate Tablets,Allergan Sales LLC,800-678-1605,5 mg tablets (NDC 0430-0471-15),New,12/9/19,,,,,Musculoskeletal,To be Discontinued,12/9/19,12/9/19
4513,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 4 mg (NDC 50458-595-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4514,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 4 mg (NDC 50458-595-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4515,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 3 mg (NDC 50458-594-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4516,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 3 mg (NDC 50458-594-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4517,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4518,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4519,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4520,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4521,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4522,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4523,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4524,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4525,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4526,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4527,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4528,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4529,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 3 mg (NDC 50458-330-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4530,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 2 mg (NDC 50458-320-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4531,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 1 mg (NDC 50458-300-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4532,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.5 mg (NDC 50458-302-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4533,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.25 mg (NDC 50458-301-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4534,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.25 mg (NDC 50458-301-01),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
4535,Rivastigmine Tartrate Capsules,Teva Pharmaceuticals,800-545-8800,"1.5 mg capsules, 60 count (NDC 0591-3208-60)",New,3/10/20,,Discontinuation of the manufacture of the drug.,,,Neurology,To be Discontinued,3/10/20,3/10/20
4536,Rivastigmine Tartrate Capsules,Teva Pharmaceuticals,800-545-8800,"3 mg capsules, 60 count (NDC 0591-3209-60)",New,3/10/20,,Discontinuation of the manufacture of the drug.,,,Neurology,To be Discontinued,3/10/20,3/10/20
4537,Rivastigmine Tartrate Capsules,Teva Pharmaceuticals,800-545-8800,"4.5 mg capsules, 60 count (NDC 0591-3210-60)",New,3/10/20,,Discontinuation of the manufacture of the drug.,,,Neurology,To be Discontinued,3/10/20,3/10/20
4538,Rivastigmine Tartrate Capsules,Teva Pharmaceuticals,800-545-8800,"6 mg capsules, 60 count (NDC 0591-3211-60)",New,3/10/20,,Discontinuation of the manufacture of the drug.,,,Neurology,To be Discontinued,3/10/20,3/10/20
4539,Rizatriptan Benzoate Orally Disintegrating Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 9 count bottle (NDC 0378-3701-59)",New,5/2/19,,,,,Neurology;Pediatric,To be Discontinued,5/2/19,5/2/19
4540,Rizatriptan Benzoate Orally Disintegrating Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 9 count bottle (NDC 0378-3702-59)",New,5/2/19,,,,,Neurology;Pediatric,To be Discontinued,5/2/19,5/2/19
4541,Rocuronium Bromide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,10 mg/mL 5mL vial (NDC 70860-651-05),Revised,11/2/18,Available,,,Available,Anesthesia,Resolved,11/2/18,
4542,Rocuronium Bromide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,10 mg/mL 10mL vial (NDC 70860-651-10),Revised,11/2/18,Available,,,Available,Anesthesia,Resolved,11/2/18,
4543,Ropinirole Hydrochloride Extended Release (Requip XL) Tablets,GlaxoSmithKline,888-825-5249,4 mg  (NDC 0007-4887-13),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of REQUIP XL 4 mg is approximately November 2019. The anticipated date that GSK will cease distribution of REQUIP XL 6 mg is approximately April 2020. The anticipated date that GSK will cease distribution of REQUIP XL 8 mg is approximately February 2020. The anticipated date that GSK will cease distribution of REQUIP XL 12 mg is approximately April 2020.,,,Neurology,To be Discontinued,6/28/19,6/28/19
4544,Ropinirole Hydrochloride Extended Release (Requip XL) Tablets,GlaxoSmithKline,888-825-5249,6 mg  (NDC 0007-4883-13),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of REQUIP XL 4 mg is approximately November 2019. The anticipated date that GSK will cease distribution of REQUIP XL 6 mg is approximately April 2020. The anticipated date that GSK will cease distribution of REQUIP XL 8 mg is approximately February 2020. The anticipated date that GSK will cease distribution of REQUIP XL 12 mg is approximately April 2020.,,,Neurology,To be Discontinued,6/28/19,6/28/19
4545,Ropinirole Hydrochloride Extended Release (Requip XL) Tablets,GlaxoSmithKline,888-825-5249,8 mg  (NDC 0007-4888-13),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of REQUIP XL 4 mg is approximately November 2019. The anticipated date that GSK will cease distribution of REQUIP XL 6 mg is approximately April 2020. The anticipated date that GSK will cease distribution of REQUIP XL 8 mg is approximately February 2020. The anticipated date that GSK will cease distribution of REQUIP XL 12 mg is approximately April 2020.,,,Neurology,To be Discontinued,6/28/19,6/28/19
4546,Ropinirole Hydrochloride Extended Release (Requip XL) Tablets,GlaxoSmithKline,888-825-5249,12 mg  (NDC 0007-4882-13),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of REQUIP XL 4 mg is approximately November 2019. The anticipated date that GSK will cease distribution of REQUIP XL 6 mg is approximately April 2020. The anticipated date that GSK will cease distribution of REQUIP XL 8 mg is approximately February 2020. The anticipated date that GSK will cease distribution of REQUIP XL 12 mg is approximately April 2020.,,,Neurology,To be Discontinued,6/28/19,6/28/19
4547,Ropivacaine Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,500 mg per 100 mL (5 mg per mL 0.5%) (NDC 25021-652-82 ),Reverified,10/22/20,Available,,,,Anesthesia,Current,,
4548,Ropivacaine Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,"1,000 mg per 200 mL (5 mg per mL 0.5%) (NDC 25021-652-87)",Reverified,10/22/20,Available,,,,Anesthesia,Current,,
4549,Ropivacaine Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,0.2% 2mg/mL 10x100mL (NDC 25021-671-82),Reverified,10/22/20,Available,,,,Anesthesia,Current,,
4550,Ropivacaine Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,0.2% 2mg/mL 10x200mL (NDC 25021-671-87),Reverified,10/22/20,Available,,,,Anesthesia,Current,,
4551,Ropivacaine Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"0.5% 5mg/mL, 30mL, 1 Vial (NDC 17478-0081-30)",Reverified,12/2/19,Available,,,Other,Anesthesia,Current,,
4552,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,20 mg/10 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9300-10),Revised,11/20/20,Next Delivery: November 2020; Estimated Recovery: January 2021,,,Demand increase for the drug,Anesthesia,Current,,
4553,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,40 mg/20 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9300-20),Revised,11/20/20,Next Delivery: November 2020; Estimated Recovery: February 2021,,,Demand increase for the drug,Anesthesia,Current,,
4554,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9301-30),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
4555,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,150 mg/20 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9302-20),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
4556,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9303-10),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
4557,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9303-20),Revised,11/20/20,Limited Supply Available. Next Delivery: January 2021; Estimated Recovery: February 2021,,,Demand increase for the drug,Anesthesia,Current,,
4558,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.2% 20 mL Single Dose Vials (NDC 55150-195-20),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
4559,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.2% 100 mL Single Dose Infusion Bottles (NDC 55150-196-99),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
4560,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 20 mL Single Dose Vials (NDC 55150-197-20),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
4561,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 30 mL Single Dose Vials (NDC 55150-198-30),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
4562,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.75% 20 mL Single Dose Vials (NDC 55150-199-20),Revised,11/20/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
4563,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 10 mL Single Dose Vials (NDC 55150-200-10),Revised,11/20/20,Currently on backorder - next shipment anticipated late Dec 20,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
4564,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 20 mL Single Dose Vials (NDC 55150-201-20),Revised,11/20/20,Currently on backorder - next shipment anticipated late Dec 20,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
4565,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (20 mg per 10 mL), Plastic Ampule, Sterile-Pak (NDC 63323-285-10)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4566,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (40 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-285-20)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4567,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (100 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-286-20)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4568,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"7.5 mg per mL / 0.75% (150 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-287-20)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4569,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (100 mg per 10 mL), Plastic Ampule, Sterile-Pak (63323-288-10)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4570,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (200 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-288-20)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4571,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (200 mg per 100 mL), Single Dose Free Flex Bag (NDC 63323-285-61)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4572,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (400 mg per 200 mL), Single Dose Free Flex Bag (NDC 63323-285-63)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4573,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (200 mg per 100 mL), Single Dose Infusion Bottle (NDC 63323-285-65)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4574,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (400 mg per 200 mL), Single Dose Infusion Bottle (NDC 63323-285-64)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4575,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (500 mg per 100 mL), Single Dose Infusion Bottle (NDC 63323-286-00)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4576,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (1,000 mg per 200 mL), Single Dose Infusion Bottle (NDC 63323-286-63)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4577,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (20 mg per 10 mL), Single Dose Vial (NDC 63323-285-13)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4578,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (40 mg per 20 mL), Single Dose Vial (NDC 63323-285-23)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4579,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (150 mg per 30 mL), Single Dose Vial (NDC 63323-286-35)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4580,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (100 mg per 20 mL), Single Dose Vial (NDC 63323-286-23)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4581,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"7.5 mg per mL / 0.75% (150 mg per 20 mL), Single Dose Vial (NDC 63323-287-21)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4582,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (100 mg per 10 mL), Single Dose Vial (NDC 63323-288-11)",Revised,11/16/20,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
4583,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (200 mg per 20 mL), Single Dose Vial (NDC 63323-288-21)",Revised,11/16/20,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
4584,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (150 mg per 30 mL), Sterile-Pack, Single Dose Vial (NDC 63323-286-31)",Revised,11/16/20,Available,Check wholesaler for inventory,,,Anesthesia,Current,,
4585,Saquinavir Mesylate (Invirase) 200mg Capsules,"Genentech, Inc",877-436-3683,200 mg capsules (NDC 0004-0245-15),New,2/6/18,,"Roche intends to stop-shipping Saquinavir Mesylate (Invirase) 200 mg Capsules on March 31, 2018 with product availability continuing until the September 2018 expiry date.  Saquinavir Mesylate (Invirase) 500mg Tablets are still available.",,,Antiviral,To be Discontinued,2/6/18,2/6/18
4586,Sclerosol Intrapleural Aerosol,Lymol Medical Corp.,781-935-0004,Sclerosol 4 GM (NDC 63256-100-30),Reverified,12/11/19,Unavailable,,,Other,Pulmonary/Allergy,Current,,
4587,Scopolamine Transdermal System,GlaxoSmithKline,908-293-5330,Transderm (Scopolamine) 1.5 mg Patch 10 count (NDC 10019-553-03),Revised,12/11/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
4588,Scopolamine Transdermal System,GlaxoSmithKline,908-293-5330,Transderm (Scopolamine) 1.5 mg Patch 24 count (NDC 10019-553-04),Revised,12/11/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
4589,Scopolamine Transdermal System,GlaxoSmithKline,908-293-5330,Transderm (Scopolamine) 1.5 mg Patch 4 count (NDC 66758-208-54),Revised,12/11/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
4590,Scopolamine Transdermal System,Perrigo Pharmaceuticals,866-634-9120,"Scopolamine Transdermal System, 1mg/3days 4-Count Pack (NDC 45802-580-84)",Revised,12/11/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
4591,Scopolamine Transdermal System,Perrigo Pharmaceuticals,866-634-9120,"Scopolamine Transdermal System, 1mg/3days 10-Count Pack (NDC 45802-580-46)",Revised,12/11/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
4592,Scopolamine Transdermal System,Perrigo Pharmaceuticals,866-634-9120,"Scopolamine Transdermal System, 1mg/3days 24-Count Pack (NDC 45802-580-62)",Revised,12/10/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
4593,Scopolamine Transdermal System,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/3 days 4s (NDC 0378-6470-99),Revised,12/10/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
4594,Scopolamine Transdermal System,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/3 days 10s (NDC 0378-6470-97),Revised,12/10/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
4595,Scopolamine Transdermal System,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/3 days 24s (NDC 0378-6470-44),Revised,12/10/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
4596,"Sertraline Hydrochloride Oral Solution, USP",Aurobindo Pharma,866-850-2876,"20mg/ml, 60ml  (NDC 16714-601-01)",Revised,7/10/20,Unavailable,Northstar Rx label. Product Distributed by: McKesson (972-446-4800),,Other,Psychiatry,Current,,
4597,"Sertraline Hydrochloride Oral Solution, USP",Aurobindo Pharma,866-850-2876,20mg/ml (NDC 64980-409-06),Revised,7/10/20,Currently available,Distributed by Rising Pharmaceuticals Contact Rising Pharmaceuticals : +1 (201) 961-9000,,Other,Psychiatry,Current,,
4598,"Sertraline Hydrochloride Oral Solution, USP",Pfizer Pharmaceuticals,800-533-4535,"Sertraline Hydrochloride 60 mL (20 mg/mL) oral concentrate, with 12% alcohol; bottle with calibrated dropper (NDC 59762-0067-1)",Reverified,11/20/20,Available,,,Other,Psychiatry,Current,,
4599,"Sertraline Hydrochloride Oral Solution, USP",Pfizer Pharmaceuticals,800-533-4535,"Zoloft (sertraline hydrochloride) 60 mL (20 mg/mL) oral concentrate, with 12% alcohol; bottle with calibrated dropper (NDC 0049-0050-01)",Reverified,11/20/20,Available,,,Other,Psychiatry,Current,,
4600,"Sertraline Hydrochloride Oral Solution, USP",Aurobindo Pharma,866-850-2876,"20mg/ml, 60ml  (NDC 16714-601-02)",New,7/10/20,Available,Northstar Rx label. Product Distributed by: McKesson (972-446-4800 ),,Demand increase for the drug,Psychiatry,Current,,
4601,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","25 mg, 30 count (NDC 16729-215-10)",Revised,8/31/20,Available,,,,Pediatric;Psychiatry,Current,,
4602,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","25 mg, 90 count (NDC 16729-215-15)",Revised,8/31/20,Available,,,,Pediatric;Psychiatry,Current,,
4603,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","25 mg, 500 count (NDC 16729-215-16)",Revised,8/31/20,Limited supply/out of stock. Cannot supoort monthly demand. Estimated shortage duration: 90 days.,API delivery has been delayed due to the impacts caused by COVID-19. Manufacturing and Packaging utilization and allocation process remains active.,,Other,Pediatric;Psychiatry,Current,,
4604,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","50 mg, 90 count (NDC 16729-216-15)",Revised,8/31/20,Limited supply/out of stock. Cannot supoort monthly demand. Estimated shortage duration: 90 days.,API delivery has been delayed due to the impacts caused by COVID-19. Manufacturing and Packaging utilization and allocation process remains active.,,Other,Pediatric;Psychiatry,Current,,
4605,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","50 mg, 500 count (NDC 16729-216-16)",Revised,8/31/20,Limited supply / out of stock.  Cannot support monthly demand.  Estimated shortage duration: 90 days.,API delivery has been delayed due to the impacts caused by COVID-19. Manufacturing and Packaging utilization and allocation process remains active.,,Other,Pediatric;Psychiatry,Current,,
4606,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","100 mg, 90 count (NDC 16729-217-15)",Revised,8/31/20,Limited supply / out of stock.  Cannot support monthly demand. Estimated shortage duration: 90 days.,API delivery has been delayed due to the impacts caused by COVID-19. Manufacturing and Packaging utilization and allocation process remains active.,,Other,Pediatric;Psychiatry,Current,,
4607,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","100 mg, 500 count (NDC 16729-217-16)",Revised,8/31/20,Limited supply / out of stock.  Cannot support monthly demand. Estimated shortage duration: 90 days.,API delivery has been delayed due to the impacts caused by COVID-19. Manufacturing and Packaging utilization and allocation process remains active.,,Other,Pediatric;Psychiatry,Current,,
4608,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 30 count (NDC 65862-011-30)",Reverified,8/31/20,Available,Sufficient quantities available for current and future demand increases.,,,Pediatric;Psychiatry,Current,,
4609,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 100 count (NDC 65862-011-01)",Reverified,8/31/20,Available,Sufficient quantities available for current and future demand increases.,,,Pediatric;Psychiatry,Current,,
4610,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 500 count (NDC 65862-011-05)",Reverified,8/31/20,Available,Sufficient quantities available for current and future demand increases.,,,Pediatric;Psychiatry,Current,,
4611,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 30 count (NDC 65862-012-30)",Reverified,8/31/20,Available,Sufficient quantities available for current and future demand increases.,,,Pediatric;Psychiatry,Current,,
4612,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 100 count (NDC 65862-012-01)",Reverified,8/31/20,Available,Sufficient quantities available for current and future demand increases.,,,Pediatric;Psychiatry,Current,,
4613,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 500 count (NDC 65862-012-05)",Reverified,8/31/20,Available,Sufficient quantities available for current and future demand increases.,,,Pediatric;Psychiatry,Current,,
4614,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 30 count (NDC 65862-013-30)",Reverified,8/31/20,Available,Sufficient quantities available for current and future demand increases.,,,Pediatric;Psychiatry,Current,,
4615,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 100 count (NDC 65862-013-01)",Reverified,8/31/20,Available,Sufficient quantities available for current and future demand increases.,,,Pediatric;Psychiatry,Current,,
4616,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 500 count (NDC 65862-013-05)",Reverified,8/31/20,Available,Sufficient quantities available for current and future demand increases.,,,Pediatric;Psychiatry,Current,,
4617,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 30 count (NDC 16714-611-01)",Reverified,8/31/20,Available,Northstar Rx label. Product distributed by: McKesson (972-446-4800),,,Pediatric;Psychiatry,Current,,
4618,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 100 count (NDC 16714-611-04)",Reverified,8/31/20,Available,Northstar Rx label. Product distributed by: McKesson (972-446-4800),,,Pediatric;Psychiatry,Current,,
4619,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 500 count (NDC 16714-611-05)",Reverified,8/31/20,Available,Northstar Rx label. Product distributed by: McKesson (972-446-4800),,,Pediatric;Psychiatry,Current,,
4620,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 1000 count (NDC 16714-611-06)",Reverified,8/31/20,Available,Northstar Rx label. Product distributed by: McKesson (972-446-4800),,,Pediatric;Psychiatry,Current,,
4621,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 30 count (NDC 16714-612-01)",Reverified,8/31/20,Available,Northstar Rx label. Product distributed by: McKesson (972-446-4800),,,Pediatric;Psychiatry,Current,,
4622,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 100 count (NDC 16714-612-04)",Reverified,8/31/20,Available,Northstar Rx label. Product distributed by: McKesson (972-446-4800),,,Pediatric;Psychiatry,Current,,
4623,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 500 count (NDC 16714-612-05)",Reverified,8/31/20,Available,Northstar Rx label. Product distributed by: McKesson (972-446-4800),,,Pediatric;Psychiatry,Current,,
4624,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 1000 count (NDC 16714-612-06)",Reverified,8/31/20,Available,Northstar Rx label. Product distributed by: McKesson (972-446-4800),,,Pediatric;Psychiatry,Current,,
4625,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 30 count (NDC 16714-613-01)",Reverified,8/31/20,Available,Northstar Rx label. Product distributed by: McKesson (972-446-4800),,,Pediatric;Psychiatry,Current,,
4626,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 100 count (NDC 16714-613-04)",Reverified,8/31/20,Available,Northstar Rx label. Product distributed by: McKesson (972-446-4800),,,Pediatric;Psychiatry,Current,,
4627,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 500 count (NDC 16714-613-05)",Reverified,8/31/20,Available,Northstar Rx label. Product distributed by: McKesson (972-446-4800),,,Pediatric;Psychiatry,Current,,
4628,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 1000 count (NDC 16714-613-06)",Reverified,8/31/20,Available,Northstar Rx label. Product distributed by: McKesson (972-446-4800),,,Pediatric;Psychiatry,Current,,
4629,Sertraline Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,Zoloft 25 mg; Bottle of 30 tablets (NDC 0049-4960-30),Reverified,11/20/20,Available,,,Other,Pediatric;Psychiatry,Current,,
4630,Sertraline Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,Zoloft 50 mg; Bottle of 30 tablets (NDC 0049-4900-30),Reverified,11/20/20,Available,,,Other,Pediatric;Psychiatry,Current,,
4631,Sertraline Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,Zoloft 50 mg; Blister of 10 tablets (NDC 0049-4900-41),Reverified,11/20/20,Available,,,Other,Pediatric;Psychiatry,Current,,
4632,Sertraline Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,Zoloft 100 mg; Bottle of 30 tablets (NDC 0049-4910-30),Reverified,11/20/20,Available,,,Other,Pediatric;Psychiatry,Current,,
4633,Sertraline Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,Zoloft 100 mg; Blister of 10 tablets (NDC 0049-4910-41),Reverified,11/20/20,Available,,,Other,Pediatric;Psychiatry,Current,,
4634,Sertraline Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,25 mg; Bottle of 30 tablets (NDC 59762-6347-1),Reverified,11/20/20,Available,,,Other,Pediatric;Psychiatry,Current,,
4635,Sertraline Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,50 mg; Bottle of 30 tablets (NDC 59762-6443-1),Reverified,11/20/20,Available,,,Other,Pediatric;Psychiatry,Current,,
4636,Sertraline Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,50 mg; Bottle of 100 tablets (NDC 59762-6443-2),Reverified,11/20/20,Next Delivery and Estimated Recovery: March 2022,,,Demand increase for the drug,Pediatric;Psychiatry,Current,,
4637,Sertraline Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,50 mg; Bottle of 500 tablets (NDC 59762-6443-3),Reverified,11/20/20,Next Delivery and Estimated Recovery: March 2022,,,Other,Pediatric;Psychiatry,Current,,
4638,Sertraline Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mg; Bottle of 30 tablets (NDC 59762-5160-1),Reverified,11/20/20,Available,,,Other,Pediatric;Psychiatry,Current,,
4639,Sertraline Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mg; Bottle of 100 tablets (NDC 59762-5160-2),Reverified,11/20/20,Available,,,Demand Increase for the drug,Pediatric;Psychiatry,Current,,
4640,Sertraline Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mg; Bottle of 500 tablets (NDC 59762-5160-3),Reverified,11/20/20,Next Delivery and Estimated Recovery: March 2022,,,Other,Pediatric;Psychiatry,Current,,
4641,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"25 mg, 30 count (NDC 68180-351-06)",Reverified,9/1/20,"Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months.",,,Shortage of an active ingredient.,Pediatric;Psychiatry,Current,,
4642,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"25 mg, 90 count  (NDC 68180-351-09)",Reverified,9/1/20,"Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months.",,,Shortage of an active ingredient.,Pediatric;Psychiatry,Current,,
4643,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"25 mg, 1000 count (NDC 68180-351-03)",Reverified,9/1/20,"Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months.",,,Shortage of an active ingredient.,Pediatric;Psychiatry,Current,,
4644,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 30 count (NDC 68180-352-06)",Reverified,9/1/20,"Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months.",,,Shortage of an active ingredient.,Pediatric;Psychiatry,Current,,
4645,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 90 count (NDC 68180-352-09)",Reverified,9/1/20,"Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months.",,,Shortage of an active ingredient.,Pediatric;Psychiatry,Current,,
4646,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 500 count (NDC 68180-352-02)",Reverified,9/1/20,"Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months.",,,Shortage of an active ingredient.,Pediatric;Psychiatry,Current,,
4647,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 5000 count (NDC 68180-352-05)",Reverified,9/1/20,"Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months.",,,Shortage of an active ingredient.,Pediatric;Psychiatry,Current,,
4648,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 30 count (NDC 68180-353-06)",Reverified,9/1/20,"Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months.",,,Shortage of an active ingredient.,Pediatric;Psychiatry,Current,,
4649,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 90 count (NDC 68180-353-09)",Reverified,9/1/20,"Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months.",,,Shortage of an active ingredient.,Pediatric;Psychiatry,Current,,
4650,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 500 count (NDC 68180-353-02)",Reverified,9/1/20,"Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months.",,,Shortage of an active ingredient.,Pediatric;Psychiatry,Current,,
4651,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 5000 count (NDC 68180-353-05)",Reverified,9/1/20,"Continuous production but due to increase in demand and API shortage, product is/will be on/off backorder for few months.",,,Shortage of an active ingredient.,Pediatric;Psychiatry,Current,,
4652,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 30 count (NDC 69097-833-02)",Revised,9/2/20,Available,Distributed by Cipla USA Inc.,,,Pediatric;Psychiatry,Current,,
4653,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 90 count (NDC 69097-833-05)",Revised,9/2/20,Available,Distributed by Cipla USA Inc.,,,Pediatric;Psychiatry,Current,,
4654,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 500 count (NDC 69097-833-12)",Revised,9/2/20,Available,Distributed by Cipla USA Inc.,,,Pediatric;Psychiatry,Current,,
4655,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 30 count (NDC 69097-834-02)",Revised,9/2/20,Available,Distributed by Cipla USA Inc.,,,Pediatric;Psychiatry,Current,,
4656,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 500 count (NDC 69097-834-12)",Revised,9/2/20,Available,Distributed by Cipla USA Inc.,,,Pediatric;Psychiatry,Current,,
4657,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 30 count (NDC 69097-835-02)",Revised,9/2/20,Available,Distributed by Cipla USA Inc.,,,Pediatric;Psychiatry,Current,,
4658,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 500 count (NDC 69097-835-12)",Revised,9/2/20,Available,Distributed by Cipla USA Inc.,,,Pediatric;Psychiatry,Current,,
4659,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 30 count (NDC 76282-212-30)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4660,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 60 count (NDC 76282-212-60)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4661,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 90 count (NDC 76282-212-90)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4662,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 100 count (NDC 76282-212-01)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4663,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 180 count (NDC 76282-212-18)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4664,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 500 count (NDC 76282-212-05)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4665,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 30 count (NDC 76282-213-30)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4666,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 60 count (NDC 76282-213-60)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4667,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 90 count (NDC 76282-213-90)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4668,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 100 count (NDC 76282-213-01)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4669,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 180 count (NDC 76282-213-18)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4670,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 500 count (NDC 76282-213-05)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4671,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 30 count (NDC 76282-214-30)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4672,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 60 count (NDC 76282-214-60)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4673,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 90 count (NDC 76282-214-90)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4674,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 100 count (NDC 76282-214-01)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4675,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 180 count (NDC 76282-214-18)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4676,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 500 count (NDC 76282-214-05)",Revised,9/2/20,Available,Distributed by Exellan,,,Pediatric;Psychiatry,Current,,
4677,Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,10 mg/12.5 mL; vial (NDC 0069-0338-01),Revised,10/24/19,, ,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,10/24/19,
4678,Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,20 mg; tablets (NDC 0069-4190-68),Revised,10/24/19,, ,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,10/24/19,
4679,Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,10 mg/mL (powder); bottle (NDC 0069-0336-21),Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,10/24/19,
4680,Sildenafil Citrate (REVATIO),Novitium Pharma LLC,845-652-0377,"10 mg/mL, (NDC 70954-168-10)",Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,10/24/19,
4681,Simeprevir Capsules,Janssen Pharmaceuticals,800-526-7736,150mg capsules (NDC 59676-225-28),New,5/23/18,,,,,Antiviral,To be Discontinued,5/23/18,5/23/18
4682,Simvastatin (Zocor) Tablets,Merck Sharp & Dohme Corp.,800-637-2579,5 mg Tablets bottles of 30 (NDC 0006-0726-31),New,2/6/18,,,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
4683,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,5 mg (NDC 0093-7152-98),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
4684,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,10 mg (NDCs 0093-7153-93 / 0093-7153-56 / 0093-7153-19 / 0093-7153-31 / 0093-7153-10),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
4685,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,20 mg (NDCs 0093-7154-93 / 0093-7154-56 / 0093-7154-31 / 0093-7154-19 / 0093-7154-10),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
4686,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,40 mg (NDCs 0093-7155-93 / 0093-7155-56 / 0093-7155-31 / 0093-7155-19 / 0093-7155-10),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
4687,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,80 mg (NDCs 0093-7156-98 / 0093-7156-93 / 0093-7156-56 / 0093-7156-19 / 0093-7156-10),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
4688,Sincalide (Kinevac) Lyophilized Powder for Injection,Bracco Diagnostics,877-272-2269,Supplied in packages of 10 single dose vials containing 5 mcg of sincalide per vial (NDC 0270-0556-15),Revised,9/18/19,Available,,,Delay in shipping of the drug,Medical Imaging;Other,Current,12/17/15,
4689,"Sodium Acetate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,32.8% 400 mEq 100mL PBP (NDC 63323-0032-00),Reverified,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Total Parenteral Nutrition,Current,,
4690,"Sodium Acetate Injection, USP","Hospira, Inc.",844-646-4398,100 mEq/50 mL (2 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-3299-05),Reverified,11/20/20,Available,,,Other,Total Parenteral Nutrition,Current,,
4691,"Sodium Acetate Injection, USP","Hospira, Inc.",844-646-4398,200 mEq/100 mL (2 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-3299-06),Reverified,11/20/20,Available,,,Other,Total Parenteral Nutrition,Current,,
4692,"Sodium Acetate Injection, USP","Hospira, Inc.",844-646-4398,40 mEq/20 mL (2 mEq/mL); Single Dose Plastic Fliptop Vial (NDC 00409-7299-73),Reverified,11/20/20,Available,,,Other,Total Parenteral Nutrition,Current,,
4693,"Sodium Bicarbonate Injection, USP","Hospira, Inc.",844-646-4398,Neut (Sodium Bicarbonate Additive Solution); 200 mg/5 mL (4%); Single Dose Glass Fliptop Vial (NDC 0409-6609-02),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
4694,"Sodium Bicarbonate Injection, USP","Hospira, Inc.",844-646-4398,Infant; 5 mEq/10 mL (4.2%; 0.5 mEq/mL); LifeShield Abboject Glass Syringe (NDC 0409-5534-34),Revised,11/20/20,Next Delivery and Estimated Recovery: January 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
4695,"Sodium Bicarbonate Injection, USP","Hospira, Inc.",844-646-4398,44.6 mEq/50 mL (7.5%; 0.9 mEq/mL); LifeShield Abboject Glass Syringe (NDC 0409-4916-34),Revised,11/20/20,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
4696,"Sodium Bicarbonate Injection, USP","Hospira, Inc.",844-646-4398,50 mEq/50 mL (8.4%; 1 mEq/mL); Single Dose Glass Fliptop Vial (NDC 0409-6625-02),Revised,11/20/20,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
4697,"Sodium Bicarbonate Injection, USP","Hospira, Inc.",844-646-4398,50 mEq/50 mL (8.4%; 1 mEq/mL); LifeShield Abboject Glass Syringe (NDC 0409-6637-34),Revised,11/20/20,Limited Supply Available. Next Delivery: November 2020; Estimated Recovery: December 2020,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
4698,"Sodium Bicarbonate Injection, USP","Hospira, Inc.",844-646-4398,Pediatric; 10 mEq/10 mL (8.4%; 1 mEq/mL); LifeShield Abboject Glass Syringe (NDC 0409-4900-34),Revised,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
4699,"Sodium Bicarbonate Injection, USP","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"Sodium Bicarbonate Inj. USP, 8.4%, 50mL Luer-Jet Prefilled Syringe, (NDC 0548-3352-00), (new NDC 76329-3352-1)",Reverified,10/30/20,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
4700,"Sodium Bicarbonate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"4.2% Single dose vial, 2.5 mEq per 5 mL (0.5 mEq per mL) (42 mg per mL)(NDC 63323-083-05)",Revised,11/16/20,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
4701,"Sodium Bicarbonate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"8.4% Single dose vial, 50 mEq per 50 mL (1 mEq per mL)  (84 mg per mL)(NDC 63323-089-50)",Revised,11/16/20,Backordered. Next release November 2020.,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
4702,"Sodium Bicarbonate Injection, USP","Exela Pharma Sciences, LLC",828-758-5474 ext. 154,"Sodium Bicarbonate Inj. USP, 8.4%, 50mL (NDC 51754-5001-1)",Revised,12/13/19,Available direct or through Premier's ProvideGx program at this time and through CIVICA Rx program in Q1 2020.,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
4703,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 50 mL Fleboflex Plastic Container (115 units/carton)(NDC 76297-001-11)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4704,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 100 mL Fleboflex Plastic Container (70 units/carton)(NDC 76297-001-21)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4705,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 250 mL Fleboflex Plastic Container (28 units/carton)(NDC 76297-001-31)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4706,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 500 mL Fleboflex Plastic Container (20 units/carton)(NDC NDC 76297-001-01)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4707,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 1000 mL Fleboflex Plastic Container (10 units/carton)(NDC NDC 76297-001-41)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4708,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, USP, 50 mL MINI-BAG Plus Container, VIAFLEX Plastic Container Product code 2B0042  (NDC 0338-0553-11)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4709,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, USP, 100 mL MINI-BAG Plus Container, VIAFLEX Plastic Container Product code 2B0043 (NDC 0338-0553-18)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4710,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride in Waiter for Injection, 100 mL, in VIAFLEX Container Product code ABB1307U (NDC 0338-9525-72)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4711,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, USP, 1000 mL.  Product code JB1324 (NDC 00338-9612-12)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4712,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,0.9% Sodium Chloride Injection USP 100mL fill in 150mL PAB S8004-5264 (NDC 0264-1800-32),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4713,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,0.9% Sodium Chloride Injection USP 50mL fill in 100mL PAB S8004-5384 (NDC 0264-1800-31),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4714,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,0.9% Sodium Chloride Injection USP 25mL fill in 100mL PAB S8004-5410 (NDC 0264-1800-36),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4715,Sodium Chloride 0.9% Injection Bags,"Hospira, Inc.",844-646-4398,50 mL (5-Pack); ADD-Vantage Flexible Container (NDC 00409-7101-66),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4716,Sodium Chloride 0.9% Injection Bags,"Hospira, Inc.",844-646-4398,100 mL (5-Pack); ADD-Vantage Flexible Container (NDC 00409-7101-67),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4717,Sodium Chloride 0.9% Injection Bags,"Hospira, Inc.",844-646-4398,250 mL (Dual Pack); ADD-Vantage Flexible Container (NDC 00409-7101-02),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4718,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Plastic Container.  Single pack (NDC 0338-0049-48, product code 2B1307)Quad Pack (NDC 0338-0049-18, product code 2B1302) Multi Pack (NDC 0338-0049-38, product code 2B1309)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4719,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, USP, 50 mL VIAFLEX Plastic Container.  Single Pack (NDC 0338-0049-41, product code 2B1306) Quad Pack (NDC 0338-0049-11, product code 2B1301) Multi Pack (NDC 0338-0049-31, product code 2B1308)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4720,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, USP, 25 mL VIAFLEX Plastic Container Quad Pack (NDC 0338-0049-10). Product code 2B1300",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4721,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, 0.9%, 50mL (NDC 63323-623-53)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4722,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, 0.9%, 100mL (NDC 63323-623-61)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4723,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, 0.9%, 250mL (NDC 63323-623-74)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4724,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, 0.9%, 500mL (NDC 63323-623-75)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4725,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, 0.9%, 1000mL (NDC 63323-623-76)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4726,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,Sodium Chloride 0.9% w/v Intravenous Infusion BP in the Ecoflac® plus container sizes: 500 mL (NDC 0264-9999-10),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4727,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"50 mL flexible container (Legacy Hospira NDC 0409-7984-13)
(ICU Medical NDC 0990-7984-13)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4728,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"100 mL flexible container-4 pack (Legacy Hospira NDC 0409-7984-37)
(ICU Medical NDC 0990-7984-37)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4729,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,"0.9% NaCl 250mL bag, PVC/DEHP-free (NDC 00264-7800-20)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4730,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,"0.9% NaCl 500mL bag, PVC/DEHP-free (NDC 00264-7800-10)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4731,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,"0.9% NaCl 1000mL bag, PVC/DEHP-free (NDC 00264-7800-00)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4732,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,150mL flexible container (NDC 0409-7983-61),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4733,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"250mL Vis-IV container, PVC/DEHP-free (NDC 0409-7983-25)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4734,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"250mL flexible container (Legacy Hospira NDC 0409-7983-02)
(ICU Medical NDC 0990-7983-02)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4735,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,250mL flexible container 2 port (NDC 0409-7983-53),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4736,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,500mL flexible container 2 port (NDC 0409-7983-55),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4737,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,500mL flexible container (NDC 0409-7983-03),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4738,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,1000mL flexible container (NDC 0409-7983-09),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4739,Sodium Chloride 0.9% Injection Bags,Fresenius Medical Care North America,800-323-5188,1000ml (NDC 49230-300-10),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4740,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,"Sodium Chloride 0.9% w/v Intravenous Infusion BP in the Ecoflac® plus 1,000 mL Product Code 9999-00, (NDC 0264-9999-00)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4741,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, 250 mL, in VIAFLEX Container.   Product code FZB1322 (NDC 0338-9517-50)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4742,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, 500 mL, in VIAFLEX Container.   Product code FZB1323 (NDC 0338-9517-30)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4743,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, 1,000 mL, in VIAFLEX Container.   Product code FZB1324 (NDC 0338-9517-16)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4744,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,250 mL Product code 2B1322Q (NDC 00338-0049-02),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4745,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,500 mL  Product code 2B1323Q (NDC 00338-0049-03),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4746,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"500 mL Non-PVC, Dripless Access Container (DAC)  VIAFLO Container  Product code UE1323D (NDC 0338-9543-04)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4747,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,1000 mL Product code 2B1324X (NDC 00338-0049-04),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4748,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"1000 mL Non-PVC, Dripless Access Container (DAC)  VIAFLO Container  Product code UE1324D (NDC 0338-9543-06)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4749,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"250 mL, Non-PVC, Dripless Access Container (DAC) VIAFLO Container Product code UE1322D (NDC 0338-9543-02)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4750,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"100 mL flexible container (Legacy Hospira NDC 0409-7984-23)
(ICU Medical NDC 0990-7984-23)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4751,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"100 mL Vis-IV container, PVC/DEHP-free (NDC 0409-7984-11)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4752,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"50 mL flexible container (Legacy Hospira NDC 0409-7984-36)
(ICU Medical NDC 0990-7984-36)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4753,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,25 mL flexible container (NDC 0409-7984-20),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4754,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"50 mL Vis-IV container, PVC/DEHP-free (NDC 0409-7984-06)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
4755,Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,30 mL vials (NDC 63323-0187-30),Revised,11/16/20,Backordered. Next release November 2020.,,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
4756,Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mL vials (NDC 63323-0088-61),Revised,11/16/20,Backordered. Next release November 2020.,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
4757,Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,200 mL vials (NDC 63323-0088-63),Revised,11/16/20,Backordered. Next release January 2021.,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
4758,Sodium Chloride 23.4% Injection,"Hospira, Inc.",844-646-4398,400 mEq/100 mL (4 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-1141-02),Revised,11/20/20,Next Delivery: November 2020; Estimated Recovery: December 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
4759,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Carpuject Luer Lock Glass Syringe (NDC 00409-1918-32),Reverified,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Other,Current,,
4760,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Carpuject Luer Lock Glass Syringe (NDC 00409-1918-33),Reverified,11/20/20,Next Delivery and Estimated Recovery: February 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Other,Current,,
4761,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Carpuject Luer Lock Glass Syringe (NDC 00409-1918-35),Reverified,11/20/20,Discontinued,,,Discontinuation of the manufacture of the drug,Other,Current,,
4762,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.9%, 2 mL vial (NDC 0641-0497-25)",Reverified,7/22/20,Inventory is currently available.,Additional lots will be scheduled for manufacturing as needed.  Product will be made available as it is released.,,Demand increase for the drug,Other,Current,,
4763,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (18 mg per 2 mL)(9 mg per mL) (NDC 63323-186-02)",Reverified,11/16/20,Available,Check wholesalers for inventory,,Increase in Demand,Other,Current,,
4764,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP,  Single dose plastic vial, 0.9%, (90 mg per 10 mL)(9 mg per mL) (NDC 63323-186-10)",Reverified,11/16/20,Available,Check wholesalers for inventory,,Manufacturing delay,Other,Current,,
4765,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP,  Single dose plastic vial, 0.9%, (180 mg per 20 mL)(9 mg per mL) (NDC 63323-186-20)",Reverified,11/16/20,Available,Check wholesalers for inventory,,Manufacturing delay,Other,Current,,
4766,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, Single dose tear top vial, 0.9%, (900 mg per 100 mL)(9 mg per mL) (NDC 63323-186-00)",Reverified,11/16/20,Backordered.  Next release date not available at this time.,,,Increase in Demand,Other,Current,,
4767,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,10 mL (0.9%); Single Dose Plastic Fliptop Vial (NDC 00409-4888-10),Reverified,11/20/20,Available,,,Other,Other,Current,,
4768,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,10 mL (0.9%); Single Dose LifeShield Plastic Fliptop Vial (NDC 00409-4888-12),Reverified,11/20/20,Available,,,Other,Other,Current,,
4769,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-20),Reverified,11/20/20,Available,,,Other,Other,Current,,
4770,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-50),Reverified,11/20/20,Available,,,Demand increase for the drug,Other,Current,,
4771,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Medefil, Inc.",630-682-4600,"Sodium Chloride Injection, USP, 0.9%, in a plastic syringe (10 mL) (NDC 64253-202-30)",Reverified,12/11/19,Available,Check wholesalers for inventory,,Available,Other,Current,,
4772,"Sodium Lactate Injection, USP","Hospira, Inc.",844-646-4398,50 mEq/10 mL (5 mEq/10 mL); Single Dose Plastic Fliptop Vial (NDC 00409-6664-02),New,1/9/20,,Discontinuation of the manufacture of the drug.,,,Endocrinology/Metabolism;Gastroenterology,To be Discontinued,1/9/20,1/9/20
4773,Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Phosphorus 15 mmol/mL, 5 mL, Sodium 20 mEq/5mL vials (NDC 63323-170-05)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,8/7/19,
4774,Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL (NDC 63323-170-15)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,8/7/19,
4775,Somatropin Recombinant (Humatrope) Injection,Eli Lilly and Co.,800-545-5979,5 mg kit (NDC 0002-7335-11) contains 5 mg/mL in 1 vial (NDC 0002-7349-01) of Humatrope and 5 mL in 1 vial (NDC 0002-7336-01) of Sterile Diluent,New,7/7/20,,Other Somatropin Recombinant (Humatrope) Injection products will continue to be available to treat patients.  The product distribution will continue until end of December 2020.,,,Hematology,To be Discontinued,7/7/20,7/7/20
4776,Sotalol Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"80 mg, 100 count bottle (NDC 0378-5123-01)",New,5/2/19,,,,,Cardiovascular;Pediatric,To be Discontinued,5/2/19,5/2/19
4777,Sotalol Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"120 mg, 100 count bottle (NDC 0378-5124-01)",New,5/2/19,,,,,Cardiovascular;Pediatric,To be Discontinued,5/2/19,5/2/19
4778,Sotalol Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"160 mg, 100 count bottle (NDC 0378-5125-01)",New,5/2/19,,,,,Cardiovascular;Pediatric,To be Discontinued,5/2/19,5/2/19
4779,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"25mg tablets, bottle of 100 (NDC 0228-2803-11)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
4780,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"25mg tablets, bottle of 500 (NDC 0228-2803-50)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
4781,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"50mg tablets, bottle of 100 (NDC 0228-2672-11)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
4782,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"50mg tablets, bottle of 500 (NDC 0228-2672-50)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
4783,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"100mg tablets, bottle of 100 (NDC 0228-2673-11)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
4784,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"100mg tablets, bottle of 500 (NDC 0228-2673-50)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
4785,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"25 mg, bottle of 100 (NDC 0603-5763-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
4786,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"25 mg, bottle of 500 (NDC 0603-5763-28)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
4787,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"25 mg, bottle of 1000 (NDC 0603-5763-32)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
4788,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"25 mg, bottle of 2500 (NDC 0603-5763-30)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
4789,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"50 mg, bottle of 100 (NDC 0603-5764-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
4790,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"50 mg, bottle of 500 (NDC 0603-5764-28)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
4791,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"100 mg, bottle of 100 (NDC 0603-5765-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
4792,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"100 mg, bottle of 500 (NDC 0603-5765-28)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
4793,Stavudine Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,40 mg  (NDC0378-5043-91),New,7/17/19,,,,,Antiviral,To be Discontinued,7/17/19,7/17/19
4794,Stavudine Capsules,Mylan Pharmaceuticals Inc.,800-496-9526,20mg capsules (NDC 0378-5041-91),New,4/30/18,,,,,Antiviral,To be Discontinued,4/30/18,4/30/18
4795,Sterile Water,American Regent/Luitpold,800-645-1706,5 mL vial (NDC 00517-3005-25),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4796,Sterile Water,American Regent/Luitpold,800-645-1706,10 mL vial (NDC 00517-3010-25),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4797,Sterile Water,American Regent/Luitpold,800-645-1706,20 mL vial (NDC 00517-3020-25),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4798,Sterile Water,West-Ward Pharmaceuticals,800-631-2174,10 mL Single Dose Vial (NDC 0641-6147-25),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4799,Sterile Water,B. Braun Medical Inc.,800-227-2862,Sterile Water for Injection in 500mL EXCEL container (NDC  0264-7850-10),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4800,Sterile Water,B. Braun Medical Inc.,800-227-2862,"Sterile Water for Injection in 1,000mL EXCEL container  (NDC 0264-7850-00)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4801,Sterile Water,B. Braun Medical Inc.,800-227-2862,"Sterile Water for Injection in 2,000mL Titan container (NDC  0264-7385-50)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4802,Sterile Water,B. Braun Medical Inc.,800-227-2862,"Sterile Water for Injection in 3,000mL Titan container (NDC  0264-7385-60)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4803,Sterile Water,"Hospira, Inc.",844-646-4398,20 mL; Single Dose Plastic Fliptop Vial (NDC 00409-4887-20),Revised,8/2/19,, ,,,Other,Resolved,8/2/19,
4804,Sterile Water,"Hospira, Inc.",844-646-4398,50 mL; Single Dose Plastic Fliptop Vial (NDC 00409-4887-50),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4805,Sterile Water,"Hospira, Inc.",844-646-4398,100 mL; Single Dose Glass Fliptop Vial (NDC 00409-4887-99),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4806,Sterile Water,"ICU Medical, Inc.",877-946-7747,Sterile Water for Injection 2000 mL (NDC 0409-7118-07),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4807,Sterile Water,"ICU Medical, Inc.",877-946-7747,Sterile Water for Irrigation 1000 mL (NDC 0409-7973-05),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4808,Sterile Water,"ICU Medical, Inc.",877-946-7747,Sterile Water for Irrigation 2000 mL (NDC 0409-7973-08),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4809,Sterile Water,"ICU Medical, Inc.",877-946-7747,Sterile Water for Irrigation 2000 mL (NDC 0409-7973-07),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4810,Sterile Water,"ICU Medical, Inc.",877-946-7747,"Sterile Water for Irrigation USP, 1000 mL Aqualite ™ Plastic Pour Bottle (NDC 0409-7139-09)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4811,Sterile Water,"ICU Medical, Inc.",877-946-7747,"Sterile Water for Irrigation, USP, Aqualite 500 mL (NDC 0409-6139-03)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4812,Sterile Water,"ICU Medical, Inc.",877-946-7747,"Sterile Water for Irrigation, USP 1500 mL (NDC 0409-7139-36)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4813,Sterile Water,"ICU Medical, Inc.",877-946-7747,"Sterile Water for Irrigation, USP, Aqualite 250 mL (NDC 0409-6139-22)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4814,Sterile Water,"Hospira, Inc.",844-646-4398,10 mL; Single Dose Plastic Fliptop Vial (NDC 00409-4887-10),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4815,Sterile Water,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose vial, 5 mL fill (NDC 63323-185-05)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4816,Sterile Water,B. Braun Medical Inc.,800-227-2862,Sterile Water for Injection in 250mL EXCEL container (NDC  0264-7850-20),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4817,Sterile Water,Baxter Healthcare,888-229-0001,"Sterile Water for Injection, USP (For Drug Diluent Use Only), 1000 mL VIAFLEX Plastic Container. Product code 2B0304X (NDC 0338-0013-04)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4818,Sterile Water,"ICU Medical, Inc.",877-946-7747,Sterile Water for Injection 1000 mL (NDC 0409-7990-09),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4819,Sterile Water,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, plastic vial, 10 mL fill (NDC 63323-185-10)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4820,Sterile Water,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, plastic vial, 20 mL fill (NDC 63323-185-20)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4821,Sterile Water,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, plastic vial, 50 mL fill (NDC 63323-185-50)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4822,Sterile Water,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, tear top vial, 100 mL (NDC 63323-185-00)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4823,Sterile Water,Baxter Healthcare,888-229-0001,"Sterile Water for Injection, USP in 2000 mL VIAFLEX Plastic Container. Pharmacy Bulk Package.   Product code 2B0306 (NDC 0338-0013-06)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4824,Sterile Water,Baxter Healthcare,888-229-0001,"Sterile Water for Injection, USP in 3000 mL VIAFLEX Plastic Container. Pharmacy Bulk Package.  Product code 2B0307  (NDC 0338-0013-08)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4825,Sterile Water,Baxter Healthcare,888-229-0001,"Sterile Water for Injection, USP in 5000 mL VIAFLEX Plastic Container, Pharmacy Bulk Package. Product code 2B0309 (NDC 0338-0013-29)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
4826,Sulfasalazine Tablets,Teva Pharmaceuticals,800-545-8800,500 mg 100 Count (NDC 00591-0796-01),Reverified,11/19/20,Available,,,,Gastroenterology,Current,,
4827,Sulfasalazine Tablets,Teva Pharmaceuticals,800-545-8800,500 mg 1000 Count (NDC 00591-0796-10),Reverified,11/19/20,Available,,,,Gastroenterology,Current,,
4828,Sulfasalazine Tablets,Teva Pharmaceuticals,800-545-8800,500 mg 500 Count (NDC 00591-0796-05),Reverified,11/19/20,Available,,,,Gastroenterology,Current,,
4829,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE (Sulfasalazine tablets) 500 mg tablets; Bottle of 100 (NDC 0013-0101-10),Revised,11/20/20,Available,,,Other,Gastroenterology,Current,,
4830,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE (Sulfasalazine tablets) 500 mg tablets; Bottle of 300 (NDC 0013-0101-20),Revised,11/20/20,Available,,,Other,Gastroenterology,Current,,
4831,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE EN-tabs® (Sulfasalazine delayed release tablets) 500 mg Delayed-Release tablets; Bottle of 100 (NDC 0013-0102-50),Revised,11/20/20,Next Delivery and Estimated Recovery: December 2020,,,Other,Gastroenterology,Current,,
4832,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE EN-tabs® (Sulfasalazine delayed release tablets) 500 mg Delayed-Release tablets; Bottle of 300 (NDC 0013-0102-20),Revised,11/20/20,Available,,,Other,Gastroenterology,Current,,
4833,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,Sulfasalazine Delayed-Release Tablets 500 mg Delayed-Release tablets; bottle of 100 (NDC 59762-0104-1/59762-0104-5),Revised,11/20/20,Next Delivery: March 2021; Estimated recovery: TBD,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
4834,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,Sulfasalazine Delayed-Release Tablets 500 mg Delayed-Release tablets; bottle of 300 (NDC 59762-0104-6),Revised,11/20/20,Next Delivery: January 2021; Estimated recovery: TBD,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
4835,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets; bottle of 100 (NDC 59762-5000-1/59762-5000-5),Revised,11/20/20,Next Delivery: March 2021; Estimated Recovery: TBD,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
4836,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets; bottle of 300 (NDC 59762-5000-6),Revised,11/20/20,Next Delivery: January 2021; Estimated recovery: TBD,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
4837,Sumatriptan (Sumavel DosePro) Injection,"Endo Pharmaceuticals, Inc.",800-462-3636,Sumavel DosePro (sumatriptan injection) 6mg/0.5mL (NDC 63481-367-06),New,2/27/18,,A business decision has been made to discontinue Sumavel DosePro 6 mg/0.5mL.,,,Neurology,To be Discontinued,2/27/18,2/27/18
4838,Sumatriptan Succinate (Imitrex) Injection,GlaxoSmithKline,888-825-5249,"6 mg, single dose vial (NDC 0173-0449-02)",New,4/3/20,,A business decision was made to discontinue manufacture of the drug product. The anticipated date that GSK will cease distribution of the product is approximately August 2020.,,,Neurology,To be Discontinued,4/3/20,4/3/20
4839,Sumatriptan Succinate Injection,Mylan Institutional,800-796-9526,"6 mg/0.5 mL, single-dose vial (NDC 67457-880-05)",New,2/21/20,,Expected discontinuation August 2020 (short dating),,,Neurology,To be Discontinued,2/21/20,2/21/20
4840,Sumatriptan Succinate Injection,Teva Pharmaceuticals,800-545-8800,6 mg/0.5 mL  (NDC 0703-7351-01),New,12/5/19,,,,,Neurology,To be Discontinued,12/5/19,12/5/19
4841,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,0.5 mg (NDC 55111-525-01),Reverified,11/13/20,Can only supply contracted customers,Manufacturer extended lead times.,,Demand increase for the drug,Transplant,Current,,
4842,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,1 mg (NDC 55111-526-01),Reverified,11/13/20,Can only supply contracted customers,Manufacturer extended lead times.,,Demand increase for the drug,Transplant,Current,,
4843,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,5 mg (NDC 55111-527-01),Reverified,11/13/20,Can only supply contracted customers,Manufacturer extended lead times.,,Demand increase for the drug,Transplant,Current,,
4844,Tacrolimus Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"0.5 mg, 100s (NDC 0378-2045-01)",Reverified,11/10/20,Available,,,,Transplant,Current,,
4845,Tacrolimus Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"1 mg, 100s (NDC 0378-2046-01)",Reverified,11/10/20,Available,,,,Transplant,Current,,
4846,Tacrolimus Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100s (NDC 0378-2047-01)",Reverified,11/10/20,Available,,,,Transplant,Current,,
4847,Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",0.5 mg 100 count (NDC 1672904101),Revised,9/14/20,Limited supply availability. Product will be allocated until Q1 2021,,,Limited API availability,Transplant,Current,,
4848,Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",1 mg 100 count (NDC 1672904201),Revised,9/14/20,Limited supply availability. Product will be allocated until Q1 2021,,,Limited API availability,Transplant,Current,,
4849,Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",5 mg 100 count (NDC 1672904301),Revised,9/14/20,Limited supply availability. Product will be allocated until Q1 2021,,,Limited API availability,Transplant,Current,,
4850,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 0.75 mg Extended-Release Tablets 30 count (NDC 68992-3075-3),Reverified,9/30/20,Available,,,,Transplant,Current,,
4851,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 0.75 mg Extended-Release Tablets 100 count (NDC 68992-3075-1),Reverified,9/30/20,Available,,,,Transplant,Current,,
4852,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 1 mg Extended-Release Tablets 30 count (NDC 68992-3010-3),Reverified,9/30/20,Available,,,,Transplant,Current,,
4853,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 1 mg Extended-Release Tablets 100 count (NDC 68992-3010-1),Reverified,9/30/20,Available,,,,Transplant,Current,,
4854,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 4 mg Extended-Release Tablets 30 count (NDC 68992-3040-3),Reverified,9/30/20,Available,,,,Transplant,Current,,
4855,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 4 mg Extended-Release Tablets 100 count (NDC 68992-3040-1),Reverified,9/30/20,Available,,,,Transplant,Current,,
4856,Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,1 mg 100 count bottles (NDC 64338-721-06),Revised,11/9/20,Available,,,,Transplant,Current,,
4857,Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,0.5 mg 100 count bottles (NDC 64380-720-06),Revised,11/9/20,Available,,,,Transplant,Current,,
4858,Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,5 mg 100 count bottles (NDC 64380-722-06),Revised,11/9/20,Available,,,,Transplant,Current,,
4859,Tacrolimus Capsules,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-2102-01),Revised,11/13/20,Intermittent supply until Feb/Mar 2021,,,Demand increase for the drug,Transplant,Current,,
4860,Tacrolimus Capsules,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-2103-04),Revised,11/13/20,Intermittent supply until Feb/Mar 2021,,,Demand increase for the drug,Transplant,Current,,
4861,Tacrolimus Capsules,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-2104-01),Revised,11/13/20,Available,,,Demand increase for the drug,Transplant,Current,,
4862,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 0.5 mg 100 count bottle (NDC 0469-0607-73),Reverified,9/11/20,Available,,,,Transplant,Current,,
4863,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 5 mg 100 count bottle (NDC 0469-0657-73),Reverified,9/11/20,Available,,,,Transplant,Current,,
4864,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 1 mg 100 count bottle (NDC 0469-0617-73),Reverified,9/11/20,Available,,,,Transplant,Current,,
4865,Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 0.5 mg 30 count bottle (NDC 0469-0647-73),Reverified,9/11/20,Available,,,,Transplant,Current,,
4866,Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 1 mg 30 count bottle (NDC 0469-0677-73),Reverified,9/11/20,Available,,,,Transplant,Current,,
4867,Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 5 mg 30 count bottle (NDC 0469-0687-73),Reverified,9/11/20,Available,,,,Transplant,Current,,
4868,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® Granules (tacrolimus for oral suspension) 0.2 mg unit dose packets (NDC 0469-1230-50),Reverified,9/11/20,Available,,,,Transplant,Current,,
4869,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® Granules (tacrolimus for oral suspension) 1 mg unit dose packets (NDC 0469-1330-50),Reverified,9/11/20,Available,,,,Transplant,Current,,
4870,Tacrolimus Capsules,"BPI Labs, LLC",727-471-0850 ext. 275,1 mg 100 count bottle (NDC 54288-135-01),Reverified,9/9/20,Available,,,,Transplant,Current,,
4871,"Talwin (Pentazocine Lactate Injection, USP, CIV)","Hospira, Inc.",844-646-4398,30 mg/mL; 1 mL glass ampul (NDC 00409-1941-01),New,4/16/18,,Discontinuation of the manufacture of the drug.,,,Analgesia/Addiction,To be Discontinued,4/16/18,4/16/18
4872,Technetium Tc99m Succimer Injection (DMSA),GE Healthcare,800-292-8514,DMSA Kit for the Preparation of Technetium Tc99m Succimer Injection (NDC 17156-525-01),Revised,12/20/19,,,,,Medical Imaging,To be Discontinued,12/20/19,12/20/19
4873,Technetium Tc99m Succimer Injection (DMSA),Theragnostics Inc.,617-286-7479,ROTOP DMSA (Kit for the Preparation of Technetium Tc99m Succimer Injection). One vial contains 1.74 mg powder with the active substance: 1.0 mg succimer.  Five vials included in a carton (NDC 71647-001-01),Reverified,12/10/19,Available,"Due to the current critical shortage of DMSA Kit for the Preparation of Technetium Tc99m Succimer, Theragnostics Inc. (Theragnostics) is coordinating with the U.S. Food and Drug Administration (FDA) to increase the availability of the drug.  Theragnostics has initiated temporary importation of DMSA Kit for the Preparation of Technetium Tc99m Succimer Injection into the U.S. market. This product is marketed in Germany and is manufactured in Dresden, Germany by ROTOP Pharmaka GmbH for Theragnostics.",,Other,Medical Imaging,Current,,
4874,Telmisartan and Amlodipine (Twynsta) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",203-798-4375,"Telmisartan and Amlodipine (Twynsta) tablets 80mg/10mg, 30 count blister (NDC 0597-0127-37)",New,3/6/18,,"Discontinuation is the result of a business decision made by Boehringer lngelheim Pharmaceuticals, Inc. All other strengths of Twynsta® tablets are still available.",,,Cardiovascular,To be Discontinued,3/6/18,3/6/18
4875,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"5 mg child-resistent sachets, 5 count (NDC 0085-3004-03)",New,1/23/20,,To be discontinued on or near March 2020.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4876,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"5 mg child-resistent sachets, 14 count (NDC 0085-3004-04)",New,1/23/20,,To be discontinued on or near March 2020.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4877,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"20 mg child-resistent sachets, 5 count (NDC 0085-1519-03)",New,1/23/20,,To be discontinued on or near Jun 2020.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4878,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"20 mg child-resistent sachets, 14 count (NDC 0085-1519-04)",New,1/23/20,,Discontinued in 2018.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4879,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"140 mg child-resistent sachets, 5 count (NDC 0085-1425-03)",New,1/23/20,,To be discontinued on or near Aug 2020.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4880,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"180 mg child-resistent sacehts, 14 count (NDC 0085-1430-04)",New,1/23/20,,Discontinued in 2018.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4881,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"5 mg, 5 capsules (NDC 0781-2691-75)",New,1/23/20,,Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4882,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"5 mg, 14 capsules (NDC 0781-2691-44)",New,1/23/20,,Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4883,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"20 mg, 5 capsules (NDC 0781-2692-75)",New,1/23/20,,Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4884,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"20 mg, 14 capsules (NDC 0781-2692-44)",New,1/23/20,,Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4885,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"100 mg, 5 capsules (NDC 0781-2693-75)",New,1/23/20,,Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4886,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"100 mg, 14 capsules (MDC 0781-2693-44)",New,1/23/20,,Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4887,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"140 mg, 5 capsules (NDC 0781-2694-75)",New,1/23/20,,Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4888,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"140 mg, 14 capsules (NDC 0781-2694-44)",New,1/23/20,,Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4889,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"180 mg, 5 capsules (NDC 0781-2695-75)",New,1/23/20,,Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4890,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"180 mg, 14 capsules (NDC 0781-2695-44)",New,1/23/20,,Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4891,Temozolomide (TEMODAR) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"250 mg, 5 capsules (NDC 0781-2696-75)",New,1/23/20,,Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.,,,Oncology,To be Discontinued,1/23/20,1/23/20
4892,Temozolomide Capsules,Teva Pharmaceuticals,800-545-8800,5 mg  (NDCs 0093-7599-41 and 0093-7599-57),New,5/8/20,,,,,Oncology,To be Discontinued,5/8/20,5/8/20
4893,Temozolomide Capsules,Teva Pharmaceuticals,800-545-8800,20 mg  (NDCs 0093-7600-41 and 0093-7600-57),New,5/8/20,,,,,Oncology,To be Discontinued,5/8/20,5/8/20
4894,Temozolomide Capsules,Teva Pharmaceuticals,800-545-8800,100 mg  (NDCs 0093-7601-41 and 0093-7601-57),New,5/8/20,,,,,Oncology,To be Discontinued,5/8/20,5/8/20
4895,Temozolomide Capsules,Teva Pharmaceuticals,800-545-8800,140 mg (NDCs 0093-7638-41 and 0093-7638-57),New,5/8/20,,,,,Oncology,To be Discontinued,5/8/20,5/8/20
4896,Temozolomide Capsules,Teva Pharmaceuticals,800-545-8800,180 mg (NDCs 0093-7639-41 and 0093-7639-57),New,5/8/20,,,,,Oncology,To be Discontinued,5/8/20,5/8/20
4897,Temozolomide Capsules,Teva Pharmaceuticals,800-545-8800,250 mg (NDC 0093-7602-57),New,5/8/20,,,,,Oncology,To be Discontinued,5/8/20,5/8/20
4898,Testosterone Buccal System,"Endo Pharmaceuticals, Inc.",800-462-3636,"Striant® 30 mg, 6 blister cards, 60 buccal system  (NDC 52244-030-60)",New,8/21/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Reproductive,To be Discontinued,8/21/19,8/21/19
4899,Testosterone Gel 1%,Par Pharmaceutical,800-828-9393,"2.5 g, 30 packets (NDC 49884-418-72)",New,4/29/19,,Par has made a business decision to discontinue the drug product.,,,Reproductive,To be Discontinued,4/29/19,4/29/19
4900,Testosterone Gel 1%,Par Pharmaceutical,800-828-9393,"5 g, 30 packets (NDC 49884-510-72)",New,4/29/19,,Par has made a business decision to discontinue the drug product.,,,Reproductive,To be Discontinued,4/29/19,4/29/19
4901,Testosterone Topical Gel,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",50mg/5g topical gel (NDC 0254-1012-11),New,4/3/20,,,,,Reproductive,To be Discontinued,4/3/20,4/3/20
4902,Theophylline Extended Release Tablets and Capsules,Teva Pharmaceuticals,800-545-8800,"100 mg, 100 count (NDC 50111-0483-01)",New,8/11/20,,"Business decision to discontinue. The both 100 mg presentations, both 200 mg presentation and 300 mg 100 count have been unavailable since Dec 2015. The 300 mg 100 count, 300 mg 500 count and 450 mg presentations have been unavailable since Jan 2016.",,,Pulmonary/Allergy,To be Discontinued,8/11/20,8/11/20
4903,Theophylline Extended Release Tablets and Capsules,Teva Pharmaceuticals,800-545-8800,"100 mg, 500 count (NDC 50111-0483-02)",New,8/11/20,,"Business decision to discontinue. The both 100 mg presentations, both 200 mg presentation and 300 mg 100 count have been unavailable since Dec 2015. The 300 mg 100 count, 300 mg 500 count and 450 mg presentations have been unavailable since Jan 2016.",,,Pulmonary/Allergy,To be Discontinued,8/11/20,8/11/20
4904,Theophylline Extended Release Tablets and Capsules,Teva Pharmaceuticals,800-545-8800,"200 mg, 100 count (NDC 50111-0482-01)",New,8/11/20,,"Business decision to discontinue. The both 100 mg presentations, both 200 mg presentation and 300 mg 100 count have been unavailable since Dec 2015. The 300 mg 100 count, 300 mg 500 count and 450 mg presentations have been unavailable since Jan 2016.",,,Pulmonary/Allergy,To be Discontinued,8/11/20,8/11/20
4905,Theophylline Extended Release Tablets and Capsules,Teva Pharmaceuticals,800-545-8800,"200 mg, 500 count (NDC 50111-0482-02)",New,8/11/20,,"Business decision to discontinue. The both 100 mg presentations, both 200 mg presentation and 300 mg 100 count have been unavailable since Dec 2015. The 300 mg 100 count, 300 mg 500 count and 450 mg presentations have been unavailable since Jan 2016.",,,Pulmonary/Allergy,To be Discontinued,8/11/20,8/11/20
4906,Theophylline Extended Release Tablets and Capsules,Teva Pharmaceuticals,800-545-8800,"200 mg, 100 count (NDC 50111-0482-03)",New,8/11/20,,"Business decision to discontinue. The both 100 mg presentations, both 200 mg presentation and 300 mg 100 count have been unavailable since Dec 2015. The 300 mg 100 count, 300 mg 500 count and 450 mg presentations have been unavailable since Jan 2016.",,,Pulmonary/Allergy,To be Discontinued,8/11/20,8/11/20
4907,Theophylline Extended Release Tablets and Capsules,Teva Pharmaceuticals,800-545-8800,"300 mg, 100 count (NDC 50111-0459-01)",New,8/11/20,,"Business decision to discontinue. The both 100 mg presentations, both 200 mg presentation and 300 mg 100 count have been unavailable since Dec 2015. The 300 mg 100 count, 300 mg 500 count and 450 mg presentations have been unavailable since Jan 2016.",,,Pulmonary/Allergy,To be Discontinued,8/11/20,8/11/20
4908,Theophylline Extended Release Tablets and Capsules,Teva Pharmaceuticals,800-545-8800,"300 mg, 500 count (NDC 50111-0459-02)",New,8/11/20,,"Business decision to discontinue. The both 100 mg presentations, both 200 mg presentation and 300 mg 100 count have been unavailable since Dec 2015. The 300 mg 100 count, 300 mg 500 count and 450 mg presentations have been unavailable since Jan 2016.",,,Pulmonary/Allergy,To be Discontinued,8/11/20,8/11/20
4909,Theophylline Extended Release Tablets and Capsules,Teva Pharmaceuticals,800-545-8800,"300 mg, 1000 count (NDC 50111-0459-03)",New,8/11/20,,"Business decision to discontinue. The both 100 mg presentations, both 200 mg presentation and 300 mg 100 count have been unavailable since Dec 2015. The 300 mg 100 count, 300 mg 500 count and 450 mg presentations have been unavailable since Jan 2016.",,,Pulmonary/Allergy,To be Discontinued,8/11/20,8/11/20
4910,Theophylline Extended Release Tablets and Capsules,Teva Pharmaceuticals,800-545-8800,"450 mg, 100 count (NDC 50111-0518-01)",New,8/11/20,,"Business decision to discontinue. The both 100 mg presentations, both 200 mg presentation and 300 mg 100 count have been unavailable since Dec 2015. The 300 mg 100 count, 300 mg 500 count and 450 mg presentations have been unavailable since Jan 2016.",,,Pulmonary/Allergy,To be Discontinued,8/11/20,8/11/20
4911,Thioridazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-0612-01),Revised,1/7/20,,,,,Psychiatry,Resolved,1/7/20,
4912,Thioridazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,25 mg (NDC 0378-0614-01),Revised,1/7/20,,,,,Psychiatry,Resolved,1/7/20,
4913,Thioridazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,50 mg (NDC 0378-0616-01),Revised,1/7/20,,,,,Psychiatry,Resolved,1/7/20,
4914,Thioridazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,100 mg (NDC 0378-0618-01),Revised,1/7/20,,,,,Psychiatry,Resolved,1/7/20,
4915,Thiothixene Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"1 mg, 100 count bottle (NDC 0378-1001-01)",Reverified,11/10/20,Available,,,Other,Psychiatry,Current,,
4916,Thiothixene Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"2 mg, 100 count bottle (NDC 0378-2002-01)",Reverified,11/10/20,Available,,,Other,Psychiatry,Current,,
4917,Thiothixene Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count bottle (NDC 0378-3005-01)",Reverified,11/10/20,Available,,,Other,Psychiatry,Current,,
4918,Thiothixene Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100 count bottle (NDC 0378-5010-01)",Reverified,11/10/20,Available,,,Other,Psychiatry,Current,,
4919,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"1 mg, 100 count bottle (NDC 70954-014-10)",Reverified,5/20/20,Available,,,,Psychiatry,Current,,
4920,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"2 mg, 100 count bottle (NDC 70954-015-10)",Reverified,5/20/20,Available,,,,Psychiatry,Current,,
4921,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"5 mg, 100 count bottle (NDC 70954-016-10)",Reverified,5/20/20,Available,,,,Psychiatry,Current,,
4922,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"10 mg, 100 count bottle (NDC 70954-017-10)",Reverified,5/20/20,Available,,,,Psychiatry,Current,,
4923,Timolol Maleate Ophthalmic Gel Forming Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC-XE®, 0.25% timolol equivalent gel forming solution, 5 mL in a 7.5 mL bottle (NDC 24208-814-25)",New,5/29/20,"New lots TIMOPTIC-XE® of 0.25% solution available not sooner than January 2021, conditional to manufacturing capacity.",Product is on back order due to manufacturing interruptions; capacity impacted due to COVID-19 Pandemic,,Other,Ophthalmology,Current,,
4924,Timolol Maleate Ophthalmic Gel Forming Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC-XE®, 0.5% timolol equivalent, gel forming solution 5 mL in a 7.5 mL bottle (NDC 24208-816-05)",New,5/29/20,"New lots TIMOPTIC-XE® of 0.5% solution available not sooner than January 2021, conditional to manufacturing capacity.",Product is on back order due to manufacturing interruptions; capacity impacted due to COVID-19 Pandemic,,Other,Ophthalmology,Current,,
4925,Timolol Maleate Ophthalmic Gel Forming Solution,"Bausch Health Americas, Inc.",800-321-4576,"Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% timolol gel forming solution, 5 mL in a 7.5 mL bottle (NDC 24208-818-25)",New,5/29/20,"New lots  of 0.25% solution available not sooner than January 2021, conditional to manufacturing capacity",Product is on back order due to manufacturing interruptions; capacity impacted due to COVID-19 Pandemic,,Other,Ophthalmology,Current,,
4926,Timolol Maleate Ophthalmic Gel Forming Solution,"Bausch Health Americas, Inc.",800-321-4576,"Timolol Maleate Ophthalmic Gel Forming Solution, equivalent and 0.5%, 5 mL in a 7.5 mL bottle (NDC 24208-819-05)",New,5/29/20,"New lots  of 0.5% solution available not sooner than January 2021, conditional to manufacturing capacity.",Product is on back order due to manufacturing interruptions; capacity impacted due to COVID-19 Pandemic,,Other,Ophthalmology,Current,,
4927,Timolol Maleate Ophthalmic Gel Forming Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Gel Forming Solution 0.5%, 5 mL bottle (NDC 61314-225-05)",Revised,11/13/20,Supply not available,,,Shortage of an active ingredient,Ophthalmology,Current,,
4928,Timolol Maleate Ophthalmic Gel Forming Solution,Sandoz,800-525-8747,Timolol Maleate Ophthalmic Gel Forming Solution 0.25% 5 mL bottle (NDC 61314-224-05),Revised,11/13/20,Limited Short dated material available,,,Shortage of an active ingredient,Ophthalmology,Current,,
4929,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.5%, 5 mL bottle, (NDC 61314-227-05)",Revised,11/13/20,Supply Available,,,API shortage,Ophthalmology,Current,,
4930,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.5%, 10 mL bottle (NDC 61314-227-10)",Revised,11/13/20,Supply Available,,,API shortage,Ophthalmology,Current,,
4931,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.5%, 15 mL bottle (NDC 61314-227-15)",Revised,11/13/20,Supply Available,,,API shortage,Ophthalmology,Current,,
4932,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.25%, 5 mL bottle, ()NDC 61314-226-05",Revised,11/13/20,Supply Available,,,API shortage,Ophthalmology,Current,,
4933,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.25%, 10 mL bottle, (NDC 61314-226-10)",Revised,11/13/20,Supply Available,,,API shortage,Ophthalmology,Current,,
4934,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.25%, 15 mL bottle, (NDC 61314-226-15)",Revised,11/13/20,Supply Available,,,API shortage,Ophthalmology,Current,,
4935,Timolol Maleate Ophthalmic Solution,Apotex Corp.,800-706-5575,Timolol Maleate Ophthalmic Solution 0.5% 2.5mL bottle (NDC 60505-1005-04),Reverified,10/1/20,Available,,,,Ophthalmology,Current,,
4936,Timolol Maleate Ophthalmic Solution,Apotex Corp.,800-706-5575,Timolol Maleate Ophthalmic Solution 0.5% 5mL bottle (NDC 60505-1005-01),Reverified,10/1/20,Available,,,,Ophthalmology,Current,,
4937,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Istalol, Timolol Maleate Ophthalmic solution 0.5% in a 7.5 mL bottle (NDC 24208-004-01)",New,5/29/20,Available,,,Other,Ophthalmology,Current,,
4938,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Istalol, Timolol Maleate Ophthalmic solution 0.5% in a 10 ml bottle (NDC 24208-004-03)",New,5/29/20,"Back-order, Estimated availability June 2020",,,Other,Ophthalmology,Current,,
4939,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Timolol Maleate Ophthalmic Solution 0.5%,  2.5ml (NDC 68682-045-25)",New,5/29/20,Available,Distributed under Oceanside Pharmaceuticals,,Other,Ophthalmology,Current,,
4940,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Timolol Maleate Ophthalmic Solution 0.5%, 5ml (NDC 68682-045-50)",New,5/29/20,Available,Distributed under Oceanside Pharmaceuticals,,Other,Ophthalmology,Current,,
4941,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.25% 5mL (NDC 64980-513-05),Reverified,9/14/20,Available,Distributed through Rising Pharmaceuticals,,Demand increase for the drug,Ophthalmology,Current,,
4942,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.25%  10 mL (NDC 64980-513-01),Reverified,9/14/20,Available,Distributed through Rising Pharmaceuticals,,Demand increase for the drug,Ophthalmology,Current,,
4943,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.25% 15 mL (NDC 64980-513-15),Reverified,9/14/20,Available,Distributed through Rising Pharmaceuticals,,Demand increase for the drug,Ophthalmology,Current,,
4944,Timolol Maleate Ophthalmic Solution,FDC Limited,201-964-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.5% 5mL (NDC 64980-514-05),Reverified,9/14/20,Available,Distributed through Rising Pharmaceuticals,,Demand increase for the drug,Ophthalmology,Current,,
4945,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.5% 10mL (NDC 64980-514-01),Reverified,9/14/20,Available,Distributed through Rising Pharmaceuticals,,Demand increase for the drug,Ophthalmology,Current,,
4946,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.5% 15mL (NDC 64980-514-15),Reverified,9/14/20,Available,Distributed through Rising Pharmaceuticals,,Demand increase for the drug,Ophthalmology,Current,,
4947,Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.25% OS 1x5ml BTL (NDC 60758-802-05),Revised,10/14/20,Available,"Distributed by Pacific Pharma, Inc.",,,Ophthalmology,Current,,
4948,Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.25% OS 1x10ml BTL (NDC 60758-802-10),Revised,10/14/20,Available,"Distributed by Pacific Pharma, Inc.",,,Ophthalmology,Current,,
4949,Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.5% OS 1x5ml BTL (NDC 60758-801-05),Revised,10/14/20,Available,"Distributed by Pacific Pharma, Inc.",,,Ophthalmology,Current,,
4950,Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.5% OS 1x10ml BTL (NDC 60758-801-10),Revised,10/14/20,Available,"Distributed by Pacific Pharma, Inc.",,,Ophthalmology,Current,,
4951,Timolol Maleate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Timolol Maleate Ophth Sol 0.5% 5mg/mL, 5mL, 1 Bottle/EA (NDC 17478-0288-10)",Revised,9/14/20,Available,,,Other,Ophthalmology,Current,,
4952,Timolol Maleate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Timolol Maleate Ophth Sol 0.5%, 10mL, 1 Bottle / EA (NDC 17478-0288-11)",Revised,9/14/20,Available,,,Other,Ophthalmology,Current,,
4953,Timolol Maleate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Timolol Maleate Ophth Sol 0.5%, 15mL, 1 Bottle / EA (NDC 17478-0288-12)",Revised,9/14/20,Available,,,Other,Ophthalmology,Current,,
4954,Timolol Maleate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count (NDC 0378-0055-01)",Reverified,11/10/20,Available,,,Other,Cardiovascular,Current,,
4955,Timolol Maleate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100 count (NDC 0378-0221-01)",Reverified,11/10/20,Available,,,Other,Cardiovascular,Current,,
4956,Timolol Maleate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"20 mg, 100 count (NDC 0378-0715-01)",Reverified,11/10/20,Available,,,Other,Cardiovascular,Current,,
4957,Tizanidine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,4 mg (NDC 0378-0724-19),New,11/21/19,,,,,Neurology,To be Discontinued,11/21/19,11/21/19
4958,Tizanidine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-0722-19),New,11/21/19,,,,,Neurology,To be Discontinued,11/21/19,11/21/19
4959,Tobramycin Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1.2 g, pharmacy bulk package, tray of 6 vials (NDC 63323-303-51)",Reverified,11/16/20,Backordered.  Next release expected November 2020.,Delay in manufacturing,,Other,Anti-Infective;Pediatric,Current,,
4960,Tobramycin Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1.2 g, pharmacy bulk package, tray of 6 vials (NDC 63323-303-55), Novaplus",Reverified,11/16/20,Backordered.  Next release expected November 2020.,Delay in manufacturing,,Other,Anti-Infective;Pediatric,Current,,
4961,Tobramycin Lyophilized Powder for Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"1.2 g, pharmacy bulk package, bottle (NDC 39822-0412-1)",New,8/24/20,Available,XGen continues to manufacture at full capacity.  Plans are underway to increase production.  Timeline TBD.,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
4962,Tobramycin Lyophilized Powder for Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"1.2 g, pharmacy bulk package, pack of 6 bottles (NDC 39822-0412-6)",New,8/24/20,Available,XGen continues to manufacture at full capacity.  Plans are underway to increase production.  Timeline TBD.,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
4963,Tolazamide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"250 mg, 100 count bottle (NDC 0378-0217-01)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
4964,Tolazamide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 100 count bottle (NDC 0378-0551-01)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
4965,Tolbutamide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 100 count bottle (NDC 0378-0215-01)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
4966,Tolcapone Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",100mg tablets (NDC 49884-254-09),New,10/5/20,,,,,Neurology,To be Discontinued,10/5/20,10/5/20
4967,Tolterodine Tartrate (Detrol LA) Extended Release Capsules,Pfizer Pharmaceuticals,800-533-4535,"2 mg, blisters (NDC 0009-5190-04)",New,10/1/19,,Discontinuation of the manufacture of the drug.,,,Urology,To be Discontinued,10/1/19,10/1/19
4968,Tolterodine Tartrate (Detrol LA) Extended Release Capsules,Pfizer Pharmaceuticals,800-533-4535,"4 mg, blisters (NDC 0009-5191-04)",New,10/1/19,,Discontinuation of the manufacture of the drug.,,,Urology,To be Discontinued,10/1/19,10/1/19
4969,Tositumomab and Iodine I 131 Tositumomab (Bexxar),GlaxoSmithKline,908-293-5330,N/A,Revised,2/18/14,,,"BEXXAR (Tositumomab and Iodine I 131 Tositumomab) is being discontinued.  The product discontinuation is not related to product safety or any FDA action.   BEXXAR will no longer be available effective February 20, 2014.",,Oncology,To Be Discontinued,2/18/14,2/18/14
4970,Tramadol Hydrochloride (Ultram) Tablets,Janssen Pharmaceuticals,800-526-7736,50 mg/1 unit (NDC 50458-659-60),New,4/1/20,,"The Company has made a business decision to permanently discontinue Ultram tablets. Product should be maintained on the formularies until the last batch produced expires (30 Sept 2022), in order to maintain continuity of the reimbursement process.",,,Analgesia/Addiction,To be Discontinued,4/1/20,4/1/20
4971,Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"4 mg tablets, 100 count (NDC 16252-543-90)",New,4/18/18,,This discontinuation is due to a business decision.,,,Cardiovascular,To be Discontinued,4/18/18,4/18/18
4972,Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"2 mg tablets, 100 count (NDC 16252-542-90)",New,4/18/18,,This discontinuation is due to a business decision.,,,Cardiovascular,To be Discontinued,4/18/18,4/18/18
4973,Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"1 mg tablets, 100 count (NDC 16252-541-30)",New,4/18/18,,This discontinuation is due to a business decision.,,,Cardiovascular,To be Discontinued,4/18/18,4/18/18
4974,Tranexamic Acid Tablets,Apotex Corp.,800-706-5575,"Tranexamic Acid 650 mg per Tablet, 30 Tablets per Bottle,  (NDC 60505-3638-3)",New,12/4/19,,Apotex has decided to Discontinue the manufacture of the drug,,,Hematology,To be Discontinued,12/4/19,12/4/19
4975,Tranexamic Acid Tablets,Apotex Corp.,800-706-5575,"Tranexamic Acid 650 mg per Tablet, 100 Tablets per Bottle,  (NDC 60505-3638-1)",New,12/4/19,,Apotex has decided to Discontinue the manufacture of the drug,,,Hematology,To be Discontinued,12/4/19,12/4/19
4976,Trazodone Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","50 mg tablets, bottle of 100 (NDC 16729-299-01); bottle of 1000 (NDC 16729-299-17)",New,4/20/20,,,,,Psychiatry,To be Discontinued,4/20/20,4/20/20
4977,Trazodone Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","100 mg tablets, bottle of 100 (NDC 16729-300-01); bottle of 1000 (NDC 16729-300-17)",New,4/20/20,,,,,Psychiatry,To be Discontinued,4/20/20,4/20/20
4978,Trazodone Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","150 mg tablets, bottle of 100 (NDC 16729-301-01); bottle of 1000 (NDC 16729-301-17)",New,4/20/20,,,,,Psychiatry,To be Discontinued,4/20/20,4/20/20
4979,Trazodone Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","300 mg tablets, bottle of 100 (NDC 16729-302-01)",New,4/20/20,,,,,Psychiatry,To be Discontinued,4/20/20,4/20/20
4980,"Triamcinolone Acetonide (Triesence) Injection, Suspension",Novartis,888-669-6682,Triesence (Triamcinolone acetonide injectable suspension) Vial 40mg/mL 1mL in 1 vial (NDC 0065-0543-01),Revised,9/22/20,Available,There are no therapeutic equivalents.,,,Ophthalmology,Current,,
4981,Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/1g (NDC 40085-029-80),New,3/20/18,,"The discontinuation of this product is a business decision and not related to product quality, safety or efficacy",,,Dermatology,To be Discontinued,3/20/18,3/20/18
4982,Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,1mg/1g (NDC 40085-029-16),New,3/20/18,,"The discontinuation of this product is a business decision and not related to product quality, safety or efficacy",,,Dermatology,To be Discontinued,3/20/18,3/20/18
4983,Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,0.25mg/1g (NDC 40085-028-80),New,3/20/18,,"The discontinuation of this product is a business decision and not related to product quality, safety or efficacy",,,Dermatology,To be Discontinued,3/20/18,3/20/18
4984,Triamterene and Hydrochlorothiazide (Dyazide) Capsules,GlaxoSmithKline,888-825-5249,25 mg; 37.5 mg (NDC 0007-3650-30),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of the product is approximately October 2019.,,,Cardiovascular,To be Discontinued,6/28/19,6/28/19
4985,Triamterene and Hydrochlorothiazide (Dyazide) Capsules,GlaxoSmithKline,888-825-5249,25 mg; 37.5 mg (NDC 0007-3650-22),New,11/16/20,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of the product is approximately December 2020.,,,Cardiovascular,To be Discontinued,11/16/20,11/16/20
4986,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 100 count bottle (NDC 0781-5068-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
4987,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 500 count bottle (NDC 0781-5068-05)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
4988,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 100 count bottle (NDC 0781-5067-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
4989,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 500 count bottle (NDC 0781-5067-05)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
4990,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 100 count bottle (NDC 68001-0216-00)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
4991,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 500 count bottle (NDC 68001-0216-03)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
4992,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 100 count bottle (NDC 68001-0215-00)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
4993,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 500 count bottle (NDC 68001-0215-03)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
4994,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-8028-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
4995,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0832-0494-11),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
4996,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,2 mg 100 count bottle (NDC 0781-8032-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
4997,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,2 mg 100 count bottle (NDC 0832-0495-11),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
4998,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-8034-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
4999,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0832-0496-11),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
5000,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0781-8036-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
5001,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0832-0497-11),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
5002,Trifluoperazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg (NDC 0378-2401-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
5003,Trifluoperazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-2402-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
5004,Trifluoperazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,5 mg (NDC 0378-2405-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
5005,Trifluoperazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-2410-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
5006,Trifluridine Ophthalmic Solution,Sandoz,800-525-8747,Trifluridine 1% 7.5 mL (NDC 61314-044-75),Reverified,11/13/20,Short-dated supply available; Fresh supply expected for delivery by end of October,,,Shortage of an active ingredient,Ophthalmology,Current,,
5007,Valacyclovir Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,1 gram  (NDCs 0093-7259-98 and 0093-7259-56),New,11/15/19,,This product is being discontinued due to a business decision.,,,Antiviral,To be Discontinued,11/15/19,11/15/19
5008,Valacyclovir Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,500 mg tablets (NDCs 45963-558-30 and 45963-558-08),New,2/21/19,,,,,Antiviral,To be Discontinued,2/21/19,2/21/19
5009,Valacyclovir Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,1 G tablets (NDCs 45963-559-30 and 45963-559-08),New,2/21/19,,,,,Antiviral,To be Discontinued,2/21/19,2/21/19
5010,Valsartan Tablets,Amneal Pharmaceutical,866-525-7270,"40 mg, 30 ct bottle (NDC 65162-837-03); 60 ct bottle (NDC 65162-837-06); 500 ct bottle (NDC 65162-837-50)",Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5011,Valsartan Tablets,Amneal Pharmaceutical,866-525-7270,"80 mg, 90 ct bottle (NDC 65162-838-09); 500 ct bottle (NDC 65162-838-50); 1000 ct bottle (NDC 65162-838-11)",Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5012,Valsartan Tablets,Amneal Pharmaceutical,866-525-7270,"160 mg, 90 ct bottle (NDC 65162-839-09); 500 ct bottle (NDC 65162-839-50); 1000 ct bottle (NDC 65162-839-11)",Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5013,Valsartan Tablets,Amneal Pharmaceutical,866-525-7270,"320 mg, 90 ct bottle (NDC 65162-840-09); 500 ct bottle (NDC 65162-840-50); 1000 ct bottle (NDC 65162-840-11)",Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5014,Valsartan Tablets,Camber Pharmaceuticals Inc.,866-827-3647,40 mg (NDC 31722-745-30),Revised,3/4/20,,,,Shortage of an active ingredient,Cardiovascular,Resolved,3/4/20,
5015,Valsartan Tablets,Camber Pharmaceuticals Inc.,866-827-3647,80 mg (NDC 31722-746-90),Revised,3/4/20,,,,Shortage of an active ingredient,Cardiovascular,Resolved,3/4/20,
5016,Valsartan Tablets,Camber Pharmaceuticals Inc.,866-827-3647,160 mg (NDC 31722-746-90),Revised,3/4/20,,,,Shortage of an active ingredient,Cardiovascular,Resolved,3/4/20,
5017,Valsartan Tablets,Camber Pharmaceuticals Inc.,866-827-3647,320 mg (NDC 31722-748-90),Revised,3/4/20,,,,Shortage of an active ingredient,Cardiovascular,Resolved,3/4/20,
5018,Valsartan Tablets,Ohm Laboratories Inc.,800-818-4555,40 mg (NDC 51660-140-30),Revised,3/4/20,,,,Discontinuation of the manufacture of the drug,Cardiovascular,Resolved,3/4/20,
5019,Valsartan Tablets,Ohm Laboratories Inc.,800-818-4555,80 mg (NDC 51660-141-90),Revised,3/4/20,,,,Discontinuation of the manufacture of the drug,Cardiovascular,Resolved,3/4/20,
5020,Valsartan Tablets,Ohm Laboratories Inc.,800-818-4555,160 mg (NDC 51660-142-90),Revised,3/4/20,,,,Discontinuation of the manufacture of the drug,Cardiovascular,Resolved,3/4/20,
5021,Valsartan Tablets,Ohm Laboratories Inc.,800-818-4555,320 mg (NDC 51660-143-90),Revised,3/4/20,,,,Discontinuation of the manufacture of the drug,Cardiovascular,Resolved,3/4/20,
5022,Valsartan Tablets,Macleods Pharmaceuticals Limited,888-677-0778,Valsartan Tablets 40mg x 30's Bottle Pack (NDC 33342006207),Revised,3/4/20,,,,Available,Cardiovascular,Resolved,3/4/20,
5023,Valsartan Tablets,Macleods Pharmaceuticals Limited,888-677-0778,Valsartan Tablets 80mg x 90's Bottle Pack (NDC 33342006310),Revised,3/4/20,,,,Available,Cardiovascular,Resolved,3/4/20,
5024,Valsartan Tablets,Macleods Pharmaceuticals Limited,888-677-0778,Valsartan Tablets 160mg x 30's Bottle Pack (NDC 33342006410),Revised,3/4/20,,,,Available,Cardiovascular,Resolved,3/4/20,
5025,Valsartan Tablets,Macleods Pharmaceuticals Limited,888-677-0778,Valsartan Tablets 320mg x 30's Bottle Pack (NDC 33342006510),Revised,3/4/20,,,,Available,Cardiovascular,Resolved,3/4/20,
5026,Valsartan Tablets,"Solco Healthcare US, LLC",866-931-9829,40mg 30’s (NDC 43547-0367-03),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5027,Valsartan Tablets,"Solco Healthcare US, LLC",866-931-9829,160mg 90’s (NDC 43547-0369-09),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5028,Valsartan Tablets,"Solco Healthcare US, LLC",866-931-9829,80mg 90’s (NDC 43547-0368-09),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5029,Valsartan Tablets,"Solco Healthcare US, LLC",866-931-9829,320mg 90’s (NDC 43547-0370-09),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5030,Valsartan Tablets,Aurobindo Pharma,732-839-9400,Valsartan Tablets USP 40 mg. - 30/Bottle (NDC 65862-0570-30),Revised,3/4/20,,,,Demand increase for the drug,Cardiovascular,Resolved,3/4/20,
5031,Valsartan Tablets,Aurobindo Pharma,732-839-9400,Valsartan Tablets USP 80 mg. - 90/Bottle (NDC 65862-0571-90),Revised,3/4/20,,,,Demand increase for the drug,Cardiovascular,Resolved,3/4/20,
5032,Valsartan Tablets,Aurobindo Pharma,732-839-9400,Valsartan Tablets USP 160 mg. - 90/Bottle (NDC 65862-0572-90),Revised,3/4/20,,,,Demand increase for the drug,Cardiovascular,Resolved,3/4/20,
5033,Valsartan Tablets,Aurobindo Pharma,732-839-9400,Valsartan Tablets USP 320 mg. - 90/Bottle (NDC 65862-0573-90 ),Revised,3/4/20,,,,Demand increase for the drug,Cardiovascular,Resolved,3/4/20,
5034,Valsartan Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,40 mg (30’s) (NDC 0378-5807-93),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5035,Valsartan Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,160 mg (90’s) (NDC 0378-5814-77),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5036,Valsartan Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,80 mg (90’s) (NDC 0378-5813-77),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5037,Valsartan Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,320 mg (90’s) (NDC 0378-5815-77),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5038,Valsartan Tablets,"Jubilant Cadista Pharmaceuticals, Inc.",800-313-4623,40 mg (30's) (NDC 59746-0360-30),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5039,Valsartan Tablets,"Jubilant Cadista Pharmaceuticals, Inc.",800-313-4623,80 mg (90's) (NDC 59746-0361-90),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5040,Valsartan Tablets,"Jubilant Cadista Pharmaceuticals, Inc.",800-313-4623,160 mg (90's) (NDC 59746-0362-90),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5041,Valsartan Tablets,"Jubilant Cadista Pharmaceuticals, Inc.",800-313-4623,320 mg (90's) (NDC 59746-0363-90),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5042,Valsartan Tablets,Teva Pharmaceuticals,800-545-8800,"Valsartan Tablets, USP 40mg, 90 count, (NDC 0591-2167-19)",New,8/3/18,,This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,8/3/18,8/3/18
5043,Valsartan Tablets,Torrent Pharma Inc.,908-280-3333,40 mg (NDC 13668-067-30),Revised,1/16/20,,,,,Cardiovascular,To be Discontinued,1/16/20,1/16/20
5044,Valsartan Tablets,Torrent Pharma Inc.,908-280-3333,80 mg (NDC 13668-068-90),Revised,1/16/20,,,,,Cardiovascular,To be Discontinued,1/16/20,1/16/20
5045,Valsartan Tablets,Torrent Pharma Inc.,908-280-3333,160 mg (NDC 13668-069-90),Revised,1/16/20,,,,,Cardiovascular,To be Discontinued,1/16/20,1/16/20
5046,Valsartan Tablets,Torrent Pharma Inc.,908-280-3333,320 mg (NDC 13668-070-90),Revised,1/16/20,,,,,Cardiovascular,To be Discontinued,1/16/20,1/16/20
5047,Valsartan Tablets,Novartis,888-669-6682,DIOVAN® scored tablets 40mg 30s 1 bottle of 30 tablets (NDC 0078-0423-15),Revised,3/4/20,,,,Demand increase for the drug,Cardiovascular,Resolved,3/4/20,
5048,Valsartan Tablets,Novartis,888-669-6682,DIOVAN® tablets 80mg 1 bottle of 90 tablets (NDC 0078-0358-34),Revised,3/4/20,,,,Demand increase for the drug,Cardiovascular,Resolved,3/4/20,
5049,Valsartan Tablets,Novartis,888-669-6682,DIOVAN® tablets 160mg 1 bottle of 90 tablets (NDC 0078-0359-34),Revised,3/4/20,,,,Demand increase for the drug,Cardiovascular,Resolved,3/4/20,
5050,Valsartan Tablets,Novartis,888-669-6682,DIOVAN® tablets 320mg 1 bottle of 90 count (NDC 0078-0360-34),Revised,3/4/20,,,,Demand increase for the drug,Cardiovascular,Resolved,3/4/20,
5051,Valsartan Tablets,Novartis,888-669-6682,Valsartan Tablets 40 mg 1 bottle of 90 tablets (NDC 0781-5607-31),Revised,3/4/20,,,,Discontinuation of the manufacture of the drug,Cardiovascular,Resolved,3/4/20,
5052,Valsartan Tablets,Novartis,888-669-6682,Valsartan Tablets 80 mg 1 bottle of 90 tablets (NDC 0781-5608-92),Revised,3/4/20,,,,Discontinuation of the manufacture of the drug,Cardiovascular,Resolved,3/4/20,
5053,Valsartan Tablets,Novartis,888-669-6682,Valsartan Tablets 160 mg 1 bottle of 90 tablets (NDC 0781-5618-92),Revised,3/4/20,,,,Discontinuation of the manufacture of the drug,Cardiovascular,Resolved,3/4/20,
5054,Valsartan Tablets,Novartis,888-669-6682,Valsartan Tablets 320 mg 1 bottle of 90 tablets (NDC 0781-5619-92),Revised,3/4/20,,,,Discontinuation of the manufacture of the drug,Cardiovascular,Resolved,3/4/20,
5055,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,40 mg bottle of 30 counts (NDC 62332-044-30),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5056,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,40 mg bottle of 90 counts (NDC 62332-044-90),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5057,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,40 mg bottle of 500 counts (NDC 62332-044-71),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5058,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,80 mg bottle of 30 counts (NDC 62332-045-30),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5059,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,80 mg bottle of 90 counts (NDC 62332-045-90),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5060,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,80 mg bottle of 500 counts (NDC 62332-045-71),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5061,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,160 mg bottle of 30 counts (NDC 62332-046-30),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5062,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,160 mg bottle of 90 counts (NDC 62332-046-90),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5063,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,160 mg bottle of 500 counts (NDC 62332-046-71),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5064,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,320 mg bottle of 30 count (NDC 62332-047-30),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5065,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,320 mg bottle of 90 count (NDC 62332-047-90),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5066,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,320 mg bottle of 500 counts (NDC 62332-047-71),Revised,3/4/20,,,,Other,Cardiovascular,Resolved,3/4/20,
5067,Vardenafil Hydrochloride (Levitra) Tablets,Bayer,888-842-2937,Levitra® (vardenafil HCL) tablets 2.5 mg tablet strength (NDC 0173-0828-13),New,5/15/18,,"Bayer will continue to market the 5 mg, 10 mg and 20 mg tablet strengths.",,,Other;Reproductive,To be Discontinued,5/15/18,5/15/18
5068,Vardenafil Hydrochloride Tablets,Bayer,888-842-2937,"Levitra 5 mg, 30 count (NDC 0173-0829-13)",Revised,9/1/20,,Bayer will continue to market the 20 mg tablet strength.,,,Reproductive,To be Discontinued,7/25/19,7/25/19
5069,Vardenafil Hydrochloride Tablets,Bayer,888-842-2937,Levitra 10 mg (NDC 0173-0830-13),Revised,9/1/20,,Discontinuation of the manufacture of the drug.,,,Other;Reproductive,To be Discontinued,9/1/20,9/1/20
5070,Vardenafil Hydrochloride Tablets,Bayer,888-842-2937,Staxyn 10 mg (NDC 0173-0822-04),Revised,9/1/20,,Discontinuation of the manufacture of the drug.,,,Other;Reproductive,To be Discontinued,9/1/20,9/1/20
5071,Vecuronium Bromide for Injection,Teva Pharmaceuticals,800-545-8800,10 mg* 10 X 10 mL *1 mg/mL when reconstituted to 10 mL (NDC 0703-2914-03),Reverified,11/19/20,Available. We are satisfying historical committed customer demand.,,,,Anesthesia,Current,,
5072,Vecuronium Bromide for Injection,"Hospira, Inc.",844-646-4398,10 mg Single Dose Glass Fliptop Vial (NDC 00409-1632-01),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
5073,Vecuronium Bromide for Injection,"Hospira, Inc.",844-646-4398,20 mg Single Dose Glass Fliptop Vial (NDC 00409-1634-01),Revised,11/20/20,Available,,,Other,Anesthesia,Current,,
5074,Vecuronium Bromide for Injection,Mylan Institutional,800-796-9526,Vecuronium Bromide Injection (Lyophilizate in Single Dose Vials) [10 mg](NDC 67457-438-10),Revised,10/14/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
5075,Vecuronium Bromide for Injection,Mylan Institutional,800-796-9526,Vecuronium Bromide Injection (Lyophilizate in Single Dose Vials) [20 mg](NDC 67457-475-20),Revised,10/14/20,Available,,,Demand increase for the drug,Anesthesia,Current,,
5076,Vecuronium Bromide for Injection,Gland Pharma Limited,,10 mg/vial (NDC 63323-781-10),Reverified,10/27/20,Currently on backorder; estimate shortage thru Q4 2020.,Distributed by marketing partner: Fresenius Kabi  LLC (888-386-1300),,Demand increase for the drug,Anesthesia,Current,,
5077,Vecuronium Bromide for Injection,Gland Pharma Limited,,20 mg/vial (NDC 63323-782-20),Reverified,10/27/20,Currently on backorder; estimate shortage thru Q4 2020.,Distributed by marketing partner: Fresenius Kabi  LLC (888-386-1300),,Demand increase for the drug,Anesthesia,Current,,
5078,Vecuronium Bromide for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,10 mg (NDC 47335-931-44),Revised,9/17/20,Available,,,Demand increase of the drug,Anesthesia,Current,,
5079,Vecuronium Bromide for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,20 mg (NDC 47335-932-44),Revised,9/17/20,Available,,,Demand increase of the drug,Anesthesia,Current,,
5080,Vecuronium Bromide for Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"10 mg/vial, packages of 10 (NDC 55150-235-10)",Revised,11/20/20,Currently on backorder - next shipment anticipated end of Oct 20,Production increase in response to increased demand.,,Demand increase for the drug,Anesthesia,Current,,
5081,Vecuronium Bromide for Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"20 mg/vial, packages of 10 (NDC 55150-236-20)",Revised,11/20/20,Currently on backorder - next shipment anticipated Jan 21,Intermittent availability expected,,Demand increase for the drug,Anesthesia,Current,,
5082,Verapamil HCl Extended-Release Tablets,Teva Pharmaceuticals,800-545-8800,"120mg, 100 count, (NDC 0093-3043-01)",New,2/22/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,2/22/19,2/22/19
5083,Verapamil HCl Extended-Release Tablets,Teva Pharmaceuticals,800-545-8800,"180mg, 500 count, (NDC 0093-3044-05)",New,2/22/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,2/22/19,2/22/19
5084,Verapamil HCl Extended-Release Tablets,Teva Pharmaceuticals,800-545-8800,"180mg, 100 count, (NDC 0093-3044-01)",New,2/22/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,2/22/19,2/22/19
5085,Verapamil HCl Extended-Release Tablets,Teva Pharmaceuticals,800-545-8800,"240mg, 100 count, (NDC 0093-3045-01)",New,2/22/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,2/22/19,2/22/19
5086,Verapamil HCl Extended-Release Tablets,Teva Pharmaceuticals,800-545-8800,"240mg, 500 count, (NDC 0093-3045-05)",New,2/22/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,2/22/19,2/22/19
5087,Verapamil Hydrochloride Extended-Release Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg capsule, 100 count bottle (NDC 0378-6201-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
5088,Verapamil Hydrochloride Extended-Release Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg capsule, 100 count bottle (NDC 0378-6202-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
5089,Verapamil Hydrochloride Extended-Release Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg capsule, 500 count bottle (NDC 0378-6202-05)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
5090,Verapamil Hydrochloride Extended-Release Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"300 mg capsule, 100 count bottle (NDC 0378-6203-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
5091,Verapamil Hydrochloride Extended-Release Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"300 mg capsule, 500 count bottle (NDC 0378-6203-05)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
5092,Verapamil Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"80 mg, 100 count bottle (NDC 0378-0512-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
5093,Verapamil Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"120 mg, 100 count bottle (NDC 0378-0772-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
5094,Verapamil Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"120 mg, 500 count bottle (NDC 0378-0772-05)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
5095,Vinblastine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 mg per 10 mL (1 mg per mL); MDV (NDC 63323-0278-10),Revised,3/3/20,Available,,,,Oncology,Resolved,,
5096,"Vincristine Sulfate (VINCASAR PFS) Injection, USP",Teva Pharmaceuticals,800-545-8800,"Vincasar PFS -- vincristine sulfate injection, solution, 1 MG/ 1 ML (NDC 0703-4402-11)",New,7/5/19,,Teva made a business decion to discontinue the product.,,,Oncology,To be Discontinued,7/5/19,7/5/19
5097,"Vincristine Sulfate (VINCASAR PFS) Injection, USP",Teva Pharmaceuticals,800-545-8800,VINCASAR PFS (vincristine sulfate injection USP) 2 mg/2 mL Vial (1 mg/mL) (NDC 0703-4412-11),New,3/20/19,,Teva made a business decision to discontinue this product size (2mL).,,,Oncology,To be Discontinued,3/20/19,
5098,"Vincristine Sulfate Injection, USP (Preservative-Free)","Hospira, Inc.",844-646-4398,1 mg/mL Single Dose Glass Fliptop Vial (NDC 61703-0309-06),Revised,1/30/20,,,,,Oncology,Resolved,1/30/20,
5099,"Vincristine Sulfate Injection, USP (Preservative-Free)","Hospira, Inc.",844-646-4398,2 mg/2 mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 61703-0309-16),Revised,1/30/20,,,,,Oncology,Resolved,1/30/20,
5100,Vinorelbine Tartrate Injection,"Pierre Fabre Pharmaceuticals, Inc.",855-737-4276,"10 mg/mL Single Dose Glass, Vial (NDC 64370-532-01)",New,11/8/19,,Discontinuation of the manufacture of the drug.,,,Oncology,To be Discontinued,11/8/19,11/8/19
5101,Vinorelbine Tartrate Injection,"Pierre Fabre Pharmaceuticals, Inc.",855-737-4276,"50 mg/5mL Single Dose Glass, Vial (NDC 64370-532-02)",New,11/8/19,,"Limited availability; distribution to end December 31, 2019. Discontinuation of the manufacture of the drug.",,,Oncology,To be Discontinued,11/8/19,11/8/19
5102,Vinorelbine Tartrate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL Single Dose Onco-Tain Glass Fliptop Vial (NDC 61703-0341-06),New,4/16/18,,Discontinuation of the manufacture of the drug.,,,Oncology,To be Discontinued,4/16/18,4/16/18
5103,Vinorelbine Tartrate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL; 50 mg/5mL Single Dose Onco-Tain Glass Fliptop Vial (NDC 61703-0341-09),New,4/16/18,,Discontinuation of the manufacture of the drug.,,,Oncology,To Be Discontinued,4/16/18,4/16/18
5104,Zoledronic Acid Injection,Teva Pharmaceuticals,800-545-8800,"0.8 mg/mL, 4 mg 5 mL/Vial (NDC 45963-440-55)",New,5/1/19,,Discontinuation of the manufacture of the drug.,,,Musculoskeletal;Oncology,To be Discontinued,5/1/19,5/1/19
5105,Zolpidem Tartrate (Edluar) Sublingual Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0037-6010-30),Revised,11/21/18,,,Available,,Psychiatry,Resolved,11/21/18,
5106,Zolpidem Tartrate Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,6.25 mg tablets (NDC 0228-3481-11),New,2/22/19,,,,,Psychiatry,To be Discontinued,2/22/19,2/22/19
5107,Zolpidem Tartrate Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,12.5 mg  (NDC 0228-3482-11),New,5/1/20,,,,,Psychiatry,To be Discontinued,5/1/20,5/1/20
5108,Zolpidem Tartrate Tablets,Wockhardt,800-346-6854,5 mg  (NDCs 64679-0714-01 and 64679-0714-04),New,7/18/19,,,,,Psychiatry,To be Discontinued,7/18/19,7/18/19
5109,Zolpidem Tartrate Tablets,Wockhardt,800-346-6854,10 mg  (NDCs 64679-0715-01 and 64679-0715-04),New,7/18/19,,,,,Psychiatry,To be Discontinued,7/18/19,7/18/19